0001193125-15-399973.txt : 20151210 0001193125-15-399973.hdr.sgml : 20151210 20151210142635 ACCESSION NUMBER: 0001193125-15-399973 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20151031 FILED AS OF DATE: 20151210 DATE AS OF CHANGE: 20151210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PATTERSON COMPANIES, INC. CENTRAL INDEX KEY: 0000891024 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047] IRS NUMBER: 410886515 STATE OF INCORPORATION: MN FISCAL YEAR END: 0426 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-20572 FILM NUMBER: 151280621 BUSINESS ADDRESS: STREET 1: 1031 MENDOTA HEIGHTS RD CITY: ST PAUL STATE: MN ZIP: 55120-1401 BUSINESS PHONE: 6516861600 MAIL ADDRESS: STREET 1: 1031 MENDOTA HEIGHTS RD CITY: ST PAUL STATE: MN ZIP: 55120-1401 FORMER COMPANY: FORMER CONFORMED NAME: PATTERSON DENTAL CO DATE OF NAME CHANGE: 19950111 10-Q 1 d12507d10q.htm FORM 10-Q Form 10-Q
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED October 31, 2015.

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File No. 0-20572

 

 

PATTERSON COMPANIES, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Minnesota   41-0886515

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification Number)

1031 Mendota Heights Road

St. Paul, Minnesota

  55120
(Address of Principal Executive Offices)   (Zip Code)

(651) 686-1600

(Registrant’s Telephone Number, Including Area Code)

 

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large Accelerated Filer   x    Accelerated Filer   ¨
Non-Accelerated Filer   ¨  (Do not check if a smaller reporting company)    Smaller Reporting Company   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of December 3, 2015, there were 99,430,000 shares of Common Stock of the registrant issued and outstanding.

 

 

 


Table of Contents

PATTERSON COMPANIES, INC.

INDEX

 

     Page  

PART I - FINANCIAL INFORMATION

  

Item 1- Financial Statements (Unaudited)

     3-17   

Condensed Consolidated Balance Sheets as of October 31, 2015 and April 25, 2015

     3   

Condensed Consolidated Statements of Income and Other Comprehensive Income for the Three and Six Months Ended October 31, 2015 and October 25, 2014

     4   

Condensed Consolidated Statements of Cash Flows for the Six Months Ended October 31, 2015 and October  25, 2014

     5   

Notes to Condensed Consolidated Financial Statements

     6-17   

Item 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations

     18-22   

Item 3 - Quantitative and Qualitative Disclosures about Market Risk

     22   

Item 4 - Controls and Procedures

     22-23   

PART II - OTHER INFORMATION

  

Item 1 - Legal Proceedings

     23   

Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds

     23   

Item 6 - Exhibits

     23   

Signatures

     24   

Exhibit Index

     25   


Table of Contents

PART I—FINANCIAL INFORMATION

PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

 

     October 31,     April 25,  
     2015     2015  
     (Unaudited)        

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 95,451      $ 347,260   

Short-term investments

     —          53,372   

Receivables, net of allowance for doubtful accounts

     734,461        586,263   

Inventory

     752,849        408,422   

Prepaid expenses and other current assets

     83,169        59,561   

Current assets held for sale

     —          118,347   
  

 

 

   

 

 

 

Total current assets

     1,665,930        1,573,225   

Property and equipment, net

     272,190        204,133   

Long-term receivables, net

     75,784        71,686   

Goodwill

     817,595        299,924   

Identifiable intangibles, net

     537,079        125,025   

Other

     83,260        37,919   

Long-term assets held for sale

     —          635,794   
  

 

 

   

 

 

 

Total assets

   $ 3,451,838      $ 2,947,706   
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

    

Current liabilities:

    

Accounts payable

   $ 492,469      $ 323,294   

Accrued payroll expense

     47,671        72,464   

Other accrued liabilities

     162,225        142,611   

Current maturities of long-term debt

     15,991        —     

Borrowings on revolving credit

     80,000        —     

Current liabilities held for sale

     —          39,316   
  

 

 

   

 

 

 

Total current liabilities

     798,356        577,685   

Long-term debt

     1,034,884        725,000   

Other non-current liabilities

     255,341        81,484   

Long-term liabilities held for sale

     —          49,414   
  

 

 

   

 

 

 

Total liabilities

     2,088,581        1,433,583   

Stockholders’ equity:

    

Common stock

     995        1,033   

Additional paid-in capital

     27,759        21,026   

Accumulated other comprehensive loss

     (63,626     (60,346

Retained earnings

     1,475,867        1,630,148   

Unearned ESOP shares

     (77,738     (77,738
  

 

 

   

 

 

 

Total stockholders’ equity

     1,363,257        1,514,123   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 3,451,838      $ 2,947,706   
  

 

 

   

 

 

 

See accompanying notes

 

3


Table of Contents

PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

AND OTHER COMPREHENSIVE INCOME

(In thousands, except per share amounts)

(Unaudited)

 

     Three Months Ended     Six Months Ended  
     October 31,     October 25,     October 31,     October 25,  
     2015     2014     2015     2014  

Net sales

   $ 1,389,210      $ 978,220      $ 2,532,080      $ 1,917,176   

Cost of sales

     1,058,311        718,933        1,912,937        1,407,272   
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     330,899        259,287        619,143        509,904   

Operating expenses

     247,436        187,147        473,503        371,768   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income from continuing operations

     83,463        72,140        145,640        138,136   

Other income and expense:

        

Other income, net

     954        777        1,624        2,147   

Interest expense

     (17,154     (8,544     (29,297     (17,312
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations before taxes

     67,263        64,373        117,967        122,971   

Income taxes

     24,700        22,508        55,093        42,781   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income from continuing operations

     42,563        41,865        62,874        80,190   

Net income (loss) from discontinued operations

     (7,142     11,913        2,250        23,877   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 35,421      $ 53,778      $ 65,124      $ 104,067   
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic earnings (loss) per share:

        

Continuing operations

   $ 0.43      $ 0.42      $ 0.64      $ 0.81   

Discontinued operations

     (0.07     0.12        0.02        0.24   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net basic earnings per share

   $ 0.36      $ 0.54      $ 0.66      $ 1.05   
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted earnings (loss) per share:

        

Continuing operations

   $ 0.43      $ 0.42      $ 0.63      $ 0.80   

Discontinued operations

     (0.07     0.12        0.02        0.24   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net diluted earnings per share

   $ 0.36      $ 0.54      $ 0.65      $ 1.04   
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average shares:

        

Basic

     98,525        98,802        98,981        99,066   
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted

     99,185        99,376        99,674        99,779   
  

 

 

   

 

 

   

 

 

   

 

 

 

Dividends declared per common share

   $ 0.22      $ 0.20      $ 0.44      $ 0.40   
  

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive income

        

Net income

   $ 35,421      $ 53,778      $ 65,124      $ 104,067   

Foreign currency translation gain (loss)

     6,941        (36,816     (4,334     (26,506

Cash flow hedges, net of tax

     437        (3,867     1,054        (6,176
  

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive income

   $ 42,799      $ 13,095      $ 61,844      $ 71,385   
  

 

 

   

 

 

   

 

 

   

 

 

 

See accompanying notes

 

4


Table of Contents

PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

     Six Months Ended  
     October 31,     October 25,  
     2015     2014  

Operating activities:

    

Net income

   $ 65,124      $ 104,067   

Net income from discontinued operations

     2,250        23,877   
  

 

 

   

 

 

 

Net income from continuing operations

     62,874        80,190   

Adjustments to reconcile net income from continuing operations to net cash provided by operating activities:

    

Depreciation

     16,791        11,663   

Amortization

     21,609        9,351   

Bad debt expense

     5,674        809   

Non-cash employee compensation

     13,541        11,940   

Accelerated amortization of debt issuance costs on early retirement of debt

     5,153        —     

Excess tax benefits from stock-based compensation

     (1,686     (175

Change in assets and liabilities, net of acquired

     (137,923     (37,233
  

 

 

   

 

 

 

Net cash (used in) provided by operating activities- continuing operations

     (13,967     76,545   

Net cash (used in) provided by operating activities- discontinued operations

     (38,985     21,850   
  

 

 

   

 

 

 

Net cash (used in) provided by operating activities

     (52,952     98,395   

Investing activities:

    

Additions to property and equipment

     (40,978     (29,190

Acquisitions and equity investments, net of cash assumed

     (1,105,229     —     

Proceeds from sale of securities

     48,744        40,775   

Purchase of investments

     —          (543
  

 

 

   

 

 

 

Net cash (used in) provided by investing activities- continuing operations

     (1,097,463     11,042   

Net cash provided by investing activities- discontinued operations

     715,430        4,598   
  

 

 

   

 

 

 

Net cash (used in) provided by investing activities

     (382,033     15,640   

Financing activities:

    

Dividends paid

     (45,356     (40,174

Repurchases of common stock

     (160,579     (47,539

Proceeds from issuance of long-term debt

     1,000,000        —     

Debt issuance costs

     (11,600     —     

Draw on revolver

     80,000        —     

Retirement of long-term debt

     (674,125     —     

Other financing activities

     2,894        844   
  

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     191,234        (86,869

Effect of exchange rate changes on cash

     (8,058     (7,202
  

 

 

   

 

 

 

Net change in cash and cash equivalents

     (251,809     19,964   

Cash and cash equivalents at beginning of period

     347,260        264,908   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 95,451      $ 284,872   
  

 

 

   

 

 

 

See accompanying notes

 

5


Table of Contents

PATTERSON COMPANIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2015

(Dollars, except per share amounts, and shares in thousands)

(Unaudited)

Note 1. General

Basis of Presentation

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of Patterson Companies, Inc. (“Patterson”) as of October 31, 2015, and our results of operations and cash flows for the periods ended October 31, 2015 and October 25, 2014. Such adjustments are of a normal recurring nature. The results of operations for the periods ended October 31, 2015 and October 25, 2014 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the financial statements included in our 2015 Annual Report on Form 10-K filed on June 24, 2015.

Such unaudited condensed consolidated financial statements include the assets and liabilities of PDC Funding Company, LLC (“PDC Funding”) and PDC Funding Company II, LLC (“PDC Funding II”), wholly owned subsidiaries and separate legal entities under Minnesota law. PDC Funding and PDC Funding II are fully consolidated special purpose entities established to sell customer installment sale contracts to outside financial institutions in the normal course of their business. The assets of PDC Funding and PDC Funding II would be available first and foremost to satisfy the claims of its creditors. There are no known creditors of PDC Funding or PDC Funding II.

Through fiscal 2015, Patterson was comprised of three reportable segments: dental supply, veterinary supply and rehabilitation supply. This fiscal year, we reorganized our reportable segments as a result of our acquisition of Animal Health International, Inc. and our divestiture of our wholly-owned subsidiary Patterson Medical Holdings, Inc., the entity through which we operated the rehabilitation supply business. We now present three different reportable segments: Dental, Animal Health and Corporate. Prior period segment results have been restated to conform to this revised current period presentation.

Fiscal Year End

We operate with a 52-53 week accounting convention with our fiscal year ending on the last Saturday in April. The second quarters of fiscal 2016 and 2015 include the 13 weeks ended October 31, 2015 and October 25, 2014, respectively. The six months ended October 31, 2015 and October 25, 2014 include 27 and 26 weeks, respectively. Fiscal 2016 will include 53 weeks and fiscal 2015 included 52 weeks of operations.

Comprehensive Income

Comprehensive income is computed as net income including certain other items that are recorded directly to stockholders’ equity. Significant items included in comprehensive income are foreign currency translation adjustments and the effective portion of cash flow hedges, net of tax. Foreign currency translation adjustments do not include a provision for income tax on earnings from foreign operations that are considered to be indefinitely reinvested outside the U.S. The income tax benefit/(loss) related to cash flow hedges was $(265) and $2,321 for the three months ended October 31, 2015 and October 25, 2014, respectively. The income tax benefit/(loss) related to cash flow hedges was $(350) and $7,134 for the six months ended October 31, 2015 and October 25, 2014, respectively.

 

6


Table of Contents

Earnings Per Share

The following table sets forth the computation of the weighted average shares outstanding used to calculate basic and diluted earnings per share (“EPS”):

 

     Three Months Ended      Six Months Ended  
     October 31,      October 25,      October 31,      October 25,  
     2015      2014      2015      2014  

Denominator for basic EPS – weighted average shares

     98,525         98,802         98,981         99,066   

Effect of dilutive securities

     660         574         693         713   
  

 

 

    

 

 

    

 

 

    

 

 

 

Denominator for diluted EPS – weighted average shares

     99,185         99,376         99,674         99,779   
  

 

 

    

 

 

    

 

 

    

 

 

 

Potentially dilutive securities consisting of stock options, restricted stock and stock purchase plans representing 899 shares for the three and six months ended October 31, 2015 and 124 shares for the three and six months ended October 25, 2014 were excluded from the calculation of diluted earnings per share because their effect would have been anti-dilutive.

Recently Issued Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU No. 2014-09 supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605),” and requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In July 2015, the FASB deferred the effective date of this pronouncement by one year to December 15, 2017 for interim and annual reporting periods beginning after that date. Early adoption is permitted, but not before the original effective date, which for annual periods was December 15, 2016. We are evaluating the new standard, but do not, at this time, anticipate a material impact to our financial statements once implemented.

In July 2015, the FASB issued ASU No. 2015-11, “Inventory (Topic 330), Simplifying the Measurement of Inventory.” ASU 2015-11 requires inventory measured using any method other than last-in, first-out (LIFO) or the retail inventory method to be subsequently measured at the lower of cost or net realizable value, rather than at the lower of cost or market. Subsequent measurement of inventory using the LIFO and retail inventory method is unchanged. We are required to adopt the new pronouncement in the first quarter of fiscal 2018, and plan to do so at that time. Early adoption is permitted. We are evaluating the effect of adopting this pronouncement, but do not, at this time, anticipate a material impact to our financial statements once implemented.

In August 2015, the FASB issued ASU No. 2015-15, “Interest – Imputation of Interest (Subtopic 835-30), Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements.” This ASU states that ASU No. 2015-03, “Interest – Imputation of Interest (Subtopic 835-30), Simplifying the Presentation of Debt Issuance Costs” does not address debt issuance costs for line-of-credit arrangements, and therefore the SEC staff would not object to an entity deferring and presenting these related debt issuance costs as an asset and subsequently amortizing the deferred issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. At this time, we do not believe that ASU No. 2015-15 will have a material impact on our financial statements and related disclosures.

In September 2015, the FASB issued ASU No. 2015-16, “Business Combinations (Topic 805), Simplifying the Accounting for Measurement-Period Adjustments.” This ASU requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. The amendments in this ASU require an entity to present separately on the face of the income statement or disclose in the notes the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. We are required to adopt the new pronouncement in the first quarter of fiscal 2017, with early adoption permitted. We are evaluating the effect and timing of adopting this pronouncement, but do not, at this time, anticipate a material impact to the financial statements once implemented.

In November 2015, the FASB issued ASU No. 2015-17, “Income Taxes (Topic 740), Balance Sheet Classification of Income Taxes.” This ASU eliminates the current requirement for an entity to separate deferred income tax liabilities and assets into current and noncurrent amounts in a classified statement of financial position. This ASU requires that deferred tax liabilities and assets be classified as noncurrent in the classified statement of financial position. We are required to adopt the ASU in the first quarter of fiscal 2018, with early adoption permitted. We are evaluating the effect and timing of adopting this pronouncement, but do not, at this time, anticipate a material impact to the financial statements once implemented.

 

7


Table of Contents

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year presentation.

Note 2. Acquisitions

During our first fiscal quarter of 2016, we completed the acquisition of Animal Health International, Inc., a leading production animal health distribution company in the U.S. This acquisition more than doubled the revenue previously attributable to our animal health business, which was previously focused on the companion animal health market. Our animal health business now offers an expanded range of products and services to a broader base of customers in North America and the U.K. Under terms of the merger agreement, we acquired all of Animal Health International’s stock for $1,100,000 in cash, subject to customary working capital adjustments.

In connection with the acquisition, we entered into a credit agreement consisting of a $1,000,000 unsecured term loan and a $500,000 unsecured cash flow revolving line of credit, described further in Note 11 to the Condensed Consolidated Financial Statements.

The acquisition has been accounted for in accordance with ASC 805, Business Combinations, with identifiable assets acquired and liabilities assumed recorded at their estimated fair values on the acquisition date. A valuation of the assets and liabilities from the business acquisition was performed utilizing cost, income and market approaches resulting in $589,833 allocated to identifiable net assets. The initial accounting for the acquisition is not complete because certain information and analysis that may impact our initial valuations are still being obtained or reviewed. The significant assets and liabilities for which provisional amounts are recognized at the acquisition date are property and equipment, intangible assets, goodwill, working capital adjustments and deferred income taxes. The provisional amounts recognized are subject to revision until our valuations are completed, not to exceed one year, and any material adjustments identified that existed as of the acquisition date will be retroactively recorded.

The following table summarizes the total purchase price consideration and the preliminary fair value amounts recognized for the assets acquired and liabilities assumed related to the acquisition, as of the acquisition date:

 

Total purchase price consideration

   $ 1,108,203   
  

 

 

 

Receivables

   $ 161,427   

Inventory

     195,367   

Prepaid expenses and other current assets

     33,005   

Property and equipment

     44,178   

Identifiable intangibles

     434,300   

Other long-term assets

     40,869   
  

 

 

 

Total assets acquired

     909,146   
  

 

 

 

Accounts payable

     122,129   

Accrued liabilities and other current liabilities

     19,395   

Deferred tax liability

     177,789   
  

 

 

 

Total liabilities assumed

     319,313   
  

 

 

 

Identifiable net assets acquired

     589,833   

Goodwill

     518,370   
  

 

 

 

Net assets acquired

   $ 1,108,203   
  

 

 

 

 

8


Table of Contents

As a result of recording the stepped up fair market basis for GAAP purposes, but receiving primarily carryover basis for tax purposes in the acquisition, we recorded a deferred tax asset and deferred tax liability of $2,569 and $177,789, respectively.

The goodwill of $518,370 resulting from the acquisition reflects the excess of our purchase price over the fair value of the net assets acquired. An adjustment to increase goodwill by $499 was recorded in the second quarter of fiscal 2016 as a result of working capital adjustments. The goodwill recorded as part of the acquisition primarily reflects the value of the assembled workforce, cost synergies, and the potential to integrate and expand existing product lines. We allocated all of the goodwill to our Animal Health reporting segment. None of the goodwill recognized is deductible for income tax purposes, and as such, no deferred taxes have been recorded related to goodwill.

Revenues of $585,950 and operating income of $12,369 attributable to the acquisition are included in our condensed consolidated statement of income for the six months ended October 31, 2015. Included in operating income for the six months ended October 31, 2015 is amortization expense of $12,048 related to the identifiable intangible assets acquired in the transaction.

The following summarizes the intangible assets, excluding goodwill, acquired as of June 16, 2015. Intangible assets are amortized using methods that approximate the pattern of economic benefit provided by the utilization of the assets.

 

     Gross Carrying
Value
     Weighted
Average Life
(years)
 

Unamortized – indefinite lived:

     

Trade names

   $ 12,300         indefinite   

Amortized:

     

Customer relationships

     291,900         15.0   

Trade names

     111,400         10.0   

Developed technology and other

     18,700         12.2   
  

 

 

    

Total amortized intangible assets

     422,000         13.6   
  

 

 

    

Total identifiable intangible assets

   $ 434,300      
  

 

 

    

The following unaudited pro forma financial results for the combined results of Patterson and Animal Health International for the six month periods ended October 31, 2015 and October 25, 2014 assume the acquisition occurred on April 27, 2014. The unaudited pro forma financial results may not be indicative of the results that would have occurred had the acquisition been completed as of April 27, 2014, nor are they indicative of future results of operations.

 

     Six Months Ended  
     October 31,      October 25,  
     2015      2014  

Pro forma net sales

   $ 2,725,116       $ 2,650,613   

Pro forma net income from continuing operations

     70,957         74,754   

Pro forma net income from continuing operations for the six month period ended October 31, 2015 includes $12,300 of income tax expense related to the repatriation of foreign earnings, described further in Note 12 to the Condensed Consolidated Financial Statements.

Note 3. Discontinued Operations

On July 1, 2015, we entered into a definitive agreement to sell all of the outstanding shares of common stock of Patterson Medical Holdings, Inc., our wholly owned subsidiary responsible for our rehabilitation supply business known as Patterson Medical (“Patterson Medical”), for $715,000 in cash to Madison Dearborn Partners. The definitive agreement includes a working capital adjustment provision that impacts the final sale price. On August 28, 2015, we completed the sale of Patterson Medical for $718,078, with such sales price including the above-described working capital adjustment. As additional consideration for the shares of Patterson Medical, we obtained a number of common units of the parent company of the buyer equal to 10% of the common units outstanding at closing. Unlike the other common units, these units will only become entitled to begin participating in distributions to the common unit holders at such time, if any, as the Madison Dearborn Partners’ investor cash inflows equal or exceed 2.5 times the Madison Dearborn Partners’ investor cash outflows. These units are non-transferrable. We recorded a pre-tax gain of $25,520 on the sale of Patterson Medical during the second quarter of fiscal 2016 within discontinued operations in the condensed consolidated statements of income.

 

9


Table of Contents

In connection with the above described transaction, we also entered into a transition services agreement with our former subsidiary, pursuant to which Patterson Medical Holdings, Inc., as owned by Madison Dearborn Partners, is paying us to provide, among other things, certain information technology, distribution, facilities, finance, tax and treasury, and human resources services for up to 24 months after closing.

As of October 31, 2015, we classified Patterson Medical’s results of operations as discontinued operations for all periods presented in the condensed consolidated statements of income. The assets and liabilities of Patterson Medical were reflected as held for sale in the condensed consolidated balance sheets as of April 25, 2015. The classification was based on our entering into the definitive agreement to sell Patterson Medical during the first quarter of fiscal 2016, the entity being available for sale in its present condition at that time and the sale being completed in the second quarter of fiscal 2016. The operations and cash flows of Patterson Medical have been eliminated from our continuing operations, which were previously recorded as the rehabilitation supply reportable segment.

The following summarizes the assets and liabilities of Patterson Medical as of April 25, 2015:

 

     April 25,  
     2015  

Assets held for sale

  

Receivables, net of allowance for doubtful accounts

   $ 57,876   

Inventory

     48,265   

Prepaid expenses and other current assets

     12,206   

Property and equipment, net

     22,672   

Goodwill

     537,175   

Identifiable intangibles, net

     74,804   

Other long-term assets

     1,143   
  

 

 

 

Total assets held for sale

   $ 754,141   
  

 

 

 

Liabilities held for sale

  

Accounts payable

   $ 26,341   

Accrued liabilities and other current liabilities

     12,975   

Long-term liabilities

     49,414   
  

 

 

 

Total liabilities held for sale

   $ 88,730   
  

 

 

 

The following summarizes the results of operations of our discontinued Patterson Medical operations for the periods presented:

 

     Three Months Ended      Six Months Ended  
     October 31,
2015 (a)
     October 25,
2014
     October 31,
2015
     October 25,
2014
 

Net sales

   $ 37,693       $ 125,105       $ 168,504       $ 245,678   

Cost of sales

     24,486         78,570         107,359         153,535   

Operating expenses

     22,915         27,454         54,954         54,304   

Gain on sale

     (25,520      —           (25,520      —     

Other expense (income)

     60         17         150         (115
  

 

 

    

 

 

    

 

 

    

 

 

 

Income before taxes

     15,752         19,064         31,561         37,954   

Income taxes

     22,894         7,151         29,311         14,077   
  

 

 

    

 

 

    

 

 

    

 

 

 

Net income from discontinued operations

   $ (7,142    $ 11,913       $ 2,250       $ 23,877   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(a)  Includes activity up until the sale date of August 28, 2015.

 

10


Table of Contents

Operating expenses for the three and six months ended October 31, 2015 include professional fees of $9,842 and $13,692, respectively, incurred in connection with the sale of Patterson Medical. Depreciation and amortization were ceased during the three and six months ended October 31, 2015 in accordance with accounting for discontinued operations. Income taxes have been allocated to Patterson Medical based on the accounting requirements for presenting discontinued operations. Income taxes as a percent of income before taxes for both the three and six months ended October 31, 2015 are higher than in the respective prior periods as a result of the requirement to calculate the tax due on the sale of Patterson Medical including certain basis differences that were appropriately not previously recognized for financial reporting purposes.

Note 4. Goodwill and Other Intangible Assets

Goodwill balances and related activity by business segment are as follows:

 

     Balance at
April 25,
2015
     Acquisition
Activity and
Divestitures
     Other Activity      Balance at
October 31,
2015
 

Corporate

   $ —         $ —         $ —         $ —     

Dental

     139,449         —           (738      138,711   

Animal Health

     160,475         518,370         39         678,884   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $  299,924       $ 518,370       $ (699    $ 817,595   
  

 

 

    

 

 

    

 

 

    

 

 

 

Balances of other intangible assets, excluding goodwill, are as follows:

 

     October 31,      April 25,  
     2015      2015  

Unamortized – indefinite lived:

     

Copyrights, trade names and trademarks

   $ 29,900       $ 17,600   

Amortized:

     

Distribution agreement, customer lists and other

     642,614         221,359   

Less: Accumulated amortization

     (135,435      (113,934
  

 

 

    

 

 

 

Net amortized intangible assets

     507,179         107,425   
  

 

 

    

 

 

 

Total identifiable intangible assets, net

   $ 537,079       $ 125,025   
  

 

 

    

 

 

 

Note 5. Derivative Financial Instruments

Patterson is a party to certain offsetting and identical interest rate cap agreements. These interest rate cap agreements are not designated for hedge accounting treatment and were entered into to fulfill certain covenants of an equipment finance contracts sale agreement between a commercial paper conduit managed by The Bank of Tokyo-Mitsubishi UFJ, Ltd. and PDC Funding. On November 25, 2014, this sale agreement was amended on terms generally consistent with the expiring agreement. The interest rate cap agreements provide a credit enhancement feature for the financing contracts sold by PDC Funding to the commercial paper conduit.

The interest rate cap agreements are cancelled and new agreements entered into periodically to maintain consistency with the dollar maximum of the sale agreements and the maturity of the underlying financing contracts. As of October 31, 2015, PDC Funding had purchased an interest rate cap from a bank with a notional amount of $500,000 and a maturity date of February 2022. Patterson sold an identical interest rate cap to the same bank.

Similar to the above agreements, PDC Funding II and Patterson entered into offsetting and identical interest rate cap agreements with a notional amount of $100,000 in fiscal 2014. In August 2015, these agreements were terminated and replaced with offsetting and identical interest rate cap agreements. The notional amount remained at $100,000 and the new maturity date is July 2023.

In addition to the purchased and sold identical interest rate cap agreements described above, in May 2012 we entered into an interest rate swap agreement with a bank to economically hedge the interest rate risk associated with a portion of the finance contracts we had sold through the special purpose entities. This agreement expired in April 2015.

 

11


Table of Contents

These interest rate contracts do not qualify for hedge accounting treatment and, accordingly, we record the fair value of the agreements as an asset or liability and the change as income or expense during the period in which the change occurs.

In January 2014 we entered into a forward interest rate swap agreement with a notional amount of $250,000 and accounted for as cash flow hedge, to hedge interest rate fluctuations in anticipation of refinancing the 5.17% senior notes due March 25, 2015 with a loan for $250,000 and a term of ten years. This note was repaid on March 25, 2015 and replaced with new $250,000 3.48% senior notes due March 24, 2025. A cash payment of $29,003 was made in March 2015 to settle the interest rate swap. This amount will be recognized as interest expense over the ten-year life of the new notes.

The following presents the fair value of interest rate contracts included in the condensed consolidated balance sheets:

 

          October 31,      April 25,  

Derivative type

  

Classification

   2015      2015  

Interest rate contracts

  

Other noncurrent assets

   $ 835       $ 1,255   

Interest rate contracts

  

Other noncurrent liabilities

     835         1,255   

The following table presents the effect of interest rate contracts on the condensed consolidated statements of income and other comprehensive income (OCI):

 

          Three Months Ended     Six Months Ended  

Derivative type

   Location of gain/(loss)
recognized on derivative
   October 31,
2015
     October 25,
2014
    October 31,
2015
     October 25,
2014
 

Interest rate swap

   OCI    $ 437       $ (3,867   $ 1,054       $ (6,176

We recorded $703 of interest expense during the three months ended October 31, 2015, and $49 as a reduction to interest expense in the three months ended October 25, 2014 related to the interest rate swap. We recorded $1,405 of interest expense during the six months ended October 31, 2015, and $97 as a reduction to interest expense in the six months ended October 25, 2014 related to the interest rate swap. We recorded no ineffectiveness during the three and six month periods ended October 31, 2015 and October 25, 2014.

Note 6. Fair Value Measurements

Fair value is the price at which an asset could be exchanged in a current transaction between knowledgeable, willing parties. The fair value hierarchy of measurements is categorized into one of three levels based on the lowest level of significant input used:

 

  Level 1 - Quoted prices in active markets for identical assets and liabilities at the measurement date.

 

  Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

 

  Level 3 - Unobservable inputs for which there is little or no market data available. These inputs reflect management’s assumptions of what market participants would use in pricing the asset or liability.

 

12


Table of Contents

Our hierarchy for assets and liabilities measured at fair value on a recurring basis is as follows:

 

     October 31, 2015  
     Total      Level 1      Level 2      Level 3  

Assets:

           

Cash equivalents

   $ 4,949       $ 4,949       $ —         $ —     

Derivative instruments

     835         —           835         —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

   $ 5,784       $ 4,949       $ 835       $ —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities:

           
  

 

 

    

 

 

    

 

 

    

 

 

 

Derivative instruments

   $ 835       $ —         $ 835       $ —     
  

 

 

    

 

 

    

 

 

    

 

 

 
     April 25, 2015  
     Total      Level 1      Level 2      Level 3  

Assets:

           

Cash equivalents

   $ 90,569       $ 90,569       $ —         $ —     

Derivative instruments

     1,255         —           1,255         —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

   $ 91,824       $ 90,569       $ 1,255       $ —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities:

           
  

 

 

    

 

 

    

 

 

    

 

 

 

Derivative instruments

   $ 1,255       $ —         $ 1,255       $ —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Cash equivalents – We value cash equivalents at their current market rates. The carrying value of cash equivalents approximates fair value and maturities are less than three months.

Derivative instruments – Our derivative instruments consist of interest rate contracts. These instruments are valued using observable inputs such as interest rates and credit spreads.

Certain assets are measured at fair value on a non-recurring basis. These assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments under certain circumstances, such as when there is evidence of impairment. There were no fair value adjustments to such assets during the six-month periods ended October 31, 2015 or October 25, 2014.

Our debt is not measured at fair value in the condensed consolidated balance sheets. The estimated fair value of our debt as of October 31, 2015 and April 25, 2015 was $1,058,425 and $746,685, respectively. The fair value of debt was measured using a discounted cash flow analysis based on expected market based yields (i.e. level 2 inputs).

The carrying amounts of receivables, net of allowances, accounts payable, and certain accrued and other current liabilities approximated fair value at October 31, 2015 and April 25, 2015.

Note 7. Securities

On October 25, 2013, we invested in three time deposits with total principal of $110,000 Canadian. On October 24, 2014, time deposits with a principal value of $45,000 Canadian matured with a value of $45,436 Canadian. The remaining time deposits with a principal value of $65,000 Canadian matured on October 28, 2015 with a value of $67,031 Canadian. Our time deposit securities were classified as held-to-maturity securities as of April 25, 2015, as we had both the intent and ability to hold them until maturity. They were carried at cost, adjusted for accrued interest and amortization. The carrying value was not materially different than fair value. The fair value was determined based on a discounted cash flow analysis using unobservable inputs (i.e. level 3 inputs), which included a forward yield curve, the estimated timing of payments and the credit quality of the underlying creditor. Significant changes in any of the significant unobservable inputs in isolation would not have resulted in a materially lower fair value estimate. The interrelationship between these inputs was insignificant.

Note 8. Customer Financing

As a convenience to our customers, we offer several different financing alternatives, including a third party program and a Company-sponsored program. For the third party program, we act as a facilitator between the customer and the third party financing entity with no on-going involvement in the financing transaction. Under our sponsored program, equipment purchased by customers with strong credit may be financed up to a maximum of $500 for any one customer. We generally sell our customers’ financing contracts to outside financial institutions in the normal course of our business. We currently have two arrangements under which we sell these contracts.

 

13


Table of Contents

First, we operate under an agreement to sell a portion of our equipment finance contracts to commercial paper conduits with The Bank of Tokyo-Mitsubishi UFJ, Ltd. serving as the agent. We utilize a special purpose entity (“SPE”), PDC Funding, a consolidated, wholly owned subsidiary, to fulfill a requirement of participating in the commercial paper conduit. We receive the proceeds of the contracts upon sale. At least 13% of the proceeds are held by the conduit as security against eventual performance of the portfolio. The capacity under the agreement at October 31, 2015 was $500,000.

Second, we also maintain an agreement with Fifth Third Bank whereby the bank purchases customers’ financing contracts. We established another SPE, PDC Funding II, a consolidated, wholly owned subsidiary, which sells financing contracts to the bank. We receive the proceeds of the contracts upon sale. At least 14% of the proceeds are held by the conduit as security against eventual performance of the portfolio. The capacity under the agreement at October 31, 2015 was $100,000.

The portion of the purchase price for the receivables held by the conduits is a deferred purchase price receivable, which is paid to the SPE as payments on the receivables are collected from customers. The deferred purchase price receivable represents a beneficial interest in the transferred financial assets and is recognized at fair value as part of the sale transaction. We value the deferred purchase price receivable based on a discounted cash flow analysis using unobservable inputs (i.e. level 3 inputs), which include a forward yield curve, the estimated timing of payments and the credit quality of the underlying creditor. Significant changes in any of the significant unobservable inputs in isolation would not result in a materially different fair value estimate. The interrelationship between these inputs is insignificant.

These financing arrangements are accounted for as a sale of assets under the provisions of ASC 860, Transfers and Servicing. During the three and six months ended October 31, 2015, we sold $48,172 and $142,939, respectively, and during the three and six months ended October 25, 2014, we sold $47,059 and $132,148, respectively, of contracts under these arrangements. We retain servicing responsibilities under both agreements, for which we are paid a servicing fee. The servicing fees we receive are considered adequate compensation for services rendered. Accordingly, no servicing asset or liability has been recorded. The agreements require us to maintain a minimum current ratio and maximum leverage ratio. We were in compliance with those covenants at October 31, 2015.

Included in cash and cash equivalents in the condensed consolidated balance sheets are $24,793 and $29,863 as of October 31, 2015 and April 25, 2015, respectively, which represents cash collected from previously sold customer financing arrangements that have not yet been settled with the third party. Included in current receivables in the condensed consolidated balance sheets are $105,852, net of unearned income of $6,781, and $88,470, net of unearned income of $4,197, as of October 31, 2015 and April 25, 2015, respectively, of finance contracts we have not yet sold. A total of $529,484 of finance contracts receivable sold under the agreements was outstanding at October 31, 2015. The deferred purchase price under the arrangements was $67,550 and $66,715 as of October 31, 2015 and April 25, 2015, respectively. Since the internal financing program began in 1994, bad debt write-offs have amounted to less than one-percent of the loans originated.

Note 9. Segment Reporting

Through fiscal 2015, Patterson was comprised of three reportable segments: dental supply, veterinary supply and rehabilitation supply. This fiscal year, we reorganized our reportable segments as a result of our acquisition of Animal Health International, Inc. and our divestiture of our wholly-owned subsidiary Patterson Medical Holdings, Inc., the entity through which we operated the rehabilitation supply business. We now present three different reportable segments: Dental, Animal Health and Corporate. Prior period segment results have been restated to conform to this revised current period presentation.

Our Dental and Animal Health reportable business segments are strategic business units that offer similar products and services to different customer bases. Dental provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout North America. Animal Health, formerly our Patterson Veterinary reportable segment, is a leading, full-line distributor in North America and the U.K. of animal health products, services and technologies to both the production-animal and companion-pet markets. Our Corporate segment, which was previously included in our dental supply reporting segment through the end of fiscal 2015, is

 

14


Table of Contents

comprised of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources and facilities. In addition, customer financing and other miscellaneous sales are reported within Corporate results. Corporate assets consist primarily of cash and cash equivalents, accounts receivable, property and equipment and long-term receivables. We evaluate segment performance based on operating income. The costs to operate the distribution centers are allocated to the operating units based on the through-put of the unit.

The following table presents information about Patterson’s reportable segments:

 

     Three Months Ended      Six Months Ended  
     October 31,      October 25,      October 31,      October 25,  
     2015      2014      2015      2014  

Net sales

           

Corporate

   $ 13,435       $ 9,110       $ 23,891       $ 18,892   

Dental

     601,322         592,636         1,176,439         1,135,510   

Animal Health

     774,453         376,474         1,331,750         762,774   
  

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated net sales

   $ 1,389,210       $ 978,220       $ 2,532,080       $ 1,917,176   
  

 

 

    

 

 

    

 

 

    

 

 

 

Operating income (loss) from continuing operations

           

Corporate

   $ (15,808    $ (15,623    $ (33,855    $ (26,163

Dental

     74,094         73,427         141,346         135,976   

Animal Health

     25,177         14,336         38,149         28,323   
  

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated operating income from continuing operations

   $ 83,463       $ 72,140       $ 145,640       $ 138,136   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

     October 31,
2015
     April 25,
2015
 

Total assets

     

Corporate

   $ 469,101       $ 539,863   

Dental

     900,668         1,022,257   

Animal Health

     2,082,069         631,445   
  

 

 

    

 

 

 

Total assets, excluding assets held for sale

     3,451,838         2,193,565   

Assets held for sale

     —           754,141   
  

 

 

    

 

 

 

Total assets

   $ 3,451,838       $ 2,947,706   
  

 

 

    

 

 

 

The following table presents sales information by product for all of Patterson’s reportable segments:

 

     Three Months Ended      Six Months Ended  
     October 31,      October 25,      October 31,      October 25,  
     2015      2014      2015      2014  

Net sales

           

Consumables

   $ 1,087,489       $ 686,165       $ 1,982,796       $ 1,381,804   

Equipment and software

     207,809         204,409         361,292         360,803   

Other

     93,912         87,646         187,992         174,569   
  

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated net sales

   $ 1,389,210       $ 978,220       $ 2,532,080       $ 1,917,176   
  

 

 

    

 

 

    

 

 

    

 

 

 

Note 10. Accumulated Other Comprehensive Loss

The following table summarizes accumulated other comprehensive loss (AOCL) at October 31, 2015 and April 25, 2015 and the activity for fiscal 2016:

 

     Cash Flow
Hedges
     Currency
Translation
Adjustment
     Total  

AOCL at April 25, 2015

   $ (18,668    $ (41,678    $ (60,346

Other comprehensive loss before reclassifications

     —           (15,417      (15,417

Amounts reclassified from AOCL

     1,054         11,083         12,137   
  

 

 

    

 

 

    

 

 

 

AOCL at October 31, 2015

   $ (17,614    $ (46,012    $ (63,626
  

 

 

    

 

 

    

 

 

 

 

15


Table of Contents

The amounts reclassified from AOCL during fiscal 2016 represent gains and losses on cash flow hedges, net of taxes of $350, and amounts reclassified related to the divestiture of Patterson Medical of $11,083. The net impact to the condensed consolidated statements of income was an increase to interest expense of $1,405.

Note 11. Debt Issuance

During the first quarter of fiscal 2016, we entered into a credit agreement with The Bank of Tokyo-Mitsubishi UFJ, Ltd., as administrative agent, and Bank of America, N.A., as syndication agent, (the “Credit Agreement”). Pursuant to the Credit Agreement, the lenders provided us with senior unsecured lending facilities of up to $1,500,000, consisting of a $1,000,000 unsecured term loan and a $500,000 unsecured revolving line of credit. Interest on borrowings under the Credit Agreement is based on LIBOR plus a spread which can range from 1.125% to 2.000%. This spread, as well as a commitment fee on the unused portion of the facility, are based on our leverage ratio, as defined in the Credit Agreement. The initial interest rate under the Credit Agreement is LIBOR plus 2.000%. Initial borrowings under the Credit Agreement were $1,000,000 under the unsecured term loan and $200,000 under the unsecured revolving line of credit. The term loan and revolving credit facilities will mature no later than June 16, 2020.

Upon certain significant asset dispositions, we agreed to use proceeds from such dispositions to effect prepayment of outstanding loan balances under the Credit Agreement. On August 28, 2015, we completed the sale of Patterson Medical, as described further in Note 3 to the Condensed Consolidated Financial Statements. As a result of this sale, $670,000 was repaid on the original outstanding $1,000,000 unsecured term loan. We recorded $5,153 of accelerated debt issuance cost amortization within interest expense concurrent with this early repayment of debt. Additionally, a $4,125 principal payment was made during the three months ended October 31, 2015. As of October 31, 2015, $325,875 was outstanding under the unsecured term loan.

We are subject to various financial covenants under the Credit Agreement including the maintenance of leverage and interest coverage ratios. In the event of our default, any outstanding obligations may become due and payable immediately. We met the covenants under the Credit Agreement as of October 31, 2015.

On June 16, 2015, our previous $300,000 credit facility, which was due to expire in December 2016, was terminated and replaced by the revolving line of credit under the Credit Agreement. As of October 31, 2015, $80,000 was outstanding under our current revolving line of credit. There were no outstanding borrowings under our current or previous revolving lines of credit at April 25, 2015.

Note 12. Income Taxes

The effective income tax rate for the three months ended October 31, 2015 was 36.7% compared to 35.0% for the three months ended October 25, 2014, and for the six months ended October 31, 2015 was 46.7% compared to 34.8% for the six months ended October 25, 2014. The increases in the rates for both periods were primarily due to the current year impact of cash repatriation and the impact of transaction-related costs incurred related to the acquisition of Animal Health International, Inc.

In the first quarter of fiscal 2016, we approved a one-time repatriation of approximately $200,000 of foreign earnings. This one-time repatriation reduced the overall cost of funding the acquisition of Animal Health International, Inc. In addition, certain foreign cash at Patterson Medical was required to be repatriated as part of the sale transaction. The continuing operations tax impact of $12,300 from the repatriation was recorded during the first six months of fiscal 2016. We have previously asserted that our foreign earnings are permanently reinvested. Except for the repatriations described above, there is no change in our on-going assertion.

Note 13. Legal Proceedings

In September 2015, we were served with a summons and complaint in an action commenced in the United States District Court for the Eastern District of New York, entitled SourceOne Dental, Inc. v. Patterson Companies, Inc., Henry Schein, Inc. and Benco Dental Supply Company, Civil Action No. 15-cv-05440-JMA-GRB. SourceOne, as plaintiff, alleges that, through its website, it markets and sells dental supplies and equipment to dentists. SourceOne alleges in the complaint, among other things, that we, along with the defendants Henry Schein and Benco, conspired to eliminate plaintiff as a competitor and to exclude them from the market for the marketing, distribution and sale of dental supplies and equipment in the United States and that defendants unlawfully agreed with one another to boycott dentists, manufacturers, and state dental associations that deal with, or considered dealing with, plaintiff. Plaintiff asserts the following claims: (i) unreasonable

 

16


Table of Contents

restraint of trade in violation of state and federal antitrust laws; (ii) tortious interference with prospective business relations; (iii) civil conspiracy; and (iv) aiding and abetting the other defendants’ ongoing tortious and anticompetitive conduct. Plaintiff seeks equitable relief, compensatory and treble damages, jointly and severally, punitive damages, interest, and reasonable costs and expenses, including attorneys’ fees and expert fees. Plaintiff has not specified a damage amount in its complaint. We intend to defend ourselves against the action vigorously. We do not anticipate that this matter will have a material adverse effect on our financial condition.

 

17


Table of Contents

MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

This Form 10-Q for the period ended October 31, 2015 contains certain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, which may be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “anticipate”, “estimate”, “believe”, “goal”, or “continue”, or comparable terminology that involves risks and uncertainties that are qualified in their entirety by cautionary language set forth herein, in our 2015 Annual Report on Form 10-K filed June 24, 2015, and in other documents previously filed with the Securities and Exchange Commission.

OVERVIEW

Our financial information for the first six months of fiscal 2016 is summarized in this Management’s Discussion and Analysis and the Condensed Consolidated Financial Statements and related Notes. The following background is provided to readers to assist in the review of our financial information.

Through fiscal 2015, Patterson had traditionally operated a specialty distribution business in three markets: dental supply, veterinary supply and rehabilitation supply. In the first half of fiscal 2016, we acquired Animal Health International, Inc. and divested our wholly-owned subsidiary Patterson Medical Holdings, Inc. (“Patterson Medical”), the entity through which we operated the rehabilitation supply business. As a result of these two transactions, we now operate in two complementary markets: dental and animal health. While our dental business remains the same, our animal health business now consists of both companion animal and production animal lines of business. As of October 31, 2015, we classified the results of operations of Patterson Medical as discontinued operations for all periods presented in the condensed consolidated statements of income. The assets and liabilities of Patterson Medical were reflected as held for sale in the condensed consolidated balance sheets as of April 25, 2015.

Operating margins of the animal health business are considerably lower than the dental business. While operating expenses run at a lower rate in the animal health business, its gross margin is substantially lower due generally to the low margins on the pharmaceutical products that are distributed.

We operate with a 52-53 week accounting convention with our fiscal year ending on the last Saturday in April. The second quarter of fiscal 2016 and 2015 represents the 13 weeks ended October 31, 2015 and October 25, 2014, respectively. The six months ended October 31, 2015 and October 25, 2014 included 27 and 26 weeks, respectively. Fiscal 2016 will include 53 weeks and fiscal 2015 included 52 weeks of operations.

We believe there are several important aspects of Patterson’s business that are useful in analyzing it, including: (1) growth in the various markets in which we operate; (2) internal growth; (3) growth through acquisition; and (4) continued focus on controlling costs and enhancing efficiency. Management defines internal growth as the increase in net sales from period to period, excluding the impact of changes in currency exchange rates, and excluding the net sales, for a period of twelve months following the transaction date, of businesses we have acquired.

The following significant activities occurred in the first and second quarters of fiscal 2016:

Animal Health International Acquisition. On June 16, 2015, we completed the acquisition of Animal Health International, Inc., a leading production animal health distribution company in the U.S. Prior to our acquisition, Animal Health International, Inc. generated sales and earnings before interest, income taxes, depreciation and amortization of $1.5 billion and $68 million, respectively, during the 12 months ended March 2015. Our acquisition more than doubled the revenue of our legacy animal health business which was previously focused solely on the companion animal market. Our animal health business now offers an expanded range of products and services to a broader base of customers in North America and the U.K. During the three and six months ended October 31, 2015, we incurred $0.7 million and $10.0 million, respectively, or $.01 and $0.10 per diluted share on an after-tax basis, respectively, of transaction costs related to the acquisition of Animal Health International, Inc. See Note 2 to the Condensed Consolidated Financial Statements for information regarding the acquisition of Animal Health International, Inc.

 

18


Table of Contents

Patterson Medical Sale. During the first quarter of fiscal 2016, we entered into a definitive agreement to sell all of the outstanding shares of common stock of Patterson Medical Holdings, Inc. for $715.0 million in cash to Madison Dearborn Partners. The definitive agreement included a working capital adjustment provision that impacts the final sale price. On August 28, 2015, we completed the sale of Patterson Medical for $718.1 million, with such sales price including the above-described working capital adjustment. See Note 3 to the Condensed Consolidated Financial Statements for additional information.

Cash Repatriation. In the first quarter of fiscal 2016, we approved a one-time repatriation of approximately $200.0 million of foreign earnings. This one-time repatriation reduced the overall cost of funding the acquisition of Animal Health International, Inc. In addition, certain foreign cash at Patterson Medical was required to be repatriated as part of the sale transaction. The continuing operations tax impact of $12.3 million from the repatriation was recorded during the first six months of fiscal 2016.

RESULTS OF OPERATIONS

QUARTER ENDED OCTOBER 31, 2015 COMPARED TO QUARTER ENDED OCTOBER 25, 2014

Continuing Operations

The following table sets forth, for the periods indicated, the percentage of net sales represented by certain operational data from continuing operations:

 

     Three Months Ended  
     October 31,
2015
    October 25,
2014
 

Net sales

     100.0     100.0

Cost of sales

     76.2        73.5   
  

 

 

   

 

 

 

Gross profit

     23.8        26.5   

Operating expenses

     17.8        19.1   
  

 

 

   

 

 

 

Operating income from continuing operations

     6.0        7.4   

Other expense (income)

     1.2        0.8   
  

 

 

   

 

 

 

Income from continuing operations before taxes

     4.8        6.6   

Income taxes

     1.7        2.3   
  

 

 

   

 

 

 

Net income from continuing operations

     3.1     4.3
  

 

 

   

 

 

 

Net Sales. Consolidated net sales for the three months ended October 31, 2015 were $1,389.2 million, which represented a 42.0% increase from consolidated net sales of $978.2 million for the three months ended October 25, 2014. The inclusion of results of Animal Health International, Inc. was the main reason for the increase. Foreign exchange rate changes had an unfavorable impact of 2.0% to current quarter sales growth.

Dental segment sales for the three months ended October 31, 2015 were $601.3 million, which represented a 1.5% increase from Dental segment sales of $592.6 million for the three months ended October 25, 2014. Current quarter sales of dental consumables increased 1.8%. Dental consumable sales were negatively impacted by 1.5% by foreign exchange rates. Sales of dental equipment and software increased 0.4% to $196.8 million and sales of other dental services and products increased 2.9%.

Animal Health segment sales for the three months ended October 31, 2015 were $774.5 million, which represented a 105.7% increase from Animal Health segment sales of $376.5 million for the three months ended October 25, 2014. Animal Health International, Inc. contributed $414.0 million of sales in the current quarter. Foreign exchange rate changes had an unfavorable impact of 2.8% to current quarter sales growth. Consumable sales increased 110.0%, equipment and software sales were $11.0 million, an increase of 30.7%, and sales of other services and products decreased 0.8% in the current quarter.

Gross Profit. Consolidated gross profit margin for the three months ended October 31, 2015 decreased 270 basis points from the prior year quarter to 23.8%. The decrease in gross profit margin was predominantly the result of the inclusion of sales and cost of sales from Animal Health International, Inc. in our results, as that business traditionally has lower gross margins than our historical businesses.

 

19


Table of Contents

Operating Expenses. Consolidated operating expenses for the three months ended October 31, 2015 were $247.4 million, a 32.2% increase from the prior year quarter of $187.1 million. Operating expenses mainly increased due to the acquisition of Animal Health International, Inc. and increased employee healthcare costs. The consolidated operating expense ratio of 17.8% decreased 130 basis points from the prior year quarter.

Operating Income From Continuing Operations. For the three months ended October 31, 2015 operating income was $83.5 million, representing approximately 6.0% of net sales, as compared to $72.1 million, or 7.4% of net sales for the three months ended October 25, 2014. The decrease in operating income as a percent of sales was mainly due to the inclusion of results of Animal Health International, Inc., which have different margins.

Other (Expense) Income, Net. Net other expense for the three months ended October 31, 2015 was $16.2 million compared to $7.8 million for the three months ended October 25, 2014. The increase was mainly due to increased interest expense we incurred relating to the new credit agreement entered into in connection with the acquisition of Animal Health International, Inc., including $5.2 million of accelerated debt issuance cost amortization incurred in the current quarter as a result of early repayment of debt.

Income Tax Expense. The effective income tax rate for the three months ended October 31, 2015 was 36.7% compared to 35.0% in the prior year quarter. The increase in the current quarter rate was primarily due to the impact of the cash repatriation and the impact of transaction-related costs.

Net Income and Earnings Per Share From Continuing Operations. Net income from continuing operations for the three months ended October 31, 2015 was $42.6 million, compared to $41.9 million for the three months ended October 25, 2014. Earnings per diluted share were $0.43 in the current quarter compared to $0.42 in the prior year quarter. Weighted average diluted shares outstanding in the current quarter were 99.2 million compared to 99.4 million in the prior year quarter. The current quarter cash dividend was $0.22 per common share compared to $0.20 in the prior year quarter.

Discontinued Operations

For the three months ended October 31, 2015, we experienced a net loss from discontinued operations of $7.1 million, compared to net income of $11.9 million for the three months ended October 25, 2014. The loss and decrease in net income from discontinued operations were driven primarily by transaction-related costs related to the sale of Patterson Medical.

SIX MONTHS ENDED OCTOBER 31, 2015 COMPARED TO SIX MONTHS ENDED OCTOBER 25, 2014

Continuing Operations

The following table sets forth, for the periods indicated, the percentage of net sales represented by certain operational data from continuing operations:

 

     Six Months Ended  
     October 31,
2015
    October 25,
2014
 

Net sales

     100.0     100.0

Cost of sales

     75.5        73.4   
  

 

 

   

 

 

 

Gross profit

     24.5        26.6   

Operating expenses

     18.7        19.4   
  

 

 

   

 

 

 

Operating income from continuing operations

     5.8        7.2   

Other expense (income)

     1.1        0.8   
  

 

 

   

 

 

 

Income from continuing operations before taxes

     4.7        6.4   

Income taxes

     2.2        2.2   
  

 

 

   

 

 

 

Net income from continuing operations

     2.5     4.2
  

 

 

   

 

 

 

Net Sales. Consolidated net sales for the six months ended October 31, 2015 were $2,532.1 million, a 32.1% increase from $1,917.2 million for the six months ended October 25, 2014. The inclusion of results of Animal Health International, Inc. and an additional week of results were the main reasons for the increase. Foreign exchange rate changes had an unfavorable impact of 2.2% to current period sales growth.

 

20


Table of Contents

Dental segment sales for the six months ended October 31, 2015 were $1,176.4 million, a 3.6% increase from $1,135.5 million for the six months ended October 25, 2014. Current period sales of consumables increased 5.9%. Consumable sales were positively impacted by an estimated 3.9% by the extra week of results and negatively impacted by 1.5% by foreign exchange rates. Sales of dental equipment and software decreased 1.2% to $340.4 million for the six months ended October 31, 2015. Sales of other dental services and products increased 4.8% for the six months ended October 31, 2015.

Animal Health segment sales for the six months ended October 31, 2015 were $1,331.8 million, a 74.6% increase from $762.8 million for the six months ended October 25, 2014. Animal Health International, Inc. contributed $586.0 million of sales for the six months ended October 31, 2015. Foreign exchange rate changes had an unfavorable impact of 3.2% to current period sales growth. Consumable sales increased 77.0%, equipment and software sales were $20.9 million, an increase of 29.9%, and sales of other services and products increased 10.9% in the current period.

Gross Profit. Consolidated gross profit margin for the six months ended October 31, 2015 decreased 210 basis points from the prior year period to 24.5%. The decrease was predominantly the result of the inclusion of sales and cost of sales from Animal Health International, Inc., which has lower gross margins than our historical businesses.

Operating Expenses. Consolidated operating expenses for the six months ended October 31, 2015 were $473.5 million, a 27.4% increase from the prior year period of $371.8 million. Operating expenses mainly increased due to the acquisition of Animal Health International, Inc. transaction-related costs and increased employee healthcare costs. The consolidated operating expense ratio of 18.7% decreased 70 basis points from the prior year period.

Operating Income From Continuing Operations. For the six months ended October 31, 2015, operating income was $145.6 million, or 5.8% of net sales, as compared to $138.1 million, or 7.2% of net sales for the six months ended October 25, 2014. The decrease in operating income as a percent of sales was mainly due to the inclusion of results of Animal Health International, Inc. and transaction-related costs.

Other (Expense) Income, Net. Net other expense was $27.7 million for the six months ended October 31, 2015 compared to $15.2 million for the six months ended October 25, 2014. The increase was mainly due to increased interest expense related to the new credit agreement entered into in connection with the acquisition of Animal Health International, Inc., including $5.2 million of accelerated debt issuance cost amortization incurred in the current period as a result of early repayment of debt.

Income Tax Expense. The effective income tax rate for the six months ended October 31, 2015 was 46.7% compared to 34.8% for the six months ended October 25, 2014. The increase in the current period rate was primarily due to the impact of the cash repatriation and the impact of the transaction-related costs.

Net Income and Earnings Per Share From Continuing Operations. Net income from continuing operations for the six months ended October 31, 2015 was $62.9 million, compared to $80.2 million for the six months ended October 25, 2014. Earnings per diluted share were $0.63 in the current period compared to $0.80 in the prior year period. Weighted average diluted shares outstanding in the current period were 99.7 million compared to 99.8 million in the prior year period. The current period cash dividend was $0.44 per common share compared to $0.40 in the prior year period.

Discontinued Operations

For the six months ended October 31, 2015, net income from discontinued operations was $2.3 million, compared to $23.9 million for the six months ended October 25, 2014. The decrease in net income from discontinued operations was driven primarily by transaction-related costs related to the sale of Patterson Medical.

LIQUIDITY AND CAPITAL RESOURCES

For the six months ended October 31, 2015, net cash flows used in operating activities were $53.0 million, compared to net cash flows provided by operating activities of $98.4 million for the six months ended October 25, 2014. The decrease was primarily a result of investments in inventory associated with the production animal business acquired from Animal Health International, Inc. and amounts expended to support new equipment product launches in preparation for the peak selling season in the Dental business.

 

21


Table of Contents

For the six months ended October 31, 2015, net cash flows used in investing activities were $382.0 million, compared to net cash flows provided by investing activities of $15.6 million for the six months ended October 25, 2014. The current period includes the purchase of Animal Health International, Inc. for $1,105.2 million, which was partially offset by the receipt of net cash proceeds from completion of the sale of Patterson Medical in the amount of $715.6 million. We expect to use a total of approximately $60 million to $70 million for capital expenditures in fiscal 2016, with our main investment in our information technology initiatives.

Cash provided by financing activities for the six months ended October 31, 2015 was $191.2 million. Cash proceeds included $988.4 million of net proceeds from a new five year term loan, described further below, and $80.0 million that is attributed to a withdrawal on our revolving line of credit. Uses of our cash from financing activities were as follows: $160.6 million for share repurchases, $674.1 million for the repayment of the new five year term loan, and $45.4 million used to fund dividend payments. For the six months ended October 25, 2014, cash used by financing activities was $86.9 million, including $47.5 million for share repurchases and $40.2 million for dividend payments.

On June 16, 2015, we entered into a credit agreement (the “Credit Agreement”), under which the lenders provided us with senior unsecured lending facilities of up to $1.5 billion, consisting of a $1.0 billion unsecured term loan and a $500 million unsecured revolving line of credit. At October 31, 2015, $325.9 million under the unsecured term loan was outstanding at an interest rate of LIBOR plus 2.000%. The Credit Agreement expires in fiscal 2021. Also on June 16, 2015, our previous $300 million credit facility, which was due to expire in December 2016, was terminated and replaced by the revolving line of credit under the Credit Agreement. As of October 31, 2015, $80.0 million was outstanding under our current revolving line of credit. There were no outstanding borrowings under our current or previous revolving lines of credit at April 25, 2015.

We expect funds generated from operations, existing cash balances and credit availability under existing debt facilities will be sufficient to meet our working capital needs and to finance anticipated expansion plans and strategic initiatives over the remainder of fiscal 2016.

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

For information on recently issued accounting pronouncements, see Note 1 to the Condensed Consolidated Financial Statements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

During the first quarter of fiscal 2016, we entered into the Credit Agreement under which the lenders provided Patterson with senior unsecured lending facilities of up to $1.5 billion, consisting of a $1.0 billion unsecured term loan and a $500 million unsecured revolving line of credit. Interest on borrowings under this Credit Agreement is based on LIBOR plus a spread which can range from 1.125% to 2.000%. Due to the interest rate being based on LIBOR, fluctuations in this rate impact our earnings. Based on our current level of debt, we estimate that a 100 basis point change in the LIBOR rate would have a $3.3 million impact on our income from continuing operations before taxes on an annualized basis. There have been no other material changes since April 25, 2015 in our market risk. For further information on market risk, refer to Item 7A in our 2015 Annual Report on Form 10-K filed June 24, 2015.

ITEM 4. CONTROLS AND PROCEDURES

Under the supervision and with the participation of our management, including our President and Chief Executive Officer (“CEO”) and our Chief Financial Officer (“CFO”), management evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of October 31, 2015. Based upon their evaluation of these disclosure controls and procedures, the CEO and CFO concluded that the disclosure controls and procedures were effective as of October 31, 2015.

Except as described below, there were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) or 15d-15(f) under the Exchange Act) that occurred during the quarter ended October 31, 2015 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

22


Table of Contents

On June 16, 2015, we acquired Animal Health International, Inc., which was a privately-held company prior to the acquisition. We are in the process of integrating Animal Health International, Inc.’s operations, and as permitted under SEC regulations, we will exclude the operations of Animal Health International, Inc. from the scope of our Sarbanes-Oxley Section 404 report on internal control over financial reporting for the fiscal year ending April 30, 2016. We are in the process of evaluating Animal Health International, Inc.’s internal controls and implementing our internal control structure over the acquired operations, and we expect to complete this effort during fiscal 2017.

PART II—OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

In September 2015, we were served with a summons and complaint in an action commenced in the United States District Court for the Eastern District of New York, entitled SourceOne Dental, Inc. v. Patterson Companies, Inc., Henry Schein, Inc. and Benco Dental Supply Company, Civil Action No. 15-cv-05440-JMA-GRB. SourceOne, a plaintiff alleges that, through its website, it markets and sells dental supplies and equipment to dentists. SourceOne alleges, among other things, that we, along with the defendants Henry Schein and Benco, conspired to eliminate plaintiff as a competitor and to exclude them from the market for the marketing, distribution and sale of dental supplies and equipment in the United States and that defendants unlawfully agreed with one another to boycott dentists, manufacturers, and state dental associations that deal with, or considered dealing with, plaintiff. Plaintiff asserts the following claims: (i) unreasonable restraint of trade in violation of state and federal antitrust laws; (ii) tortious interference with prospective business relations; (iii) civil conspiracy; and (iv) aiding and abetting the other defendants’ ongoing tortious and anticompetitive conduct. Plaintiff seeks equitable relief, compensatory and treble damages, jointly and severally, punitive damages, interest, and reasonable costs and expenses, including attorneys’ fees and expert fees. Plaintiff has not specified a damage amount in its complaint. We intend to defend ourselves against the action vigorously. We do not anticipate that this matter will have a material adverse effect on our financial condition.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On March 19, 2013, our Board of Directors approved a new share repurchase plan that replaced the existing share repurchase plan. Under this new plan, up to 25 million shares may be purchased in open market transactions through March 19, 2018.

The following table presents activity under the stock repurchase program during the second quarter of fiscal 2016:

 

     Total
Number of
Share
Purchased
     Average
Price Paid
per Share
     Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
     Maximum
Number of Shares
That May Be
Purchased Under
the Plan
 

August 2, 2015 to August 29, 2015

     —         $ —           —           20,851,993   

August 30, 2015 to September 26, 2015

     1,002,185         45.13         1,002,185         19,849,808   

September 27, 2015 to October 31, 2015

     2,871,139         45.44         2,871,139         16,978,669   
  

 

 

    

 

 

    

 

 

    

 

 

 
     3,873,324       $ 45.36         3,873,324         16,978,669   

As of October 31, 2015, a total of 17.0 million shares remain available under the current repurchase authorization.

ITEM 6. EXHIBITS

The exhibits listed in the accompanying exhibit index are filed as part of this Quarterly Report on Form 10-Q.

All other items under Part II have been omitted because they are inapplicable or the answers are negative, or were previously reported in the 2015 Annual Report on Form 10-K filed June 24, 2015.

 

23


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

      PATTERSON COMPANIES, INC.
      (Registrant)

Dated: December 10, 2015

     
    By:   /s/ Ann B. Gugino
      Ann B. Gugino
      Executive Vice President, Chief Financial Officer and Treasurer
      (Principal Financial Officer and Principal Accounting Officer)

 

24


Table of Contents

EXHIBIT INDEX

 

Exhibit

No.

  

Exhibit Description

10.1    2015 Omnibus Incentive Plan (incorporated by reference to our Definitive Schedule 14A (Proxy Statement), filed on August 7, 2015 (File No. 000-20572)).
31.1    Certification of the Chief Executive Officer pursuant to Rules 13a-4(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2    Certification of the Chief Financial Officer pursuant to Rule 13a-4(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1    Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2    Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101    Financials in XBRL format.

 

25

EX-31.1 2 d12507dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

Certification of the Chief Executive Officer Pursuant to

Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as

adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Scott P. Anderson, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the period ended October 31, 2015 of Patterson Companies, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter ended (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: December 10, 2015

 

/s/ Scott P. Anderson

Scott P. Anderson

President and Chief Executive Officer

EX-31.2 3 d12507dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

Certification of the Chief Financial Officer Pursuant to

Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as

adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Ann B. Gugino, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the period ended October 31, 2015 of Patterson Companies, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter ended (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: December 10, 2015    

/s/ Ann B. Gugino

    Ann B. Gugino
   

Executive Vice President, Chief Financial Officer

and Treasurer

EX-32.1 4 d12507dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

Certification of the Chief Executive Officer

pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906

of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Patterson Companies, Inc., (the “Company”) on Form 10-Q for the quarterly period ended October 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officer of the Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

/s/ Scott P. Anderson

Scott P. Anderson
President and Chief Executive Officer
December 10, 2015
EX-32.2 5 d12507dex322.htm EX-32.2 EX-32.2

Exhibit 32.2

Certification of the Chief Financial Officer

pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906

of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Patterson Companies, Inc., (the “Company”) on Form 10-Q for the quarterly period ended October 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officer of the Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to her knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

/s/ Ann B. Gugino

Ann B. Gugino

Executive Vice President, Chief Financial Officer

and Treasurer

December 10, 2015

EX-101.INS 6 pdco-20151031.xml XBRL INSTANCE DOCUMENT 12975000 577685000 72464000 725000000 142611000 1433583000 113934000 1033000 21026000 81484000 49414000 -60346000 1630148000 1514123000 746685000 2947706000 1255000 0 39316000 88730000 323294000 26341000 22672000 125025000 204133000 88470000 1573225000 299924000 71686000 53372000 48265000 90569000 221359000 74804000 1255000 107425000 77738000 118347000 17600000 347260000 1143000 586263000 57876000 2947706000 91824000 12206000 59561000 754141000 37919000 537175000 408422000 635794000 66715000 4197000 2193565000 0 539863000 160475000 631445000 139449000 1022257000 -18668000 -41678000 90569000 90569000 1255000 1255000 1255000 1255000 1255000 29863000 300000000 434300000 422000000 291900000 18700000 111400000 12300000 100000000 99430000 715000000 110000000 45000000 45436000 250000000 0.0517 250000000 284872000 500000000 200000000 500000000 1000000000 1000000000 1000000000 19395000 0 319313000 122129000 177789000 434300000 2569000 195367000 161427000 518370000 0 1108203000 40869000 33005000 589833000 44178000 909146000 1500000000 798356000 47671000 1034884000 162225000 15991000 2088581000 80000000 135435000 995000 27759000 255341000 -63626000 1475867000 1363257000 1058425000 3451838000 835000 0 492469000 537079000 272190000 105852000 1665930000 529484000 65000000 817595000 75784000 4949000 642614000 835000 507179000 77738000 29900000 95451000 734461000 3451838000 5784000 83169000 83260000 752849000 67550000 67031000 500000 6781000 3451838000 0 469101000 678884000 2082069000 138711000 900668000 325875000 -17614000 -46012000 4949000 4949000 835000 835000 835000 100000000 835000 835000 500000000 0.0348 250000000 24793000 500000000 250000000 264908000 100000000 P13Y7M6D P15Y P12Y2M12D P10Y indefinite 718078000 5153000 670000000 3 0.40 98395000 0.24 124000 99066000 0.348 0.80 76545000 0.81 1.05 0.24 99779000 1.04 713000 175000 71385000 29190000 2147000 543000 132148000 37954000 138136000 80190000 122971000 74754000 1917176000 23877000 -6176000 40174000 37233000 245678000 104067000 509904000 -26506000 47539000 23877000 2650613000 17312000 -7202000 371768000 11663000 -86869000 14077000 153535000 1407272000 42781000 40775000 809000 4598000 19964000 54304000 21850000 9351000 844000 11940000 15640000 -7134000 11042000 -115000 -6176000 -26163000 18892000 28323000 762774000 135976000 1135510000 1381804000 174569000 360803000 97000 10-Q P24M PDCO <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The following presents the fair value of interest rate contracts included in the condensed consolidated balance sheets:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"> <tr> <td width="42%"></td> <td valign="bottom" width="5%"></td> <td width="36%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>April&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 52.15pt"> <b>Derivative type</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 46.1pt"> <b>Classification</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Interest rate contracts</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Other&#xA0;noncurrent assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">835</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,255</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Interest rate contracts</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Other&#xA0;noncurrent liabilities</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">835</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,255</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> </table> </div> 0000891024 2015-10-31 0.44 <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Note 7. Securities</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> On October&#xA0;25, 2013, we invested in three time deposits with total principal of $110,000 Canadian. On October&#xA0;24, 2014, time deposits with a principal value of $45,000 Canadian matured with a value of $45,436 Canadian. The remaining time deposits with a principal value of $65,000 Canadian matured on October&#xA0;28, 2015 with a value of $67,031 Canadian. Our time deposit securities were classified as held-to-maturity securities as of April&#xA0;25, 2015, as we had both the intent and ability to hold them until maturity. They were carried at cost, adjusted for accrued interest and amortization. The carrying value was not materially different than fair value. The fair value was determined based on a discounted cash flow analysis using unobservable inputs (i.e. level 3 inputs), which included a forward yield curve, the estimated timing of payments and the credit quality of the underlying creditor. Significant changes in any of the significant unobservable inputs in isolation would not have resulted in a materially lower fair value estimate. The interrelationship between these inputs was insignificant.</p> </div> <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"> <i>Reclassifications</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Certain prior year amounts have been reclassified to conform to the current year presentation.</p> </div> <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The following table sets forth the computation of the weighted average shares outstanding used to calculate basic and diluted earnings per share (&#x201C;EPS&#x201D;):</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="60%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Three Months Ended</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Six Months Ended</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Denominator for basic EPS&#xA0;&#x2013;&#xA0;weighted average shares</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">98,525</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">98,802</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">98,981</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">99,066</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Effect of dilutive securities</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">660</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">574</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">693</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">713</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Denominator for diluted EPS&#xA0;&#x2013;&#xA0;weighted average shares</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">99,185</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">99,376</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">99,674</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">99,779</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> Large Accelerated Filer <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Note 11. Debt Issuance</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> During the first quarter of fiscal 2016, we entered into a credit agreement with The Bank of Tokyo-Mitsubishi UFJ, Ltd., as administrative agent, and Bank of America, N.A., as syndication agent, (the &#x201C;Credit Agreement&#x201D;). Pursuant to the Credit Agreement, the lenders provided us with senior unsecured lending facilities of up to $1,500,000, consisting of a $1,000,000 unsecured term loan and a $500,000 unsecured revolving line of credit. Interest on borrowings under the Credit Agreement is based on LIBOR plus a spread which can range from 1.125% to 2.000%. This spread, as well as a commitment fee on the unused portion of the facility, are based on our leverage ratio, as defined in the Credit Agreement. The initial interest rate under the Credit Agreement is LIBOR plus 2.000%. Initial borrowings under the Credit Agreement were $1,000,000 under the unsecured term loan and $200,000 under the unsecured revolving line of credit. The term loan and revolving credit facilities will mature no later than June&#xA0;16, 2020.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Upon certain significant asset dispositions, we agreed to use proceeds from such dispositions to effect prepayment of outstanding loan balances under the Credit Agreement. On August&#xA0;28, 2015, we completed the sale of Patterson Medical, as described further in Note 3 to the Condensed Consolidated Financial Statements. As a result of this sale, $670,000 was repaid on the original outstanding $1,000,000 unsecured term loan. We recorded $5,153 of accelerated debt issuance cost amortization within interest expense concurrent with this early repayment of debt. Additionally, a $4,125 principal payment was made during the three months ended October&#xA0;31, 2015. As of October&#xA0;31, 2015, $325,875 was outstanding under the unsecured term loan.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> We are subject to various financial covenants under the Credit Agreement including the maintenance of leverage and interest coverage ratios. In the event of our default, any outstanding obligations may become due and payable immediately. We met the covenants under the Credit Agreement as of October&#xA0;31, 2015.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> On June&#xA0;16, 2015, our previous $300,000 credit facility, which was due to expire in December 2016, was terminated and replaced by the revolving line of credit under the Credit Agreement. As of October&#xA0;31, 2015, $80,000 was outstanding under our current revolving line of credit. There were no outstanding borrowings under our current or previous revolving lines of credit at April&#xA0;25, 2015.</p> </div> -52952000 <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The following summarizes the intangible assets, excluding goodwill, acquired as of June&#xA0;16, 2015. Intangible assets are amortized using methods that approximate the pattern of economic benefit provided by the utilization of the assets.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="72%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Gross&#xA0;Carrying<br /> Value</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Weighted<br /> Average&#xA0;Life<br /> (years)</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Unamortized &#x2013; indefinite lived:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Trade names</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,300</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">indefinite</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Amortized:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Customer relationships</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">291,900</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">15.0</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Trade names</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">111,400</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">10.0</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Developed technology and other</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">18,700</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">12.2</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Total amortized intangible assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">422,000</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">13.6</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Total identifiable intangible assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">434,300</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Note 9. Segment Reporting</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Through fiscal 2015, Patterson was comprised of three reportable segments: dental supply, veterinary supply and rehabilitation supply. This fiscal year, we reorganized our reportable segments as a result of our acquisition of Animal Health International, Inc. and our divestiture of our wholly-owned subsidiary Patterson Medical Holdings, Inc., the entity through which we operated the rehabilitation supply business. We now present three different reportable segments: Dental, Animal Health and Corporate. Prior period segment results have been restated to conform to this revised current period presentation.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Our Dental and Animal Health reportable business segments are strategic business units that offer similar products and services to different customer bases. Dental provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout North America. Animal Health, formerly our Patterson Veterinary reportable segment, is a leading, full-line distributor in North America and the U.K. of animal health products, services and technologies to both the production-animal and companion-pet markets. Our Corporate segment, which was previously included in our dental supply reporting segment through the end of fiscal 2015, is comprised of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources and facilities. In addition, customer financing and other miscellaneous sales are reported within Corporate results. Corporate assets consist primarily of cash and cash equivalents, accounts receivable, property and equipment and long-term receivables. We evaluate segment performance based on operating income. The costs to operate the distribution centers are allocated to the operating units based on the through-put of the unit.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The following table presents information about Patterson&#x2019;s reportable segments:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="58%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Three Months Ended</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Six Months Ended</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Net sales</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Corporate</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">13,435</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,110</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">23,891</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">18,892</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Dental</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">601,322</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">592,636</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,176,439</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,135,510</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Animal Health</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">774,453</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">376,474</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,331,750</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">762,774</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"> Consolidated net sales</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,389,210</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">978,220</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,532,080</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,917,176</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Operating income (loss) from continuing operations</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Corporate</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(15,808</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(15,623</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(33,855</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(26,163</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Dental</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">74,094</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">73,427</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">141,346</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">135,976</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Animal Health</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">25,177</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">14,336</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">38,149</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">28,323</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"> Consolidated operating income from continuing operations</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">83,463</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">72,140</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">145,640</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">138,136</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="74%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>October 31,</b><br /> <b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>April 25,</b><br /> <b>2015</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Total assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Corporate</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">469,101</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">539,863</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Dental</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">900,668</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,022,257</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Animal Health</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">2,082,069</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">631,445</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"> Total assets, excluding assets held for sale</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">3,451,838</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">2,193,565</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Assets held for sale</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">754,141</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"> Total assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,451,838</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,947,706</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The following table presents sales information by product for all of Patterson&#x2019;s reportable segments:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="58%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Three Months Ended</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Six Months Ended</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Net sales</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Consumables</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,087,489</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">686,165</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,982,796</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,381,804</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Equipment and software</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">207,809</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">204,409</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">361,292</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">360,803</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Other</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">93,912</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">87,646</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">187,992</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">174,569</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"> Consolidated net sales</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,389,210</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">978,220</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,532,080</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,917,176</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> 0.02 899000 <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>Note 3. Discontinued Operations</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> On July&#xA0;1, 2015, we entered into a definitive agreement to sell all of the outstanding shares of common stock of Patterson Medical Holdings, Inc., our wholly owned subsidiary responsible for our rehabilitation supply business known as Patterson Medical (&#x201C;Patterson Medical&#x201D;), for $715,000 in cash to Madison Dearborn Partners. The definitive agreement includes a working capital adjustment provision that impacts the final sale price. On August&#xA0;28, 2015, we completed the sale of Patterson Medical for $718,078, with such sales price including the above-described working capital adjustment. As additional consideration for the shares of Patterson Medical, we obtained a number of common units of the parent company of the buyer equal to 10% of the common units outstanding at closing. Unlike the other common units, these units will only become entitled to begin participating in distributions to the common unit holders at such time, if any, as the Madison Dearborn Partners&#x2019; investor cash inflows equal or exceed 2.5&#xA0;times the Madison Dearborn Partners&#x2019; investor cash outflows. These units are non-transferrable. We recorded a pre-tax gain of $25,520 on the sale of Patterson Medical during the second quarter of fiscal 2016 within discontinued operations in the condensed consolidated statements of income.</p> <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> In connection with the above described transaction, we also entered into a transition services agreement with our former subsidiary, pursuant to which Patterson Medical Holdings, Inc., as owned by Madison Dearborn Partners, is paying us to provide, among other things, certain information technology, distribution, facilities, finance, tax and treasury, and human resources services for up to 24 months after closing.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> As of October&#xA0;31, 2015, we classified Patterson Medical&#x2019;s results of operations as discontinued operations for all periods presented in the condensed consolidated statements of income.&#xA0;The assets and liabilities of Patterson Medical were reflected as held for sale in the condensed consolidated balance sheets as of April&#xA0;25, 2015. The classification was based on our entering into the definitive agreement to sell Patterson Medical during the first quarter of fiscal 2016, the entity being available for sale in its present condition at that time and the sale being completed in the second quarter of fiscal 2016. The operations and cash flows of Patterson Medical have been eliminated from our continuing operations, which were previously recorded as the rehabilitation supply reportable segment.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> The following summarizes the assets and liabilities of Patterson Medical as of April&#xA0;25, 2015:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"> <tr> <td width="87%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>April&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Assets held for sale</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Receivables, net of allowance for doubtful accounts</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">57,876</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Inventory</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">48,265</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Prepaid expenses and other current assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">12,206</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Property and equipment, net</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">22,672</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Goodwill</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">537,175</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Identifiable intangibles, net</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">74,804</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Other long-term assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,143</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"> Total assets held for sale</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">754,141</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Liabilities held for sale</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Accounts payable</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">26,341</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Accrued liabilities and other current liabilities</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">12,975</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Long-term liabilities</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">49,414</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"> Total liabilities held for sale</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">88,730</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> The following summarizes the results of operations of our discontinued Patterson Medical operations for the periods presented:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="61%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"><b>Three Months Ended</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"><b>Six Months Ended</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>October&#xA0;31,<br /> 2015&#xA0;<sup style="FONT-SIZE: 9px; VERTICAL-ALIGN: top">(a)</sup></b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>October&#xA0;25,</b><br /> <b>2014</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>October&#xA0;31,</b><br /> <b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>October&#xA0;25,<br /> 2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Net sales</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">37,693</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">125,105</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">168,504</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">245,678</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Cost of sales</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">24,486</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">78,570</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">107,359</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">153,535</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Operating expenses</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">22,915</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">27,454</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">54,954</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">54,304</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Gain on sale</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(25,520</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(25,520</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-BOTTOM: 1pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"> Other expense (income)</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">60</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">150</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(115</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Income before taxes</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">15,752</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">19,064</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">31,561</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">37,954</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Income taxes</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">22,894</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">7,151</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">29,311</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">14,077</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Net income from discontinued operations</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(7,142</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">11,913</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,250</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">23,877</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><sup style="FONT-SIZE: 11px; VERTICAL-ALIGN: top">(a)</sup>&#xA0;</td> <td valign="top" align="left">Includes activity up until the sale date of August&#xA0;28, 2015.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> Operating expenses for the three and six months ended October&#xA0;31, 2015 include professional fees of $9,842 and $13,692, respectively, incurred in connection with the sale of Patterson Medical. Depreciation and amortization were ceased during the three and six months ended October&#xA0;31, 2015 in accordance with accounting for discontinued operations. Income taxes have been allocated to Patterson Medical based on the accounting requirements for presenting discontinued operations.&#xA0;Income taxes as a percent of income before taxes for both the three and six months ended October&#xA0;31, 2015 are higher than in the respective prior periods as a result of the requirement to calculate the tax due on the sale of Patterson Medical including certain basis differences that were appropriately not previously recognized for financial reporting purposes.</p> </div> --04-30 <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> <i>Basis of Presentation</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of Patterson Companies, Inc. (&#x201C;Patterson&#x201D;) as of October&#xA0;31, 2015, and our results of operations and cash flows for the periods ended October&#xA0;31, 2015 and October&#xA0;25, 2014. Such adjustments are of a normal recurring nature. The results of operations for the periods ended October&#xA0;31, 2015 and October&#xA0;25, 2014 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the financial statements included in our 2015 Annual Report on Form 10-K filed on June&#xA0;24, 2015.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Such unaudited condensed consolidated financial statements include the assets and liabilities of PDC Funding Company, LLC (&#x201C;PDC Funding&#x201D;) and PDC Funding Company II, LLC (&#x201C;PDC Funding II&#x201D;), wholly owned subsidiaries and separate legal entities under Minnesota law. PDC Funding and PDC Funding II are fully consolidated special purpose entities established to sell customer installment sale contracts to outside financial institutions in the normal course of their business. The assets of PDC Funding and PDC Funding II would be available first and foremost to satisfy the claims of its creditors. There are no known creditors of PDC Funding or PDC Funding II.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Through fiscal 2015, Patterson was comprised of three reportable segments: dental supply, veterinary supply and rehabilitation supply. This fiscal year, we reorganized our reportable segments as a result of our acquisition of Animal Health International, Inc. and our divestiture of our wholly-owned subsidiary Patterson Medical Holdings, Inc., the entity through which we operated the rehabilitation supply business. We now present three different reportable segments: Dental, Animal Health and Corporate. Prior period segment results have been restated to conform to this revised current period presentation.</p> </div> <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> The following summarizes the assets and liabilities of Patterson Medical as of April&#xA0;25, 2015:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"> <tr> <td width="87%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>April&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Assets held for sale</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Receivables, net of allowance for doubtful accounts</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">57,876</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Inventory</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">48,265</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Prepaid expenses and other current assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">12,206</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Property and equipment, net</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">22,672</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Goodwill</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">537,175</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Identifiable intangibles, net</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">74,804</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Other long-term assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,143</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"> Total assets held for sale</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">754,141</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Liabilities held for sale</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Accounts payable</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">26,341</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Accrued liabilities and other current liabilities</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">12,975</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Long-term liabilities</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">49,414</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"> Total liabilities held for sale</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">88,730</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> The following summarizes the results of operations of our discontinued Patterson Medical operations for the periods presented:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="61%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"><b>Three Months Ended</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"><b>Six Months Ended</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>October&#xA0;31,<br /> 2015&#xA0;<sup style="FONT-SIZE: 9px; VERTICAL-ALIGN: top">(a)</sup></b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>October&#xA0;25,</b><br /> <b>2014</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>October&#xA0;31,</b><br /> <b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>October&#xA0;25,<br /> 2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Net sales</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">37,693</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">125,105</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">168,504</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">245,678</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Cost of sales</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">24,486</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">78,570</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">107,359</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">153,535</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Operating expenses</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">22,915</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">27,454</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">54,954</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">54,304</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Gain on sale</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(25,520</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(25,520</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-BOTTOM: 1pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"> Other expense (income)</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">60</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">150</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(115</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Income before taxes</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">15,752</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">19,064</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">31,561</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">37,954</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Income taxes</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">22,894</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">7,151</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">29,311</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">14,077</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Net income from discontinued operations</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(7,142</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">11,913</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,250</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">23,877</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><sup style="FONT-SIZE: 11px; VERTICAL-ALIGN: top">(a)</sup>&#xA0;</td> <td valign="top" align="left">Includes activity up until the sale date of August&#xA0;28, 2015.</td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <i>Fiscal Year End</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> We operate with a 52-53 week accounting convention with our fiscal year ending on the last Saturday in April. The second quarters of fiscal 2016 and 2015 include the 13 weeks ended October&#xA0;31, 2015 and October&#xA0;25, 2014, respectively. The six months ended October&#xA0;31, 2015 and October&#xA0;25, 2014 include 27 and 26 weeks, respectively. Fiscal 2016 will include 53 weeks and fiscal 2015 included 52 weeks of operations.</p> </div> Q2 <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Goodwill balances and related activity by business segment are as follows:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="57%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Balance at<br /> April&#xA0;25,<br /> 2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Acquisition<br /> Activity&#xA0;and<br /> Divestitures</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Other&#xA0;Activity</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Balance at<br /> October&#xA0;31,<br /> 2015</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Corporate</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Dental</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">139,449</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(738</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">138,711</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Animal Health</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">160,475</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">518,370</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">39</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">678,884</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Total</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">&#xA0;299,924</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">518,370</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(699</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">817,595</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"> <i>Earnings Per Share</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The following table sets forth the computation of the weighted average shares outstanding used to calculate basic and diluted earnings per share (&#x201C;EPS&#x201D;):</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="60%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Three Months Ended</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Six Months Ended</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Denominator for basic EPS&#xA0;&#x2013;&#xA0;weighted average shares</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">98,525</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">98,802</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">98,981</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">99,066</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Effect of dilutive securities</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">660</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">574</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">693</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">713</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Denominator for diluted EPS&#xA0;&#x2013;&#xA0;weighted average shares</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">99,185</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">99,376</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">99,674</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">99,779</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Potentially dilutive securities consisting of stock options, restricted stock and stock purchase plans representing 899 shares for the three and six months ended October&#xA0;31, 2015 and 124 shares for the three and six months ended October&#xA0;25, 2014 were excluded from the calculation of diluted earnings per share because their effect would have been anti-dilutive.</p> </div> 98981000 <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Note 6. Fair Value Measurements</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Fair value is the price at which an asset could be exchanged in a current transaction between knowledgeable, willing parties. The fair value hierarchy of measurements is categorized into one of three levels based on the lowest level of significant input used:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="2%">&#xA0;</td> <td valign="top" width="8%" align="left"> <b>Level&#xA0;1</b>&#xA0;-</td> <td valign="top" align="left">Quoted prices in active markets for identical assets and liabilities at the measurement date.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="2%">&#xA0;</td> <td valign="top" width="8%" align="left"> <b>Level&#xA0;2</b>&#xA0;-</td> <td valign="top" align="left">Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="2%">&#xA0;</td> <td valign="top" width="8%" align="left"> <b>Level&#xA0;3</b>&#xA0;-</td> <td valign="top" align="left">Unobservable inputs for which there is little or no market data available. These inputs reflect management&#x2019;s assumptions of what market participants would use in pricing the asset or liability.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"> Our hierarchy for assets and liabilities measured at fair value on a recurring basis is as follows:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="71%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="14" align="center"><b>October&#xA0;31, 2015</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Total</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Level 1</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Level 2</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Level 3</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Assets:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Cash equivalents</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">4,949</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">4,949</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Derivative instruments</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">835</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">835</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Total assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,784</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">4,949</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">835</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Liabilities:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Derivative instruments</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">835</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">835</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 1pt"> <td height="16"></td> <td height="16" colspan="16"></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="14" align="center"><b>April 25, 2015</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Total</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Level 1</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Level 2</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Level&#xA0;3</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Assets:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Cash equivalents</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">90,569</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">90,569</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Derivative instruments</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,255</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,255</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Total assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">91,824</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">90,569</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,255</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Liabilities:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Derivative instruments</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,255</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,255</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> <i>Cash equivalents</i> &#x2013; We value cash equivalents at their current market rates. The carrying value of cash equivalents approximates fair value and maturities are less than three months.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> <i>Derivative instruments</i> &#x2013; Our derivative instruments consist of interest rate contracts. These instruments are valued using observable inputs such as interest rates and credit spreads.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Certain assets are measured at fair value on a non-recurring basis. These assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments under certain circumstances, such as when there is evidence of impairment. There were no fair value adjustments to such assets during the six-month periods ended October&#xA0;31, 2015 or October&#xA0;25, 2014.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Our debt is not measured at fair value in the condensed consolidated balance sheets. The estimated fair value of our debt as of October&#xA0;31, 2015 and April&#xA0;25, 2015 was $1,058,425 and $746,685, respectively. The fair value of debt was measured using a discounted cash flow analysis based on expected market based yields (i.e. level 2 inputs).</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The carrying amounts of receivables, net of allowances, accounts payable, and certain accrued and other current liabilities approximated fair value at October&#xA0;31, 2015 and April&#xA0;25, 2015.</p> </div> <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <i>Recently Issued Accounting Pronouncements</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> In May 2014, the Financial Accounting Standards Board (&#x201C;FASB&#x201D;) issued Accounting Standards Update (&#x201C;ASU&#x201D;) No.&#xA0;2014-09, &#x201C;Revenue from Contracts with Customers (Topic 606).&#x201D; ASU No.&#xA0;2014-09 supersedes the revenue recognition requirements in &#x201C;Revenue Recognition (Topic 605),&#x201D; and requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In July 2015, the FASB deferred the effective date of this pronouncement by one year to December&#xA0;15, 2017 for interim and annual reporting periods beginning after that date. Early adoption is permitted, but not before the original effective date, which for annual periods was December&#xA0;15, 2016. We are evaluating the new standard, but do not, at this time, anticipate a material impact to our financial statements once implemented.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> In July 2015, the FASB issued ASU No.&#xA0;2015-11, &#x201C;Inventory (Topic 330), Simplifying the Measurement of Inventory.&#x201D; ASU 2015-11 requires inventory measured using any method other than last-in, first-out (LIFO) or the retail inventory method to be subsequently measured at the lower of cost or net realizable value, rather than at the lower of cost or market. Subsequent measurement of inventory using the LIFO and retail inventory method is unchanged. We are required to adopt the new pronouncement in the first quarter of fiscal 2018, and plan to do so at that time. Early adoption is permitted. We are evaluating the effect of adopting this pronouncement, but do not, at this time, anticipate a material impact to our financial statements once implemented.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> In August 2015, the FASB issued ASU No.&#xA0;2015-15, &#x201C;Interest &#x2013; Imputation of Interest (Subtopic 835-30), Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements.&#x201D; This ASU states that ASU No.&#xA0;2015-03, &#x201C;Interest &#x2013; Imputation of Interest (Subtopic 835-30), Simplifying the Presentation of Debt Issuance Costs&#x201D; does not address debt issuance costs for line-of-credit arrangements, and therefore the SEC staff would not object to an entity deferring and presenting these related debt issuance costs as an asset and subsequently amortizing the deferred issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. At this time, we do not believe that ASU No.&#xA0;2015-15 will have a material impact on our financial statements and related disclosures.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> In September 2015, the FASB issued ASU No.&#xA0;2015-16, &#x201C;Business Combinations (Topic 805), Simplifying the Accounting for Measurement-Period Adjustments.&#x201D; This ASU requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. The amendments in this ASU require an entity to present separately on the face of the income statement or disclose in the notes the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. We are required to adopt the new pronouncement in the first quarter of fiscal 2017, with early adoption permitted. We are evaluating the effect and timing of adopting this pronouncement, but do not, at this time, anticipate a material impact to the financial statements once implemented.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> In November 2015, the FASB issued ASU No.&#xA0;2015-17, &#x201C;Income Taxes (Topic 740), Balance Sheet Classification of Income Taxes.&#x201D; This ASU eliminates the current requirement for an entity to separate deferred income tax liabilities and assets into current and noncurrent amounts in a classified statement of financial position. This ASU requires that deferred tax liabilities and assets be classified as noncurrent in the classified statement of financial position. We are required to adopt the ASU in the first quarter of fiscal 2018, with early adoption permitted. We are evaluating the effect and timing of adopting this pronouncement, but do not, at this time, anticipate a material impact to the financial statements once implemented.</p> </div> 0.467 <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>Note 2. Acquisitions</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> During our first fiscal quarter of 2016, we completed the acquisition of Animal Health International, Inc., a leading production animal health distribution company in the U.S. This acquisition more than doubled the revenue previously attributable to our animal health business, which was previously focused on the companion animal health market. Our animal health business now offers an expanded range of products and services to a broader base of customers in North America and the U.K. Under terms of the merger agreement, we acquired all of Animal Health International&#x2019;s stock for $1,100,000 in cash, subject to customary working capital adjustments.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> In connection with the acquisition, we entered into a credit agreement consisting of a $1,000,000 unsecured term loan and a $500,000 unsecured cash flow revolving line of credit, described further in Note 11 to the Condensed Consolidated Financial Statements.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> The acquisition has been accounted for in accordance with ASC 805,&#xA0;<i>Business Combinations</i>, with identifiable assets acquired and liabilities assumed recorded at their estimated fair values on the acquisition date. A valuation of the assets and liabilities from the business acquisition was performed utilizing cost, income and market approaches resulting in $589,833 allocated to identifiable net assets. The initial accounting for the acquisition is not complete because certain information and analysis that may impact our initial valuations are still being obtained or reviewed. The significant assets and liabilities for which provisional amounts are recognized at the acquisition date are property and equipment, intangible assets, goodwill, working capital adjustments and deferred income taxes. The provisional amounts recognized are subject to revision until our valuations are completed, not to exceed one year, and any material adjustments identified that existed as of the acquisition date will be retroactively recorded.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> The following table summarizes the total purchase price consideration and the preliminary fair value amounts recognized for the assets acquired and liabilities assumed related to the acquisition, as of the acquisition date:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"> <tr> <td width="85%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Total purchase price consideration</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,108,203</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Receivables</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">161,427</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Inventory</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">195,367</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Prepaid expenses and other current assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">33,005</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Property and equipment</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">44,178</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Identifiable intangibles</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">434,300</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Other long-term assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">40,869</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Total assets acquired</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">909,146</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Accounts payable</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">122,129</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Accrued liabilities and other current liabilities</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">19,395</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Deferred tax liability</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">177,789</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Total liabilities assumed</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">319,313</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Identifiable net assets acquired</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">589,833</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Goodwill</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">518,370</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Net assets acquired</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,108,203</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> As a result of recording the stepped up fair market basis for GAAP purposes, but receiving primarily carryover basis for tax purposes in the acquisition, we recorded a deferred tax asset and deferred tax liability of $2,569 and $177,789, respectively.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> The goodwill of $518,370 resulting from the acquisition reflects the excess of our purchase price over the fair value of the net assets acquired. An adjustment to increase goodwill by $499 was recorded in the second quarter of fiscal 2016 as a result of working capital adjustments. The goodwill recorded as part of the acquisition primarily reflects the value of the assembled workforce, cost synergies, and the potential to integrate and expand existing product lines. We allocated all of the goodwill to our Animal Health reporting segment. None of the goodwill recognized is deductible for income tax purposes, and as such, no deferred taxes have been recorded related to goodwill.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> Revenues of $585,950 and operating income of $12,369 attributable to the acquisition are included in our condensed consolidated statement of income for the six months ended October&#xA0;31, 2015. Included in operating income for the six months ended October&#xA0;31, 2015 is amortization expense of $12,048 related to the identifiable intangible assets acquired in the transaction.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> The following summarizes the intangible assets, excluding goodwill, acquired as of June&#xA0;16, 2015. Intangible assets are amortized using methods that approximate the pattern of economic benefit provided by the utilization of the assets.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="72%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Gross&#xA0;Carrying<br /> Value</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Weighted<br /> Average&#xA0;Life<br /> (years)</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Unamortized &#x2013; indefinite lived:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Trade names</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,300</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">indefinite</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Amortized:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Customer relationships</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">291,900</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">15.0</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Trade names</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">111,400</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">10.0</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Developed technology and other</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">18,700</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">12.2</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Total amortized intangible assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">422,000</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">13.6</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Total identifiable intangible assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">434,300</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> The following unaudited pro forma financial results for the combined results of Patterson and Animal Health International for the six month periods ended October&#xA0;31, 2015 and October&#xA0;25, 2014 assume the acquisition occurred on April&#xA0;27, 2014. The unaudited pro forma financial results may not be indicative of the results that would have occurred had the acquisition been completed as of April&#xA0;27, 2014, nor are they indicative of future results of operations.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="74%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"><b>Six Months Ended</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Pro forma net sales</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,725,116</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,650,613</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Pro forma net income from continuing operations</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">70,957</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">74,754</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> Pro forma net income from continuing operations for the six month period ended October&#xA0;31, 2015 includes $12,300 of income tax expense related to the repatriation of foreign earnings, described further in Note 12 to the Condensed Consolidated Financial Statements.</p> </div> 0.63 <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> The following table presents the effect of interest rate contracts on the condensed consolidated statements of income and other comprehensive income (OCI):</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="51%"></td> <td valign="bottom" width="6%"></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Three Months Ended</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Six Months Ended</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 52.15pt"> <b>Derivative type</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom"> <b>Location&#xA0;of&#xA0;gain/(loss)</b><br /> <b>recognized&#xA0;on&#xA0;derivative</b></td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>October&#xA0;31,<br /> 2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>October&#xA0;25,<br /> 2014</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>October&#xA0;31,<br /> 2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>October&#xA0;25,<br /> 2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Interest rate swap</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">OCI</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">437</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,867</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,054</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(6,176</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> </table> </div> -13967000 <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Note 10. Accumulated Other Comprehensive Loss</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The following table summarizes accumulated other comprehensive loss (AOCL) at October&#xA0;31, 2015 and April&#xA0;25, 2015 and the activity for fiscal 2016:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"> <tr> <td width="70%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Cash&#xA0;Flow</b><br /> <b>Hedges</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Currency</b><br /> <b>Translation</b><br /> <b>Adjustment</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Total</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> AOCL at April&#xA0;25, 2015</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(18,668</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(41,678</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(60,346</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Other comprehensive loss before reclassifications</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(15,417</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(15,417</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Amounts reclassified from AOCL</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,054</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">11,083</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">12,137</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> AOCL at October&#xA0;31, 2015</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(17,614</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(46,012</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(63,626</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"> The amounts reclassified from AOCL during fiscal 2016 represent gains and losses on cash flow hedges, net of taxes of $350, and amounts reclassified related to the divestiture of Patterson Medical of $11,083. The net impact to the condensed consolidated statements of income was an increase to interest expense of $1,405.</p> </div> <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The unaudited pro forma financial results may not be indicative of the results that would have occurred had the acquisition been completed as of April&#xA0;27, 2014, nor are they indicative of future results of operations.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="74%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Six Months Ended</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Pro forma net sales</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,725,116</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,650,613</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Pro forma net income from continuing operations</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">70,957</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">74,754</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The following table presents sales information by product for all of Patterson&#x2019;s reportable segments:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="58%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Three Months Ended</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Six Months Ended</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Net sales</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Consumables</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,087,489</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">686,165</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,982,796</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,381,804</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Equipment and software</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">207,809</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">204,409</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">361,292</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">360,803</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Other</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">93,912</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">87,646</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">187,992</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">174,569</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"> Consolidated net sales</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,389,210</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">978,220</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,532,080</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,917,176</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> false 0.64 <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Note 4. Goodwill and Other Intangible Assets</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Goodwill balances and related activity by business segment are as follows:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="57%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Balance at<br /> April&#xA0;25,<br /> 2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Acquisition<br /> Activity&#xA0;and<br /> Divestitures</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Other&#xA0;Activity</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Balance at<br /> October&#xA0;31,<br /> 2015</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Corporate</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Dental</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">139,449</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(738</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">138,711</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Animal Health</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">160,475</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">518,370</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">39</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">678,884</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Total</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">&#xA0;299,924</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">518,370</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(699</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">817,595</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Balances of other intangible assets, excluding goodwill, are as follows:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="76%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>April&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Unamortized &#x2013; indefinite lived:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Copyrights, trade names and trademarks</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">29,900</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">17,600</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Amortized:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Distribution agreement, customer lists and other</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">642,614</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">221,359</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Less: Accumulated amortization</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(135,435</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(113,934</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"> Net amortized intangible assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">507,179</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">107,425</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Total identifiable intangible assets, net</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">537,079</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">125,025</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Note 13. Legal Proceedings</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> In September 2015, we were served with a summons and complaint in an action commenced in the United States District Court for the Eastern District of New York, entitled SourceOne Dental, Inc. v. Patterson Companies, Inc., Henry Schein, Inc. and Benco Dental Supply Company, Civil Action No.&#xA0;15-cv-05440-JMA-GRB. SourceOne, as plaintiff, alleges that, through its website, it markets and sells dental supplies and equipment to dentists. SourceOne alleges in the complaint, among other things, that we, along with the defendants Henry Schein and Benco, conspired to eliminate plaintiff as a competitor and to exclude them from the market for the marketing, distribution and sale of dental supplies and equipment in the United States and that defendants unlawfully agreed with one another to boycott dentists, manufacturers, and state dental associations that deal with, or considered dealing with, plaintiff. Plaintiff asserts the following claims: (i)&#xA0;unreasonable restraint of trade in violation of state and federal antitrust laws; (ii)&#xA0;tortious interference with prospective business relations; (iii)&#xA0;civil conspiracy; and (iv)&#xA0;aiding and abetting the other defendants&#x2019; ongoing tortious and anticompetitive conduct. Plaintiff seeks equitable relief, compensatory and treble damages, jointly and severally, punitive damages, interest, and reasonable costs and expenses, including attorneys&#x2019; fees and expert fees. Plaintiff has not specified a damage amount in its complaint. We intend to defend ourselves against the action vigorously. We do not anticipate that this matter will have a material adverse effect on our financial condition.</p> </div> PATTERSON COMPANIES, INC. <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> <b>Note 1. General</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> <i>Basis of Presentation</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of Patterson Companies, Inc. (&#x201C;Patterson&#x201D;) as of October&#xA0;31, 2015, and our results of operations and cash flows for the periods ended October&#xA0;31, 2015 and October&#xA0;25, 2014. Such adjustments are of a normal recurring nature. The results of operations for the periods ended October&#xA0;31, 2015 and October&#xA0;25, 2014 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the financial statements included in our 2015 Annual Report on Form 10-K filed on June&#xA0;24, 2015.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Such unaudited condensed consolidated financial statements include the assets and liabilities of PDC Funding Company, LLC (&#x201C;PDC Funding&#x201D;) and PDC Funding Company II, LLC (&#x201C;PDC Funding II&#x201D;), wholly owned subsidiaries and separate legal entities under Minnesota law. PDC Funding and PDC Funding II are fully consolidated special purpose entities established to sell customer installment sale contracts to outside financial institutions in the normal course of their business. The assets of PDC Funding and PDC Funding II would be available first and foremost to satisfy the claims of its creditors. There are no known creditors of PDC Funding or PDC Funding II.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Through fiscal 2015, Patterson was comprised of three reportable segments: dental supply, veterinary supply and rehabilitation supply. This fiscal year, we reorganized our reportable segments as a result of our acquisition of Animal Health International, Inc. and our divestiture of our wholly-owned subsidiary Patterson Medical Holdings, Inc., the entity through which we operated the rehabilitation supply business. We now present three different reportable segments: Dental, Animal Health and Corporate. Prior period segment results have been restated to conform to this revised current period presentation.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <i>Fiscal Year End</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> We operate with a 52-53 week accounting convention with our fiscal year ending on the last Saturday in April. The second quarters of fiscal 2016 and 2015 include the 13 weeks ended October&#xA0;31, 2015 and October&#xA0;25, 2014, respectively. The six months ended October&#xA0;31, 2015 and October&#xA0;25, 2014 include 27 and 26 weeks, respectively. Fiscal 2016 will include 53 weeks and fiscal 2015 included 52 weeks of operations.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <i>Comprehensive Income</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Comprehensive income is computed as net income including certain other items that are recorded directly to stockholders&#x2019; equity. Significant items included in comprehensive income are foreign currency translation adjustments and the effective portion of cash flow hedges, net of tax. Foreign currency translation adjustments do not include a provision for income tax on earnings from foreign operations that are considered to be indefinitely reinvested outside the U.S. The income tax benefit/(loss) related to cash flow hedges was $(265) and $2,321 for the three months ended October&#xA0;31, 2015 and October&#xA0;25, 2014, respectively. The income tax benefit/(loss) related to cash flow hedges was $(350) and $7,134 for the six months ended October&#xA0;31, 2015 and October&#xA0;25, 2014, respectively.</p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 18px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"> <i>Earnings Per Share</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The following table sets forth the computation of the weighted average shares outstanding used to calculate basic and diluted earnings per share (&#x201C;EPS&#x201D;):</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="60%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Three Months Ended</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Six Months Ended</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Denominator for basic EPS&#xA0;&#x2013;&#xA0;weighted average shares</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">98,525</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">98,802</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">98,981</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">99,066</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Effect of dilutive securities</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">660</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">574</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">693</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">713</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Denominator for diluted EPS&#xA0;&#x2013;&#xA0;weighted average shares</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">99,185</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">99,376</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">99,674</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">99,779</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Potentially dilutive securities consisting of stock options, restricted stock and stock purchase plans representing 899 shares for the three and six months ended October&#xA0;31, 2015 and 124 shares for the three and six months ended October&#xA0;25, 2014 were excluded from the calculation of diluted earnings per share because their effect would have been anti-dilutive.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <i>Recently Issued Accounting Pronouncements</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> In May 2014, the Financial Accounting Standards Board (&#x201C;FASB&#x201D;) issued Accounting Standards Update (&#x201C;ASU&#x201D;) No.&#xA0;2014-09, &#x201C;Revenue from Contracts with Customers (Topic 606).&#x201D; ASU No.&#xA0;2014-09 supersedes the revenue recognition requirements in &#x201C;Revenue Recognition (Topic 605),&#x201D; and requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In July 2015, the FASB deferred the effective date of this pronouncement by one year to December&#xA0;15, 2017 for interim and annual reporting periods beginning after that date. Early adoption is permitted, but not before the original effective date, which for annual periods was December&#xA0;15, 2016. We are evaluating the new standard, but do not, at this time, anticipate a material impact to our financial statements once implemented.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> In July 2015, the FASB issued ASU No.&#xA0;2015-11, &#x201C;Inventory (Topic 330), Simplifying the Measurement of Inventory.&#x201D; ASU 2015-11 requires inventory measured using any method other than last-in, first-out (LIFO) or the retail inventory method to be subsequently measured at the lower of cost or net realizable value, rather than at the lower of cost or market. Subsequent measurement of inventory using the LIFO and retail inventory method is unchanged. We are required to adopt the new pronouncement in the first quarter of fiscal 2018, and plan to do so at that time. Early adoption is permitted. We are evaluating the effect of adopting this pronouncement, but do not, at this time, anticipate a material impact to our financial statements once implemented.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> In August 2015, the FASB issued ASU No.&#xA0;2015-15, &#x201C;Interest &#x2013; Imputation of Interest (Subtopic 835-30), Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements.&#x201D; This ASU states that ASU No.&#xA0;2015-03, &#x201C;Interest &#x2013; Imputation of Interest (Subtopic 835-30), Simplifying the Presentation of Debt Issuance Costs&#x201D; does not address debt issuance costs for line-of-credit arrangements, and therefore the SEC staff would not object to an entity deferring and presenting these related debt issuance costs as an asset and subsequently amortizing the deferred issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. At this time, we do not believe that ASU No.&#xA0;2015-15 will have a material impact on our financial statements and related disclosures.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> In September 2015, the FASB issued ASU No.&#xA0;2015-16, &#x201C;Business Combinations (Topic 805), Simplifying the Accounting for Measurement-Period Adjustments.&#x201D; This ASU requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. The amendments in this ASU require an entity to present separately on the face of the income statement or disclose in the notes the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. We are required to adopt the new pronouncement in the first quarter of fiscal 2017, with early adoption permitted. We are evaluating the effect and timing of adopting this pronouncement, but do not, at this time, anticipate a material impact to the financial statements once implemented.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> In November 2015, the FASB issued ASU No.&#xA0;2015-17, &#x201C;Income Taxes (Topic 740), Balance Sheet Classification of Income Taxes.&#x201D; This ASU eliminates the current requirement for an entity to separate deferred income tax liabilities and assets into current and noncurrent amounts in a classified statement of financial position. This ASU requires that deferred tax liabilities and assets be classified as noncurrent in the classified statement of financial position. We are required to adopt the ASU in the first quarter of fiscal 2018, with early adoption permitted. We are evaluating the effect and timing of adopting this pronouncement, but do not, at this time, anticipate a material impact to the financial statements once implemented.</p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 18px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"> <i>Reclassifications</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Certain prior year amounts have been reclassified to conform to the current year presentation.</p> </div> <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Note 12. Income Taxes</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The effective income tax rate for the three months ended October&#xA0;31, 2015 was 36.7% compared to 35.0% for the three months ended October&#xA0;25, 2014, and for the six months ended October&#xA0;31, 2015 was 46.7% compared to 34.8% for the six months ended October&#xA0;25, 2014. The increases in the rates for both periods were primarily due to the current year impact of cash repatriation and the impact of transaction-related costs incurred related to the acquisition of Animal Health International, Inc.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> In the first quarter of fiscal 2016, we approved a one-time repatriation of approximately $200,000 of foreign earnings. This one-time repatriation reduced the overall cost of funding the acquisition of Animal Health International, Inc. In addition, certain foreign cash at Patterson Medical was required to be repatriated as part of the sale transaction. The continuing operations tax impact of $12,300 from the repatriation was recorded during the first six months of fiscal 2016. We have previously asserted that our foreign earnings are permanently reinvested. Except for the repatriations described above, there is no change in our on-going assertion.</p> </div> 3 0.66 <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"> Our hierarchy for assets and liabilities measured at fair value on a recurring basis is as follows:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="71%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="14" align="center"><b>October&#xA0;31, 2015</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Total</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Level 1</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Level 2</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Level 3</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Assets:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Cash equivalents</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">4,949</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">4,949</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Derivative instruments</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">835</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">835</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Total assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,784</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">4,949</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">835</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Liabilities:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Derivative instruments</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">835</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">835</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 1pt"> <td height="16"></td> <td height="16" colspan="16"></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="14" align="center"><b>April 25, 2015</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Total</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Level 1</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Level 2</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Level&#xA0;3</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Assets:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Cash equivalents</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">90,569</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">90,569</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Derivative instruments</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,255</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,255</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Total assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">91,824</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">90,569</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,255</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Liabilities:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Derivative instruments</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,255</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,255</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> 2016 0.02 99674000 <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> The following table summarizes the total purchase price consideration and the preliminary fair value amounts recognized for the assets acquired and liabilities assumed related to the acquisition, as of the acquisition date:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"> <tr> <td width="85%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Total purchase price consideration</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,108,203</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Receivables</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">161,427</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Inventory</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">195,367</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Prepaid expenses and other current assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">33,005</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Property and equipment</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">44,178</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Identifiable intangibles</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">434,300</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Other long-term assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">40,869</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Total assets acquired</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">909,146</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Accounts payable</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">122,129</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Accrued liabilities and other current liabilities</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">19,395</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Deferred tax liability</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">177,789</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Total liabilities assumed</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">319,313</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Identifiable net assets acquired</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">589,833</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Goodwill</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">518,370</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Net assets acquired</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,108,203</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> </div> 0.65 <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <i>Comprehensive Income</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Comprehensive income is computed as net income including certain other items that are recorded directly to stockholders&#x2019; equity. Significant items included in comprehensive income are foreign currency translation adjustments and the effective portion of cash flow hedges, net of tax. Foreign currency translation adjustments do not include a provision for income tax on earnings from foreign operations that are considered to be indefinitely reinvested outside the U.S. The income tax benefit/(loss) related to cash flow hedges was $(265) and $2,321 for the three months ended October&#xA0;31, 2015 and October&#xA0;25, 2014, respectively. The income tax benefit/(loss) related to cash flow hedges was $(350) and $7,134 for the six months ended October&#xA0;31, 2015 and October&#xA0;25, 2014, respectively.</p> </div> <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The following table presents information about Patterson&#x2019;s reportable segments:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="58%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Three Months Ended</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Six Months Ended</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Net sales</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Corporate</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">13,435</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,110</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">23,891</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">18,892</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Dental</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">601,322</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">592,636</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,176,439</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,135,510</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Animal Health</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">774,453</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">376,474</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,331,750</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">762,774</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"> Consolidated net sales</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,389,210</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">978,220</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,532,080</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,917,176</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Operating income (loss) from continuing operations</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Corporate</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(15,808</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(15,623</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(33,855</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(26,163</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Dental</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">74,094</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">73,427</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">141,346</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">135,976</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Animal Health</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">25,177</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">14,336</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">38,149</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">28,323</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"> Consolidated operating income from continuing operations</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">83,463</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">72,140</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">145,640</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">138,136</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="74%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>October 31,</b><br /> <b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>April 25,</b><br /> <b>2015</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Total assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Corporate</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">469,101</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">539,863</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Dental</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">900,668</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,022,257</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Animal Health</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">2,082,069</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">631,445</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"> Total assets, excluding assets held for sale</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">3,451,838</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">2,193,565</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Assets held for sale</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">754,141</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"> Total assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,451,838</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,947,706</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Note 5. Derivative Financial Instruments</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Patterson is a party to certain offsetting and identical interest rate cap agreements. These interest rate cap agreements are not designated for hedge accounting treatment and were entered into to fulfill certain covenants of an equipment finance contracts sale agreement between a commercial paper conduit managed by The Bank of Tokyo-Mitsubishi UFJ, Ltd. and PDC Funding. On November&#xA0;25, 2014, this sale agreement was amended on terms generally consistent with the expiring agreement. The interest rate cap agreements provide a credit enhancement feature for the financing contracts sold by PDC Funding to the commercial paper conduit.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The interest rate cap agreements are cancelled and new agreements entered into periodically to maintain consistency with the dollar maximum of the sale agreements and the maturity of the underlying financing contracts. As of October&#xA0;31, 2015, PDC Funding had purchased an interest rate cap from a bank with a notional amount of $500,000 and a maturity date of February 2022. Patterson sold an identical interest rate cap to the same bank.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Similar to the above agreements, PDC Funding II and Patterson entered into offsetting and identical interest rate cap agreements with a notional amount of $100,000 in fiscal 2014. In August 2015, these agreements were terminated and replaced with offsetting and identical interest rate cap agreements. The notional amount remained at $100,000 and the new maturity date is July 2023.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> In addition to the purchased and sold identical interest rate cap agreements described above, in May 2012 we entered into an interest rate swap agreement with a bank to economically hedge the interest rate risk associated with a portion of the finance contracts we had sold through the special purpose entities. This agreement expired in April 2015.</p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"> These interest rate contracts do not qualify for hedge accounting treatment and, accordingly, we record the fair value of the agreements as an asset or liability and the change as income or expense during the period in which the change occurs.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> In January 2014 we entered into a forward interest rate swap agreement with a notional amount of $250,000 and accounted for as cash flow hedge, to hedge interest rate fluctuations in anticipation of refinancing the 5.17% senior notes due March&#xA0;25, 2015 with a loan for $250,000 and a term of ten years. This note was repaid on March&#xA0;25, 2015 and replaced with new $250,000 3.48% senior notes due March&#xA0;24, 2025. A cash payment of $29,003 was made in March 2015 to settle the interest rate swap. This amount will be recognized as interest expense over the ten-year life of the new notes.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The following presents the fair value of interest rate contracts included in the condensed consolidated balance sheets:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"> <tr> <td width="42%"></td> <td valign="bottom" width="5%"></td> <td width="36%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>April&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 52.15pt"> <b>Derivative type</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 46.1pt"> <b>Classification</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Interest rate contracts</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Other&#xA0;noncurrent assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">835</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,255</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Interest rate contracts</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Other&#xA0;noncurrent liabilities</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">835</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,255</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> The following table presents the effect of interest rate contracts on the condensed consolidated statements of income and other comprehensive income (OCI):</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="51%"></td> <td valign="bottom" width="6%"></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Three Months Ended</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Six Months Ended</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 52.15pt"> <b>Derivative type</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom"> <b>Location&#xA0;of&#xA0;gain/(loss)</b><br /> <b>recognized&#xA0;on&#xA0;derivative</b></td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>October&#xA0;31,<br /> 2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>October&#xA0;25,<br /> 2014</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>October&#xA0;31,<br /> 2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>October&#xA0;25,<br /> 2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Interest rate swap</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">OCI</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">437</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,867</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,054</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(6,176</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> We recorded $703 of interest expense during the three months ended October&#xA0;31, 2015, and $49 as a reduction to interest expense in the three months ended October&#xA0;25, 2014 related to the interest rate swap. We recorded $1,405 of interest expense during the six months ended October&#xA0;31, 2015, and $97 as a reduction to interest expense in the six months ended October&#xA0;25, 2014 related to the interest rate swap. We recorded no ineffectiveness during the three and six month periods ended October&#xA0;31, 2015 and October&#xA0;25, 2014.</p> </div> <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The following table summarizes accumulated other comprehensive loss (AOCL) at October&#xA0;31, 2015 and April&#xA0;25, 2015 and the activity for fiscal 2016:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"> <tr> <td width="70%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Cash&#xA0;Flow</b><br /> <b>Hedges</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Currency</b><br /> <b>Translation</b><br /> <b>Adjustment</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Total</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> AOCL at April&#xA0;25, 2015</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(18,668</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(41,678</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(60,346</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Other comprehensive loss before reclassifications</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(15,417</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(15,417</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Amounts reclassified from AOCL</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,054</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">11,083</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">12,137</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> AOCL at October&#xA0;31, 2015</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(17,614</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(46,012</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(63,626</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> 693000 1686000 61844000 40978000 11600000 1105229000 1624000 -15417000 142939000 31561000 145640000 62874000 117967000 70957000 2532080000 2250000 1054000 45356000 674125000 137923000 168504000 65124000 619143000 -4334000 160579000 2250000 2725116000 29297000 -8058000 473503000 13692000 16791000 191234000 29311000 107359000 1912937000 55093000 48744000 5153000 -12137000 80000000 5674000 715430000 518370000 -699000 -251809000 54954000 -38985000 1000000000 12300000 21609000 2894000 13541000 -382033000 350000 -1097463000 0.01 <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Balances of other intangible assets, excluding goodwill, are as follows:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="76%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>October&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" colspan="2" align="center"> <b>April&#xA0;25,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Unamortized &#x2013; indefinite lived:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Copyrights, trade names and trademarks</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">29,900</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">17,600</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Amortized:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Distribution agreement, customer lists and other</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">642,614</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">221,359</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Less: Accumulated amortization</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(135,435</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(113,934</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"> Net amortized intangible assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">507,179</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">107,425</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Total identifiable intangible assets, net</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">537,079</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">125,025</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> 2 1405000 <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Note 8. Customer Financing</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> As a convenience to our customers, we offer several different financing alternatives, including a third party program and a Company-sponsored program. For the third party program, we act as a facilitator between the customer and the third party financing entity with no on-going involvement in the financing transaction. Under our sponsored program, equipment purchased by customers with strong credit may be financed up to a maximum of $500 for any one customer. We generally sell our customers&#x2019; financing contracts to outside financial institutions in the normal course of our business. We currently have two arrangements under which we sell these contracts.</p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"> First, we operate under an agreement to sell a portion of our equipment finance contracts to commercial paper conduits with The Bank of Tokyo-Mitsubishi UFJ, Ltd. serving as the agent. We utilize a special purpose entity (&#x201C;SPE&#x201D;), PDC Funding, a consolidated, wholly owned subsidiary, to fulfill a requirement of participating in the commercial paper conduit. We receive the proceeds of the contracts upon sale. At least 13% of the proceeds are held by the conduit as security against eventual performance of the portfolio. The capacity under the agreement at October&#xA0;31, 2015 was $500,000.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Second, we also maintain an agreement with Fifth Third Bank whereby the bank purchases customers&#x2019; financing contracts. We established another SPE, PDC Funding II, a consolidated, wholly owned subsidiary, which sells financing contracts to the bank. We receive the proceeds of the contracts upon sale. At least 14% of the proceeds are held by the conduit as security against eventual performance of the portfolio. The capacity under the agreement at October&#xA0;31, 2015 was $100,000.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The portion of the purchase price for the receivables held by the conduits is a deferred purchase price receivable, which is paid to the SPE as payments on the receivables are collected from customers. The deferred purchase price receivable represents a beneficial interest in the transferred financial assets and is recognized at fair value as part of the sale transaction. We value the deferred purchase price receivable based on a discounted cash flow analysis using unobservable inputs (i.e. level 3 inputs), which include a forward yield curve, the estimated timing of payments and the credit quality of the underlying creditor. Significant changes in any of the significant unobservable inputs in isolation would not result in a materially different fair value estimate. The interrelationship between these inputs is insignificant.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> These financing arrangements are accounted for as a sale of assets under the provisions of ASC 860, <i>Transfers and Servicing</i>. During the three and six months ended October&#xA0;31, 2015, we sold $48,172 and $142,939, respectively, and during the three and six months ended October&#xA0;25, 2014, we sold $47,059 and&#xA0;$132,148, respectively, of contracts under these arrangements. We retain servicing responsibilities under both agreements, for which we are paid a servicing fee. The servicing fees we receive are considered adequate compensation for services rendered. Accordingly, no servicing asset or liability has been recorded. The agreements require us to maintain a minimum current ratio and maximum leverage ratio. We were in compliance with those covenants at October&#xA0;31, 2015.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Included in cash and cash equivalents in the condensed consolidated balance sheets are $24,793 and $29,863 as of October&#xA0;31, 2015 and April&#xA0;25, 2015, respectively, which represents cash collected from previously sold customer financing arrangements that have not yet been settled with the third party. Included in current receivables in the condensed consolidated balance sheets are $105,852, net of unearned income of $6,781, and $88,470, net of unearned income of $4,197, as of October&#xA0;31, 2015 and April&#xA0;25, 2015, respectively, of finance contracts we have not yet sold. A total of $529,484 of finance contracts receivable sold under the agreements was outstanding at October&#xA0;31, 2015. The deferred purchase price under the arrangements was $67,550 and $66,715 as of October&#xA0;31, 2015 and April&#xA0;25, 2015, respectively. Since the internal financing program began in 1994, bad debt write-offs have amounted to less than one-percent of the loans originated.</p> </div> 150000 25520000 1054000 -33855000 23891000 0 0 38149000 1331750000 518370000 39000 141346000 1176439000 -738000 -1054000 -15417000 -11083000 1982796000 187992000 361292000 0.14 1405000 2022-02 1 1 P10Y 2025-03-24 12369000 585950000 12048000 0.13 P10Y 2023-07 2015-04 29003000 2015-03-25 3 0.20 0.12 124000 98802000 0.350 0.42 0.42 0.54 0.12 99376000 0.54 574000 13095000 777000 47059000 19064000 72140000 41865000 64373000 978220000 11913000 -3867000 125105000 53778000 259287000 -36816000 11913000 8544000 187147000 7151000 78570000 718933000 22508000 27454000 -2321000 17000 -3867000 -15623000 9110000 14336000 376474000 73427000 592636000 686165000 87646000 204409000 49000 0.22 -0.07 899000 98525000 0.367 0.43 0.43 0.36 -0.07 99185000 0.36 660000 42799000 954000 48172000 15752000 83463000 42563000 67263000 1389210000 -7142000 437000 37693000 35421000 330899000 6941000 -7142000 17154000 247436000 9842000 22894000 24486000 1058311000 24700000 22915000 265000 60000 25520000 0.10 2.5 437000 -15808000 13435000 25177000 774453000 74094000 601322000 4125000 1087489000 93912000 207809000 703000 200000000 1100000000 1108203000 499000 P1Y 0.01125 0.02000 0.02000 2020-06-16 0000891024 pdco:CreditAgreementMember 2015-04-26 2015-08-01 0000891024 pdco:CreditAgreementMemberus-gaap:LondonInterbankOfferedRateLIBORMember 2015-04-26 2015-08-01 0000891024 pdco:CreditAgreementMemberus-gaap:MaximumMemberus-gaap:LondonInterbankOfferedRateLIBORMember 2015-04-26 2015-08-01 0000891024 pdco:CreditAgreementMemberus-gaap:MinimumMemberus-gaap:LondonInterbankOfferedRateLIBORMember 2015-04-26 2015-08-01 0000891024 pdco:AnimalHealthInternationalMember 2015-04-26 2015-08-01 0000891024 2015-04-26 2015-08-01 0000891024 us-gaap:InterestRateSwapMember 2015-08-02 2015-10-31 0000891024 pdco:EquipmentAndSoftwareMember 2015-08-02 2015-10-31 0000891024 pdco:OtherProductMember 2015-08-02 2015-10-31 0000891024 pdco:ConsumablesMember 2015-08-02 2015-10-31 0000891024 pdco:UnsecuredTermLoanMemberpdco:CreditAgreementMember 2015-08-02 2015-10-31 0000891024 pdco:DentalMember 2015-08-02 2015-10-31 0000891024 pdco:AnimalHealthMember 2015-08-02 2015-10-31 0000891024 us-gaap:CorporateMember 2015-08-02 2015-10-31 0000891024 us-gaap:InterestRateSwapMemberus-gaap:OtherComprehensiveIncomeMember 2015-08-02 2015-10-31 0000891024 2015-08-02 2015-10-31 0000891024 us-gaap:InterestRateSwapMember 2014-07-27 2014-10-25 0000891024 pdco:EquipmentAndSoftwareMember 2014-07-27 2014-10-25 0000891024 pdco:OtherProductMember 2014-07-27 2014-10-25 0000891024 pdco:ConsumablesMember 2014-07-27 2014-10-25 0000891024 pdco:DentalMember 2014-07-27 2014-10-25 0000891024 pdco:AnimalHealthMember 2014-07-27 2014-10-25 0000891024 us-gaap:CorporateMember 2014-07-27 2014-10-25 0000891024 us-gaap:InterestRateSwapMemberus-gaap:OtherComprehensiveIncomeMember 2014-07-27 2014-10-25 0000891024 2014-07-27 2014-10-25 0000891024 2014-04-27 2015-04-25 0000891024 pdco:FivePointOneSevenPercentageSeniorNotesMemberpdco:InterestRateSwapAgreementMember 2014-01-01 2014-01-31 0000891024 pdco:InterestRateSwapAgreementMember 2015-03-01 2015-03-31 0000891024 pdco:InterestRateSwapAgreementWithBankMember 2012-05-01 2012-05-31 0000891024 pdco:NewInterestRateCapAgreementMember 2015-08-02 2015-08-31 0000891024 us-gaap:LongTermDebtMember 2015-04-26 2015-10-31 0000891024 pdco:BankOfTokyoMitsubishiUfjLimitedMemberus-gaap:MinimumMember 2015-04-26 2015-10-31 0000891024 pdco:AnimalHealthInternationalMember 2015-04-26 2015-10-31 0000891024 pdco:SeniorNotesSevenMemberpdco:InterestRateSwapAgreementMember 2015-04-26 2015-10-31 0000891024 us-gaap:InterestRateCapMember 2015-04-26 2015-10-31 0000891024 us-gaap:InterestRateSwapMember 2015-04-26 2015-10-31 0000891024 pdco:FifthThirdNationalBankMemberus-gaap:MinimumMember 2015-04-26 2015-10-31 0000891024 pdco:EquipmentAndSoftwareMember 2015-04-26 2015-10-31 0000891024 pdco:OtherProductMember 2015-04-26 2015-10-31 0000891024 pdco:ConsumablesMember 2015-04-26 2015-10-31 0000891024 us-gaap:AccumulatedTranslationAdjustmentMember 2015-04-26 2015-10-31 0000891024 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2015-04-26 2015-10-31 0000891024 pdco:DentalMember 2015-04-26 2015-10-31 0000891024 pdco:AnimalHealthMember 2015-04-26 2015-10-31 0000891024 us-gaap:CorporateMember 2015-04-26 2015-10-31 0000891024 us-gaap:InterestRateSwapMemberus-gaap:OtherComprehensiveIncomeMember 2015-04-26 2015-10-31 0000891024 2015-04-26 2015-10-31 0000891024 us-gaap:InterestRateSwapMember 2014-04-27 2014-10-25 0000891024 pdco:EquipmentAndSoftwareMember 2014-04-27 2014-10-25 0000891024 pdco:OtherProductMember 2014-04-27 2014-10-25 0000891024 pdco:ConsumablesMember 2014-04-27 2014-10-25 0000891024 pdco:DentalMember 2014-04-27 2014-10-25 0000891024 pdco:AnimalHealthMember 2014-04-27 2014-10-25 0000891024 us-gaap:CorporateMember 2014-04-27 2014-10-25 0000891024 us-gaap:InterestRateSwapMemberus-gaap:OtherComprehensiveIncomeMember 2014-04-27 2014-10-25 0000891024 2014-04-27 2014-10-25 0000891024 2013-10-25 2013-10-25 0000891024 pdco:UnsecuredTermLoanMemberpdco:CreditAgreementMember 2015-08-28 2015-08-28 0000891024 2015-08-28 2015-08-28 0000891024 pdco:AnimalHealthInternationalMemberpdco:TradeNamesIndefiniteLifeMember 2015-06-16 2015-06-16 0000891024 pdco:AnimalHealthInternationalMemberpdco:TradeNamesDefiniteLifeMember 2015-06-16 2015-06-16 0000891024 pdco:AnimalHealthInternationalMemberpdco:DevelopedTechnologyAndOtherIntangibleAssetsMember 2015-06-16 2015-06-16 0000891024 pdco:AnimalHealthInternationalMemberus-gaap:CustomerRelationshipsMember 2015-06-16 2015-06-16 0000891024 pdco:AnimalHealthInternationalMember 2015-06-16 2015-06-16 0000891024 pdco:NewInterestRateCapAgreementMember 2014-04-26 0000891024 2014-04-26 0000891024 us-gaap:LongTermDebtMember 2015-10-31 0000891024 pdco:BankOfTokyoMitsubishiUfjLimitedMember 2015-10-31 0000891024 pdco:UnsettledContractsMember 2015-10-31 0000891024 pdco:SeniorNotesSevenMemberpdco:InterestRateSwapAgreementMember 2015-10-31 0000891024 us-gaap:InterestRateCapMember 2015-10-31 0000891024 us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:InterestRateContractMember 2015-10-31 0000891024 us-gaap:OtherNoncurrentAssetsMemberus-gaap:InterestRateContractMember 2015-10-31 0000891024 pdco:FifthThirdNationalBankMember 2015-10-31 0000891024 us-gaap:FairValueInputsLevel2Member 2015-10-31 0000891024 us-gaap:FairValueInputsLevel1Member 2015-10-31 0000891024 us-gaap:AccumulatedTranslationAdjustmentMember 2015-10-31 0000891024 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2015-10-31 0000891024 pdco:UnsecuredTermLoanMemberpdco:CreditAgreementMember 2015-10-31 0000891024 pdco:DentalMember 2015-10-31 0000891024 pdco:AnimalHealthMember 2015-10-31 0000891024 us-gaap:CorporateMember 2015-10-31 0000891024 2015-10-31 0000891024 pdco:CreditAgreementMember 2015-08-01 0000891024 pdco:AnimalHealthInternationalMember 2015-08-01 0000891024 pdco:AnimalHealthInternationalMemberpdco:TermLoanMember 2015-08-01 0000891024 pdco:UnsecuredTermLoanMemberpdco:CreditAgreementMember 2015-08-01 0000891024 pdco:UnsecuredRevolvingLineOfCreditMemberpdco:CreditAgreementMember 2015-08-01 0000891024 pdco:AnimalHealthInternationalMemberpdco:UnsecuredRevolvingLineOfCreditMember 2015-08-01 0000891024 2014-10-25 0000891024 pdco:InterestRateSwapAgreementMember 2014-01-31 0000891024 2014-10-24 0000891024 2013-10-25 0000891024 2015-07-01 0000891024 2015-12-03 0000891024 pdco:NewInterestRateCapAgreementMember 2015-08-31 0000891024 pdco:AnimalHealthInternationalMemberpdco:TradeNamesIndefiniteLifeMember 2015-06-16 0000891024 pdco:AnimalHealthInternationalMemberpdco:TradeNamesDefiniteLifeMember 2015-06-16 0000891024 pdco:AnimalHealthInternationalMemberpdco:DevelopedTechnologyAndOtherIntangibleAssetsMember 2015-06-16 0000891024 pdco:AnimalHealthInternationalMemberus-gaap:CustomerRelationshipsMember 2015-06-16 0000891024 pdco:AnimalHealthInternationalMember 2015-06-16 0000891024 pdco:PriorCreditFacilityExpiringOnDecemberTwoThousandAndSixteenMember 2015-06-16 0000891024 pdco:UnsettledContractsMember 2015-04-25 0000891024 us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:InterestRateContractMember 2015-04-25 0000891024 us-gaap:OtherNoncurrentAssetsMemberus-gaap:InterestRateContractMember 2015-04-25 0000891024 us-gaap:FairValueInputsLevel2Member 2015-04-25 0000891024 us-gaap:FairValueInputsLevel1Member 2015-04-25 0000891024 us-gaap:AccumulatedTranslationAdjustmentMember 2015-04-25 0000891024 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2015-04-25 0000891024 pdco:DentalMember 2015-04-25 0000891024 pdco:AnimalHealthMember 2015-04-25 0000891024 us-gaap:CorporateMember 2015-04-25 0000891024 2015-04-25 iso4217:USD shares iso4217:CAD pure pdco:Time_Deposit iso4217:USD shares pdco:Segment pdco:Customer pdco:Derivative EX-101.SCH 7 pdco-20151031.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:calculationLink link:presentationLink link:definitionLink 104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME (Unaudited) link:calculationLink link:presentationLink link:definitionLink 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:calculationLink link:presentationLink link:definitionLink 106 - Disclosure - General link:calculationLink link:presentationLink link:definitionLink 107 - Disclosure - Acquisitions link:calculationLink link:presentationLink link:definitionLink 108 - Disclosure - Discontinued Operations link:calculationLink link:presentationLink link:definitionLink 109 - Disclosure - Goodwill and Other Intangible Assets link:calculationLink link:presentationLink link:definitionLink 110 - Disclosure - Derivative Financial Instruments link:calculationLink link:presentationLink link:definitionLink 111 - Disclosure - Fair Value Measurements link:calculationLink link:presentationLink link:definitionLink 112 - Disclosure - Securities link:calculationLink link:presentationLink link:definitionLink 113 - Disclosure - Customer Financing link:calculationLink link:presentationLink link:definitionLink 114 - Disclosure - Segment Reporting link:calculationLink link:presentationLink link:definitionLink 115 - Disclosure - Accumulated Other Comprehensive Loss link:calculationLink link:presentationLink link:definitionLink 116 - Disclosure - Debt Issuance link:calculationLink link:presentationLink link:definitionLink 117 - Disclosure - Income Taxes link:calculationLink link:presentationLink link:definitionLink 118 - Disclosure - Legal Proceedings link:calculationLink link:presentationLink link:definitionLink 119 - Disclosure - General (Policies) link:calculationLink link:presentationLink link:definitionLink 120 - Disclosure - General (Tables) link:calculationLink link:presentationLink link:definitionLink 121 - Disclosure - Acquisitions (Tables) link:calculationLink link:presentationLink link:definitionLink 122 - Disclosure - Discontinued Operations (Tables) link:calculationLink link:presentationLink link:definitionLink 123 - Disclosure - Goodwill and Other Intangible Assets (Tables) link:calculationLink link:presentationLink link:definitionLink 124 - Disclosure - Derivative Financial Instruments (Tables) link:calculationLink link:presentationLink link:definitionLink 125 - Disclosure - Fair Value Measurements (Tables) link:calculationLink link:presentationLink link:definitionLink 126 - Disclosure - Segment Reporting (Tables) link:calculationLink link:presentationLink link:definitionLink 127 - Disclosure - Accumulated Other Comprehensive Loss (Tables) link:calculationLink link:presentationLink link:definitionLink 128 - Disclosure - General - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 129 - Disclosure - General - Computation of Basic and Diluted Earnings Per Share (EPS) (Detail) link:calculationLink link:presentationLink link:definitionLink 130 - Disclosure - Acquisitions - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 131 - Disclosure - Acquisitions - Summary of Total Purchase Price Consideration and Preliminary Fair Value of Assets Acquired and Liabilities Assumed (Detail) link:calculationLink link:presentationLink link:definitionLink 132 - Disclosure - Acquisitions - Summary of Acquired Intangible Assets Excluding Goodwill (Detail) link:calculationLink link:presentationLink link:definitionLink 133 - Disclosure - Acquisitions - Summary of Unaudited Pro Forma Financial Result (Detail) link:calculationLink link:presentationLink link:definitionLink 134 - Disclosure - Discontinued Operations - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 135 - Disclosure - Discontinued Operations - Summary of Assets and Liabilities Held For Sale (Detail) link:calculationLink link:presentationLink link:definitionLink 136 - Disclosure - Discontinued Operations - Summary of Results of Operations Under Discontinued Operation Activities (Detail) link:calculationLink link:presentationLink link:definitionLink 137 - Disclosure - Goodwill and Other Intangible Assets - Goodwill Balances and Related Activity by Business Segment (Detail) link:calculationLink link:presentationLink link:definitionLink 138 - Disclosure - Goodwill and Other Intangible Assets - Balances of Other Intangible Assets Excluding Goodwill (Detail) link:calculationLink link:presentationLink link:definitionLink 139 - Disclosure - Derivative Financial Instruments - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 140 - Disclosure - Derivative Financial Instruments - Fair Value of Interest Rate Contracts Included in Condensed Consolidated Balance Sheets (Detail) link:calculationLink link:presentationLink link:definitionLink 141 - Disclosure - Derivative Financial Instruments - Effect of Interest Rate Contracts on Condensed Consolidated Statements of Income and Other Comprehensive Income (OCI) (Detail) link:calculationLink link:presentationLink link:definitionLink 142 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) link:calculationLink link:presentationLink link:definitionLink 143 - Disclosure - Fair Value Measurements - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 144 - Disclosure - Securities - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 145 - Disclosure - Customer Financing - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 146 - Disclosure - Segment Reporting - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 147 - Disclosure - Segment Reporting - Information about Reportable Segments (Detail) link:calculationLink link:presentationLink link:definitionLink 148 - Disclosure - Segment Reporting - Sales Information by Product (Detail) link:calculationLink link:presentationLink link:definitionLink 149 - Disclosure - Accumulated Other Comprehensive Loss - Summary of Accumulated Other Comprehensive Loss (Detail) link:calculationLink link:presentationLink link:definitionLink 150 - Disclosure - Accumulated Other Comprehensive Loss - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 151 - Disclosure - Debt Issuance - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 152 - Disclosure - Income Taxes - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 8 pdco-20151031_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 pdco-20151031_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 pdco-20151031_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 11 pdco-20151031_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R39.htm IDEA: XBRL DOCUMENT v3.3.1.900
Derivative Financial Instruments - Fair Value of Interest Rate Contracts Included in Condensed Consolidated Balance Sheets (Detail) - USD ($)
$ in Thousands
Oct. 31, 2015
Apr. 25, 2015
Derivatives, Fair Value [Line Items]    
Interest rate contracts, assets, fair value $ 835 $ 1,255
Interest rate, liabilities, fair value 835 1,255
Other Noncurrent Assets [Member] | Interest Rate Contracts [Member]    
Derivatives, Fair Value [Line Items]    
Interest rate contracts, assets, fair value 835 1,255
Other Noncurrent Liabilities [Member] | Interest Rate Contracts [Member]    
Derivatives, Fair Value [Line Items]    
Interest rate, liabilities, fair value $ 835 $ 1,255
XML 13 R48.htm IDEA: XBRL DOCUMENT v3.3.1.900
Accumulated Other Comprehensive Loss - Summary of Accumulated Other Comprehensive Loss (Detail)
$ in Thousands
6 Months Ended
Oct. 31, 2015
USD ($)
Accumulated Other Comprehensive Income (Loss) [Line Items]  
AOCL at April 25, 2015 $ (60,346)
Other comprehensive loss before reclassifications (15,417)
Amounts reclassified from AOCL 12,137
AOCL at October 31, 2015 (63,626)
Cash Flow Hedges [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
AOCL at April 25, 2015 (18,668)
Amounts reclassified from AOCL 1,054
AOCL at October 31, 2015 (17,614)
Currency Translation Adjustment [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
AOCL at April 25, 2015 (41,678)
Other comprehensive loss before reclassifications (15,417)
Amounts reclassified from AOCL 11,083
AOCL at October 31, 2015 $ (46,012)
EXCEL 14 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`'MSBD?UR6KY[`$``*0?```3````6T-O;G1E;G1?5'EP97-= M+GAM;,W9W4[;,!0'\%>IO7SR5.<;&T_Q$75I>2_,A:;CJR.M?,TY,C2!:M3 M/@TKYG6SUBMB8C8[9XT;$@UIFDJ.ZOKJ^X9","U-;G:!DGM1:>][T^ADW,`V M0[N7=>J62]-0ZYH'F[?4*9>FLQRO)O*C^+O)2^9:6^J%/1Q5^OG=UH'Y<$SOCGTO=;7.6F'];5#D: M/U1A?^-[G1E;AN:'U5\[ROD_7LO>3=S8_C;H1[-78'.R,95C;;49#HWJT87U M+^?6G_F84+FJEMJI#WEA2.;`4Y(7W^=H9#GU?]5^>5(:%^A#!GZ*',=O[\U]#$8V7@X(1)']2%`^I`@?2B0/N8@?9R#]'$! MTLQW8OG*\M"_V/Z'D4X$G1H>)%]2-F`Q+M*;V"^GH`A3&^ M.R6:E((C-Z."N[_8_`)02P,$%`````@`>W.*1^N^@:7C`0``1A\``!H```!X M;"]?Q.BA3_7J1SRV^3#T MJ3N,:?'G=.S3:KZ_KKJ/LQ?/VW4U/6^E6OQLIWW,Z^KW,+VF+L:BM';P5Z*^E;&WUL<_16H+=R]%:@ MMW+T5J"W1]DK0 M9@E';P-Z&T=O`WH;1V\#>AM';P-Z&T=O`WH;1V\#>AM';P=Z.T=O!WH[1V\' M>CM';P=Z.VFO&VUV<_1VH+=S]':@MW/T=J"W<_1VH+=S]':@MW/T;H#>#4?O M!NC=#OT^7;OFO^&PZ`+OE-^.\?HIYZFPX4+K/*\4P_EX M]5=TGOHW)'SZ9?[X#E!+`P04````"`![- MI3%1UW$T6\**ZDN$"-R=2[6B!J=JX<]P#+0\@Q8K+C9NLT4DUVRF!FC M(?31ESNGH884];9H,7VYBJC8.NGL@8M7_13YY>`:EDTBO6I=-_#ND8+^>V@8:<+&84JZTVUN; M[AJ8D6I7IK7Y:)4"R9*BZVCY-;[\$;]X>D#F?FX[_'X?@#G$XAYQX$*!H6[GGL=\PU3^+2A8`!UTQB M#D0,`9F@WFDY]E[*X`\/0YNXB5F"PKP9O!G\)03B%=L'Q==HK+J-6N M(Z/*LQT)X52B*A31^E)9@0OB!8'-L0UEWW].K:C:)HY\:1(T#FI);1=:38YU69_3OJXOZ7:)#BHY M7^M?@_:W#W"^U^=TFK6N&]9':ZC5Z2MK^M;Q"Z_0F9^!'/?,5I!S=S;GU-.B MB#/#)["NO*<5?:=3K(-J3ID.,E^OXW2?_)Z=Z#M'3\=W#T4G_P/'_0=02P,$ M%`````@`>W.*1[7"AM@_`0``:0,``!$```!D;V-0W)LJYEP*4W;G7M M__/O."F$9<(X>'+&@D,%_F)?5]HS8>?)!M$R0KS80,W])%3HD%P95W,,H5L3 MR\66KX'D679%:D`N.7)R`*:V)R9E(043#C@:U^&EZ/%VYZH(DX)`!35H](1. M*$G*%[W5IM$%&?1E$1Q7W./"2+52(&_;H>QW*G1&<+4_RD'V[>/?/SW$#$FZ MRKU7?573-)-F&NO"P)2\+1Z?X]FD2GOD6D!0><6PM3!/3IU?IW?WRX>DS#-Z MF=(\I=F2SEA^S68W[X?)SOP-ANMNB'_K^&0P;A<55C!RMU$CXW+C9P1)\,(I MB\KH4;B(^2:.,+_[^`2!XT&=,%ZV+;2-<=*7\7X-T>'EA)6MC6N/J1_1V:LJ MOP!02P,$%`````@`>W.*1YE&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M3A^%$5B-;'ED MD81_OTV23;J;/`0LZ?O.14?GZ#AY\^XN8NB&B)3R> +]O6N[!3+UES@6QHO(];J MM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!$U=!)KF(M/+Y M;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9KQ]'22(""R7V4 M!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2BW`A(5M>5`TR``6'!VULS2`Y9> M*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D`4.`#?$T4Q0?*]!MHK@ MPI+27)#6SRFU4!H(FLB!]4>"(<7K;YH]5Z%82=J$^!!& M&N*<<^9ST6S[!Z5&T?95O-RCEU@5`9<8WS2J-2S%UGB5P/&MG#P=$Q+-E`L& M08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9-AIRM1:!MG&I MA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+D!&_'H8X2IKM MHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T!Z.:60F]A%9J MGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+`.7\N?<^E[[GT M/:'2MSAD6R4)RU3393>*$IY"&V[I4_5* ME=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y"M-2D&_#^>G% M>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#0X=Y>U^89Y7& M4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O&`RN0HGQ,C$7H<.>7 M7%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55ORL+YJ/;053L_^ M6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SCYL=Q3E.X$G:V M#P(RN;LYJ7IE,6>F\M\M#`DL6XA9$N)-7>W5YYNTB42%(JP#`4A%W+C[^^3:G>, MU_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF8$O#>FZ=+2?_ MVU[4/;07/4;SHYG@'K.'YA,L0Z1^P7V* MBH`1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW>`,?-2K6J5D*Q$_2P=\'Y(&8XQ; M]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!U4#E/]O4#6CV M#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_`5!+`P04````"`![6QE_?KKXEK"0K+LE+SKZ=,YWOB/).0HKM:'X M:86Q`@VCO(K@2JGR@^=5Z0HS5$U$B;E>R85D2.FI++RJE!AEE0EBU)OZ_LQC MB'`8A[QF"Z8JD(J:JPB^[R'@XN)N%S^W M"Q<0.(Y/602#V17TCB>=^/MY]=H.]6P/=>NNF;K(G<#K`YKF]Q_WE#JL_+38 M&T/LM;L:A[G@P^9.H0/BL'H!:T2U?V#<4T&%!$J?GE9@$8X8=AYS1$DBB0%S MQ`C=.'AJ`'O@K1\C7$B;VV78S3/QATRR2"+HM[_CTR4#NQU,>832[?(T$(DX`P[L0Y:B'9VB#[80Q^' MJ&,%*R')B_8W%R'5`)80K+%4)!TCWR4JE[A1[0WVFGR?PM>6_#_)A^?C?T,X8Z>(X[BL68)E@O[S_SKPBZO3U69Z88G*VUVJM(N;T]5 MF7E)G*RTF]^4YK4]:]08M]IBCX*D)E01WFE`YB'S:'33K8XUM$3-F35#-[2K M"B7Z8;N519-E.$:]E31'"P'W!&:G9K%0ROY_@' M4$L#!!0````(`'MSBD>ZCUY@7P0``(X0```/````>&PO=V]R:V)O;VLN>&UL ME9=;<]HX%(#_BL9/NP]9L"U(PI3.D$"ZS"20*6SZ+&P!FLH2*\E)VE_?8P/M M<3BXZ1.^<#[K\NE(YX,?O%CW=67M5_9::.,';AAM0]@-.AV?;64A_#]V)PV\ M6UM7B`"W;M.QZ[7*Y-AF92%-Z"3=;K_CI!9!6>.W:N>C`\V_A^9W3HK<;Z4, MA=[#"J%,]/&#'ZR5ED_2>0`SL=O-1"&'T:N.F!8^3'(59#Z,.-S:%]EXX,K= M3:ET==/K]J).!3MV]=&QS.9R#UMNE?]R>!&Q7*Y%J<,2&GO\[C"*$YXD_3VC M^MN3DB\>`ZL'3&1!/R=TD&ZL0CRD[/E3ID-L"*V5LZ'1=7= M^I^%,JI0WZMVPYW?VI=_K5/?K0E"+S)GM:ZCJA=U$'S!_WP";0PJ:_PQB-7G M:B:&4;\+P&?EU4II%;X-H_I:RZHGG3==J8?_UQ4S]>`?]@-%%RX:1[OAPJ#;N>S\62VF(P97"WF]]/Q:`DW-Z/[T>QV MPA`H0:#DW:#%$GX>)C,$2A$H_5,01R".0/P4]$D:Z81&`3T4T#L-&&7_ES`1 M]6)!47T4U3^-&BN?@1/*E#)G\QU\\BW@$@$NB79:F[\HK>NYG(>M=#"509A- MI00;(=`5`ET1+9%./8M*=G:GC#"9$AI0/KC:%02Z1J#K4]"=4(X]"5U*]B"% M+YVLXG&7XB[6JGN*6,BL=#"4LA'5D)&RL?3!%C``A_:;#8[&!L:$@@NYJ=?$ M9[FSL/J:P=BZF-!NE,&**B%5RN,DW-H"$N!6&@\CBE'8NY@0;RQ7@4V]+Z$+ MC4#L7TP(.#49])XMQ6MSV+"!,:'@O=S`3#\ZFTF90[\;P=B^F-)OOTS87X]6 MJPPF[&\=^1D/VTV]BL64QH1E>;Q0@P9(EA&1GEMZ1A5'8O(0PKW41 M)@E&-1(AH6'K,DQ2C,)2)H249Q8BU4$L94)(>;(XR!''AB9DBFQ9);`5(Q26 M-B&D/9ISP49Y7DM0#]-Q#\,HK'#2HO!%W9HRU!HPNV8WPJNLL8EAGQ/"YX:3 MITW#**QW\CN]+]BB+`KAOE7-6MK0V)=2+'I*B'X>5;_!*"QZ2HA^'O6?$66. M45CTE!+]S/([#!M&-?9\0O3SJ+J!&(5%3ZGLVX9*>QB%;4\)VUN30HIM3['M M*65[*^H2H[#M*6%[:WY)KS`*VY[^Z8DAO<8H;'M*V-Z*XEU\;,.V<\+V8J\XMIT3MK>@WBC*L>VNN-P;#O'MG,RM[>AL.T< MV\Y)V]$1[]0'7'-@VWN$[?C0U[[C]+#MO?A0+?XJ$*%&5D;F5?GLZ\]`_9E5 M-37\[`_0O%<=RJK[!ZBSAU%5#$/=6VI]"\_FYMZ*NF3&PO=V]R:W-H965T&ULA97+;J,P%(9?Q>(!"C:7A(@@-1E5G<5(51*42W\WU>E*3!_(EVI)5O+I0U6,@N MN_J\8P2?M:FI?10$B=_@JO7R3(^]L3RC-U%7+7EC@-^:!K-_!U+3?N]![S'P M7EU+H0;\//,'W[EJ2,LKV@)&+GOO&>Z.,%(2K?A=D9Z/VD!-_D3IA^K\/.^] M0,V!U*00*@26CSLYDKI6D23YKPWZQ53&;F>EU_<`"YQFC/6#F8W18?7.X"^7.%8#K0;DD[BF!W*D\ MN^=!YM]5&*M`(\7!*."@\&7L`8!<@(D=:3N:!QR-(G0#0A<@'*\@U/;(;8]< M]FALC[0]GLYOK#@81>(&Q*N`6-LW"P"CV+H!R2H@T?9T`6`4,'`3-JN$C?'# M*2+1DM8@C`0%<&:?MJN0K8%\.RGQ>!U6,G-4TE5$:OS1PE992>Q&J-MAA0$# M$R%9@#PTFQF*,VVG%)N5VX5/8C7;%`9H)CV@,W^G)).><.E\60V:.6#0F<13 MBLEB!)]OI8OE`HB)Q$\R6-?R@H\=&IR$:JY MD6UF:I+I"-H]2NQ0Y_/_4$L#!!0````(`'MSBD>DO.G@3`0``*X4```8```` M>&PO=V]R:W-H965T&ULC9A-DZ,V$(;_BLOW7="W-.5Q54PJ ME1Q2M;6'Y,S8FK%KP3C`C#?_/H)N'-B@5N8P?/AM]2LA/33:W9OV6W?VOM]\ MKZMK][P]]_WM*YN?EK^.6U:>NR#Y?M6];=6E^>QJ"ZRGB>ZZPN M+]?M?C?>^]+N=\U[7UVN_DN[Z=[KNFS_/OBJN3]OV7:Z\?7R=NZ'&]E^ESWB M3I?:7[M+<]VT_O5Y^Q-[*H0>)*/BCXN_=[/SS6#^I6F^#1>_G9ZW^>#!5_[8 M#TV4X?#A"U]50TLA\U_8Z+\YA\#Y^=3Z+V-W@_V7LO-%4_UY.?7GX#;?;D[^ MM7RO^J_-_5>/?5!#@\>FZL;_F^-[US?U%++=U.5W.%ZNX_$.OVB!8>L!'`/X M(X!),D!@@/@A(`-G8[]^+OMROVN;^Z:%AW$KAV?.GD08N>.F&V^&+G7;01!& M:K_[V'.YRSZ&=E#"9Y(#2N**`A7J(IP&)$L+P]2PJF45!%A?/ M<@")$5)J1I@!F;*::['N1B?=:!BWG'`#$J.XE83I`F0RMY)'QL8DW1AP0W3Z M`!(KF*;,@$HY-1O`A1>;]&+!"R>R@(0Q&^;=>AJ73.,@C2"Z#!*FM7+4@RI0 MIXS@L14]0#)AB.6XE`A'J.&&,T/% M)&/:1IC%5J&W]`/4$YKR`QK+3)B$E"$DJ'-NAO*EHS1&&>+/4(X$LLODAEHZ MJ&-H4\9H&RNTTP#C"A<7Y0@T+!?2DJ]!%)K`^.C3 M2)..`YP413K4<*6$I)8@ZBR3-K8$T^4CQ[*/3(0H=)+%$J5IR(%@BJ(A:GAN MK;*D(RPCI1#*1JHDOLK#Y:>8P_=[Y%LL33`!U%$4P5#CR*(&16$>QLRDX24` M3(J"%VJX"44690=E+(]^J*89)X!?U$H_H.:3%II31'CHPD*-.?H?W\Y8T%%% M'VJ8-.$SD:+F)-0B9S/J+3VEN2F0=10W4?/)&$/6/NNZI:,T-P5^)5/<1`T3 M6G!J.(M)J)AD/#:WT^`4`+L?J][EM@=1(BYW/J@2,9OM+-W*-_][V;Y=KMWF MI>G[IAYWE%Z;IO>AH?QS&,RS+T^/B\J_]L.I">W.*1ZO:MAR3!0``EAL``!@```!X;"]W;W)K5FU;TU5/IV#CH<5,):MCN7^M-RLS]>^-IMU M_=X=]J?J:[-HWX_'LOEG6QWJC_LE7XX7ONU?7KOAPFJS7OFXI_VQ.K7[^K1H MJN?[Y1=^MQ-B0,[$7_OJH[WZOA@&_U#7/X8??SS=+]DPANI0/79#$V7_\;/* MJ\-A:*GO^6]L]-+G$'C]?6S]M[/'[_JE[[4?+EHNGZKE\/W3? MZH_?*]2@A@8?ZT-[_G_Q^-YV]7$,62Z.Y2_WN3^=/S_<7PS#L/D`P`#P`;Z? M^0"!`>(2(,D`B0'RO_:@,$!->E@Y[>>9*\JNW*R;^F/1N.5^*X>LXG>J7YO' M17N^V$]:NQR`?BTVZY^;C*]7/X=V$($K9(L(Q)'"(9=&5GW_?A`P-XB@!SB' M$QWDCL@$,89D([M/C03#%'/#%-=S)5R\G(^7<_'R.EZZ>!4.49^1DYL)AW!A M+'`6YW+'66T`"*QP&"@!S!#<#KNU7'.=S0[A3!G!>9S+ M':>YL4+$L4*-PP8K=)S;(2>9!@WS\K*DO,S)(_K9.D0(9JPEU&6X*A8,T5J! M'?;R)#$).XV0@NO\"77-FEJHB^-24;H< M<],?>;0TY(R2!%:,&%BPU%%TZ5;PR%'$9PTS%.BL3!/IND4FTT!F]8A)0;56 M(,:YMM01N!LYZ*W6E'J)':DZ-5#C)MI61&JP]*C-QQR[SG,,&YCATJZ#.!H MWE0=@,Q-[Q+$'LT1X[T%DKFI_!)3XI`21L=.EG01P#,\Z(@:#AFA)/`XEB.F MA-8FCA6(98I/C\V@@D.,,\FRF+S9.B!P%.X,5T?,EJ?=EJ-+3NS6!!/D&'8[ MK6M,,#^>@CA5>"J3<6KG*"\V$1\&-(^##";[>'<0"3;P[F!2+:'R/S/],:H1'I[BDQO3T73.VW&@)Y''$5;9#ZG=W!@>6J:WL&!Y:FI M80<'%E)]>L>4S1IQF-[.\$RLA;3;@3,50Q4JR%BC@,!RCYGIB@96[C$[/6\" M+Q\QR[+(W1.D;WK!F9VA"A5DK.74).0>$U394W@L(\LPC^FK@R54ES9BP)M: M3>7U:(M`6&Q^H:BT]FY-^?"%BNA*W_0"&F_D;!-I0Q/CS2I1PR&3JN$02]5P MB*5J.,2H&DZD;WX%NAKUP`.9S$KJ*1Q2-R(SG$KKD9-"4&D]8I`I%MFU(FVY MPIF;)4K]+3*2>BB8(W0C#'5#6R#&&?648#V9Q/0WH--' MC&%B"GR^Q"SQN+E`+.-FNFW#Q,3;<2[,M-I:7;UT.%;-R_EU3[MXK-]/W;!S MKZ[Z5TI?8'AI,;F^Y7\+N=>V%T:7ZS?BM?JC_+YF5_:A>Z[JI^Q+T'+Q>O5?GD?QRJYV[XJOOOC7MMY'YT]=OX%LR_BMO\"U!+`P04 M````"`![1(@3C,(9;D=X;OD-1#FKM[W?QHS\YUJU]5>6V?U^>NNSUMM^WQ[*JB_5+? MW-5_\UHW5='YV^9MV]X:5YR&H*K<`F-Z6Q67ZWJ_&YY]:_:[^KTK+U?WK5FU M[U55-/\=7%G?G]=\/3[X?GD[=_V#[7ZW?<2=+I6[MI?ZNFKKWOQ+7?_H;_X\/:]9[\&5[MCU*0K_\=/EKBS[3+[E?S'I1YM] MX/1ZS/[[4*ZW_U*T+J_+?RZG[NS=LO7JY%Z+][+[7M__<%B#ZA,>Z[(=_J^. M[VU75V/(>E45O\+GY3I\WL,W&<.PY0#``'@$/-I9#A`8(#X"Y%!I<#;4]5O1 M%?M=4]]731B,6]&/.7\2ON>.JW9XZ$MJU[W`]]1^]W-O^6[[L\^#$IA(#D'R MH=CZY(\68*F%63@,X1!O(`\*+99;$$LMB&D-(M0`R_%R*5Y.X^40;\S5!Q)IDVRV94THP*Q8AY,WIJ)D@`%(N+J,5C+62VD\(0!'24`0D&:.HB"+IUV&*T:.,F1@=($U%`#1$+4THVB@9>>4A MC45`+'(*BS#RSH^\U!2'/M+)R%81TF@$1".GT(@BPWWUU!X-=5)-5KRYH307 M`;G(*2ZBR%,(F"#["+,I'5LV81&,LY<>$(P\-O1ID@&2C%,D0]%&*J&H)?&A M8]Q$-I"0WD'"N/.C]I`H\HLT4X9\/U`HC1(Q-J39"';1H`.?Y$?66GH M"80>IZ`G'M#3T:;2R!/CYHU"'HHRHJ@TRP2,VT2J)629W_]RB'!3I'$FD#]` MX0Q%D%F*XZC*9&0ZBS3(!((,*)"-(LM!D'YPBY?YO6ED-HLTR@3"!RB4H6B3 M,44M]*/,`(O`7J1W>`)!1FUO#RC:@.(9N22.V:S5L6%+@U$@&#^?0\PM!9&0 M!C2U_J`.M+0LL@*)-!@%@A$^@7%V@"+&'^!2\;@L1QED?B?S>=RVD_.MRC5O MP[E?NSK6[]>N/U&:/'V<+7Z%_GSLT_,#?\K#">%'FOWN5KRYOXKF[7)M5R]U MU]75<%3V6M>=\];8%S^!SZXX/6Y*]]KUE\9?-^&<,-QT]6T\]GR[_!U!+ M`P04````"`![VF]R?&7-6!%NX.>S#A3X-6"Q]2 MVS+76Q!U(FG%>)8],"VDH661:J^V+'#P2AIXM<0-6@O[YP(*QS/-Z5)XDVWG M8X&5!5MYM=1@G$1#+#1G^IR?+L>(2("?$D:WB4GT?D5\C\GW^DRS:`$45#XJ MB+#]9\[-E)&[C1?UKFC:XOPH'+ZA^R=IWP6Q&20V-&)1_P_$; MS"/<1\$*E4M?4@W.HUXHE&CQ,:W2I'6<_ASRF;9/X#.!KX2G+!F?&B6;7X07 M96%Q)';:VE[$$\Q//&Q$15PJ!H>.1D`8O"QN9:+S??IACW[8.CS,#A_W!8Y[`L>MP'%_Q"WFLF">_FO"-GNJP;;I MZCA2X6#21=U4U]OYS-.9?,++HA&PO=V]R:W-H965T&UL;5/!;IPP$/T5RQ\0LV:3 MMBL6*9LH2@Z5HAS:LQ<&L&)[B&V6].]K&Y;0B@N>&=Y[,^,9%R/:=]/*I ME7%'VGG?'QAS50=:N!OLP80_#5HM?'!MRUQO0=2)I!7C67;'M)"&ED6*O=JR MP,$K:>#5$C=H+>R?$R@`"EHE!(_#%K?J6,Q+5]57]* MW8;JS\+!`ZK?LO9=*#:CI(9&#,J_X?@,X./%Q$15P*A@H= MC8#0>%E1"@>3%G457;;SGJ>9?,'+HAS.`H:'\UOP;;32DV.Q_[Z0)976OX% M4$L#!!0````(`'MSBD?WU&*VH@$``+$#```8````>&PO=V]R:W-H965T&UL;5/;;IPP$/T5RQ\0LX9MJQ6+E$U4-0^1HCRTSUX8P(K-4-LL MZ=_7-I>0B!<\,YQSYHPO^8CFS;8`CKQKU=DS;9WK3XS9L@4M[!WVT/D_-1HM MG$]-PVQO0%21I!7C2?*-:2$[6N2Q]F**'`>G9`*8'NA1> M9=.Z4&!%SE9>)35T5F)'#-1G>G\X7;*`B(#?$D:[B4GP?D5\"\E3=:9)L``* M2A<4A%]N\`!*!2'?^.^L^=$R$+?QHOXS3NO=7X6%!U1_9.5:;S:AI():#,J] MXO@+YA&.0;!$9>.7E(-UJ!<*)5J\3ZOLXCI.?XX+;9_`9P)?"3^2:'QJ%&T^ M"B>*W.!(S+2UO0@G>#AQOQ$EL;'H'5H:`'[P(K\5AY3G[!:$9@S?8"XS9D4P MK[ZVX'LM/M%YI/-]>KI'3[<.T]EANB^0[0ED6X%L?\0MYK)@LB]-V&9/-9@F M7AU+2ARZ>%$WU?5VWO-X)A_P(N]%`\_"-+*SY(K.GVP\AAK1@6^?W!TI:?W[ M61,%M0OA=Q^;Z4I-B<-^>2#K*RW^`U!+`P04````"`![=3TS#;&>!5)"G)TB2Y98H+38L\UIY- MD6/OI-#P;(CME>+FWQDD#B>ZHW/A132M"P56Y&SA54*!M@(U,5"?Z,/N>-X' M1`2\"ACL*B;!^P7Q/21_JA--@@604+J@P/URA4>0,@CYQA^3YG?+0%S'L_I3 MG-:[OW`+CRC?1.5:;S:AI(*:]]*]X/`;IA$.0;!$:>.7E+UUJ&8*)8I_CJO0 M<1W&/X=LHFT3THF0+H3[)!H?&T6;O[CC16YP(&;('/8WT=)N>;=&SM<-L2$GL=+^JJNMS.AS2>R3>\R#O> MP%]N&J$MN:#S)QN/H49TX-LG-P=*6O]^ED1"[4)XYV,S7JDQ<=C-#V1YI<47 M4$L#!!0````(`'MSBD<-/1K+I0$``+$#```8````>&PO=V]R:W-H965T&UL;5/;;IPP$/T5RQ\0LUZ2;EZP!Q/^-&BU M\"&U+7.]!5$GDE:,9]D#TT(:6A:I]F++`@>OI($72]R@M;!_SJ!P/-$=O15> M9=OY6&!EP19>+348)]$0"\V)/NZ.YSPB$N"7A-&M8A*]7Q#?8O*C/M$L6@`% ME8\*(BQ7>`*EHE!H_#YK?K:,Q'5\4_^6I@WN+\+!$ZK?LO9=,)M14D,C!N5? MZ./&Q$15PJ!H>.1D`8O"RNY6Y_*-@U"LT8OL*<9\R" M8$%]:<&W6OQ#YXG.M^G[+?I^[7`_._RZ+9!O">1K@7Q[Q#7F/&/R[+\F;+6G M&FR;KHXC%0XF7=15=;F=CSR=R2>\+'K1PD]A6VD4 M=.']+(F"QL?P2XCM=*6FQ&-_>R#+*RW_`E!+`P04````"`![)W^?0%?XE;NBYD9GW/F#)=R0O-J M>P!'WI74]DQ[YX838[;N07%[AP-H_Z=%H[CSJ>F8'0SP)I*49%F2?&**"TVK M,M:>357BZ*30\&R('97BYO<%)$YGFM*U\"*ZWH4"JTJV\1JA0%N!FAAHS_0A M/5V*@(B`GP(FNXM)\'Y%?`W)]^9,DV`!)-0N*'"_W.`1I`Q"OO';HOG1,A#W M\:K^%*?U[J_;4-)`RT?I7G#Z!LL(]T&P1FGCE]2C=:A6"B6* MO\^KT'&=YC]YL="."=E"R#;"ER0:GQM%FU^YXU5I<")FWMJ!AQ-,3YG?B)K8 M6/0.+0T`/WA5WJJT2$MV"T(+)MMA+@MF0S"OOK7(CEK\1<\B/3NFYT?T?.\P M7QS^1Z`X$BCV`L7QB'O,9<7D_S1ANSU58+IX=2RI<=3QHNZJV^U\R.*9?,"K M M:?4'4$L#!!0````(`'MSBD=G/.[ZHP$``+$#```9````>&PO=V]R:W-H965T MVF]#^ M3X-&<>=3TS+;&^!U)"G)LB2Y9XH+3#@I-#P:H@=E.+F[P4DCF>: MTJ7P)MK.A0(K"[;R:J%`6X&:&&C.]#$]7?*`B(!?`D:[B4GP?D5\#\F/^DR3 M8`$D5"XH<+_TZ;S:AI(:& M#]*]X?@"\PC'(%BAM/%+JL$Z5`N%$L4_IE7HN([3GV,ZT_8)V4S(5L)#$HU/ MC:+-[]SQLC`X$C-M;<_#"::GS&]$16PL>H>6!H`?O"QN99KG!;L%H1F3;3"7 M&;,BF%=?6V1[+?ZA9Y&>[=,/>_3#UN%A=GC<%\CW!/*M0+X_XA9S63#W_S5A MFSU58-IX=2RI<-#QHFZJZ^U\S.*9?,'+HN&PO=V]R:W-H965TTJ0K%BF;JFH?*D5Y:)^],(`5VT-MLZ1_7]M<0BM>\,QPSIDSOA0C MVC?7`7CRKI5Q9]IYWY\86C@@C+#9Y!J2@4&O^>-3]: M1N(V7M2_IFF#^ZMP\(SJEZQ]%\QFE-30B$'Y5QR_P3S"?12L4+GT)=7@/.J% M0HD6[],J35K'Z0_G,VV?P&<"7PF/63(^-4HVOP@ORL+B2.RTM;V()W@X\;`1 M%7&I&!PZ&@%A\+*XE8?\H6"W*#1C^`9SF3$K@@7UM07?:_$/G2.R7 M![*^TO(O4$L#!!0````(`'MSBD>,^.F)H@$``+$#```9````>&PO=V]R:W-H M965TZ:E ME42$Y"HD9:5_7Y)Z1"G4B[B[FIF=Y2,?T+ZX%L"3-ZV,.]/6^^[$F"M;T,+= M80,A+7\:S^+4T;W%^%@P=4OV7EVV`V MHZ2"6O3*/^/P':81CE&P1.72EY2]\ZAG"B5:O(VK-&D=QC_\ZT3;)O")P!?" MERP9'QLEFX_"BR*W.!`[;FTGX@GN3CQL1$E<*@:'CD9`&+S(;\7NF.7L%H4F M#%]A+A-F0;"@OK3@6RT^T'FB\VWZ?HN^7SO<3P[_T_^P)7!8"QRV1UQC+C/F M7Y=LM:<:;).NCB,E]B9=U%5UN9WW/)W).[S(.]'`3V$;:1RYH@\GFXZA1O00 MVF=W1TK:\'Z61$'M8_@YQ':\4F/BL9L?R/)*B[]02P,$%`````@`>W.*1X+# MCXVC`0``L0,``!D```!X;"]W;W)K&UL;5/;;IPP M$/T5RQ\0L\`FT8I%RJ:JFH=*41[:9R\,8,7V4-LLZ=_'-I?0BA<\,YQSYHPO MQ8CFW78`CGPHJ>V9=L[U)\9LU8'B]@Y[T/Y/@T9QYU/3,ML;X'4D*4?X6M>N\V822&AH^2/>&XP^81S@&P0JEC5]2#=:A M6BB4*/XQK4+'=9S^9`\S;9^0SH1T)3PFT?C4*-K\QATO"X,C,=/6]CR/5L:3"0<>+NJFNM_,I MC6?R!2^+GK?PDYM6:$NNZ/S)QF-H$!WX]LG=D9+.OY\UD="X$#[XV$Q7:DH< M]LL#65]I^0E02P,$%`````@`>W.*1Y^L':&D`0``L0,``!D```!X;"]W;W)K M&UL;5/+;MLP$/P5@A\0RK0=!X8L($Y1M(<"00[M MF996$A&2JY*4E?Y]2>H1M=!%W%W-S,[RD0]HWUT+X,F'5L9=:.M]=V;,E2UH MX1ZP`Q/^U&BU\"&U#7.=!5$EDE:,9]DCTT(:6N2I]FJ+''NOI(%72UROM;!_ MKJ!PN-`=G0MOLFE]++`B9PNODAJ,DVB(A?I"GW?GZR$B$N"GA,&M8A*]WQ#? M8_*]NM`L6@`%I8\*(BQW>`&EHE!H_'O2_&P9B>MX5O^:I@WN;\+!"ZI?LO)M M,)M14D$M>N7?M[40\P=V9AXTHB4O%X-#1"`B#%_F]V!T?:+S;?I^B[Y?.]Q/#D_;`HS)`IJ'\-3B.UXI<;$8S<_D.65%G\!4$L#!!0````(`'MS MBD=G\ABWI0$``+$#```9````>&PO=V]R:W-H965T,A+7]EW]6^HV5'\5#IY0_9:U[T*Q&24U-&)0_@7'[S"W<(B"%2J7 MOJ0:G$=]IU"BQ=MT2I/.%$6%D=BIZOM M19S@[L3#153$I6"HT-$("(V7Q:W<';X4[!:%9@Q?82XS9D&PH+ZDX%LI/M!Y MHO-M>KY%S]<5YE/V8[8ML-\2V*\%]MLMKC&7&7/\OTFVNE,-MDVKXTB%@TF+ MNHHNV_G(TTS>X671BQ9^"MM*X\@5?9AL&D.#Z"&DSQX.E'3A_2R.@L9'\U.P M[;12D^.QOS^0Y966_P!02P,$%`````@`>W.*1T*%2]2C`0``L0,``!D```!X M;"]W;W)K&UL;5/;;IPP$/T5RQ\0LUXVK58L4C95 MU3Y4BO+0/GMA`"NVA]IF2?^^MKF$5KS@F>&<,V=\*4:T;ZX#\.1=*^,NM/.^ M/S/FJ@ZT<`_8@PE_&K1:^)#:EKG>@J@322O&L^R1:2$-+8M4>[%E@8-7TL"+ M)6[06M@_5U`X7NB!+H57V78^%EA9L)572PW&233$0G.A3X?S-8^(!/@I872; MF$3O-\2WF'RO+S2+%D!!Y:."",L=GD&I*!0:_YXU/UI&XC9>U+^F:8/[FW#P MC.J7K'T7S&:4U-"(0?E7'+_!/,(I"E:H7/J2:G`>]4*A1(OW:94FK>/TY\1G MVCZ!SP2^$CYGR?C4*-G\(KPH"XLCL=/6]B*>X.',PT94Q*5B<.AH!(3!R^)> M'AYYP>Y1:,;P#>8Z8U8$"^IK"[[7XA\Z3W2^3S_NT8];A\?9X7%?(-\3R+<" M^?Z(6\QUP>3_-6&;/=5@VW1U'*EP,.FB;JKK[7Q*A\@^X&71BQ9^"-M*X\@- M?3C9=`P-HH?0/GLX4=*%][,F"AH?PT\AMM.5FA*/_?)`UE=:_@502P,$%``` M``@`>W.*1['LZ_#L`0``J@4``!D```!X;"]W;W)K&ULA93?;ILP%,9?Q>(!:N(`^2."U'2:MHM)52^V:X><`*J-F>V$[NUG&YO2 MBI*;8)OO^W['.#YY+^2KJ@$T>N.L58>HUKK;8ZS*&CA5#Z*#UKRY",FI-E-9 M8=5)H&=GX@R3.,XPITT;%;E;>Y9%+JZ:-2T\2Z2NG%/Y[PA,](=H%86%EZ:J MM5W`18Y'W[GAT*I&M$C"Y1`]KO;'G54XP>\&>C49(UO[28A7._EY/D2Q+0$8 ME-HF4/.XP1,P9H,,^*_/?$=:XW0F M7T3_`_P64AM8"J;<+RJO2@L>+!'B]&UX-JU[]L.;A'C;O(%X`QD-V]@5/H!< MF=^HID4N18_D\&D[:D]PM2?F0Y1(N453H8JLP&R\R&_%*DMS?+-!7D,FFJ/7 MC`ILTD<$F4-\L!-G)_/V]9Q]/:UP/=#)9CX@F0M(I@&)WV+V<8M3S3%HOH"D M=R&I#]@N0()F-P_)[D*R(6`3+T""YHOCVMR%;'P`68`$S7H>LKT+V?J`9`$2 M-.D\9'<7LO,!2PM0D]6Q+3VZVXO?Y47>T0I^ M45DUK4(GHLDPT:(+G7%LS\5_ M4$L#!!0````(`'MSBD?R:/K&PO=V]R:W-H965T M^1<Y+=B@A MI,\>]I2TX?W,CH+:1_,0;#NNU.AX[.X/9'ZEQ7]02P,$%`````@`>W.*1V,G MEAZ_`0``>P0``!D```!X;"]W;W)K&ULA53=3NP@ M$'X5P@-(2W>KV72;N)X8O3`Q7N@UVTY_(I0>H%O/VQ^@M%;3Z$V!X?N9H0S9 M*-6[;@`,^A"\TT?<&-,?"-%%`X+I*]E#9W69'`QO.WA62`]",/7O!%R.1QSC.?#2UHUQ`9)G9.&5K8!.M[)# M"JHCOHT/I]0A/."UA5&OYLCE?I;RW2T>RR..7`K`H3!.@=GA`G?`N1.RQG^# MYJ>E(Z[GL_J]K]9F?V8:[B1_:TO3V&0CC$JHV,#-BQP?()2P=X*%Y-I_43%H M(\5,P4BPCVEL.S^.T\Y-%&C;!!H(]!N!3$8^S3_,L#Q3N3\8'Z@] MB`)I'[09:NP`MO`\N^3Q39R1BQ,*&+K"G`)F01"KOEC0+8LO=.KI=)N>;-&3 M=8;)Y)Y$VP*[+8'=6F`72J1?2UQC3C,FV3;9_VJR#P*['TQFS'[;)/W5)`T" MZ0\F,^;ZFPE9W0X!JO9-H%$AA\ZWW"JZ]-DM];?K$YYG/:OAB:FZ[30Z2V/O MJ+]0E90&K'UT98^JL2_!LN!0&3>]MG,U-<>T,+*?6WUY;_+_4$L#!!0````( M`'MSBD<)X##EI@$``+$#```9````>&PO=V]R:W-H965TQ$GN#OR8\8Q8$"^I+"KZ5X@.= M)SK?IN=;]'Q=83YES_-M@?V6P'XML)];?/C8XAISGC$/V:1 M"@>3%G457;;SD:>9O,/+HAS.`H: M'\VOP;;32DV.Q_[V0)976OX'4$L#!!0````(`'MSBD>,)0\^M`$``!8$```9 M````>&PO=V]R:W-H965TVB4I1%N_;`!:SX06PSI']?VSQ"(M1NL'TYKXMMBE&;%]L!./0FA;(G MW#G7'PFQ50>2V1O=@_)O&FTD#+*#E,S\.8/0XPFG>"D\\[9SH4#*@JR\FDM0EFN%##0G?)\>SWE`1,`O M#J/=S%'(?M'Z)2Q^U">%E!LV MU?4*W-.X\>_PLNA9"S^9:;FRZ**=/SYQKQNM'7C[Y,9WT?E+NBX$-"Y,O_BY MF<[MM'"Z7V[A^BLH_P)02P,$%`````@`>W.*1VAF>DBU`0``%@0``!D```!X M;"]W;W)K&ULA53-;MP@$'X5Q`,$KW M#;&=4MS\.8/$_D0W=`J\B+IQ(<#RC,V\4BC05J`F!JH3?=@:A!1`0N&"`O?#%1Y!RB#DC=]&S0_+0%S.)_5OL5J?_85; M>$3Y6Y2N\.7%)UUJ"8*)8J_#Z/0<>R'G?MD MI*T3TI&0?B&PP2BF^<0=SS.#/3'#T;8\W.#FF/J#*(B-09^AI0'@"\^S:[XY MW&;L&H1&3+K`G$?,C&!>?;9(URP^T=-(3]?IVS7Z=IGA=G#?'M8%=FL"NZ7` M;BSQ[G.)2\QYPMROF^S_:[(?!0[_,!DPOC>^F+#%Q2DP=7R?EA38Z=@-B^C< M`@]IO/@/>)ZUO(:?W-1"6W)!YY]/O.L*T8&W3VY\%8UOTGDAH7)A>N?G9GBW MP\)A.W7A_"O(_P)02P,$%`````@`>W.*1]GS&H2D`0``L0,``!D```!X;"]W M;W)K&UL=5/;;IPP$/T5RQ\0LUZ25BL6*9LH2AXB M17EHG[TP@!5?B&V6]._K"["DHB_8'LYEQC,N1FT^;`?@T)<4RAYQYUQ_(,16 M'4AF;W0/RO]IM)',^:-IB>T-L#J2I"`TR^Z(9%SALHBQ-U,6>G""*W@SR`Y2 M,O/G!$*/1[S#<^"=MYT+`5(69.'57(*R7"MDH#GB^]WAE`=$!/SB,-K5'H7< MSUI_A,-+?<192`$$5"XH,+]^'/2O%H&XGH_JS_%:GWV9V;A08O? MO':=3S;#J(:&#<*]Z_$9IA)N@V"EA8U?5`W6:3E3,)+L*ZUQ8ZN#M0?Q$5LC'H,[0X`'SA97$I:;8K MR"4(31BZPIP2YHH@7GVQH%L6W^@T66S3]UOT_3K#?7+/_R.0;PGD:X%\*I%^ M+W&-.B2@\J#NHJNDSG/8T]N<++HF&PO=V]R:W-H965TK%=NW`#UCU@=DF=&\_'X#2B6TW MV/[Y3C^V*49M7FT'X-";%,J><>=\PW/AA;>="P52%F3A MU5R"LEPK9*`YX\?=Z9('1`1\YS#:U1R%[%>M7\/B:WW&68@``BH7%)@?;O`$ M0@0A;_QSTGRW#,3U?%;_'+OUZ:_,PI,6/WCM.A\VPZB&A@W"O>CQ"TPMQ(25 M%C8^4358I^5,P4BRMS1R%<C&+,3\RQLC!Z1"9] MVIZ%'=R=J/\0%;*QZ!-:'`"^\;*XE30[%.06A"8,76$N";-;$,2K+Q9TR^(# MG2:+;?I^B[Y?)]PG]_PO_HM?"-F98KBZ[:^>,3][K1 MVH&WS^Y\%YV_I,M"0./"],'/33JW:>%T/]_"Y5=0_@902P,$%`````@`>W.* M1Y4N'+2F`0``L0,``!D```!X;"]W;W)K&UL;5/; M;IPP$/T5RQ\0@Y=MTQ6+E$T5M0^5HCRTSUX8P(HOQ#9+^O?U!0BI>,'V<"XS MGG$Y:?-J>P"'WJ50]HQ[YX83(;;N03)[IP=0_D^KC63.'TU'[&"`-9$D!:%9 M]H5(QA6NRAA[-E6I1R>X@F>#["@E,W\O(/1TQCE>`B^\ZUT(D*HD*Z_A$I3E M6B$#[1D_Y*=+$1`1\)O#9#=[%'*_:OT:#C^;,\Y""B"@=D&!^>4&CR!$$/+& M;[/FAV4@;O>+^E.LUF=_918>M?C#&]?[9#.,&FC9*-R+GG[`7,(Q"-9:V/A% M]6B=E@L%(\G>T\I57*?TI[B?:?L$.A/H2KC/8N+)**;YG3E6E49/R*2K'5CH M8'ZB_B)J9&/09VAQ`/C"J_)6T>Q;26Y!:,;0#>:2,/F*(%Y]M:![%I_H-%GL MTP][],,VPT-R/Q;[`L6>0+$5*))_GGTN<8NY+)C_BR2;.Y5@NC@Z%M5Z5'%0 M-]%U.A]H[,D'O"H'UL$O9CJN++IJYSL;V]!J[<#;9W='C'K_?M:#@-:%[5>_ M-VFDTL'I87D@ZRNM_@%02P,$%`````@`>W.*1SQ.=D]&`@``1`<``!D```!X M;"]W;W)K&ULC571DIL@%/T5Q_>N"HK9C'%F8Y)I M'SJSLP_M,S$D.HMB@<3MWQ<$C=EJ-B\!KN><>^Z%0-(R_BX*0J3S4=%:K-Q" MRF;I>2(O2(7%$VM(K;X<&:^P5$M^\D3#"3YTI(IZP/>15^&R=M.DB[WR-&%G M2L7>]^'%8N;ZV0"C)I5;`:KB0C%"JA53B/U;SFE(3Q_-> M?==5J]SOL2`9H[_+@RR46=]U#N2(SU2^L?8[L25$6C!G5'2_3GX6DE4]Q74J M_&'&LN[&UGR)%Y8V30"6``8"B.\2H"7`1PFA)80#`89W"9$E1(]F0):`K@33 M?-.LKM4;+'&:<-8ZW!R/!NM3&"R1VLS<$5U0=5FX&J`V+TTN*0A`XEVTD,6` M$69M,.@.9&,@P3QBUR>"`\93)@>G8,KIC0M@!<+Y)%F/B>Y8[3%H'K-]0&?7 M8^+I@N!407#<>FAZ!F8$PBF!<"P06@>+6Y>HP]2F6H.!\XC=9\2-B>A+$Y$U M\7R;(AZE6!O,-X"B>5!FA2`(YD$;JP0C?QZT-:`X@.%T4>C+HI#Q`OSYOJT- M9O'\/(_)D-WB\,X./:"S_5_'%.2-_O(5X:?N=A9.SLZUU*=M%!T>@!>@KXQ/ M\76PS(*)^"98;LT5M*& M!25'J:>QFG-SRYN%9$W_9@T/9_H/4$L#!!0````(`'MSBD=DM@^O0@(``!T' M```9````>&PO=V]R:W-H965TJ^[!2U8?=9XQ+L(=SSLP9DW':4O;!"XR% M\TFJFJ_=0HAFY7D\+S!!_(DVN)9O3I01).26G3W>,(R.FD0J#_@^]`@J:S=+ M=>R-92F]B*JL\1MS^(40Q/YN<$7;M1NX7>"]/!="!;PL]7K>L22XYB6M'89/ M:_FE%NHK'D3[R?X, MU/"XBV^"U388B>_D36`&]TT^2QMTQC\1.Y5?UFPJ?A%HF&PO=V]R:W-H965TAAD`&2;D8D%_WZR>I'VA[ ME\W/]B)$Y_VNRKI]\"]==]T$07NXB"IOO\BKJ/M_3K*I\JY_;,Y!>VU$?AR" MJC*`,(R#*B]J?[<=QKXUNZV\=651BV^-U]ZJ*F_^>Q2EO#_XQ!\'OA?G2Z<& M@MTVF.*.127JMI"UUXC3@_^5;%Z`*\B`^+<0]W9V[ZGB7Z7\J1[^/C[XH:I! ME.+0J11Y?WD3F2A+E:EG_H5)WSE5X/Q^S/X\R.W+?\U;D\= MQ2F_E=UW>?]+H(9()3S(LAU^O<.M[60UAOA>E?_6UZ(>KG?]3Q)BV'H`8`!, M`1//>@#%`/K9`(8![#V`60,B#(@^RQ!C0/S9`(X!_$-)@9[=86V>\B[?;1MY M]QJ]H:ZYVK=DP_O5/WCM,-@O2^LK0+_:N^W;#B#>!F\J$6)@AGG4F!C,D+V& MD`D1]`5,52L M/D+YZ9(JGI>O,80F*9#06M63AJ8\`?@3.4^Z1^*(0IC8DSXC?THXX;%1:^S4 M&FM*:N%ZU)B$LIC:E6H@!\(<0C60L"A>02YTQN,\$VJ6R9TR.@T M*$K2A%(SVZH3+]G0W&BT9)N#L@D4&WA6/7#)@R9(N4T5@J(X-6MRVR5!XZ*) M>7MF""*<\\3"YK8W$JVZ\Y),8R*24&[9'&Y_(:/!6,PT0Y")Q=W>!/N;64PG M0Y")Q=W:!'N;65PD0Q!++6NT:@)+JM$%+-.V1U"4Z!>C@0WG$^174B>/#^"/9/)&5\3W9/.OSY'OZW?::G\4_>7,NZM9[E5U_ MSAD.)2OXR%Y.JGO_@=02P,$ M%`````@`>W.*1[-E0ACV`@``N@L``!D```!X;"]W;W)K&ULC5;;;IPP$/T5Q`<47P%'!"FWJGVH%.6A?2:[WET4P%OLS:9_7V,; M`I4-?0G@/6?.C.TYF>(J^C=YXEQ%'VW3R=OXI-3Y)DGD[L3;2GX19][I7PZB M;RNE/_MC(L\]K_:&U#8)`B!-VJKNXK(P:\]]68B+:NJ./_>1O+1MU?^YYXVX MWL8P'A=>ZN-)#0M)6203;U^WO).UZ**>'V[C.WCSA`S$('[6_"IG[]&0_*L0 M;\/']_UM#(8<>,-W:@A1Z<<[?^!-,T32RK]=T$_-@3A_'Z-_->7J]%\KR1]$ M\ZO>JY/.%L31GA^J2Z->Q/4;=S70(>!.--+\C787J40[4N*HK3[LL^[,\VI_ MR8&C^0G($=!$F'3\!.P(^)-`5@G$$(9$7R/@1R#W%M,BB9(HL-/&LBG ML>`CJX%6-!X<)HQX=`B2AS%/#D/]F6)?IGB^&]AEFOL#$%\`,@]`3`"<+G/, M#*2SE5I(#C/*:!CV9&&(,8:(/QNZF0VU,7#@Y-+-_4C7]R/;S"!SA\;"E=Y; M#(0@1P#[A?)-H=R=/%@*I7,ABX$I)+.KN-!AFSK,'O":C(5`1G$:D!EL;$,' M`BL$5X1&#`8@<..AUP"60LX!Z*J2!1$"L\!5@%X;6"J-W8G6E"R(8**K"E^: M1S]NF9*WWY"TE"R(@3UE`:=L8H.MG2M:4+(@!!DD:D-KN>FC;GJQN ML\5`A"`*%>6UAZ62\P=*UZ12UP^8A6[IMH]`9R0X7U-R3I)E61XJ:MM)X&@E MZ9I4[MJ381CP++AM)I"YJE8OA071G.4X((6V_00![W^FA9+#4)CC+-!3:-M0 MT&@HV8KG.Y#?])/9(-/R_FA&2!GMQ*4S$^ML=1I3[Y`9A#[A97&NCOQ'U1_K M3D:O0NEQRLP^!R$4USF`+[J53GJ0GCX:?E##:Z;?>SM:V@\ESN.D/(WKY5]0 M2P,$%`````@`>W.*1UF?<%)U`@``W@D``!D```!X;"]W;W)K&ULC5;;CILP%/P5Q`[3M,+K*HKKRH._'7HW*QLTSN?;:Y1EYL*IL\&OGT$==H^[O$5>D M/[C`'1;>RGO!Q(*79]Y8=RUKW-"2-$Z';P?W"]B?H(1(Q*\2]W0R=H3Y,R'O M8O+C>G!]X0%7^,($!>*7)S[AJA),7/F/)OVO*0JGXX']F]PNMW]&%)](];N\ MLH*[]5WGBF_H4;$WTG_'>@^1(+R0BLI?Y_*@C-1#B>O4Z$-=RT9>>_7/SM=E MY@*H"^!8`./5@D`7!&,!".5.E3.YKZ^(H3SK2.]TZC!:),X<[`.>W,6A]S`:@28CP=0(U`0[,T%@ M(@BG!('>23IWF4A,HW:B,"'D=[1OU@FM.J'2B?T5'84)@S#P5V`G(VQF)[+: MB;0=,->98HX#!II%8JM(K`D",T%B/=UD_71W5@<[[2!<25UA`%Q,,[7*I%HF M6DESP,1F$?$$L:@`7U,L=`LP]NTL4`#6$P7&CIN[@!LZ9@"E(%U*%=A[$P0; M[M(1M+0E>V^"H3G3!0IC/\V#C2S!VKL%Q%N"52``0+@8K+&OYE+)EF`U*%G2 ML;-.?7ZH"2/M M\#4U?M+E_P!02P,$%`````@`>W.*1X8SN57D`0``U@0``!D```!X;"]W;W)K M&ULA53;;IPP$/T5BP\(=VA7+%*6JFH?*D5Y:)^] M,%P4&U/;NZ1_7]]@2<0F+]@>SF7&]KB8&7\1/8!$KY2,XNCU4DX'WQ=U#Q2+ M!S;!J/ZTC%,LU9)WOI@XX,:0*/&C(,A\BH?1*PL3>^)EP2Z2#",\<20NE&+^ M[P2$S4P+)5B!Q`NG;)'.#&6T9"R9*PS"[CZL<+DN#++Q34?II0JDS^\#H M9#%Y\#7-/TC'H9(\?;\[_N:^4."=Z2.!:G89I3Z@371MU<=(W[=W\9-J8=MQ M-YFRF'`'OS#OAE&@,Y/J-INKUS(F0246/*A=Z-4CLRX(M%)/476IZS\#U!+`P04````"`![!6253W%=2K\T;5E;=JV>Q-# M2YLG^);@#P0O?$@(+"'X+B&TA/"[!&0)Z`L!=+6;E=MCB;.4L];AW6XW6']4 MW@:IO3DZPDRJ11.N!JB]R-);YD=1"FY:R&+\$6;78^+[F-QB[B/VBXBGWB<9 M,$#5,13CSQ43C(OQC8`7!/,"P9Q`.!8(N@0QG*:,#*;N4G:8R$,0PGF?<-$G MM#[>?9]=:'UB.%KXB0]:]$'6Q[_ODUL,0OZ#JO=SJ$F8]6*8M0T33&W&F+S' MA/,FT:))9`70U$0?')\E6]`*S;O$BRZQ=5G?+V7?8Z)YDV31)+$"\8/-ZS!) M'#[8X7UB?XMUXG_)`D9'1H,OY!?FE[(6SH%)=?J8H^+,F"1*!:[4YU:H:V<8 M4'*6NANI/N].XFX@6=/?*\/EEOT'4$L#!!0````(`'MSBD=_!]:73`(``/4' M```9````>&PO=V]R:W-H965TVY:*OWO6\&$7@O`^\59?*F4FHK*(QKA3W;).UKP+ M!#OOPB_@>0^PD5C%KYH-V%-8S)I M\A^?]#_3!$[[]^S?['*U_0.5[(4WO^N3JK3;.`Q.[$ROC7KCPW?FUV`='GDC M[3,X7J7B[3TD#%KZX=JZL^W@WF2Q#YL/@#X`C@'0&7<@:_,K5;0L!!\"X?:V MI^83@F>H-^(82#NI'31(KZ9Q))\$D(^D\!6U2D$V1Q(^4=$IQ$I3!%,]3 M\"8%.PI8H3@)@#!>6$NZ24D=!:U0G`3"E,!Y"MFD$$=)5RA.@A,"R,*699N8 MS&'("L9)",IB-$_)-RFYVP^$*QXL(1@`M5`V8 M+>Z'N@/WREUR.UNZCVY=[:)5L[Z^TV31ZW:)`U_C&*^1$E\9^=+/!+;+'""_ M*VO%X44HUQ]@@;1=Z@![$EXYN+PHRTCR^8"-)B=Z3R_L)Q67NI/!@2M].=B3 M_,RY8CI-_*3M5/H.'@<-.RO3);HOW*WD!HKW]TMVO.G+?U!+`P04````"`![ M MRN-)J`XO3;PA;E_6M.$E:YR6'M;N$UAM08=TQ*^27OFH[2CQKXR]J9L?^[7K M*PVTHCNA4A3R\DXS6E4JDQSYCTGZ.:8*'+?[[-\ZNU+^:\%IQJK?Y5ZRZ:Y7_23R3=A\`#0! M<`@8QID/0"8`?08$UH#`!`3_.P(V`?AF!$][[V8N+T21)BV[.JU>[G.A=A58 M8;DV.X=WG7+2N*L`N19I\I[".$R\=Y7(,'#$;#03PF4DUP@8"$\*&%3`.163 M$:!6L3Q`IHD0633<3;+]DF0B$\W)1./)0MHE6D@0S"4(Q@D"+0!/-9(.:?14 M:`21,$;+5*8I`#'P+^R%U?Q+SZQ&),,P\08VA;C5EL(B>Z*RFF;P0[]Y7H4`ZG_P!02P,$%``` M``@`>W.*1P<[JZ&N`@``^@H``!D```!X;"]W;W)K&ULC59=;YLP%/TKB/<6;+XC@M1TFK:'254?MF>'.`DJX,QVFN[?SU]0J$S, M2["=<\^YMN^!6]X(?6-GC+GWT;4]V_IGSB^;(&#U&7>(/9(+[L4_1T([Q,64 MG@)VH1@=5%#7!C`,TZ!#3>]7I5I[H55)KKQM>OQ"/7;M.D3_[7!+;EL?^,/" M:W,Z<[D05&4PQAV:#O>L(;U'\7'K/X'-#L82HA"_&WQCD[$GD]\3\B8G/P]; M/Y0YX!;77%(@\7C'S[AM)9-0_FM(/S5EX'0\L']7VQ7I[Q'#SZ3]TQSX660; M^MX!']&UY:_D]@.;/222L"8M4[]>?66<=$.([W7H0S^;7CUO^I\\-&'V`&@" MX!@`=>):2*7Y#7%4E93TPMB@R9+P%BXU7Y7D5A6`;O MDLA@X`2STQ@P(@+!/DI`F\0L'!J)!8+(1A!-$H0&X)HOLE, M87J=I<;`HBA@;-=)G#J)T8GG.NE41V,2D$=9:-=)G3JIT4GNZ&C,0UH4=I7, MJ9(9E?2.BL;D($N*Q*Z3.W5RHY/9"0IG?13WZT,ZU)$"".T5,MNK`2W<&K!Z M;:X"5M2'`2VI6.TV5X$KJL.`EE2LGIRK1"NJPX"65-S&!8-S\P4*JR=GQ0$2 M1W6X[0;2-=6A02`JXGC!LBBI6-QFP[D:^XO-WO*,[#P]@96 M>\ZE!G\N'`NT^G-VB3"\?XG0;3X(5ERB`8$TC+.%]QET.Q#"%3XWH'L?`NBV M(8Q6U,L`6CI_MP]A;*^6V1?4@-(LS_.OG]!@TIMTF)Y4"\:\FEQ[U?%-5LL+)9>@TQW:W^@]02P,$%`````@`>W.*1W*0`)4)`@``\04``!D```!X M;"]W;W)K&ULA93+CILP%$!_!;'O^,6CB0A20U6U MBTJC6;1K)W$"&H.I[0S3OZ]?84A*R`8_./=RKFU<#$*^JIHQ';VWO%.;N-:Z M7P.@]C5KJ7H2/>O,FZ.0+=5F*$]`]9+1@PMJ.<`09J"E31>7A9M[EF4ASIHW M'7N6D3JW+95_MXR+81.C^#+QTIQJ;2=`68`Q[M"TK%.-Z"+)CIOX"UI7N24< M\*MA@YKT(^N^$^+5#GX<-C&T"HRSO;89J&G>6,4XMXG,A_^$G!^?M('3_B7[ M-U>ML=]1Q2K!?S<'71M9&$<'=J1GKE_$\)V%$E*;<"^X0.&KI MNV^;SK6#?_,9AK#Y`!P"\!B`DL4`$@+(30#P9JZNKU33LI!BB*3?BY[:+4=K M8E9N'RDW:4I2L07,2I7%6TD0+,";3108/&&VGL'WB2H0Z8@`(S!:X#D+,K7` M+AZ1;#X!F4N03!.04`:ZELP=T_DR/(-7*PCO4Y6G4)Y-J"N9Y*%,$F1N5BR; MRG@F2W"&DOM8Y3&,$4E7\SKI0YTTZ)`%'<]\,I])2+K@<^$069%D7BA[*)0% MH87"MYY)88[RU8*/QQ#,DWN'+W^HDP>==.'L>"8E.;S5N3H\'D,XA?_I@,G? MV=,3^TGEJ>E4M!/:_.CNKSP*H9E)`Y_,IM;F_AT'G!VU[>:F+_V5Y`=:])<+ M=KSERW]02P,$%`````@`>W.*1_0:[50#!```W!0``!D```!X;"]W;W)K&ULC9A;;Z,X%,>_"N(##/C"+4HC39JV::651O.P^TP3 M)T$#.`NDF?WVB^&8@?.KO3#6>;^KLFZ?_$O775=! MT!XNK,K;;_S*ZOZ7$V^JO.N_-N>@O38L/PY&51G@,(R#*B]J?[,>QGXTFS6_ M=651LQ^-U]ZJ*F_^V[*2WY]\Y,N!G\7YTHF!8+,.)KMC4;&Z+7CM->STY']' MJP^2"60@_B[8O9T]>R+Y3\Y_B2_OQR<_%#FPDATZX2+O/[[8,RM+X:F/_"\X M_1-3&,Z?I??78;I]^I]YRYYY^4]Q["Y]MJ'O'=DIOY7=3W[?,YA#)!P>>-D. M_[W#K>UX)4U\K\I_CY]%/7S>QU_B%,S4!A@,\&2`D=&`@`%Q-:!@0%T-(C"( M)@-$C08Q&,2N$1(P2%P-4C!()P-B-LC`('.-(/9\W+GPP208MWPHF%W>Y9MU MP^]>,U;Y-1=B0BLD:O+@M<-H7RRM+XB^!C?KKPU!\3KX$IZ`P3-F*YE$S[R. M3(SUR'Y$T$0$?993JEB9ZB(-#&FD^AC/DLGTS`X8'.J9%\D@PY2!"0W,F_1C M6A?)$#WS[N#G0S)4O<)$N<)D7@P$/$1J#U3I@#;"*81-7/[D<,9SA(C^"XC$X3GX&*.D7V.$:Q2K/80V]%!?/MW-DV%]:-%E9@[]`*7VPMI.D*8_(@>)(]`X2=0^L(/&L47CV$'C&-G/,\F$ MQ'R<`44,'7H%EFT@U?AP>&W`EO<&[*!Q3.VE]3)! MFM:/'52.0>54MV@.*L<6E6,'E6,'E>\`LIR9V$&Z&%1)#>N[FR#-F8`=I(M! MNI28YI6YS(NH5;X(1T#EE.K#/0.$>^D1?32'?D#@S*>:C2=JQ2U?LK&Y>(C# MP4N(?3=?)RC60WL%M,S&0;N$.KR-`J1]'24.VB52N\9`$M)T-*(6^#(0")QF MAL8/D,NKKQ9=9N;0-@BTC4CG0]T+EA686BK00>8DLV_%3D+1XUM9,+NKJ%AS M'B['6N_`;W4G?,Q&IPNX[UC<=3R,;]'J!2G&7]'J336^1ZOW\<[D3]C-^IJ? MV5]YKX9;DQ'G'^GF$W_K:O+#\.'TIV:D3CTG_W(R7;^.7CE_E M7>)TH;GY'U!+`P04````"`![Q,?^.?GF[&9E!/CKZ+#6((W2@9Q"#HIQSV$HNDP M1>*!C7A03UK&*9)JR<]0C!RCDPFB!,9AF$.*^B&H2K/WS*N2723I!_S,@;A0 MBOC?)TS8=`BBX+;QTI\[J3=@5<(Y[M13/(B>#8#C]A!\B?9U%&J)4?SJ\206 M,_.Y/LE.T80!.N$47(E_8]!V['#)MV#`BS"]H+D(R>@L)`$5O=NP',T[V MR2YT8?Z`V`7$',2)]YM$^495K@#"; M*B41:(&J5%5>JR2+2WC51DX3+S1/5K.BJ)TBFR50`HG66KJ=(,D MVR3)'$GN-\@W3R5?/Y5BDZ#PG\I=+8I/U*+8J,5NDV3G2`J_P>-F+1[7:Z'; MQ@9"%/IOQMT==:+U2^I$GGK`10L8T1G_1/S<#P(4%P*_6T4'-N^YY=2#;>VOC\7U+]`U!+`P04````"`![D9AL8/Q= M-!A+\$%))]9>(V6_@E"4#:9(/+$>=^I+Q3A%4AUY#47/,3H8$B4P]/T44M1V M7IZ9V`O/,W:4I.WP"P?B2"GB?S:8L&'M!=XY\-K6C=0!F&=PY!U:BCO1L@YP M7*V]YV"U2S3"`'ZU>!"3/=#>]XR]Z\./P]KSM05,<"FU`E++"1>8$"VD$O]V MFI>4FCC=G]6_F6J5^ST2N&#DK3W(1IGU/7#`%3H2^*1Z@Z,.N;6?6P7Y9^HXV3P@=(1P)8YYY0N0(T840/R3$CA#_;X;$$9*; M#-#6;CJW11+E&6<#X/:V>Z0?5;!*U-V40)B@:IKP-$#=19Z=\BA99O"DA1PF MG&`V%I.&]R%;"PE&!%0&1A?AG(NK#*&A/TA06$0:/?#PJY,)C.-M-BXFAQ'U-8S)=HF3Y` M;2TJ\)/X/FCGI-)@D=Y4!2FU$@0,F.G=2-F43':?,W.*1VVKQ]A5`@``'@D``!D```!X M;"]W;W)K&ULC9;;CILP$(9?!?$`:\R9B"!UJ5;M M1:757K373N($M`:SMA.V;U\;&PHMP;G!!_X9?QZ&L?.>LG=>82RZ5%3F] M"E*W^)4Y_-HTB/U^QH3V>Q>ZX\1;?:F$F@!%#B:[4]W@EM>T=1@^[]TO<%?" M2$D&Q<\:]WS6=Q3\@=)W-?A^VKN>8L`$'X5R@61SPR4F1'F2*W\8IW_75(;S M_NC]9=BNQ#\@CDM*?M4G44E:SW5.^(RN1+S1_ALV>Q@(CY3PX>D9%<;;.$EI90L,2 M+9>)YRQ:DP8;FE)KH!_="6MD)8GTCKT-$"V)DC3<(-&B#*9^N(X26U%B$Y1X M@R5^("BQ)2B)E20Q),FZ@]2:K.EVLF96@FP]61>QR.XDZR(8F2U9536SP$#/ MGB2C9IO&J+9P5NO1$F^(>-:#M?C>A^PD)[08'A M`Y_HD8H";24%VFL*C-;_Y$6I-:+_:!:EUHA6:,#L).O0!?]`[%*WW#E0(0_% MX00[4RJP].(]2>1*7E:F`<%GH;J)[#-]?.N!H-UX&YFN1,4?4$L#!!0````( M`'MSBD=7S(]RI@$``+8#```9````>&PO=V]R:W-H965T!#4W:@#I=CJE!;4NU4=B!@VT M#23!298D:R(HD[@J0^U)5Z4Z6<.N!KW.,67PC,[]M872%62 MF=T0`_&8PFD6,O/>#4J\^>6CW./$6@$-CO0)URQEJ MX-P+N8/?)LV/(SUQ&5_4?X9NG?L#-5`K_L):VSNS"48M=/3$[;,:?\'4PLH+ M-HJ;\$7-R5@E+A2,!'V/*Y-A'>/.-IEHUPG91,AF0EI\2\@G0OZ%0**ST-<] MM;0JM1J1CGX"95E>*!'>*3ZR*1!!V7=;871=DI9<#+)S0JCWCVB.>'0 M61]N7*SC?Q43JX;+*YF?:O474$L#!!0````(`'MSBD>;M:Q[W@$``"<%```9 M````>&PO=V]R:W-H965T-R$O)-=91J\,[9 MH/91I_6X@U#5'>5$/8B1#N9-*R0GV@SE&:I14M(X$6,<*B63_0%PG4A7,B_SY2)J9]A*)YXK4_=]I.P*J$BZ[I.1U4+P8@:;N/OJ/= M,;.$`W[U=%*K/K#93T*\V<&/9A_%-@)EM-;6@9CF2@^4,6MD"O\)GO]+6N&Z M/[L_N=6:]">BZ$&PWWVC.Q,VCD!#6W)A^E5,SS0LP26L!5/N%]07I06?)1'@ MY-VW_>#:R;_)DR"[+TB"(%D$R;=-01H$Z2)`Q:8`!P'^((!^*6XCCD23JI1B M`M)_O)'8,X)VV&QU#92;-'N@(@N8K:W*:Y46J(17:Q289,4\SDSR.7.8F?1S MYC@S>&&@R;F$3>Z%3==A$V>`<';?(+UG@-<&:4B0W:;,'3/XU0;F?@G\90D< M2N2W)1!:U_`00K%Y-KB#Y_)L&SMZ#-]@-[&S+V-G(7:Q%<=#>1&G:"M.%N+@ M-/\0!ZZ.Z$C.]">1YWY0X"2T.>WN:+9":&IW.*1SV%6(.D`P``]Q```!D```!X;"]W M;W)K&ULC9C;DILX$(9?A>(!`A(20BZ/JV)[/+L7 M6Y7*Q>::L66;"B`'\#C[]@NH8<#1@;D8@_QU]Z_6H26O'[+Z65^%:+S?15[6 M+_ZU:6ZK(*B/5U&D]1=Y$V7[S5E61=JTK]4EJ&^52$^]49$'.`SCH$BSTM^L M^[9OU68M[TV>E>);Y=7WHDBK_[8BEX\7'_E#P_?L/'N=^'_+#3(')Q;#H7:?OQ(78B MSSM/;>1?X/0S9FR=Q3N]Y\UT^_A+0 M!]HY/,J\[O][QWO=R&(P\;TB_:T^L[+_?*AO6`1F>@,,!G@TP,AJ$(%!M-2` M@`'Y-.!6`PH&=&F$&`SBI08,#-B30:"RVX_-/FW2S;J2#Z]2$^J6=O,6K5@[ M^D>O[AO;8:G]#FA'>[/^V$0L600<@"RFW)T>!B&`>V2_"5 MD$23C]G8+'7Y:G4Y)0^*C`C#L7T"OH'/F/#0G+G$F;D$)@BQI$XQ**0)=61D M,7E09)*TL\FHGCO5H5$[/DST&::5_('11'$&=&X5U==RA'(4B/+=(! MHIB3A-C5&]&Y,&U]FPN#`I?8%A-`,:/4L4]:R5E>!S)FB)H[H"V-\PY`G4F> M*O04VH\0-\315J-Y'"A'W"156X]F!0T-!`N0JOF.U6A"Y\+<&QR" M'8Y'>A=8N]/,TH-#>WJP>T_`2)^>V<$)(*1/SVR:&=&Y,/=:Q[",N>%,B=V' M2NPX56+WL1+#,N;4LN.,4&R(XU[K&`Z,G!E<:)?;O+>QH[?NLQ9F2WH[0,E3 MG&!RYRI$=>GOT[5WE/>RZ;1.6L<[^U?VK=HM4.:]CU:O:H[WJ?[S?J6 M7L0_:77)RMI[ETU[4^RO=6W.*1[`>:]K%`0``200``!D```!X;"]W;W)K M&UL?53)3N0P$/T5RQ^`LW6/:*4C049HYC`2X@!G M=U)9A)=@.QWX>[RDTP&%N<1V^;U7KVQ7\DFJ5]T!&/3.F=!'W!DS'`C150>< MZALY@+`[C52<&KM4+=&#`EI[$F=<0%2Y&3AU3T'H7LID(+FB._B0YDYA`<\]S#IU1PY[RF MLV8CC&IHZ,C,DYS^P%S"S@E6DFG_1=6HC>07"D:Q%WZ M5)&?B_3V-B=G)S1CDA7F/F#BGQ%E0"1QNF"(=;#82+9L?$F1!('_I)@1N^T, MZ5:&=%UH&HK8Q=L"V99`MA;(O$`615]-[CU&A#(")OT947Y'!!-D=74<5.N? MM$:5'(5OH%5TZ9H[_[C(%5[D`VWA'U5M+S0Z26,?D+_M1DH#-GETL\.HLWV] M+!@TQDU_V;D*3STLC!PNC;O\/8I/4$L#!!0````(`'MSBD?:AE^5\0,``(T1 M```9````>&PO=V]R:W-H965T>GY]V.P22`"FTL`YZO5=I5A>2_*7]59 MRMK[DZ5Y]>:?Z_JZ"()J?Y994GTIKC)7_QR+,DMJ]5B>@NI:RN30"F5I@&'( M@RRYY/YJV8Y]+U?+XE:GEUQ^+[WJEF5)^=^[3(O[FP]^-_#C M=L8%B!$@3P%J%:!&@,ZUP(P`FVN!&P'^(A#H9+6IWB1ULEJ6Q=TK]?JX)LTR MA`57D[GWJG909;GR&T!-WFKYN:(A+(//1I%AL,>\:X;C-++1R%-)H!QX>(%C M7@PL8"MN,;#6!"<6'YQ*MFXE.Z.$C4="QB(A_7P2DT\<5T#'%-"^`JI]9$,? M18OD.EL:`1+%".$TM]9<+")$"[:A)F2"863AML9L#`($'P^/.<-C)C\O<\#[ M\6DF(O1UIOK46E,"@8;3U$930!FW85O6I13(1&C<&1HWH5%+:)HAE$%$(HO; M%JX_)SO-(<2$\8DU*YR."ZTDAFF'=IH1C`*=V.61TTYD$F3)3S0S/S.Y761" MHT*$$Q,;._V.M;%0C"MHNIBC*D!H+PLP6J@'3@",%H9!]@P#A!(+MC98#*_5 M8Y!B0Z$J,Y:%L>UL1JH:300W6O^'P>&,LF"@OX!%H67.UT^.HT7?IN,(B9@E M7=N.0PZ]@C0,<;0Q#$,D,\I#!_$87CORT/5YW,YPC,31I.ONE@34;(!H0L5H MV1]N`.;8`.[R"GS&!C!,"`31MD0TQV+DO7H_DF?-@6IXE,2V-=*!A+'>KAK& MZ*[$(.;L`U.+:1A;UM*ZPPA%80M1F`ZIJH8E%=N.(RR>ZO[@;@$0S=D%&HK5 MFQ"W-8&9W,YP$"(BFRKB[C8`71^(QU6@NP^@HP^@NP_@C#Y@&"$H9;8CE.&( M6MW",B$;[/H*`<%LQZC.,$?14S@,T=T-<$XWP.ZD#N)E>0_.P`8#2JP;W6#J M_$?C:6W;SFA$<**#.@)R`6A4OS@>]5\=, MEJ?V+;_R]L4MKYLEW!M]?$GXBLVKY\OX.RS6,#*^@<56?R=XJE\MK\E)_I.4 MITM>>1]%K5YXV[?38U'44KDZN17JOM1?"_1#75R[CQ^/ M+S"K_P%02P,$%`````@`>W.*1U1G#[.R`@``I0D``!D```!X;"]W;W)K&ULC59=DYL@%/TKCC]@!?P`,\:9S4>G?>C,SCZTSVQ" M$F=54B')]M\7!%V31>U+!#SGW'L/YD)VX\V[.#$FO8^JK,72/TEY7@2!V)U8 M1<43/[-:O3GPIJ)239MC(,X-H_N65)4!`B`)*EK4?IZU:R]-GO&++(N:O32> MN%05;?ZN6,EO2Q_ZW<)K<3Q)O1#D6=#S]D7%:E'PVFO88>D_P\46AAK2(GX5 M["8&8T\G_\;YNY[\V"]]H'-@)=M)+4'5X\K6K"RUDHK\QXI^QM3$X;A3_]:6 MJ])_HX*M>?F[V,N3RA;XWIX=Z*64K_SVG=D:8BVXXZ5H?[W=14A>=13?J^B' M>19U^[R9-P18FIN`+`'UA#Z.FQ!:0OA)B"8)D25$_QLAMH3X(4)@:F^=VU!) M\ZSA-Z\QVWVF^JN"BUCMS(N M+YXM+[;^C`@DLP8GTP;CV0RPT^!D:+"!0$!P1-)QW-I*D01.R6VL7$H03I-Q MW!9W^PH)B-SED=GRB/4'NP7268/3:8-U?YU)`8)YBRT&`4S`E,4]+HJF\U]%N%\K["8-$PA MFF@5%D9P$B43K<+"(,'IH\MWK:+#X2A.TH?Z@L$95+'FV)[^PMOQ2RVU1X/5 M_H;QC/09]K"^@HLU=*QO](VD/?,^Y?/L3(_L)VV.12V\-R[5R=D>HC5N#&W"#.1_-Q=BOJ;6?X/4$L#!!0````(`'MSBD?4 MU<':=0(``.`(```9````>&PO=V]R:W-H965TVK,!`]$F,;4-;/]]_44VD1S"A=C.._., M/1XFY97Q#W&D5`:?;=.)57B4\K2,(K$]TI:()W:BG7JS9[PE4DWY(1(G3LG. M&+5-A!'*HI;475B59NV-5R4[RZ;NZ!L/Q+EM"?^WI@V[KD((;POO]>$H]4)4 ME5%OMZM;VHF:=0&G^U7X`LLU%%IB%+]K>A6#<:"#WS#VH2<_=ZL0Z1AH0[=2 MNR#J<:&OM&FT)T7^ZYQ^,;7A<'SS_MUL5X6_(8*^LN9/O9-'%2T*@QW=DW,C MW]GU!W5[2+7#+6N$^0VV9R%9>S,)@Y9\VF?=F>?5OBF0,_,;8&>`>P-L`[<@ M$^8W(DE5BYC"[:D=/@@69M M-=`K(N6]1V`?8F2.C7F,)AS$/@?Q,,;8Q@C([R#Q.4B&#A+G`,:;S(VFLU%: MS2)#<9+Y.>DL)W4Y@ MD.?[%T27Z$P(@/Q79+17)UI`D67%!,I;<6,4 M/)`])P*4)A,@;]V-0?B!_#G1`O(,IE#>"AVC;B4Z<0?`6Z.C'$(RD\3Y\H/T MD22Z`E2QYE-)G*]`R!XH=2>Z5^LP7X60/W)?K`@`%?$$:;X.H?!?F-'_I!,M MD@P--F]1T:`#M90?3*,5P9:=.]/7!ZM],W_!IH-]R:OR1`[T%^&'NA/!ADG5 M!TW3VC,FJ0H!/:FK<%2?&_VDH7NIA[D:<]N`[42RT^U[HO^HJ?X#4$L#!!0` M```(`'MSBD?Q8^Q^/@(``"4'```9````>&PO=V]R:W-H965T33`DFCA.;4.F;U]OA$`- MZ878/]_F1;_SGK(/7F$LO$_2M'SI5T)TBR#@984)XB^TPZW\YT`904).V3'@ M'<-HKTFD"6`8I@%!=>L7N:Z]L2*G)]'4+7YC'C\1@MB?%6YHO_2!?RF\U\=* MJ$)0Y,'`V]<$M[RFKF_@L5VKA`:\+/&/1^-/95]1^F'FGS?+_U01<`- M+H520/)SQFO<-$I(&O^VFE=+11R/+^I?]6IE^AWB>$V;7_5>5#)LZ'M[?$"G M1KS3_ANV2TB48$D;KG^]\L0%)1>*[Q'T:;YUJ[^]^6<66IJ;`"T!#H3!QTV( M+"&Z$N*GA-@2XO]U2"PAN7,(S-KUSFV00$7.:.\Q<]H=4I<*+!)Y-J7'=5%N M&O<50)Y%D9^+&&1Y<%9"%@-'F)7!I/`Q9&,@8$`$,L"0`KI2W#A`37]BL#:( M-'J285)D^X_(32B$KNHN[-)QU$,!D`096Z;=-(FM3;S M)S8&`^(P<;MDDRZ9=4G=`K/).S)[?D?FDPGF[NV\.5F#`2"51&E[&XB]02P,$%``` M``@`>W.*1UU&ULC5?;:>QXVH?.9/+0/A-;MID`@J#9'D69-7?R)"I]9R_K M,E/ZM#X$S:D6V:X+*HL`PC`)RBRO_.6\N_9<+^?RK(J\$L^UUYS+,JO_/HI" M7A8^\_L++_GAJ-H+P7(>7.-V>2FJ)I>55XO]PO_&'C:\@W2(7[FX-(.QUQ;_ M*N5;>_)CM_##M@91B*UJ4V3Z\"Y6HBC:3)KY#R;]Y&P#A^,^^Z:3J\M_S1JQ MDL7O?*>.NMK0]W9BGYT+]2(OWP5JB-N$6UDTW;^W/3=*EGV([Y79ASGF57>\ MF#LI8)@]`#``K@$LF@S@&,!O#8@P(/H,2"8#8@R(;V5(,"#Y$A"89G6M7F?%J,S].63L-V4.B'^;6:[J+NLN-WP+TPUO.WY<1A//@O4V$&!A@'@T& MTID;LT*,&[%&!*1NS!-BH@FF#6+B*R308J^*P::8#Q4#*F;V!-R6(!HFX)C@ MB]BTPU2F'083NA&;KXA1$1%91&2*2,8,R;`&`YF%YFX*$['^4K"#%29&XN[DV&!:'DVIG)-<,BXW&7$/,NLDM:E/BV=)N86@%#HX45B^,U=Y/JP6K&4950&A? M($:+(8(XQ+,T'BX0_Z\E"&7A]&("M,>@MP^X*ULCB*2CK09H-<[=ZAX1E*33 M;/0V".A*'DVQ&5#,8N[FHNT+O3-C-]>J!S&(W5RTA:&WL&-Y!MK"0%@8:`N# M8]<;3QT#(G8]H(T,,_M$'?O"@(!@H_<_0,_SU)Z"TQL@)S9`3IN3,WN'AYJ? M$,0=FH/!*_OVGLIE="IPCL]]8[Z0^]Z4HB]:H>I M'M?FT\><*'GJO^2NGY/+?U!+`P04````"`![29C;V(/.-G M1:N:O`@@SXQA\6]%*&^7011T@=?J5"H3@'D&>]ZA8J26%:^!(,=E\!PM=JE! M6,#OBK1R,`LVKI2$.YYWZ MSNY69[_'DJPY_5,=5*F3#0-P($=\INJ5MS^(W\+,"!:<2OL/BK-4G'64`##\ M[L:JMF/KGLR1IXT3D">@GM#[C!-B3XBOA.0N(?&$Y*N$F2?,OII2Z@GI!P?H MBF5+O<$*YYG@+1#N]6BP>0NC1:H/LP#2!G6596``^O#R[)(G\;<,7HR0QZ`! M9N4P*9J&;!TDZA%0)]!G@<:RN'%`EG['8.T1:#Z-V3A,&M_)\Z'1[I/(S5;B ML:W$PX+&KA)I."Z0C`DD0X'$G\CWVR2'F)7').$T9M-AHFG,ML.@:Z]KE5?Y/&OPB?S"XE35$NRYTG?> M7M`CYXKHA,,G7=]2?QWZ!25'9:9S/1>N8;J%XDW7_OMO4/X?4$L#!!0````( M`'MSBD=,L=T&E4X``)\M`0`4````>&PO2F@Y^?R2^9L=^,BR5'9/8U&/F3:89)W/?OZ^ZK:!KL\_3WX;?%EG>?5/OWW8;C?/O_VV6CXDZ[CJ%YLDAR=W1;F.M_#/\O[;:E,F M\:IZ2)+M.OMV.!A,OUW':?[;/_R^2O_P^^T?7A;+W3K)MT&CT7[>OYMXO;:EO&R^W_[/SRXWZ3U!]&@]X_U_]V`6^O MZ(M767Q??WH79U5C&#/'^Z1,"US@*G@9;QOOZ?VKW_SFX"9?I=4RSH)_3>(R M>`5_;!QS_4V9M_7=?Q[6__*QC%=I?A_<[->W159_^O[EY;OZW^3$/R3W*1XS M3/PV7C>V]_[BX\>K#S?OW@:7[]Z\OWA[?743!M=O+_L=PUW"#DI8_37`RI?@ M3\F^_M[EKBSKY]%UMKW>8-P;#3JF>I5F21E!"\VVVK+2`+G&MC%^_>OKQZ>W/U$H[E[WD5W'Q_=?7Q!C#JT\W+X/SL67`6I'GP\:'853!>XSHO M-F4_&$[:T40?6%Q5R;9ZWG@<5P^$T4O\)?G++OT<9_!^8Y*;AZ+<]K9)N8:U M?$ZJ[;KMK0_),H$1;K.D"H,\V0;%71!G6?$8Y\LD`.0,5L7N=GNWRX)XN40R MU1CB&D;/MRU7\KY,-G&Z"I(O0+PJ.&!<=K%]@%M<>IL\?`3!0Y*M:"D5[+2! M",46P.KP>.]+()\E7#LN`(]L@V=!^VV`49'?\Z&5M9.IO_E=4:P>TZR!>]!K=:SC]``X?9`:K2;-TFR9-@+J0:PTV\1[7W/*\ MW`$ZP>.RR#)]FZT[01BAEYT)N]8$5']7TAL((5-\]^8JN'C[,GCW\?NK#\0P/UQ]#Q]>_\N5 M?GS^*8]W<*C)ZIG#'GAK'H\(C_",T7&I3#C*N$F@X6X28'9P6R1Q=$M:;X$# M(.@UL;:HB#>T/ORNA-L.-F5QUT3&=QMDQXBLF@UTOY'R0N_*8@W@!%0TW^&? M"WZAR)N?$N3)9T3<>8X&T+LOMA+BZQQP$9AD%WF[/K:TX#8!O$V";?REN47Y MNO49'OF3-^Y\=(ZH]HR_78&0Q9\C6I[P=8/0QE6Z-/BIQX:!&&1;B,D)BWUY M^JIN_?G-Q,TAL]W6H23'5XJCK^I?=8[_0Y+>/^"K\6=8+@B6C+&-4>F\.A;7 M_//G%&2#507,8YG!<"N:?RGTN&T9EQY-;;^R5P!UZ7TN[&NY#U"XKS+6J>Z! MX,K9M`J2=R#I`=-9W3OB'T#I5Q'$RXN;[X-7K]_]<--!]0X3.$L&@##!4;4* M*W5D.1'@+U9_WHD`'&P+%.V*?`GJ`6WY*/+A)_@B2=Q`Y?`:5\'M7K]R>,DO M$[C"94I#-?54D-'3O[8^>Q&O2,KHHDAO4P`1J8)\`#*CY, M8K4]0&F8\]#:+A]`1D;PUO(N4G*';UO%9`GLNFQBUEM].><[G"O-GQV]IM[I M=/:I(S^!"#]QZ#;-JSH&?UJF(S#>M&I"36"!)Y5\I=^$CQP]TMP);0'N;;=N MW@OH7#H6Z.Y:CN:D.[6W<.R#WZ?H`FFZ\OO@'R7K;H>6@APTO=% MEBY1E3J@0A1P,E$_D,$4BD@$=>]!@()E$)ZHZSR`&P3$27/A0NLX!T&+#3/X M",U-ZTV<[W'>G98G$(]7R`Y7"GZK8#DKXFERC:0:BII3$ M(,>*R[TBDDC+"N[B%/D=3FT'VQ1,!FG]\1;`L8)_7-+"D#/!/I;]X/SGG_[= M//WYI__[#`@B?@%:67$+8*K-Y2%;P':E@CEWV99>'>P[?J@])7^HU8!^\'-;OG@;EJ!>$D\-,C1XIZA$`02(QYNCI:8I`^B&MUO@4I,-NMB"C@ M#?&&+O)\!Z\!^02)"=!<@;"]#J)![T\P2(:$/P_^N,N38#CF(^@K.O<6<`V. M@ZLL01'TMTI"!(8O+X-7.[)2"R#NP^#UZTN&PI>72AXR',+W+1\$U]?>-_JY MNK[&S\+@\:'(X)Z*1[3&5+O;*EVE<'7:AI)L8B*`67(/6T![)ZY.P2!P\V^` M0"55L8V#+'[L>]/7EW-]C>`1X.WN?7RN-@DCX*X$'$S,'`&PR_@V2RM06A!8 MJB1#RQVPLG52JC2'IUE&+(3$#:0`2*4(L(K=%O;AWC^^GVYW#.0ID20EZ`$D MKZPT>*9E<+NK4MA6Q6@BUU.[#MF>5%\&,.UV.?RF+,Y(`Y_E'WU<>' MLMC=`WEA7PR3)$O6'N.*K7@IPBOMO$P0EQ#Z<>FJ2NX)5)\':.1&Z-UM-AG` MW^<$QH!C+??R)]H?J*X,NDSS^0GN`AB"K`%Q&L`-9RG*>R"J?TV(0CJS!GI6 M.'45"Z4@`K4K626P-/HB3_'ROD_B#)"=C#IYS!;-,$!:K80"@_Q&DA=2/CT6 M`WVO!O1[>T+J38)T"\8O,CS4BL=D?I6P9VDK9_SXD`(A>$R$C"*TPLWZ)Z+/ MRL+6#WBSCX8G\06L4I`_T)ZL6@[E>?"2KB*L[1WW>5D`\N#D@(5`N$NAW_I; M0W0?8B#$MTF"HAG1(T(MP!UTSN*O6[@QF/PS`88V;LM@&X>M]U7-S:=^,`<0 M$/V-@\FP-QG!P20_:H\26?(+\B+AH=![>!\,(@I!!#D.`36+#5D,2'.#;&L5 M(S<)+@!H,T;-"I7[5?"775SBK<'E*@OO4SH7HNU";6F\B!?4PMA4)V,+\;"0 M30$@,53#W.F78,UFVBBPJ?F[G$% MARYO>'R]KWP#$YLI59O5"41[H@UD/XLKUW#"D]`E@FH)\I9BAP#P/R!BVP>0 M.I%BH=&EQ+6L0,A?;E'4*CQK_,\__5VQH@G22WJ?IW>`:P!G/([+GY=M"T0Y MX^Z0+A^N#4J?([))X&(E(^DM[G^5`$N#8P(F"M^12DE4E-D= M[O-3_X8AU)E5C#7?BNFT3,B;@R)Q_0"(,YR=#Z<3EBC.AN%H&!GYE*D4P[UZ M@F@8JB8&'5U?X*Y/>>L;30:ROED8C<9F?5^'E37L4U?::/P>7J*(`84+OBO0 M6X[0K^GREN1ED3499XRI#?_T*+9EY=N6Z;XD_"`@]91VFBW)RR:6<5RH6+%5 MTXI-XMS5^QN4X9XCMX=K<;U&@%9?O#^X)Z&<`^C\.YT6T2SSFP+^4ZR!]X,0 M0D?.*X5E!#__]+_-;K4E7;75OZC*UB$T7R"/T:S*?Z8PJ#P8S9;J/>@Q`(W MBE$(;EL#(2$;;M"BA50,D)4PE:!Z6Z:DO_`3XW<,M!DFV&1`-%#(8>Z)`\T7 M"P$%Y6,6?5Z#X78,BX9CO;LG#*$A'KA.B;J7$%JB1`3#`H3:7-SI15&WR3(& MT!61F8FKB,!6Q@":GO;TH?851J#DR`ZNJPIM::ZUH2QR^'W)^A':#-X`NV?D MQ(6],H*\\]$-XE!<@I;ZHH`?"G'BU<7-"]*'TL8<]O5/&U0]Z/V+FT_T^MNB M3]/U!HL08.G?/R0@I.S$5W"I=0O6+"]%":F"\X_%!C!@.I@^Z\,P`8SFCH12 M'[R6K."B6?7E09%!`M>C8RX3LG1KO="=^X-]39F9)L]"G(F%;OJTLBJ3>#SN M4;@VLZ%91#W&>V8LJP3&02T)(0;Y&0B<9">"C9+0=U^@WH^!"4GY.5W2J&II MMHRCY>A8V)'4&J-L>9DC-LQB&8#TL':-$+&(S:_Q&_\<_9LSLCP+-E(F=6:/%XV"(A$Y8 MS$N`SC4B2<1(,L-E@)Z)ZLZ:SCMF&P&+Y@A1VDAB377Q';PN!XW2./(25)%6 M3#)0MH*/UBFH&:L0M($M"0[:H8QFLC*%L5#5UEM0.%`HYX@G(\O0DR-'K*]] M2OH%XFGR.K-8QG@$J MT>L-8`$KV&6[9:-`FS"\E]&_DU5?==R7QD^+,9->!#P(X-^$F6G\&HT&ST)@ M:3!L>K?7>WF3Q-7.6)&5^OWCT+A.*6&.:2V6'U&`S:J%?"S$SRS(1TSA@U\\AX MMZ1PBQ(%3V`G<9;^E80+O#:X!\`CLYRN+]=Q^6.R17N4GD_/I@WL=M^\71P& M-R)4!#>AW+.A30`L`*H00JXT..FCI"T24&NH4CYNL85%#""BH.%*K'XV9Q,I M1+H3P3T)3@%Q9EK3Z`TC\[AHK>$%_/1I(>HH5R#.QVK`PL^F@3DO;G6 MWAL,]JG41545Z+>&11&#>YWF2:^XZUV2Q2FX*$N$`MHG(1>9=7#YM'_D;7"( MWG8P,OS@=M2![30PW=N>[$'Y>\!EK0K`<:2G\6I5HJ.ZS=V-1#V3_;%%#>#( M[B_4"F-I:?+-U27N].Y.!!R80A6W?TX8(@!^A;,Q"]+F04?>VY(A6ZLUN"I5 M6U5<$5=%6R-+<"[M$"^^/@W-Z>IC`*T`T@%,[7,B`B&ZU$05\;>LG"VC]G,/ M["##$X.W'Q\2H3G:`HEF9$=E4;=>C&9S=/=`^\&%QU@>$T1U9GI9"A)*T`0> M$'')Z$&"9`,+59%W8R$3-#EGH#6@4`+L5X2,-\EFRUSR%'R<$CZ^$'L=FM-O MTUPT=&%+B:<9(4&X35&>_9) M38YU1H;8V854R-X<='$\([$4F&L.2/6CRTTTIP&(HG-+ ME)AW],;-)H-R`0(B`K-$/Q(=85&G>4#5I)BUW5(@^F=ZIV M8&193=S;,F?X$*_LX/=L%B>G(H_A6+U)HOSE.?$L9*I/44#*L-MCO%8K?40O MTS4KR.KKV.Y1>;/3F=QK9R(3 MLEV/4!KG^=&5-`%>68#'%9XD;/YW`O$/R=(#PTI=LCT>5I,"1)%*:^F+0[WL ML=?=/G`G?K.10UU@AF;.681X)(AB`F.&.JE\RMF,WCK+6BZ) M$VAWS1+M=GNJEQ#N)<@2RK!#PKG:+46&IN\>^+L5YM&EM^0]#B1614.=V-O3 MRIMZS;(CH#8F565BEM`6&`.\PBY/@$ MND0.6&EL093$X%WG^.B.5`7Z'TD63;[`.,CJ2)03"Q$>CPX,,,8A.,';LH@Q M(``C0,FOXIJ+WI*)_`+^">!J_#&?^G_J!Y\HC`#EATKX-:C0Y3VF%]V7B:#4 M8V+"02F^IWZMRKO6GW_Z>R4F6"2N9U$8#0;A8##0D5DA"MLU\8F2*'D0E8!FC0$0ETM`;*`4M_M2LF)"#AB*]+D MYM*$K%RZ$1G&V*I,(DDELIT#X@]Q)59>%G@EAB?E/Y0K8IIT5!*@5YL23'4T!&R M4!-T`W`,C-4B<23DU75+U2A-*%%@;0+;<_6Q9?$U.^E9@&`Z#X>#D7+R-/'O MTR@<#V?6NA5$BTDXFL[4R3F7P6@$\#-1[;F1P7@<1K.YZDIF#,:C<3@:#!3' M86;UC,7Q()Q/%\K-3;1'N1@LPF@\5?7,PR`:#L-HN%`7S2S"EGVX3Z-%.%I, MU$MC[G7D$#B=B_P`O[NQ*ZPSJ`EBFJ;;#9H=]PP=#)=)D\:>W*^N[AXKR06JF)Y@O-3 M2<$HTS7'U2U!Q]Z3IF\_Q:/07RIA3W429328V+&8PW?6]-`JX>UQ)V?#<#)= ML-]5#KKN.D5L$O>]LO%@@9U6NAK=MQ)CX4N64S#;VJM4A'A)X M1V.O`7&BW&KNYYZ)O6S/P^)M&;>[1OF"Y@8@6(*D28;A:I\#)Z6<"D,:M:N3 MCV&;W).F@9H$6%/PNN)JW"P$J:*+SFIA*]VZ^X'6"G>E2]N6<58PI#Z MP(#RI/ZQ4Q?Z^^=*>Z/YDE"B>D@W53!<1.$" M/H(3&7C#11%(%/A@``]>`@9DQ8;$SN5#7F3%_=YAP$"\9_CJL#_4'-XLO'GO M8V#J**A&H_Y47C\"*6=&NO#!PD95PVD'5#C&T8UU,*,.&5^2-$E(;D+:;:PK M[N:`&FC$0(,HP?'8=]6,?2?QHD$,BB7),*B>*8I<#(8S';>/6SYMH^MX+R;S M0_'T-8.EF1H-C'7>0L31:LZ,1_X"D;"6A#KP\5[Y$]_M*)RV-8>@KTX./K*A M1>_-]G.=F`[0,0QG\%H$G!9_GTX&X11$-__=XTF=LP$0]EDP&X>S27VFXU\W M"*F.K>T`#Z']%3,,0`=+VX$[*4U=?6T">64,?,60$1T7J(W3!Q6ZX=M/J-^T#&:>B=!`R:=IJE="RU$@+0:-C`H MRA-P9!0WV$['W_F)<1Z]Z(S\MG'C]62)/0G!J-")T*(XK/U0`+C$]`/B64HE M,RLOR4C_E;,UR*0Q@P-Q#!IX^6_B58J+?PGP.W(Q6%C:P0E72J`.A'JV^+"Q4/YZN]O#)Z![LPP>#;[13_PQ')"%,T=' M%_R*YK(L_5'BA+8/MJ(`?16*FYF'8`4L1XA+B/:80"L*3KE'6S&`"%ND66ST MS)R5%FV=*0()W\8UT;VP83N]"R@S*6:HZ`3%GW_ZNV3!PF$3X*8YI[_Q@DB?J8X" M*;N3<#(<:`]W)]"ZGE56%E6'LHCPS*?T+T5B!<0A;&^W7/*0Z,46! M@XCH[5YUWF]((3\QIX5:;_<*G2D`D_>,!!C:1R-+3@)"E:DT:*7:T`/O$!W, MNNB`8HD+AB5+"&K+)?G(]ZQI/NS6,27,P`'@L9CS0:JQVR#3&8ZUDL41@!IE MT1C4FA[ZZ/G(&MR'K-@=J:-5%PBQ-S&SH8'BQ+&:V%'@4A:XW.RWMN3$!O6F MF&(Q5;!,Z=6X.KP&=2MN5JIR6?D2Z42K=K@DW_5%1ALN/"%Q(0373-&$A'5( M"I11J`XB]`&7XC3D@#/VW-XF1*MMYI^S:21!.M`!-R]F`@YU4TCGC(6&/N&Q M+,\\8HE2'.^)1].=8-Q*N8R91!E/M<2"B\VB*0T;)Q3>M?5"*=>>Q>)LF_#3 M3&H[8@\X`?R,O-8&,<^5^3?I&ACIUBBSI[ZB,B+H(Y-9.)]-'!X.IY,G MV.5!/Q@.IAUV>5X):-33V="Q08]F832;=%KK^2O0=.:#<9?%/@JC\<@WV/N( M>A:`G@0O1>IU5\&ZID4?%+1I.()OOL*D/PP7L*?V.GGC13@&_;!IT*^O>3X/ M9Z.Z(:$&3^T4E0W-RJ.J36QI40F%SBI#9Y^HI<_"\60<`&`L^,<((.P[$I9ROH)SD9B>J9]_^C_^OP04 MM>Y[SBSF63"%%R60:X>):(GL4!##L+S.$7$GN05!3B?IMIWP\B:?%<"OYAEB.#U1* M,6A'/8!QJKSJ(1@,G0]]6$^/E.(HQ:I4@1>9L<$M1VI](5&^-=`S(Q MAV5"3)F9J3J\M38CBN-%YJR;V(^K[+C!?N"!A&5QUG\!G+^)W4:$8`N>F]LY=29;PA`/Z;W)$1!9P5XT1P29 M-3OT\Q!I+2`0K]#=E*O#6E`C-5C\DCJC?:G#Q`DXR-Z^07,70"*% M;#L1+;Z+WII#W?!4\00UC%B&45*>)Q$=QQUPT5HZU_NF\3:9J#B,^)@]:]P/ M3IG??VP94-0;AUKD<[C)T\&`B(RN.JYTL&)&$+MF'=YY@L]DGU+F4(! MP1F1Z<;_%1<9"*(1,-[Q@FGY;#0'BAB-@,5&P.$]:WHT'83CV42[QX/1(@"N M$\[GFFD#W5PLPL40>9)^">CL=+$@*CN/9N%D,=%;878L]LU3O$&-,W&-S;[X M1SAS@O?ELMCL2_35H%'%<9VP:@C_1J\]V:<7Y&,!5@&,>#!PW3(OW9@Q)YI) MAT;!7-76E8RF8Y#U,-UV&"%+5J_AWI\';O5=C\B>1Z-).!X!TT3>.0H7HS'P M3XI-.."BF0Q0?EP0WQ\/)R=Y:5BF/"/94\:(/8 MFJX.G+#K6L"W!=9*ND,ZHA>]+$`7B<5&A#%\)LA'+!Q.E1R24*PZ?)ML'RF8 MBPQ^P*TH!C?FLJ7Y:I=NI6P7^3U1R'X1YV@Y!Q#Z<5_TWH"6N[M-JXKOJUXL`H7W8BN1'0=#!.^YT!B&OW`D'890 M&WD%9*F4LV_T*+K00/=M:&^NB=:#,WZ(=>S\74+ULHQP9BO(F7-459'1D;@5 M>!S3:=M)LM)[%$B6N(XLDX@TS-QTUNV!`G-W!$^NM8'-000@Y)B6>RO7K8!0 MQJ5:QU_2]ST.\4CJL!W?7 MKY+;"9U6AAX\Y`SA3_ MR=8N68,:@KA_A4`7)'=X.")KMW;@F(0:!XI6?*L'EJ><;5OK.%TCJD.ZYL"P MZ6W,:W2_>G0WJR&4H!5>US$CA(],V+<.QO,095K]B!S6R[R,@UKZ4I-PP]H0 M?VBON@05P6E''35)Y;"+)3I)AG]M+2.EM)5UF5FEQ`TZ:M*[?2O'4A['"D6! M@P>H;)K0P_;8/?=FW%S(HG1"$#6<2)6`N#+16:5QJSO&V[8<-OF48B,XKON/ M<2X4`F2OII<9-OH8EZO:N>#UJ\;UMZ'E<.(0*"]0&D366O6=$&&'3]6?[B[; M+;<[XR>R2S`8T>1KE,I3,S5.2Q;][38C9%/-"].(P)?#"E@2^%EW!D5- M$)Q-ILU[E!D#\.]$G#[R#NIV;+$25"W0WH%ARHT9/."K\?TD7=J.(_]N]YM$ MU=+6K#)TW;$:T^&D9K,^PRQM"G<>3I[PM6NXQ0'X<__,V#'@G9Q-Y^\ZM>)$ MQY9C>3$JEVJM+G;^[O+ZQ)I*]5-^79BT0*K';PM:&1C#K`#[E2LFN5;@CK_7 MSIN8$*R6PNAFJ%./POETQK;+<#`9DYH-^MX4-$/7VWTV`RQR#[6%>KJEOCH, MD.P=/1LOM%E)9T])>+$[M(Y';P[;-'_7$BW:,-G;#<8S3@[LQP_OZ[(YRFX6 ML]IN5,MNC$_N:*&E6IC7L;WD.)T'W2,KUY9PIA6DKV3LC6+6;:1`Y:ZN*JN$;3BLD:: MOC@1#D:5Q0BK#+DITI60"#Z19@Q[8;$H40YI?DA!MP1F0IJ.DR-?44%$[D6G MK2I%P''LBF\DPRC:RKOZ84H^.==P6&@ M%%E`]F\B$9P@PG4KK&C;X1B5$C%NAC^7(>)9AL&[6PQ>$#L/+*)RZ]W\A9:@ MS!(L/Y)%AASV`_CQ%V^UY(5CW4AUK*RQH=\UQW#V9P?LVBH,J(_&U#M`LPK/ M\CL<05L1:9_FI<(>`84-Y92OC"4M;LDPNE)8&,J^)!DZ<(ZQ/L=1\"DO&B>) MIV`DS1+H5@4+)GF$Y!QW(!LI8$U&-(:$3RA;(ITB02BZ>&.\E8^X%QG.1'&1 M+H=H@H#%!0I2(Q$VI>F^PE10"_0LDK8>M5N[R)5ES!PX7+L8+^],S6!M^FCIF1!`SZ"7YZ3N\SX)) M.)N/G7%)K*$7':?W\Z[!G?>];_WP@Z_?[6)`J5;VE^/[99$*7S._U?>\B,(Y MF>'-\/3JD_;M?%'[OKZ-CC%,KKJ3G-$)8:15Y;T:E&EEU1D!E=,#HZ"7^KXP M`X0*\^KP.YL+[&6+.D56N-2Y+GB[3,OE;HW1F4N,MM#T\!&$2$9[Q("$.G1P M`1,,F$U+8XT$ND`&E[QS/E1C>%3:G!M>F'[IN1'HG=Y30.4&SR=TEX)(ATZK MKGVH`]H'VWBPN/::[=B>HE/(A*J]10(G9GCXPM5=472=DW>"*[R.I^%T/FDK MPNS/1YLCW5!V)ID^,3MJ6?.V*C=0V&R/),NP;=.+@$FKA)7MTR2#HSY/^T"L M,T%A)M?/6.U;Z@0?G63,69_=,455:`*)E,3/L/2I#?FZN>;!N!GE9"UY9P\7 M>OBPR1G6D`)O.KOU7+O=@*B`&`YWQ:V"[&?'),%9WWD90_QK0#HB,Y&I:DR0 MB.(5AC^161TLGH6YS^>T33MLG1-`TVYB+)[.Q MB.DL'(PB=_.`?N[43E%;)D%^C18,I^IMBYXQP#HU<&NA=4K4)6V+M*$+J-Z( MPTH;[="DQ:;*9,T!,DI/00>UEW`1P*&4B1&FKX9"$K6M3/#!F&?J,2<2&JH1 MD8_E,19*)\56J,*O+K!/$J]%F@9!P8]M:2M+)&)UF)HPS=FUR(<.!5$C34%T M0*61MJW)D0@/(CY:I[H];X<=YV;RZ@5.G%=R-2/ M9*US%MB@9R8QTK35:O2-3;YL@Q<9I@`=(5WS?M`"KB8\B>< M,X(@!^B$-:DS!P*=?E29)"1^1M9@0VEB=(V6*_%.`[&_+V,I1:NDOTN/$H^* MDC,(\3G5K1=S0>-CJ::RY:@DB8&G>MI::R88TEO50.6.9):M8Y_9PHLJ<8]% M+*#@V/7++S]F[--N,C#7?\$C:VPC=+S7ULL#JIFM+4.D%&X-4P$$[-@SE#JZ5`#8U#8F2XQU,5,>F7>;F&]B=__TAC-!O>$,Y8EY M+4&$S:/;"'%H^UAXU2E%&-4QV)SKQFAA7;#J%4:MATY'$ODLSIOQ[[['"<-@ M#P4-4-&H=J>VL%(TJDAD0'`@,H!2*!#")<[[GN3C'W0V=0(_*RZ,B)V`M_@QMI)$4==.2+[2XA"S#6'M0M]4Q6 MESZYW4;"9*D@9I9@6Y-H9-*_](?4NXLBFR6[7`=?8+4#9LA[.*T8H2O`Z@5; M*05-*2^LG!C;7PY45E)7'QKO?5#>4>V-PA M$V#@@10!P*OTCL``"08!PB,J/;=[6A4Y2&V#PG;,BOVF;5MEKR^>,*G!L.GGC#XV_,A>@/O^:&E7_#P=-O MN!D]S+J6ON&/#TG=]5PKO**#8!S-QMV',G2``JI,18[:*/9K(_EP(TM=6P*N MEHNB['7UN\:LW!LEDSPCC!2Q]>E-ONN1V6U#!F2$7-M!Z+98Z-WB%3*:I>Z. MI2RMW`(FOC+M5W?A&!N7`2+]H#=IZR>LVHJA=:56?848&E@Q5'EBZ$E2J%,2 M\I$$33P1-`4IW8E4#%+.8*= MR[LI3K46`@!+TS'5#%+*HJ_)O&;MZ^8RF$\'8?!1`)(/^X9R$5$><:O!='8@ M?6(2'JSX##3GV6+$SK'A(IQ/1QT]+U73H%-/.6`@78^V&Q!1P)24]G,TC<33.Y^%X-M"OJ[;7QV&TF(4=QTVQ6(>/VQ14;<0/ M\6$I/"P\8V!94F./!&2XYO%\W/ZY0XSP2]7";E@YJR6Q-\H7D:C81?*<4=VK M)IXUG843KM.DSJ9PHG@4IUH8ZXVH;E)2VS3.4P*-@3*M<-TF]YQ:$2T6XQ"0 M1-JU/P*OQK+G=Y)GPN8_=O92-76R,8"*T7/2/Y!58LA-I5M]8$77IBF.P_T_ MZ(R'HR\<4V`7:'NK??-KE\A?NT3^1W>)1"ND9)0T"S$YRZ]GNC!118C>)O=8 M?4L_YY(.Y,T5PXKXB5O+TV+PAF7XAI.@&%7U]<(D!AR9\>>T1'F;(LPY_UJ9 M^K?(`79K6NW*?$A3NK8*CD.]VX+PE(0*P"G_,4&AXY[JD0#)W-D$;9(]>O$* M^9!;4)?06HL".-5UVW[Q]PJ+A<`VK!<`\6L__%HF<3 MA$*6X*4JV!>?X=,#]>`W:>YG0?&>6(9"N-C[*IK M8:I74(_FD,M5*%NN`@_.5KN@B'`=1AVV"E`X9E+;.D(G9.KW/H7?!5HX!-+&NEI7CEP"A@6Z5[GF.KB.;8J(Y,M M+T)((*L'NH15D-)&281:6*0+!4`2X%NG'_W?JU:6\)_6(-+DIKMYAD$THD2U MLV`11I'.HUY$^&0.OPQURN%T$(6CX3"8+(;A=#3%0@6S*7RZP-]&DW`2#6JY MA[/9.!Q/1L$(WYN-X;T1+',&TN%L.@SAJ?+JH+FEY>#5^2(:_SX8P(AT)EA3@WW"6T;1I5FJ-@!'= MUCV4\12@81!17B%IE7KCB\$@G$[G&,$ZQ,3[67VS<#WPWW013&'2\=B?PTT1 M;2UN`7N:1.%\-(>!HL4HG$P[JH)@@(NN@U&+H[%C(,0LQK-P-I@>1EL&.Q=Y M;_>FRJ[4[5%N9K54`/HO@LQ:\F',&$+N);98BJX%5$) MDJM6N0C&G\%C@-$!X"_\'$VC<+@8PL\!_'TD\>-P.XMH&,!D4P1]^+F`=R+` MC,ET\8M@=K.QA,?JP:?NR,86K`.6,@ M85+G%^\N7S\['@=B_T0I.#I=G+/N3:$C"5![A?;%[[D+\Z7NB/W1Z;IMVUH% MA"\*5T&9Z?Y\2`3GA.)$^("R36?R.UP_4KEG`@#-K>FR"66C`PKEJ0-Q'4'*9Y2DS2N?AI@LQBL? M`5G'E>/]Q8?GE)`NMS:<,8E1_3D)P83])F0`/]2F7*I]C":#D&7.MKEK4>@U M7;>ISW(X#9Z)I/$EVUJGFF,5K=V$BT?.Z#*%U]L"ZHL[Q7'\S;JD;L/"UH>G M9X9'4=]O@*@[S;"/^E"QKQ/:>V@':'#<`1J2[<)7#\@)RL9!/8#H5F'PMG_! M5?.JO=3AQ>A;_N`<%__S3_^NNS7J]:"+%!1]ISH?OLAOJ0M;D8"BU3&2L*P" M4]QZ)_Y<2=.RO4?P34K^-1H%&3O)SPXW*"[#\$"O$]79ZR1HZ772Z'`B`2Q] MVQ`3F:EM26A-A_4#"72P'V8-O;Y^\>Y#L,EV9(,'[(M78J/!D'!6^@EEHWXT MG'R#VQOV86G?2+:$%_EU.''M^]I@]PSP4LO!)V M62+]XDD6HSFH1(5-#JO?HO9;I%O/A^4X_SL.1#GGH/=W+<.<=*@<2^9ULM&O M=MWSV=!]5?FO=G6TX1WZ`YEW!28<-9?S^SB"#H-3D/Y)FH-3+GXXZ*M/&]+B M./#2=35QS/R*:AJGNOJ=F+F)E,*M6H\_P0JIZNX7E`W,26P;S)[@;4BWG"S2>">:PH9T@R<2BVNSW6BM,Q>:*1F[:TB8J MBK<(@[BI^[!W:3@^[-@4$49+=ZS033.<.!&=^@N3I_JTM+KN&@IG(Q"BYC/R MW7M'=Q#G^DJ:VSFQ[I]!G$2;CO5HV]HA=0!4#KWPBB]3%$B2ZZ`$0[7(*ZXC M-7%<2\O8_$2VM,\&$]`(=Q<#`(5!O=5L<9NE]Z*0Z0)#7]'ITK/[*RWPZ*6Q M)7[;4MF/N;=M-GSK[#RI-[!J"7'Z*%%R;&%4CH41<MFZ78?J#>:?"JV#N MKQH5FAV<\"^/N`&Y,YUBQ2C8E2PMH1>1JYI[%T3L$KO#QCE'X\)C24OIJZLO MRV2S=>+A[#);RLIL=5(8$$NI/@("%TYJXJ5Y/6E+H]77Z-$)WK.,B0MKQ+@; MA:,2#R^58DF`IS^I9%H$BGYCLK:FZ8]"^M&+EYBB-6B@,E6G41A%R8`KE022 ME4TQM!23K1NGYM3WAF1)6BH<(D#")1R-.5QU%5?4B,D\ANM]FSP&_UJ4/X:V MI\$-N;K>`:/2SF^"^,]]I\X;!\Q30S1VTG^?Y.4^N%D^P-W*!Z1[PRH+&4?= ML%M0@NW#X#+]#,SI@K>$/:2C26_YN3>8C,>#WA_?7/2^^_"BK\QR2.+FTTCO M[D(T\B;WTDHY-*Y%"IY.;@&7L0P1)O]R7C,[LC%*U752ZGK*UOWE>(R=N M)%N,^6-27XBE/N'4((WVLGN#7OQ/"O#V_&YT.*+IU(Y'^QO MEV?Q(WJ[]TJ4/"Y_A6C2BH0TF!B+%"A^9DZP'[QW#A.IA526,8;B)3Q?5\_5>?H, M]H$\&R@_Q[DBWJ>YYJA<-@=(8688%R\6EWV7K,1Y#1=5HIX))U+]+CA/8=@M MV2]V4B1'JKIR$@8P/E-PUD1JF`!*^AX&6!+R"+3$R_WO:,[S]/.S`'1#[7J. M;Z76&#%`.G5[1Q@H+IF\RJR'OL+"`0)AN`J*1EYNW8.KDN1'ZC62\CLG8^F>8;BLA3)+&DU'?"VDJ8%[42D\HDKRY!)9: M""QU#(!RTGRV,'6>[#D,/DGLFR79D2IW%P^0U$5@V MMW`4G`FV!7$##JNR97QRZ>BM"_J:;@C-.KX217'^OLA2Y&7/&GW&J=P`FCF< M>*.37M)"7[%)<\$`6VXAE&.0QCVL'.D>;1U)T:U=VU'DH0R)S.L#&N0)-C>- MR[VB?B8S91",T)AI;LV-J:(97G-HM#DVQ$,R3")"3X=;47\AA&U M$O==JD9K>9G@AB)6[*8IJX6LP)(!9?/Y<[+0Z939MH5I4>!X5[YF)2&,(4/( MU8>>4@!09P>]@BO,2!:XGA@Y`JDONE9'ZWU7#[I$#9F2N?CFGWSA:$XMMO,+@NVC0^Q,,DK&QF.P3DMH\`=Z/Y]X"KL%Q<)4E M>`VQ6[IN."DW1B9Z_?J2H?#EI9*'#(=^]5?]`>7J.-_HY^KZFI.ZVO.VM-A3 M@;A-BCA%.YDJAV)Q>)/FP'N*;8R,J^]-7U\.UN?$VJ[$[_VJ81V5%`,W%4GG MS^D`*DP%`&:?DDJ7QUYC$9R'>0G6NUDV)N,X!B3']VZW)SO;5ME ML$A#G9C(QI4("D@9,$P#O$$FMXJ1]W`P!".RW]&)3+9>5-%JZG/\,IK>Y=EYKN)7CZ1(-._:F)9X&0H M;WA20#.YWPL-8?OM*>^HR[::CQ+$NQ.#EM,8MM'70DE5,6"<3E$QXYA:@1Z\ MW'(9;FHN*CT30;2GS.KMWJ^[P..X`D!K44H49(RI3@??;)W@&U?$U)94:\06 MU[/2(;<=L214.J!S#N7.(2J!S1>T?4)K7=L+:U93I.3K?;B60'V.CBK,TIAM MSD!=QDQQ&,U/.>+\QEBK]:S2K=M6X,QT7&[]`#BIZ'PXG3P3[W0X&D:M=O[. M+BQM2*>:2'=T?8&[/N6M;S09R/IF830:/\$=<`)):,2T:3OH>TRVQIZHQ]]H MCUR3TH4B_3*2>;W2'W53]%C\A+H%J^N>JO31Z-XT6,5K23M;I1FBK3*F6\S/ MIS%(P+QZ?X-2Y7]>U"1PQ((,8$7);7UHI;`,ZC6B=QO(;G7#V<4\G`PG^&,^ M&.*/Q3P*%MCQ:JJN3!%6.TH&0W'>G=/&,*4;N66&U^$,ANWA`9"@6%]ODWX M4[?),L9:C"S$BQ'$Z=!.4@\:57KZ4!N(B*T)R?:$`6LPRX650]Z710Z_+]MK MM9[\(5I#I.[]F(5)&^?A?'2#N!B7H'^_*.`']:A^=7'S@C2]M#&'??W3!I4J M>O_BYA.]CG9SG*XW6(08N/8!8P%V$FYU:4H[DW1U::J]G'\L-H!)T\'T61^& M"6`T=R249]'8M*)&4^0WIT$E-U]<:[:9%[):9^X/]C5E9IH\"W$F5B?HT\HJ M@T"/3-Z_F8UJ'3W&>VWFA7'$5*OK"%#1)M@HB;/8Q*BB8J4_]L MQZQJZV0YX;:>S=0K:8[V]Q1#O_#?Z)KLN"^-GQ9C)KT(>!G`OVU?*E`_&@V> MA<`:8=CT;J_WXI1MQALV7QE,E#$MGJ1F8%-H4LHQYGNU3@#D5F[M8=23>NB' M(PM%#_.:SE]?OWKW+#!N5I"^,SNL'H-!&S5FF)E)GEO9DG0P*CA&&9P5!:*` MQ`ML*<[2OY*00FF8(88VF.5T?*+2TZ?F\8LL4\ZSWS=O%87`C0D5P$\H] M&]H$%NS(I;"U!B?/Z4Y`K:%*^;B5'HUAF+/Q%[DL>0`*516Z`3$!83\X@#MF M03Y\*UN$%_/1I(>HH5Q7`I?@L+#@HXD?:AY@']8*Y#2M-+RMZR<+:/:=0_L M@*I#4"'O1&B.MJW6`R"=&&QM4>H\4"H\Y3"61_3<*69Z69I\9K=='1?:77>, MA:KNLG.QD`F:G+/M!]!O"QLYC(]3PL<7VG%\6:QOTUQ,`\*6YBB,U8%57?@] M81WTZ[UG"Z%-2O+121E&Q;:'G*VY95(Z4EVM++,Q<<292;,QE@O=0S%9N>&^ M+G.P_8C8&NM+-H'7I\C.;)*)S-01?'UZ@=*%@: M33A';*N*B8G"7',@K7:SPG:]X)X]Y)/S*X:)I&J,8;:V3D\V:;0D$`@1D!7: MOR3VI*88N:,XD:-U>3#E\FK.@>G68/:VS!E2L5H]N.WZ(R7:7'L^292_/">> MA4SU*;A<&79[C-=JY9'HI:FZ]75L]ZB\V>FF;)4W;3_'$Q!])HS71MMJ_)Z- MD1GI1K4W6%5^F9Y(V)?1:9$D4$85QVSVG7*0Z:[%O]^WN_")DF$^+>O17L#;>AUG9SU" M:9SG1U?2!'AE`1Y7>)*P^=\(Q%OL*G[BZ=$73+\#ZL3-*K"E1PZUL]=4=X`E MRHNB/NCU,I$S'RE?NQ$W<^F;8%\80^I+;2AL6':#\ZOW-XV!?C7W_C<]8K>^??:MON>"KI=>K8J"E8HA6;#5TZ#*'2D,VF[6`H1 MPK>=YB3X?+=.&@[=5H"TF?,DI7/;`*_6G%HVEL;B@UV>6]'3IE<[3>J]L!EW MV1[5YF77VYLY4H!Q&L[FZ;N\E7@7C MT1CC^R6UWY3KT8./!^%\NO`K;9BC7`P`7,=3+>]7)O$K&@[#:+C`!]0@H,XE M.YMGP/;#T6("^*--F0Z/A<.9S<+97"^G[19'.``@H+=?=*76USZ9+\+Y:*2^ MDX;UP018Y&@VX%[MM9>="SR`808SKFVO=D&:*U/]1,]W&$UJ"-+2_-W64[F7 M$4-E89S@U4N3Z[NKF,8!;,;8*AHLH7,!'<"(#;[@HPD('`RP),@#X^YQD@$].*;2] M`[D`*C-\==@?:M0P"V_<53`&;,"4HVC4G\KK:3LZVEHV@I8'H.V3"2@$S,<( M@77L^(@^4!Q/[?/@RSI[7H&TE?S3;TE:*3\GOR7(L]&)<(T!5<-Q)#$=%(2I MGFRW\,,UE1>N6=,:J:DO`B5J>742BD*6LGG27D>3F?:)YZ@AL"&J%B>J[G84 MK=4:HHHUC$\4+:S@\-YLWZU=,PQG6,PIFM+OT\D@G`*-\=\]7KII-@@7DQF6 MD)I-QD&C9@86CJ;/T.MIOSJ!M5_8R%"7(7^/A9.PZ\0--9&'IQ_L.3DS<+N' M]ODIJ>9S:_NA@Q3K0+!J(W2NUL>&R-5SY?>U:2\&]>%0.R<6O(K=[?9NEYG. M3EC9:A;.9U.'YXZ!LD\G3V"Y0'B&@VD'R^65`,Y/9T.'O8RPM-&DDQ'S5P`; M6)^I@QD#$QJ/?%[L5]$Z,Z6Q7#CPSZS!K`&DI^$(OOD*;CT,%["GUV:A[L/Q M(AP#1C5Y=7W-@:P>2#X#R".9YI&Y#VXY(1 M*9H`I1NB3#>8CO%,)M,(=P[KT._SB[#2.5;5"Z-)!!P:)+@(R^8-9C,Z-)>T M>G?MU<4[A\_'7/%+XO-OD3) M&=-$'4&6<^7@W^@5)^EE01(OH`40'5#U'"'YI9>[:8M/F?JSF2YX++N=CH=4 M:6TXC)#\J-<`3,^]$GI>:9=SK(R)54:Q]ELT"A>C,=`*4K$.",R3`?+*!=$X M;#AYBLS,_/.,^.Q@MA#*.A@VX,!I?VK%Y6NGF6H7OOK6$..\_8"P;\*CO`X& M'15[/'-Z7:SJEM$M;S3E*]E-Y';;]&M,F5P7Y88R2Y#2\0X*75#J'.%VOTE4 MS2-@@?BZ8S6,?ZZ-7NL]U+-76N6>_+4K7.``W/ZV$1MK+'A==U=T7MF-8XN^ MTW5)+-%O"VD/SM]=7M>!Z)3;K94H=8SP!^ZW.'BMK?7_;$'IUMAV6OYI8E$= M'EX7QC<48!:K#:N]<8);G()18XAC))426FO]?%^;??]:[OO M7[#=]_&.)%V`?=VH8/[!II;),$=L`+_61/^U)OJO-='_Z]=$;Q`)`K1KOPKZ M>ZZ"_B2,_[6<^G^7\*:^DYY5<]0G+^DF+K MG^F`$E`_/SX4NPIN!0C@F??O^N`PN8ON#1F>[MCB+Q`&/:*AC\K(Q.G8Z,'PGV/S MN=$_)\_HQ?<(.#:&&=WWP\&`M(-Z6K>V%:!-._(CQ.;_0]A@"R4[(A[\<9?W37A3@]X< MCEIVP0<&TV_&#%[/7 MM0_066B&#B9QXFF`"MTZBHT!_.C'`#("=PXWE$L;ZDN#O[3=6C>^G!+:]W1Z MV2;KA[40+@GR,!'3H)$8AW4T60K6;>\[#,^I^EZ MS-J2`#;WC1)O>LOQ.+UI=,R)4]*J6QQJ#I7T4%R[=Z)Y&N]PD_-8=TO&DN#2 M][2XQ0R8)L9C".S@FP:#Q$U3A)U.R21I.LVY-*E61HO=EO^`8:#(=0>OFG23(J,]AB5YVZ_81BV(+,[I_B`[M1[_<"QXV7(O=X`>#%]4 M[U?W,Y">6UT-?$X'X*?&;!K(/@+/KA&B2PUL,1P?E#D.OMD97MAXL2TT\+@4 MX`!K:'T'68>]P`NJ\*-^L%7Q]8=BK`M9G).A=[R)SP MPI2-D;4>8))VY6Q6,L4Z.R1L_7K#E,/I;!T36L=/%X,7YT_78U]F[7KKQ*O\ MNJ"UIX/O:;%D+8CXI.BQ!G$X&#S6JH+\LM([!8T].4#LJ"#2-.TLC[_P1N[').^/.$I9O)3,-\>6#MCFAX^-U>J5%K]P*P.L_X2:,>`#='N):NK%2(H_[F MI!_-&B+UC?.!AJ#5KG'D-\EVFYD"`1CN]E6+)U<33?B6)ASUQ_-O.K=&3P\" M\'$L([(U'(?J-[\9MH3B7MS?8^&=;>)T:>13^-K]T2G[N^S:'Z]MPFMK:GHG M<('_H(#@IW-ONU;@:,ZJ#M'3CN#:T'!&&V-X\-/0E=L/?<7BRUL;M2OBBW-[ M74?8=86-(5VUY!\8]X2[__\23/QTR#A`5>%<#LQWPM$X!Q(&I/^A;E@M[7B1,;+Z>>ADZO&G M!TX^=4^^7?KM>ON`%N[N[CK?[/!U'33;!0[=WPQ/^*9QH[^0?>\*%,,U-U7Q MDB.P[%R3MYK@B.,+N+QX>5PO%@EZ!"]_3-?)_WJ94"&?@Y(TO-L^%C>1&;<\ MMU(<-:M<\2QI-UVN\%"P#5GJPLM6D8>MP3 MYCN$8F_$'ZI;`]-'7"K$J9BA9>I*2LURC=QEQQ+L-1BM]\XLQO::^5O0M8=7 M+6^3$,ZM;K[]%2#T,V_4`8<&$*;+6O MS!W,,7C3$KESBBD1U"1"$B[@^V$;1J!8>H0_`JAA$<6[BFRY(ED;/W9#K6ZS M4J/_?$OEE.W!NM4[.\D21B:2WD!.[Q_W1>\-0/CN-JT>TN#3JS\"8=NN^MW. M=_&LR[5U6O]?I7>@H'Q\2,O5837E39H3L+IQ"/_8$GUEI8[Z3NTQ#Q;)%$MM M@#*TT91->W` MNCT]]/^0_?]8=/HI1W0HKOQK;)0V/KL++A ME!#K$[T[1\;2&L)QX;L]8KG]4)X0G-R8YF!,BZN'(K?*Q&Z7=28F/1&__ M@[?\2PFIJ#%)EA\,G)#"V.P"M(V_M#B*3"2=4:+$N]3DP&ZIZW\@BK06@O9* M8LP.:S3U>#2.0V,S?XNPJ6MM'[6Z-0:&W:?BQ&NSK.I(,39#-62IU]AHVI\U@70T:0/=7!E&UL4$L!`A0#%`````@`>W.*1TAU!>[%````*P(` M``L``````````````(`!'0(``%]R96QS+RYR96QS4$L!`A0#%`````@`>W.* M1^N^@:7C`0``1A\``!H``````````````(`!"P,``'AL+U]R96QS+W=OW.*1\U8V5<8`P``\0P``!`````` M`````````(`!)@4``&1O8U!R;W!S+V%P<"YX;6Q02P$"%`,4````"`![&PO=&AE;64O=&AE;64Q+GAM;%!+`0(4`Q0````(`'MSBD?A3E,$7`(` M`$H+```-``````````````"``1L0``!X;"]S='EL97,N>&UL4$L!`A0#%``` M``@`>W.*1[J/7F!?!```CA````\``````````````(`!HA(``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`A0#%`````@`>W.*1ZO:MAR3!0``EAL``!@````` M`````````(`!.QX``'AL+W=O&PO=V]R:W-H965T&UL4$L! M`A0#%`````@`>W.*1\R5MH:D`0``L0,``!@``````````````(`!GRH``'AL M+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`>W.*1PT] M&LNE`0``L0,``!@``````````````(`!*C```'AL+W=O&UL4$L!`A0#%`````@` M>W.*1V<\[OJC`0``L0,``!D``````````````(`!WC,``'AL+W=O&PO=V]R:W-H965T,^.F)H@$``+$#```9``````````````"``9(W``!X;"]W M;W)K&UL4$L!`A0#%`````@`>W.*1X+#CXVC`0`` ML0,``!D``````````````(`!:SD``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`>W.*1T*%2]2C`0``L0,``!D````````` M`````(`!_#X``'AL+W=OSK\.P!``"J!0``&0``````````````@`'60```>&PO=V]R:W-H M965T&UL4$L! M`A0#%`````@`>W.*1V,GEAZ_`0``>P0``!D``````````````(`!V$0``'AL M+W=O`PY:8! M``"Q`P``&0``````````````@`'.1@``>&PO=V]R:W-H965T,)0\^M`$``!8$```9``````````````"` M`:M(``!X;"]W;W)K&UL4$L!`A0#%`````@`>W.* M1VAF>DBU`0``%@0``!D``````````````(`!EDH``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`>W.*1Y4N'+2F`0``L0,` M`!D``````````````(`!2%```'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`>W.*1\OO+-&+`P``M0\``!D````````````` M`(`!&U<``'AL+W=O&PO=V]R:W-H965T M``!X;"]W;W)K&UL4$L!`A0# M%`````@`>W.*1X8SN57D`0``U@0``!D``````````````(`!MF```'AL+W=O M&PO=V]R:W-H965T&UL4$L!`A0#%`````@`>W.*1PL, MX('W`@``&@L``!D``````````````(`!JV<``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`>W.*1_0:[50#!```W!0``!D` M`````````````(`!_F\``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`A0#%`````@`>W.*1VVKQ]A5`@``'@D``!D``````````````(`! MI'@``'AL+W=OP``>&PO=V]R:W-H965T;M:Q[W@$``"<%```9```````` M``````"``0U]``!X;"]W;W)K&UL4$L!`A0#%``` M``@`>W.*1SV%6(.D`P``]Q```!D``````````````(`!(G\``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`>W.*1U1G#[.R M`@``I0D``!D``````````````(`!(8D``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`>W.*1UU&PO=V]R M:W-H965T v3.3.1.900
Segment Reporting - Information about Reportable Segments (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Oct. 31, 2015
Oct. 25, 2014
Oct. 31, 2015
Oct. 25, 2014
Apr. 25, 2015
Segment Reporting Information [Line Items]          
Net sales $ 1,389,210 $ 978,220 $ 2,532,080 $ 1,917,176  
Operating income (loss) from continuing operations 83,463 72,140 145,640 138,136  
Total assets, excluding assets held for sale 3,451,838   3,451,838   $ 2,193,565
Assets held for sale         754,141
Total assets 3,451,838   3,451,838   2,947,706
Corporate [Member]          
Segment Reporting Information [Line Items]          
Net sales 13,435 9,110 23,891 18,892  
Operating income (loss) from continuing operations (15,808) (15,623) (33,855) (26,163)  
Total assets, excluding assets held for sale 469,101   469,101   539,863
Dental [Member]          
Segment Reporting Information [Line Items]          
Net sales 601,322 592,636 1,176,439 1,135,510  
Operating income (loss) from continuing operations 74,094 73,427 141,346 135,976  
Total assets, excluding assets held for sale 900,668   900,668   1,022,257
Animal Health [Member]          
Segment Reporting Information [Line Items]          
Net sales 774,453 376,474 1,331,750 762,774  
Operating income (loss) from continuing operations 25,177 $ 14,336 38,149 $ 28,323  
Total assets, excluding assets held for sale $ 2,082,069   $ 2,082,069   $ 631,445
XML 16 R33.htm IDEA: XBRL DOCUMENT v3.3.1.900
Discontinued Operations - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Aug. 28, 2015
Oct. 31, 2015
Oct. 31, 2015
Jul. 01, 2015
Discontinued Operations and Disposal Groups [Abstract]        
Consideration receivable as per definitive agreement       $ 715,000
Proceeds from the sale including working capital adjustment $ 718,078      
Pre-tax gain on sale   $ 25,520 $ 25,520  
Percentage of common units obtained   10.00%    
Ratio of acquirer cash inflows to cash outflows at which common units obtained begin participating in distributions   2.5    
Transition services agreement, period of involvement     24 months  
Professional fees incurred with sale of Patterson Medical   $ 9,842 $ 13,692  
XML 17 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 18 R25.htm IDEA: XBRL DOCUMENT v3.3.1.900
Segment Reporting (Tables)
6 Months Ended
Oct. 31, 2015
Segment Reporting [Abstract]  
Information about Reportable Segments

The following table presents information about Patterson’s reportable segments:

 

     Three Months Ended      Six Months Ended  
     October 31,      October 25,      October 31,      October 25,  
     2015      2014      2015      2014  

Net sales

           

Corporate

   $ 13,435       $ 9,110       $ 23,891       $ 18,892   

Dental

     601,322         592,636         1,176,439         1,135,510   

Animal Health

     774,453         376,474         1,331,750         762,774   
  

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated net sales

   $ 1,389,210       $ 978,220       $ 2,532,080       $ 1,917,176   
  

 

 

    

 

 

    

 

 

    

 

 

 

Operating income (loss) from continuing operations

           

Corporate

   $ (15,808    $ (15,623    $ (33,855    $ (26,163

Dental

     74,094         73,427         141,346         135,976   

Animal Health

     25,177         14,336         38,149         28,323   
  

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated operating income from continuing operations

   $ 83,463       $ 72,140       $ 145,640       $ 138,136   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

     October 31,
2015
     April 25,
2015
 

Total assets

     

Corporate

   $ 469,101       $ 539,863   

Dental

     900,668         1,022,257   

Animal Health

     2,082,069         631,445   
  

 

 

    

 

 

 

Total assets, excluding assets held for sale

     3,451,838         2,193,565   

Assets held for sale

     —           754,141   
  

 

 

    

 

 

 

Total assets

   $ 3,451,838       $ 2,947,706   
  

 

 

    

 

 

 
Sales Information by Product

The following table presents sales information by product for all of Patterson’s reportable segments:

 

     Three Months Ended      Six Months Ended  
     October 31,      October 25,      October 31,      October 25,  
     2015      2014      2015      2014  

Net sales

           

Consumables

   $ 1,087,489       $ 686,165       $ 1,982,796       $ 1,381,804   

Equipment and software

     207,809         204,409         361,292         360,803   

Other

     93,912         87,646         187,992         174,569   
  

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated net sales

   $ 1,389,210       $ 978,220       $ 2,532,080       $ 1,917,176   
  

 

 

    

 

 

    

 

 

    

 

 

 
XML 19 R50.htm IDEA: XBRL DOCUMENT v3.3.1.900
Debt Issuance - Additional Information (Detail) - USD ($)
3 Months Ended
Aug. 28, 2015
Oct. 31, 2015
Aug. 01, 2015
Jun. 16, 2015
Apr. 25, 2015
Line of Credit Facility [Line Items]          
Credit facility, borrowed amount   $ 0     $ 0
Borrowings on revolving credit   80,000,000      
Credit Agreement [Member]          
Line of Credit Facility [Line Items]          
Credit facility, maximum borrowing capacity     $ 1,500,000,000    
Credit facility, expiration date     Jun. 16, 2020    
LIBOR [Member] | Credit Agreement [Member]          
Line of Credit Facility [Line Items]          
Credit facility, basis spread rate     2.00%    
LIBOR [Member] | Minimum [Member] | Credit Agreement [Member]          
Line of Credit Facility [Line Items]          
Credit facility, basis spread rate     1.125%    
LIBOR [Member] | Maximum [Member] | Credit Agreement [Member]          
Line of Credit Facility [Line Items]          
Credit facility, basis spread rate     2.00%    
Unsecured Term Loan [Member] | Credit Agreement [Member]          
Line of Credit Facility [Line Items]          
Credit facility, maximum borrowing capacity   325,875,000 $ 1,000,000,000    
Credit facility, borrowed amount     1,000,000,000    
Credit facility, amount repaid $ 670,000,000        
Debt issuance cost amortization $ 5,153,000        
Principal payment   $ 4,125,000      
Unsecured Revolving Line of Credit [Member] | Credit Agreement [Member]          
Line of Credit Facility [Line Items]          
Credit facility, maximum borrowing capacity     500,000,000    
Credit facility, borrowed amount     $ 200,000,000    
Credit Facility Expiring on December 2016 [Member]          
Line of Credit Facility [Line Items]          
Credit facility, maximum borrowing capacity       $ 300,000,000  
XML 20 R42.htm IDEA: XBRL DOCUMENT v3.3.1.900
Fair Value Measurements - Additional Information (Detail) - USD ($)
$ in Thousands
Oct. 31, 2015
Apr. 25, 2015
Fair Value Disclosures [Abstract]    
Estimated fair value of debt $ 1,058,425 $ 746,685
XML 21 R37.htm IDEA: XBRL DOCUMENT v3.3.1.900
Goodwill and Other Intangible Assets - Balances of Other Intangible Assets Excluding Goodwill (Detail) - USD ($)
$ in Thousands
Oct. 31, 2015
Apr. 25, 2015
Goodwill and Intangible Assets Disclosure [Abstract]    
Copyrights, trade names and trademarks $ 29,900 $ 17,600
Distribution agreement, customer lists and other 642,614 221,359
Less: Accumulated amortization (135,435) (113,934)
Net amortized intangible assets 507,179 107,425
Total identifiable intangible assets, net $ 537,079 $ 125,025
XML 22 R47.htm IDEA: XBRL DOCUMENT v3.3.1.900
Segment Reporting - Sales Information by Product (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Oct. 31, 2015
Oct. 25, 2014
Oct. 31, 2015
Oct. 25, 2014
Segment Reporting Information [Line Items]        
Net sales $ 1,389,210 $ 978,220 $ 2,532,080 $ 1,917,176
Consumables [Member]        
Segment Reporting Information [Line Items]        
Net sales 1,087,489 686,165 1,982,796 1,381,804
Equipment and Software [Member]        
Segment Reporting Information [Line Items]        
Net sales 207,809 204,409 361,292 360,803
Other Products [Member]        
Segment Reporting Information [Line Items]        
Net sales $ 93,912 $ 87,646 $ 187,992 $ 174,569
XML 23 R9.htm IDEA: XBRL DOCUMENT v3.3.1.900
Derivative Financial Instruments
6 Months Ended
Oct. 31, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments

Note 5. Derivative Financial Instruments

Patterson is a party to certain offsetting and identical interest rate cap agreements. These interest rate cap agreements are not designated for hedge accounting treatment and were entered into to fulfill certain covenants of an equipment finance contracts sale agreement between a commercial paper conduit managed by The Bank of Tokyo-Mitsubishi UFJ, Ltd. and PDC Funding. On November 25, 2014, this sale agreement was amended on terms generally consistent with the expiring agreement. The interest rate cap agreements provide a credit enhancement feature for the financing contracts sold by PDC Funding to the commercial paper conduit.

The interest rate cap agreements are cancelled and new agreements entered into periodically to maintain consistency with the dollar maximum of the sale agreements and the maturity of the underlying financing contracts. As of October 31, 2015, PDC Funding had purchased an interest rate cap from a bank with a notional amount of $500,000 and a maturity date of February 2022. Patterson sold an identical interest rate cap to the same bank.

Similar to the above agreements, PDC Funding II and Patterson entered into offsetting and identical interest rate cap agreements with a notional amount of $100,000 in fiscal 2014. In August 2015, these agreements were terminated and replaced with offsetting and identical interest rate cap agreements. The notional amount remained at $100,000 and the new maturity date is July 2023.

In addition to the purchased and sold identical interest rate cap agreements described above, in May 2012 we entered into an interest rate swap agreement with a bank to economically hedge the interest rate risk associated with a portion of the finance contracts we had sold through the special purpose entities. This agreement expired in April 2015.

 

These interest rate contracts do not qualify for hedge accounting treatment and, accordingly, we record the fair value of the agreements as an asset or liability and the change as income or expense during the period in which the change occurs.

In January 2014 we entered into a forward interest rate swap agreement with a notional amount of $250,000 and accounted for as cash flow hedge, to hedge interest rate fluctuations in anticipation of refinancing the 5.17% senior notes due March 25, 2015 with a loan for $250,000 and a term of ten years. This note was repaid on March 25, 2015 and replaced with new $250,000 3.48% senior notes due March 24, 2025. A cash payment of $29,003 was made in March 2015 to settle the interest rate swap. This amount will be recognized as interest expense over the ten-year life of the new notes.

The following presents the fair value of interest rate contracts included in the condensed consolidated balance sheets:

 

          October 31,      April 25,  

Derivative type

  

Classification

   2015      2015  

Interest rate contracts

  

Other noncurrent assets

   $ 835       $ 1,255   

Interest rate contracts

  

Other noncurrent liabilities

     835         1,255   

The following table presents the effect of interest rate contracts on the condensed consolidated statements of income and other comprehensive income (OCI):

 

          Three Months Ended     Six Months Ended  

Derivative type

   Location of gain/(loss)
recognized on derivative
   October 31,
2015
     October 25,
2014
    October 31,
2015
     October 25,
2014
 

Interest rate swap

   OCI    $ 437       $ (3,867   $ 1,054       $ (6,176

We recorded $703 of interest expense during the three months ended October 31, 2015, and $49 as a reduction to interest expense in the three months ended October 25, 2014 related to the interest rate swap. We recorded $1,405 of interest expense during the six months ended October 31, 2015, and $97 as a reduction to interest expense in the six months ended October 25, 2014 related to the interest rate swap. We recorded no ineffectiveness during the three and six month periods ended October 31, 2015 and October 25, 2014.

XML 24 R43.htm IDEA: XBRL DOCUMENT v3.3.1.900
Securities - Additional Information (Detail)
CAD in Thousands
Oct. 25, 2013
CAD
Time_Deposit
Oct. 31, 2015
CAD
Oct. 24, 2014
CAD
Investments, Debt and Equity Securities [Abstract]      
Number of time deposits invested | Time_Deposit 3    
Total principal amount CAD 110,000 CAD 65,000 CAD 45,000
Maturity value of time deposits   CAD 67,031 CAD 45,436
XML 25 R29.htm IDEA: XBRL DOCUMENT v3.3.1.900
Acquisitions - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Oct. 31, 2015
Aug. 01, 2015
Oct. 25, 2014
Oct. 31, 2015
Oct. 25, 2014
Apr. 25, 2015
Business Acquisition [Line Items]            
Goodwill $ 817,595,000     $ 817,595,000   $ 299,924,000
Revenues 1,389,210,000   $ 978,220,000 2,532,080,000 $ 1,917,176,000  
Operating income $ 83,463,000   $ 72,140,000 145,640,000 $ 138,136,000  
Tax impact of repatriation of foreign earnings       12,300,000    
Animal Health International [Member]            
Business Acquisition [Line Items]            
Business acquisition cash paid   $ 1,100,000,000        
Identifiable net assets acquired   $ 589,833,000        
Revision period after valuation completion for provisional amounts   1 year        
Deferred tax asset   $ 2,569,000        
Deferred tax liability   177,789,000        
Goodwill   518,370,000        
Goodwill recognized, deductible for income tax purpose   0        
Deferred taxes recorded related to goodwill   0        
Increase in goodwill due to working capital adjustments   499,000        
Revenues       585,950,000    
Operating income       12,369,000    
Amortization expense related to identifiable intangible assets       $ 12,048,000    
Animal Health International [Member] | Term Loan [Member]            
Business Acquisition [Line Items]            
Unsecured term loan   1,000,000,000        
Animal Health International [Member] | Unsecured Revolving Line of Credit [Member]            
Business Acquisition [Line Items]            
Credit facility, maximum borrowing capacity   $ 500,000,000        
XML 26 R28.htm IDEA: XBRL DOCUMENT v3.3.1.900
General - Computation of Basic and Diluted Earnings Per Share (EPS) (Detail) - shares
shares in Thousands
3 Months Ended 6 Months Ended
Oct. 31, 2015
Oct. 25, 2014
Oct. 31, 2015
Oct. 25, 2014
Earnings Per Share [Abstract]        
Denominator for basic EPS - weighted average shares 98,525 98,802 98,981 99,066
Effect of dilutive securities 660 574 693 713
Denominator for diluted EPS - weighted average shares 99,185 99,376 99,674 99,779
XML 27 R44.htm IDEA: XBRL DOCUMENT v3.3.1.900
Customer Financing - Additional Information (Detail)
3 Months Ended 6 Months Ended
Oct. 31, 2015
USD ($)
Oct. 25, 2014
USD ($)
Oct. 31, 2015
USD ($)
Customer
Oct. 25, 2014
USD ($)
Apr. 25, 2015
USD ($)
Apr. 26, 2014
USD ($)
Customer Financing [Line Items]            
Maximum credit financed for equipment purchases for any one customer $ 500,000   $ 500,000      
Number of customer financing contracts | Customer     2      
Financing contracts sold under ASC 860 48,172,000 $ 47,059,000 $ 142,939,000 $ 132,148,000    
Cash and cash equivalents 95,451,000 $ 284,872,000 95,451,000 $ 284,872,000 $ 347,260,000 $ 264,908,000
Current receivables of finance contracts not yet sold 105,852,000   105,852,000   88,470,000  
Unearned income 6,781,000   6,781,000   4,197,000  
Finance contracts receivable sold and outstanding 529,484,000   529,484,000      
Deferred purchase price 67,550,000   $ 67,550,000   66,715,000  
Bad debt write-offs, percentage, maximum     1.00%      
Unsettled Financing Arrangements [Member]            
Customer Financing [Line Items]            
Cash and cash equivalents 24,793,000   $ 24,793,000   $ 29,863,000  
The Bank of Tokyo-Mitsubishi UFJ, Ltd. [Member]            
Customer Financing [Line Items]            
Capacity under agreement 500,000,000   500,000,000      
Fifth Third Bank [Member]            
Customer Financing [Line Items]            
Capacity under agreement $ 100,000,000   $ 100,000,000      
Minimum [Member] | The Bank of Tokyo-Mitsubishi UFJ, Ltd. [Member]            
Customer Financing [Line Items]            
Percentage of principal amount of financing contracts held as collateral     13.00%      
Minimum [Member] | Fifth Third Bank [Member]            
Customer Financing [Line Items]            
Percentage of principal amount of financing contracts held as collateral     14.00%      
XML 28 R30.htm IDEA: XBRL DOCUMENT v3.3.1.900
Acquisitions - Summary of Total Purchase Price Consideration and Preliminary Fair Value of Assets Acquired and Liabilities Assumed (Detail) - USD ($)
$ in Thousands
3 Months Ended
Aug. 01, 2015
Oct. 31, 2015
Jun. 16, 2015
Apr. 25, 2015
Business Acquisition [Line Items]        
Goodwill   $ 817,595   $ 299,924
Animal Health International [Member]        
Business Acquisition [Line Items]        
Total purchase price consideration $ 1,108,203      
Receivables 161,427      
Inventory 195,367      
Prepaid expenses and other current assets 33,005      
Property and equipment 44,178      
Identifiable intangibles 434,300   $ 434,300  
Other long-term assets 40,869      
Total assets acquired 909,146      
Accounts payable 122,129      
Accrued liabilities and other current liabilities 19,395      
Deferred tax liability 177,789      
Total liabilities assumed 319,313      
Identifiable net assets acquired 589,833      
Goodwill 518,370      
Net assets acquired $ 1,108,203      
XML 29 R31.htm IDEA: XBRL DOCUMENT v3.3.1.900
Acquisitions - Summary of Acquired Intangible Assets Excluding Goodwill (Detail) - Animal Health International [Member] - USD ($)
$ in Thousands
Jun. 16, 2015
Aug. 01, 2015
Business Acquisition [Line Items]    
Total amortized intangible assets $ 422,000  
Total identifiable intangible assets $ 434,300 $ 434,300
Finite lived intangible assets, Weighted average life (years) 13 years 7 months 6 days  
Unamortized Trade Names [Member]    
Business Acquisition [Line Items]    
Unamortized - indefinite lived $ 12,300  
Indefinite lived intangible assets, Weighted average life (years) indefinite  
Customer Relationships [Member]    
Business Acquisition [Line Items]    
Total amortized intangible assets $ 291,900  
Finite lived intangible assets, Weighted average life (years) 15 years  
Amortized Trade Names [Member]    
Business Acquisition [Line Items]    
Total amortized intangible assets $ 111,400  
Finite lived intangible assets, Weighted average life (years) 10 years  
Developed Technology and Other [Member]    
Business Acquisition [Line Items]    
Total amortized intangible assets $ 18,700  
Finite lived intangible assets, Weighted average life (years) 12 years 2 months 12 days  
XML 30 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900
Goodwill and Other Intangible Assets
6 Months Ended
Oct. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets

Note 4. Goodwill and Other Intangible Assets

Goodwill balances and related activity by business segment are as follows:

 

     Balance at
April 25,
2015
     Acquisition
Activity and
Divestitures
     Other Activity      Balance at
October 31,
2015
 

Corporate

   $ —         $ —         $ —         $ —     

Dental

     139,449         —           (738      138,711   

Animal Health

     160,475         518,370         39         678,884   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $  299,924       $ 518,370       $ (699    $ 817,595   
  

 

 

    

 

 

    

 

 

    

 

 

 

Balances of other intangible assets, excluding goodwill, are as follows:

 

     October 31,      April 25,  
     2015      2015  

Unamortized – indefinite lived:

     

Copyrights, trade names and trademarks

   $ 29,900       $ 17,600   

Amortized:

     

Distribution agreement, customer lists and other

     642,614         221,359   

Less: Accumulated amortization

     (135,435      (113,934
  

 

 

    

 

 

 

Net amortized intangible assets

     507,179         107,425   
  

 

 

    

 

 

 

Total identifiable intangible assets, net

   $ 537,079       $ 125,025   
  

 

 

    

 

 

 
XML 31 R32.htm IDEA: XBRL DOCUMENT v3.3.1.900
Acquisitions - Summary of Unaudited Pro Forma Financial Result (Detail) - USD ($)
$ in Thousands
6 Months Ended
Oct. 31, 2015
Oct. 25, 2014
Business Acquisition, Pro Forma Information [Abstract]    
Pro forma net sales $ 2,725,116 $ 2,650,613
Pro forma net income from continuing operations $ 70,957 $ 74,754
XML 32 R40.htm IDEA: XBRL DOCUMENT v3.3.1.900
Derivative Financial Instruments - Effect of Interest Rate Contracts on Condensed Consolidated Statements of Income and Other Comprehensive Income (OCI) (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Oct. 31, 2015
Oct. 25, 2014
Oct. 31, 2015
Oct. 25, 2014
Interest Rate Swap [Member] | Other Comprehensive Income [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Effect of interest rate contracts $ 437 $ (3,867) $ 1,054 $ (6,176)
XML 33 R2.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Oct. 31, 2015
Apr. 25, 2015
Current assets:    
Cash and cash equivalents $ 95,451 $ 347,260
Short-term investments   53,372
Receivables, net of allowance for doubtful accounts 734,461 586,263
Inventory 752,849 408,422
Prepaid expenses and other current assets 83,169 59,561
Current assets held for sale   118,347
Total current assets 1,665,930 1,573,225
Property and equipment, net 272,190 204,133
Long-term receivables, net 75,784 71,686
Goodwill 817,595 299,924
Identifiable intangibles, net 537,079 125,025
Other 83,260 37,919
Long-term assets held for sale   635,794
Total assets 3,451,838 2,947,706
Current liabilities:    
Accounts payable 492,469 323,294
Accrued payroll expense 47,671 72,464
Other accrued liabilities 162,225 142,611
Current maturities of long-term debt 15,991  
Borrowings on revolving credit 80,000  
Current liabilities held for sale   39,316
Total current liabilities 798,356 577,685
Long-term debt 1,034,884 725,000
Other non-current liabilities 255,341 81,484
Long-term liabilities held for sale   49,414
Total liabilities 2,088,581 1,433,583
Stockholders' equity:    
Common stock 995 1,033
Additional paid-in capital 27,759 21,026
Accumulated other comprehensive loss (63,626) (60,346)
Retained earnings 1,475,867 1,630,148
Unearned ESOP shares (77,738) (77,738)
Total stockholders' equity 1,363,257 1,514,123
Total liabilities and stockholders' equity $ 3,451,838 $ 2,947,706
XML 34 R45.htm IDEA: XBRL DOCUMENT v3.3.1.900
Segment Reporting - Additional Information (Detail) - Segment
6 Months Ended 12 Months Ended
Oct. 31, 2015
Apr. 25, 2015
Segment Reporting [Abstract]    
Number of reportable segments 3 3
XML 35 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
Acquisitions
6 Months Ended
Oct. 31, 2015
Business Combinations [Abstract]  
Acquisitions

Note 2. Acquisitions

During our first fiscal quarter of 2016, we completed the acquisition of Animal Health International, Inc., a leading production animal health distribution company in the U.S. This acquisition more than doubled the revenue previously attributable to our animal health business, which was previously focused on the companion animal health market. Our animal health business now offers an expanded range of products and services to a broader base of customers in North America and the U.K. Under terms of the merger agreement, we acquired all of Animal Health International’s stock for $1,100,000 in cash, subject to customary working capital adjustments.

In connection with the acquisition, we entered into a credit agreement consisting of a $1,000,000 unsecured term loan and a $500,000 unsecured cash flow revolving line of credit, described further in Note 11 to the Condensed Consolidated Financial Statements.

The acquisition has been accounted for in accordance with ASC 805, Business Combinations, with identifiable assets acquired and liabilities assumed recorded at their estimated fair values on the acquisition date. A valuation of the assets and liabilities from the business acquisition was performed utilizing cost, income and market approaches resulting in $589,833 allocated to identifiable net assets. The initial accounting for the acquisition is not complete because certain information and analysis that may impact our initial valuations are still being obtained or reviewed. The significant assets and liabilities for which provisional amounts are recognized at the acquisition date are property and equipment, intangible assets, goodwill, working capital adjustments and deferred income taxes. The provisional amounts recognized are subject to revision until our valuations are completed, not to exceed one year, and any material adjustments identified that existed as of the acquisition date will be retroactively recorded.

The following table summarizes the total purchase price consideration and the preliminary fair value amounts recognized for the assets acquired and liabilities assumed related to the acquisition, as of the acquisition date:

 

Total purchase price consideration

   $ 1,108,203   
  

 

 

 

Receivables

   $ 161,427   

Inventory

     195,367   

Prepaid expenses and other current assets

     33,005   

Property and equipment

     44,178   

Identifiable intangibles

     434,300   

Other long-term assets

     40,869   
  

 

 

 

Total assets acquired

     909,146   
  

 

 

 

Accounts payable

     122,129   

Accrued liabilities and other current liabilities

     19,395   

Deferred tax liability

     177,789   
  

 

 

 

Total liabilities assumed

     319,313   
  

 

 

 

Identifiable net assets acquired

     589,833   

Goodwill

     518,370   
  

 

 

 

Net assets acquired

   $ 1,108,203   
  

 

 

 

 

As a result of recording the stepped up fair market basis for GAAP purposes, but receiving primarily carryover basis for tax purposes in the acquisition, we recorded a deferred tax asset and deferred tax liability of $2,569 and $177,789, respectively.

The goodwill of $518,370 resulting from the acquisition reflects the excess of our purchase price over the fair value of the net assets acquired. An adjustment to increase goodwill by $499 was recorded in the second quarter of fiscal 2016 as a result of working capital adjustments. The goodwill recorded as part of the acquisition primarily reflects the value of the assembled workforce, cost synergies, and the potential to integrate and expand existing product lines. We allocated all of the goodwill to our Animal Health reporting segment. None of the goodwill recognized is deductible for income tax purposes, and as such, no deferred taxes have been recorded related to goodwill.

Revenues of $585,950 and operating income of $12,369 attributable to the acquisition are included in our condensed consolidated statement of income for the six months ended October 31, 2015. Included in operating income for the six months ended October 31, 2015 is amortization expense of $12,048 related to the identifiable intangible assets acquired in the transaction.

The following summarizes the intangible assets, excluding goodwill, acquired as of June 16, 2015. Intangible assets are amortized using methods that approximate the pattern of economic benefit provided by the utilization of the assets.

 

     Gross Carrying
Value
     Weighted
Average Life
(years)
 

Unamortized – indefinite lived:

     

Trade names

   $ 12,300         indefinite   

Amortized:

     

Customer relationships

     291,900         15.0   

Trade names

     111,400         10.0   

Developed technology and other

     18,700         12.2   
  

 

 

    

Total amortized intangible assets

     422,000         13.6   
  

 

 

    

Total identifiable intangible assets

   $ 434,300      
  

 

 

    

The following unaudited pro forma financial results for the combined results of Patterson and Animal Health International for the six month periods ended October 31, 2015 and October 25, 2014 assume the acquisition occurred on April 27, 2014. The unaudited pro forma financial results may not be indicative of the results that would have occurred had the acquisition been completed as of April 27, 2014, nor are they indicative of future results of operations.

 

     Six Months Ended  
     October 31,      October 25,  
     2015      2014  

Pro forma net sales

   $ 2,725,116       $ 2,650,613   

Pro forma net income from continuing operations

     70,957         74,754   

Pro forma net income from continuing operations for the six month period ended October 31, 2015 includes $12,300 of income tax expense related to the repatriation of foreign earnings, described further in Note 12 to the Condensed Consolidated Financial Statements.

XML 36 R35.htm IDEA: XBRL DOCUMENT v3.3.1.900
Discontinued Operations - Summary of Results of Operations Under Discontinued Operation Activities (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Oct. 31, 2015
Oct. 25, 2014
Oct. 31, 2015
Oct. 25, 2014
Discontinued Operations and Disposal Groups [Abstract]        
Net sales $ 37,693 $ 125,105 $ 168,504 $ 245,678
Cost of sales 24,486 78,570 107,359 153,535
Operating expenses 22,915 27,454 54,954 54,304
Gain on sale (25,520)   (25,520)  
Other expense (income) 60 17 150 (115)
Income before taxes 15,752 19,064 31,561 37,954
Income taxes 22,894 7,151 29,311 14,077
Net income from discontinued operations $ (7,142) $ 11,913 $ 2,250 $ 23,877
XML 37 R22.htm IDEA: XBRL DOCUMENT v3.3.1.900
Goodwill and Other Intangible Assets (Tables)
6 Months Ended
Oct. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill Balances and Related Activity by Business Segment

Goodwill balances and related activity by business segment are as follows:

 

     Balance at
April 25,
2015
     Acquisition
Activity and
Divestitures
     Other Activity      Balance at
October 31,
2015
 

Corporate

   $ —         $ —         $ —         $ —     

Dental

     139,449         —           (738      138,711   

Animal Health

     160,475         518,370         39         678,884   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $  299,924       $ 518,370       $ (699    $ 817,595   
  

 

 

    

 

 

    

 

 

    

 

 

 
Balances of Other Intangible Assets Excluding Goodwill

Balances of other intangible assets, excluding goodwill, are as follows:

 

     October 31,      April 25,  
     2015      2015  

Unamortized – indefinite lived:

     

Copyrights, trade names and trademarks

   $ 29,900       $ 17,600   

Amortized:

     

Distribution agreement, customer lists and other

     642,614         221,359   

Less: Accumulated amortization

     (135,435      (113,934
  

 

 

    

 

 

 

Net amortized intangible assets

     507,179         107,425   
  

 

 

    

 

 

 

Total identifiable intangible assets, net

   $ 537,079       $ 125,025   
  

 

 

    

 

 

 
XML 38 R36.htm IDEA: XBRL DOCUMENT v3.3.1.900
Goodwill and Other Intangible Assets - Goodwill Balances and Related Activity by Business Segment (Detail)
$ in Thousands
6 Months Ended
Oct. 31, 2015
USD ($)
Goodwill [Line Items]  
Beginning Balance $ 299,924
Acquisition Activity and Divestitures 518,370
Other Activity (699)
Ending Balance 817,595
Corporate [Member]  
Goodwill [Line Items]  
Beginning Balance 0
Acquisition Activity and Divestitures 0
Other Activity 0
Ending Balance 0
Dental [Member]  
Goodwill [Line Items]  
Beginning Balance 139,449
Other Activity (738)
Ending Balance 138,711
Animal Health [Member]  
Goodwill [Line Items]  
Beginning Balance 160,475
Acquisition Activity and Divestitures 518,370
Other Activity 39
Ending Balance $ 678,884
XML 39 R24.htm IDEA: XBRL DOCUMENT v3.3.1.900
Fair Value Measurements (Tables)
6 Months Ended
Oct. 31, 2015
Fair Value Disclosures [Abstract]  
Assets and Liabilities Measured at Fair Value on Recurring Basis

Our hierarchy for assets and liabilities measured at fair value on a recurring basis is as follows:

 

     October 31, 2015  
     Total      Level 1      Level 2      Level 3  

Assets:

           

Cash equivalents

   $ 4,949       $ 4,949       $ —         $ —     

Derivative instruments

     835         —           835         —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

   $ 5,784       $ 4,949       $ 835       $ —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities:

           
  

 

 

    

 

 

    

 

 

    

 

 

 

Derivative instruments

   $ 835       $ —         $ 835       $ —     
  

 

 

    

 

 

    

 

 

    

 

 

 
     April 25, 2015  
     Total      Level 1      Level 2      Level 3  

Assets:

           

Cash equivalents

   $ 90,569       $ 90,569       $ —         $ —     

Derivative instruments

     1,255         —           1,255         —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

   $ 91,824       $ 90,569       $ 1,255       $ —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities:

           
  

 

 

    

 

 

    

 

 

    

 

 

 

Derivative instruments

   $ 1,255       $ —         $ 1,255       $ —     
  

 

 

    

 

 

    

 

 

    

 

 

 
XML 40 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 41 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
Discontinued Operations
6 Months Ended
Oct. 31, 2015
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations

Note 3. Discontinued Operations

On July 1, 2015, we entered into a definitive agreement to sell all of the outstanding shares of common stock of Patterson Medical Holdings, Inc., our wholly owned subsidiary responsible for our rehabilitation supply business known as Patterson Medical (“Patterson Medical”), for $715,000 in cash to Madison Dearborn Partners. The definitive agreement includes a working capital adjustment provision that impacts the final sale price. On August 28, 2015, we completed the sale of Patterson Medical for $718,078, with such sales price including the above-described working capital adjustment. As additional consideration for the shares of Patterson Medical, we obtained a number of common units of the parent company of the buyer equal to 10% of the common units outstanding at closing. Unlike the other common units, these units will only become entitled to begin participating in distributions to the common unit holders at such time, if any, as the Madison Dearborn Partners’ investor cash inflows equal or exceed 2.5 times the Madison Dearborn Partners’ investor cash outflows. These units are non-transferrable. We recorded a pre-tax gain of $25,520 on the sale of Patterson Medical during the second quarter of fiscal 2016 within discontinued operations in the condensed consolidated statements of income.

 

In connection with the above described transaction, we also entered into a transition services agreement with our former subsidiary, pursuant to which Patterson Medical Holdings, Inc., as owned by Madison Dearborn Partners, is paying us to provide, among other things, certain information technology, distribution, facilities, finance, tax and treasury, and human resources services for up to 24 months after closing.

As of October 31, 2015, we classified Patterson Medical’s results of operations as discontinued operations for all periods presented in the condensed consolidated statements of income. The assets and liabilities of Patterson Medical were reflected as held for sale in the condensed consolidated balance sheets as of April 25, 2015. The classification was based on our entering into the definitive agreement to sell Patterson Medical during the first quarter of fiscal 2016, the entity being available for sale in its present condition at that time and the sale being completed in the second quarter of fiscal 2016. The operations and cash flows of Patterson Medical have been eliminated from our continuing operations, which were previously recorded as the rehabilitation supply reportable segment.

The following summarizes the assets and liabilities of Patterson Medical as of April 25, 2015:

 

     April 25,  
     2015  

Assets held for sale

  

Receivables, net of allowance for doubtful accounts

   $ 57,876   

Inventory

     48,265   

Prepaid expenses and other current assets

     12,206   

Property and equipment, net

     22,672   

Goodwill

     537,175   

Identifiable intangibles, net

     74,804   

Other long-term assets

     1,143   
  

 

 

 

Total assets held for sale

   $ 754,141   
  

 

 

 

Liabilities held for sale

  

Accounts payable

   $ 26,341   

Accrued liabilities and other current liabilities

     12,975   

Long-term liabilities

     49,414   
  

 

 

 

Total liabilities held for sale

   $ 88,730   
  

 

 

 

The following summarizes the results of operations of our discontinued Patterson Medical operations for the periods presented:

 

     Three Months Ended      Six Months Ended  
     October 31,
2015 (a)
     October 25,
2014
     October 31,
2015
     October 25,
2014
 

Net sales

   $ 37,693       $ 125,105       $ 168,504       $ 245,678   

Cost of sales

     24,486         78,570         107,359         153,535   

Operating expenses

     22,915         27,454         54,954         54,304   

Gain on sale

     (25,520      —           (25,520      —     

Other expense (income)

     60         17         150         (115
  

 

 

    

 

 

    

 

 

    

 

 

 

Income before taxes

     15,752         19,064         31,561         37,954   

Income taxes

     22,894         7,151         29,311         14,077   
  

 

 

    

 

 

    

 

 

    

 

 

 

Net income from discontinued operations

   $ (7,142    $ 11,913       $ 2,250       $ 23,877   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(a)  Includes activity up until the sale date of August 28, 2015.

 

Operating expenses for the three and six months ended October 31, 2015 include professional fees of $9,842 and $13,692, respectively, incurred in connection with the sale of Patterson Medical. Depreciation and amortization were ceased during the three and six months ended October 31, 2015 in accordance with accounting for discontinued operations. Income taxes have been allocated to Patterson Medical based on the accounting requirements for presenting discontinued operations. Income taxes as a percent of income before taxes for both the three and six months ended October 31, 2015 are higher than in the respective prior periods as a result of the requirement to calculate the tax due on the sale of Patterson Medical including certain basis differences that were appropriately not previously recognized for financial reporting purposes.

XML 42 R3.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Oct. 31, 2015
Oct. 25, 2014
Oct. 31, 2015
Oct. 25, 2014
Income Statement [Abstract]        
Net sales $ 1,389,210 $ 978,220 $ 2,532,080 $ 1,917,176
Cost of sales 1,058,311 718,933 1,912,937 1,407,272
Gross profit 330,899 259,287 619,143 509,904
Operating expenses 247,436 187,147 473,503 371,768
Operating income from continuing operations 83,463 72,140 145,640 138,136
Other income and expense:        
Other income, net 954 777 1,624 2,147
Interest expense (17,154) (8,544) (29,297) (17,312)
Income from continuing operations before taxes 67,263 64,373 117,967 122,971
Income taxes 24,700 22,508 55,093 42,781
Net income from continuing operations 42,563 41,865 62,874 80,190
Net income (loss) from discontinued operations (7,142) 11,913 2,250 23,877
Net income $ 35,421 $ 53,778 $ 65,124 $ 104,067
Basic earnings (loss) per share:        
Continuing operations $ 0.43 $ 0.42 $ 0.64 $ 0.81
Discontinued operations (0.07) 0.12 0.02 0.24
Net basic earnings per share 0.36 0.54 0.66 1.05
Diluted earnings (loss) per share:        
Continuing operations 0.43 0.42 0.63 0.80
Discontinued operations (0.07) 0.12 0.02 0.24
Net diluted earnings per share $ 0.36 $ 0.54 $ 0.65 $ 1.04
Weighted average shares:        
Basic 98,525 98,802 98,981 99,066
Diluted 99,185 99,376 99,674 99,779
Dividends declared per common share $ 0.22 $ 0.20 $ 0.44 $ 0.40
Comprehensive income        
Net income $ 35,421 $ 53,778 $ 65,124 $ 104,067
Foreign currency translation gain (loss) 6,941 (36,816) (4,334) (26,506)
Cash flow hedges, net of tax 437 (3,867) 1,054 (6,176)
Comprehensive income $ 42,799 $ 13,095 $ 61,844 $ 71,385
XML 43 R17.htm IDEA: XBRL DOCUMENT v3.3.1.900
Legal Proceedings
6 Months Ended
Oct. 31, 2015
Commitments and Contingencies Disclosure [Abstract]  
Legal Proceedings

Note 13. Legal Proceedings

In September 2015, we were served with a summons and complaint in an action commenced in the United States District Court for the Eastern District of New York, entitled SourceOne Dental, Inc. v. Patterson Companies, Inc., Henry Schein, Inc. and Benco Dental Supply Company, Civil Action No. 15-cv-05440-JMA-GRB. SourceOne, as plaintiff, alleges that, through its website, it markets and sells dental supplies and equipment to dentists. SourceOne alleges in the complaint, among other things, that we, along with the defendants Henry Schein and Benco, conspired to eliminate plaintiff as a competitor and to exclude them from the market for the marketing, distribution and sale of dental supplies and equipment in the United States and that defendants unlawfully agreed with one another to boycott dentists, manufacturers, and state dental associations that deal with, or considered dealing with, plaintiff. Plaintiff asserts the following claims: (i) unreasonable restraint of trade in violation of state and federal antitrust laws; (ii) tortious interference with prospective business relations; (iii) civil conspiracy; and (iv) aiding and abetting the other defendants’ ongoing tortious and anticompetitive conduct. Plaintiff seeks equitable relief, compensatory and treble damages, jointly and severally, punitive damages, interest, and reasonable costs and expenses, including attorneys’ fees and expert fees. Plaintiff has not specified a damage amount in its complaint. We intend to defend ourselves against the action vigorously. We do not anticipate that this matter will have a material adverse effect on our financial condition.

XML 44 R1.htm IDEA: XBRL DOCUMENT v3.3.1.900
Document and Entity Information - shares
6 Months Ended
Oct. 31, 2015
Dec. 03, 2015
Document And Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Oct. 31, 2015  
Document Fiscal Year Focus 2016  
Document Fiscal Period Focus Q2  
Trading Symbol PDCO  
Entity Registrant Name PATTERSON COMPANIES, INC.  
Entity Central Index Key 0000891024  
Current Fiscal Year End Date --04-30  
Entity Filer Category Large Accelerated Filer  
Entity Common Stock, Shares Outstanding   99,430,000
XML 45 R18.htm IDEA: XBRL DOCUMENT v3.3.1.900
General (Policies)
6 Months Ended
Oct. 31, 2015
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of Patterson Companies, Inc. (“Patterson”) as of October 31, 2015, and our results of operations and cash flows for the periods ended October 31, 2015 and October 25, 2014. Such adjustments are of a normal recurring nature. The results of operations for the periods ended October 31, 2015 and October 25, 2014 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the financial statements included in our 2015 Annual Report on Form 10-K filed on June 24, 2015.

Such unaudited condensed consolidated financial statements include the assets and liabilities of PDC Funding Company, LLC (“PDC Funding”) and PDC Funding Company II, LLC (“PDC Funding II”), wholly owned subsidiaries and separate legal entities under Minnesota law. PDC Funding and PDC Funding II are fully consolidated special purpose entities established to sell customer installment sale contracts to outside financial institutions in the normal course of their business. The assets of PDC Funding and PDC Funding II would be available first and foremost to satisfy the claims of its creditors. There are no known creditors of PDC Funding or PDC Funding II.

Through fiscal 2015, Patterson was comprised of three reportable segments: dental supply, veterinary supply and rehabilitation supply. This fiscal year, we reorganized our reportable segments as a result of our acquisition of Animal Health International, Inc. and our divestiture of our wholly-owned subsidiary Patterson Medical Holdings, Inc., the entity through which we operated the rehabilitation supply business. We now present three different reportable segments: Dental, Animal Health and Corporate. Prior period segment results have been restated to conform to this revised current period presentation.

Fiscal Year End

Fiscal Year End

We operate with a 52-53 week accounting convention with our fiscal year ending on the last Saturday in April. The second quarters of fiscal 2016 and 2015 include the 13 weeks ended October 31, 2015 and October 25, 2014, respectively. The six months ended October 31, 2015 and October 25, 2014 include 27 and 26 weeks, respectively. Fiscal 2016 will include 53 weeks and fiscal 2015 included 52 weeks of operations.

Comprehensive Income

Comprehensive Income

Comprehensive income is computed as net income including certain other items that are recorded directly to stockholders’ equity. Significant items included in comprehensive income are foreign currency translation adjustments and the effective portion of cash flow hedges, net of tax. Foreign currency translation adjustments do not include a provision for income tax on earnings from foreign operations that are considered to be indefinitely reinvested outside the U.S. The income tax benefit/(loss) related to cash flow hedges was $(265) and $2,321 for the three months ended October 31, 2015 and October 25, 2014, respectively. The income tax benefit/(loss) related to cash flow hedges was $(350) and $7,134 for the six months ended October 31, 2015 and October 25, 2014, respectively.

Earnings Per Share

Earnings Per Share

The following table sets forth the computation of the weighted average shares outstanding used to calculate basic and diluted earnings per share (“EPS”):

 

     Three Months Ended      Six Months Ended  
     October 31,      October 25,      October 31,      October 25,  
     2015      2014      2015      2014  

Denominator for basic EPS – weighted average shares

     98,525         98,802         98,981         99,066   

Effect of dilutive securities

     660         574         693         713   
  

 

 

    

 

 

    

 

 

    

 

 

 

Denominator for diluted EPS – weighted average shares

     99,185         99,376         99,674         99,779   
  

 

 

    

 

 

    

 

 

    

 

 

 

Potentially dilutive securities consisting of stock options, restricted stock and stock purchase plans representing 899 shares for the three and six months ended October 31, 2015 and 124 shares for the three and six months ended October 25, 2014 were excluded from the calculation of diluted earnings per share because their effect would have been anti-dilutive.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU No. 2014-09 supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605),” and requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In July 2015, the FASB deferred the effective date of this pronouncement by one year to December 15, 2017 for interim and annual reporting periods beginning after that date. Early adoption is permitted, but not before the original effective date, which for annual periods was December 15, 2016. We are evaluating the new standard, but do not, at this time, anticipate a material impact to our financial statements once implemented.

In July 2015, the FASB issued ASU No. 2015-11, “Inventory (Topic 330), Simplifying the Measurement of Inventory.” ASU 2015-11 requires inventory measured using any method other than last-in, first-out (LIFO) or the retail inventory method to be subsequently measured at the lower of cost or net realizable value, rather than at the lower of cost or market. Subsequent measurement of inventory using the LIFO and retail inventory method is unchanged. We are required to adopt the new pronouncement in the first quarter of fiscal 2018, and plan to do so at that time. Early adoption is permitted. We are evaluating the effect of adopting this pronouncement, but do not, at this time, anticipate a material impact to our financial statements once implemented.

In August 2015, the FASB issued ASU No. 2015-15, “Interest – Imputation of Interest (Subtopic 835-30), Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements.” This ASU states that ASU No. 2015-03, “Interest – Imputation of Interest (Subtopic 835-30), Simplifying the Presentation of Debt Issuance Costs” does not address debt issuance costs for line-of-credit arrangements, and therefore the SEC staff would not object to an entity deferring and presenting these related debt issuance costs as an asset and subsequently amortizing the deferred issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. At this time, we do not believe that ASU No. 2015-15 will have a material impact on our financial statements and related disclosures.

In September 2015, the FASB issued ASU No. 2015-16, “Business Combinations (Topic 805), Simplifying the Accounting for Measurement-Period Adjustments.” This ASU requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. The amendments in this ASU require an entity to present separately on the face of the income statement or disclose in the notes the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. We are required to adopt the new pronouncement in the first quarter of fiscal 2017, with early adoption permitted. We are evaluating the effect and timing of adopting this pronouncement, but do not, at this time, anticipate a material impact to the financial statements once implemented.

In November 2015, the FASB issued ASU No. 2015-17, “Income Taxes (Topic 740), Balance Sheet Classification of Income Taxes.” This ASU eliminates the current requirement for an entity to separate deferred income tax liabilities and assets into current and noncurrent amounts in a classified statement of financial position. This ASU requires that deferred tax liabilities and assets be classified as noncurrent in the classified statement of financial position. We are required to adopt the ASU in the first quarter of fiscal 2018, with early adoption permitted. We are evaluating the effect and timing of adopting this pronouncement, but do not, at this time, anticipate a material impact to the financial statements once implemented.

Reclassifications

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year presentation.

XML 46 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Oct. 31, 2015
Oct. 25, 2014
Operating activities:    
Net income $ 65,124 $ 104,067
Net income from discontinued operations 2,250 23,877
Net income from continuing operations 62,874 80,190
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities:    
Depreciation 16,791 11,663
Amortization 21,609 9,351
Bad debt expense 5,674 809
Non-cash employee compensation 13,541 11,940
Accelerated amortization of debt issuance costs on early retirement of debt 5,153  
Excess tax benefits from stock-based compensation (1,686) (175)
Change in assets and liabilities, net of acquired (137,923) (37,233)
Net cash (used in) provided by operating activities- continuing operations (13,967) 76,545
Net cash (used in) provided by operating activities-discontinued operations (38,985) 21,850
Net cash (used in) provided by operating activities (52,952) 98,395
Investing activities:    
Additions to property and equipment (40,978) (29,190)
Acquisitions and equity investments, net of cash assumed (1,105,229)  
Proceeds from sale of securities 48,744 40,775
Purchase of investments   (543)
Net cash (used in) provided by investing activities- continuing operations (1,097,463) 11,042
Net cash provided by investing activities- discontinued operations 715,430 4,598
Net cash (used in) provided by investing activities (382,033) 15,640
Financing activities:    
Dividends paid (45,356) (40,174)
Repurchases of common stock (160,579) (47,539)
Proceeds from issuance of long-term debt 1,000,000  
Debt issuance costs (11,600)  
Draw on revolver 80,000  
Retirement of long-term debt (674,125)  
Other financing activities 2,894 844
Net cash provided by (used in) financing activities 191,234 (86,869)
Effect of exchange rate changes on cash (8,058) (7,202)
Net change in cash and cash equivalents (251,809) 19,964
Cash and cash equivalents at beginning of period 347,260 264,908
Cash and cash equivalents at end of period $ 95,451 $ 284,872
XML 47 R12.htm IDEA: XBRL DOCUMENT v3.3.1.900
Customer Financing
6 Months Ended
Oct. 31, 2015
Text Block [Abstract]  
Customer Financing

Note 8. Customer Financing

As a convenience to our customers, we offer several different financing alternatives, including a third party program and a Company-sponsored program. For the third party program, we act as a facilitator between the customer and the third party financing entity with no on-going involvement in the financing transaction. Under our sponsored program, equipment purchased by customers with strong credit may be financed up to a maximum of $500 for any one customer. We generally sell our customers’ financing contracts to outside financial institutions in the normal course of our business. We currently have two arrangements under which we sell these contracts.

 

First, we operate under an agreement to sell a portion of our equipment finance contracts to commercial paper conduits with The Bank of Tokyo-Mitsubishi UFJ, Ltd. serving as the agent. We utilize a special purpose entity (“SPE”), PDC Funding, a consolidated, wholly owned subsidiary, to fulfill a requirement of participating in the commercial paper conduit. We receive the proceeds of the contracts upon sale. At least 13% of the proceeds are held by the conduit as security against eventual performance of the portfolio. The capacity under the agreement at October 31, 2015 was $500,000.

Second, we also maintain an agreement with Fifth Third Bank whereby the bank purchases customers’ financing contracts. We established another SPE, PDC Funding II, a consolidated, wholly owned subsidiary, which sells financing contracts to the bank. We receive the proceeds of the contracts upon sale. At least 14% of the proceeds are held by the conduit as security against eventual performance of the portfolio. The capacity under the agreement at October 31, 2015 was $100,000.

The portion of the purchase price for the receivables held by the conduits is a deferred purchase price receivable, which is paid to the SPE as payments on the receivables are collected from customers. The deferred purchase price receivable represents a beneficial interest in the transferred financial assets and is recognized at fair value as part of the sale transaction. We value the deferred purchase price receivable based on a discounted cash flow analysis using unobservable inputs (i.e. level 3 inputs), which include a forward yield curve, the estimated timing of payments and the credit quality of the underlying creditor. Significant changes in any of the significant unobservable inputs in isolation would not result in a materially different fair value estimate. The interrelationship between these inputs is insignificant.

These financing arrangements are accounted for as a sale of assets under the provisions of ASC 860, Transfers and Servicing. During the three and six months ended October 31, 2015, we sold $48,172 and $142,939, respectively, and during the three and six months ended October 25, 2014, we sold $47,059 and $132,148, respectively, of contracts under these arrangements. We retain servicing responsibilities under both agreements, for which we are paid a servicing fee. The servicing fees we receive are considered adequate compensation for services rendered. Accordingly, no servicing asset or liability has been recorded. The agreements require us to maintain a minimum current ratio and maximum leverage ratio. We were in compliance with those covenants at October 31, 2015.

Included in cash and cash equivalents in the condensed consolidated balance sheets are $24,793 and $29,863 as of October 31, 2015 and April 25, 2015, respectively, which represents cash collected from previously sold customer financing arrangements that have not yet been settled with the third party. Included in current receivables in the condensed consolidated balance sheets are $105,852, net of unearned income of $6,781, and $88,470, net of unearned income of $4,197, as of October 31, 2015 and April 25, 2015, respectively, of finance contracts we have not yet sold. A total of $529,484 of finance contracts receivable sold under the agreements was outstanding at October 31, 2015. The deferred purchase price under the arrangements was $67,550 and $66,715 as of October 31, 2015 and April 25, 2015, respectively. Since the internal financing program began in 1994, bad debt write-offs have amounted to less than one-percent of the loans originated.

XML 48 R11.htm IDEA: XBRL DOCUMENT v3.3.1.900
Securities
6 Months Ended
Oct. 31, 2015
Investments, Debt and Equity Securities [Abstract]  
Securities

Note 7. Securities

On October 25, 2013, we invested in three time deposits with total principal of $110,000 Canadian. On October 24, 2014, time deposits with a principal value of $45,000 Canadian matured with a value of $45,436 Canadian. The remaining time deposits with a principal value of $65,000 Canadian matured on October 28, 2015 with a value of $67,031 Canadian. Our time deposit securities were classified as held-to-maturity securities as of April 25, 2015, as we had both the intent and ability to hold them until maturity. They were carried at cost, adjusted for accrued interest and amortization. The carrying value was not materially different than fair value. The fair value was determined based on a discounted cash flow analysis using unobservable inputs (i.e. level 3 inputs), which included a forward yield curve, the estimated timing of payments and the credit quality of the underlying creditor. Significant changes in any of the significant unobservable inputs in isolation would not have resulted in a materially lower fair value estimate. The interrelationship between these inputs was insignificant.

XML 49 R23.htm IDEA: XBRL DOCUMENT v3.3.1.900
Derivative Financial Instruments (Tables)
6 Months Ended
Oct. 31, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Fair Value of Interest Rate Contracts Included in Condensed Consolidated Balance Sheets

The following presents the fair value of interest rate contracts included in the condensed consolidated balance sheets:

 

          October 31,      April 25,  

Derivative type

  

Classification

   2015      2015  

Interest rate contracts

  

Other noncurrent assets

   $ 835       $ 1,255   

Interest rate contracts

  

Other noncurrent liabilities

     835         1,255   
Effect of Interest Rate Contracts on Condensed Consolidated Statements of Income and Other Comprehensive Income (OCI)

The following table presents the effect of interest rate contracts on the condensed consolidated statements of income and other comprehensive income (OCI):

 

          Three Months Ended     Six Months Ended  

Derivative type

   Location of gain/(loss)
recognized on derivative
   October 31,
2015
     October 25,
2014
    October 31,
2015
     October 25,
2014
 

Interest rate swap

   OCI    $ 437       $ (3,867   $ 1,054       $ (6,176
XML 50 R19.htm IDEA: XBRL DOCUMENT v3.3.1.900
General (Tables)
6 Months Ended
Oct. 31, 2015
Accounting Policies [Abstract]  
Computation of Basic and Diluted Earnings Per Share (EPS)

The following table sets forth the computation of the weighted average shares outstanding used to calculate basic and diluted earnings per share (“EPS”):

 

     Three Months Ended      Six Months Ended  
     October 31,      October 25,      October 31,      October 25,  
     2015      2014      2015      2014  

Denominator for basic EPS – weighted average shares

     98,525         98,802         98,981         99,066   

Effect of dilutive securities

     660         574         693         713   
  

 

 

    

 

 

    

 

 

    

 

 

 

Denominator for diluted EPS – weighted average shares

     99,185         99,376         99,674         99,779   
  

 

 

    

 

 

    

 

 

    

 

 

 
XML 51 R15.htm IDEA: XBRL DOCUMENT v3.3.1.900
Debt Issuance
6 Months Ended
Oct. 31, 2015
Debt Disclosure [Abstract]  
Debt Issuance

Note 11. Debt Issuance

During the first quarter of fiscal 2016, we entered into a credit agreement with The Bank of Tokyo-Mitsubishi UFJ, Ltd., as administrative agent, and Bank of America, N.A., as syndication agent, (the “Credit Agreement”). Pursuant to the Credit Agreement, the lenders provided us with senior unsecured lending facilities of up to $1,500,000, consisting of a $1,000,000 unsecured term loan and a $500,000 unsecured revolving line of credit. Interest on borrowings under the Credit Agreement is based on LIBOR plus a spread which can range from 1.125% to 2.000%. This spread, as well as a commitment fee on the unused portion of the facility, are based on our leverage ratio, as defined in the Credit Agreement. The initial interest rate under the Credit Agreement is LIBOR plus 2.000%. Initial borrowings under the Credit Agreement were $1,000,000 under the unsecured term loan and $200,000 under the unsecured revolving line of credit. The term loan and revolving credit facilities will mature no later than June 16, 2020.

Upon certain significant asset dispositions, we agreed to use proceeds from such dispositions to effect prepayment of outstanding loan balances under the Credit Agreement. On August 28, 2015, we completed the sale of Patterson Medical, as described further in Note 3 to the Condensed Consolidated Financial Statements. As a result of this sale, $670,000 was repaid on the original outstanding $1,000,000 unsecured term loan. We recorded $5,153 of accelerated debt issuance cost amortization within interest expense concurrent with this early repayment of debt. Additionally, a $4,125 principal payment was made during the three months ended October 31, 2015. As of October 31, 2015, $325,875 was outstanding under the unsecured term loan.

We are subject to various financial covenants under the Credit Agreement including the maintenance of leverage and interest coverage ratios. In the event of our default, any outstanding obligations may become due and payable immediately. We met the covenants under the Credit Agreement as of October 31, 2015.

On June 16, 2015, our previous $300,000 credit facility, which was due to expire in December 2016, was terminated and replaced by the revolving line of credit under the Credit Agreement. As of October 31, 2015, $80,000 was outstanding under our current revolving line of credit. There were no outstanding borrowings under our current or previous revolving lines of credit at April 25, 2015.

XML 52 R13.htm IDEA: XBRL DOCUMENT v3.3.1.900
Segment Reporting
6 Months Ended
Oct. 31, 2015
Segment Reporting [Abstract]  
Segment Reporting

Note 9. Segment Reporting

Through fiscal 2015, Patterson was comprised of three reportable segments: dental supply, veterinary supply and rehabilitation supply. This fiscal year, we reorganized our reportable segments as a result of our acquisition of Animal Health International, Inc. and our divestiture of our wholly-owned subsidiary Patterson Medical Holdings, Inc., the entity through which we operated the rehabilitation supply business. We now present three different reportable segments: Dental, Animal Health and Corporate. Prior period segment results have been restated to conform to this revised current period presentation.

Our Dental and Animal Health reportable business segments are strategic business units that offer similar products and services to different customer bases. Dental provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout North America. Animal Health, formerly our Patterson Veterinary reportable segment, is a leading, full-line distributor in North America and the U.K. of animal health products, services and technologies to both the production-animal and companion-pet markets. Our Corporate segment, which was previously included in our dental supply reporting segment through the end of fiscal 2015, is comprised of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources and facilities. In addition, customer financing and other miscellaneous sales are reported within Corporate results. Corporate assets consist primarily of cash and cash equivalents, accounts receivable, property and equipment and long-term receivables. We evaluate segment performance based on operating income. The costs to operate the distribution centers are allocated to the operating units based on the through-put of the unit.

The following table presents information about Patterson’s reportable segments:

 

     Three Months Ended      Six Months Ended  
     October 31,      October 25,      October 31,      October 25,  
     2015      2014      2015      2014  

Net sales

           

Corporate

   $ 13,435       $ 9,110       $ 23,891       $ 18,892   

Dental

     601,322         592,636         1,176,439         1,135,510   

Animal Health

     774,453         376,474         1,331,750         762,774   
  

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated net sales

   $ 1,389,210       $ 978,220       $ 2,532,080       $ 1,917,176   
  

 

 

    

 

 

    

 

 

    

 

 

 

Operating income (loss) from continuing operations

           

Corporate

   $ (15,808    $ (15,623    $ (33,855    $ (26,163

Dental

     74,094         73,427         141,346         135,976   

Animal Health

     25,177         14,336         38,149         28,323   
  

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated operating income from continuing operations

   $ 83,463       $ 72,140       $ 145,640       $ 138,136   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

     October 31,
2015
     April 25,
2015
 

Total assets

     

Corporate

   $ 469,101       $ 539,863   

Dental

     900,668         1,022,257   

Animal Health

     2,082,069         631,445   
  

 

 

    

 

 

 

Total assets, excluding assets held for sale

     3,451,838         2,193,565   

Assets held for sale

     —           754,141   
  

 

 

    

 

 

 

Total assets

   $ 3,451,838       $ 2,947,706   
  

 

 

    

 

 

 

The following table presents sales information by product for all of Patterson’s reportable segments:

 

     Three Months Ended      Six Months Ended  
     October 31,      October 25,      October 31,      October 25,  
     2015      2014      2015      2014  

Net sales

           

Consumables

   $ 1,087,489       $ 686,165       $ 1,982,796       $ 1,381,804   

Equipment and software

     207,809         204,409         361,292         360,803   

Other

     93,912         87,646         187,992         174,569   
  

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated net sales

   $ 1,389,210       $ 978,220       $ 2,532,080       $ 1,917,176   
  

 

 

    

 

 

    

 

 

    

 

 

 
XML 53 R14.htm IDEA: XBRL DOCUMENT v3.3.1.900
Accumulated Other Comprehensive Loss
6 Months Ended
Oct. 31, 2015
Equity [Abstract]  
Accumulated Other Comprehensive Loss

Note 10. Accumulated Other Comprehensive Loss

The following table summarizes accumulated other comprehensive loss (AOCL) at October 31, 2015 and April 25, 2015 and the activity for fiscal 2016:

 

     Cash Flow
Hedges
     Currency
Translation
Adjustment
     Total  

AOCL at April 25, 2015

   $ (18,668    $ (41,678    $ (60,346

Other comprehensive loss before reclassifications

     —           (15,417      (15,417

Amounts reclassified from AOCL

     1,054         11,083         12,137   
  

 

 

    

 

 

    

 

 

 

AOCL at October 31, 2015

   $ (17,614    $ (46,012    $ (63,626
  

 

 

    

 

 

    

 

 

 

 

The amounts reclassified from AOCL during fiscal 2016 represent gains and losses on cash flow hedges, net of taxes of $350, and amounts reclassified related to the divestiture of Patterson Medical of $11,083. The net impact to the condensed consolidated statements of income was an increase to interest expense of $1,405.

XML 54 R16.htm IDEA: XBRL DOCUMENT v3.3.1.900
Income Taxes
6 Months Ended
Oct. 31, 2015
Income Tax Disclosure [Abstract]  
Income Taxes

Note 12. Income Taxes

The effective income tax rate for the three months ended October 31, 2015 was 36.7% compared to 35.0% for the three months ended October 25, 2014, and for the six months ended October 31, 2015 was 46.7% compared to 34.8% for the six months ended October 25, 2014. The increases in the rates for both periods were primarily due to the current year impact of cash repatriation and the impact of transaction-related costs incurred related to the acquisition of Animal Health International, Inc.

In the first quarter of fiscal 2016, we approved a one-time repatriation of approximately $200,000 of foreign earnings. This one-time repatriation reduced the overall cost of funding the acquisition of Animal Health International, Inc. In addition, certain foreign cash at Patterson Medical was required to be repatriated as part of the sale transaction. The continuing operations tax impact of $12,300 from the repatriation was recorded during the first six months of fiscal 2016. We have previously asserted that our foreign earnings are permanently reinvested. Except for the repatriations described above, there is no change in our on-going assertion.

XML 55 R34.htm IDEA: XBRL DOCUMENT v3.3.1.900
Discontinued Operations - Summary of Assets and Liabilities Held For Sale (Detail)
$ in Thousands
Apr. 25, 2015
USD ($)
Assets held for sale  
Receivables, net of allowance for doubtful accounts $ 57,876
Inventory 48,265
Prepaid expenses and other current assets 12,206
Property and equipment, net 22,672
Goodwill 537,175
Identifiable intangibles, net 74,804
Other long-term assets 1,143
Total assets held for sale 754,141
Liabilities held for sale  
Accounts payable 26,341
Accrued liabilities and other current liabilities 12,975
Long-term liabilities 49,414
Total liabilities held for sale $ 88,730
XML 56 R51.htm IDEA: XBRL DOCUMENT v3.3.1.900
Income Taxes - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Oct. 31, 2015
Aug. 01, 2015
Oct. 25, 2014
Oct. 31, 2015
Oct. 25, 2014
Income Tax Disclosure [Abstract]          
Effective income tax rate 36.70%   35.00% 46.70% 34.80%
Repatriation of foreign earnings   $ 200,000      
Tax impact of repatriation of foreign earnings       $ 12,300  
XML 57 R21.htm IDEA: XBRL DOCUMENT v3.3.1.900
Discontinued Operations (Tables)
6 Months Ended
Oct. 31, 2015
Discontinued Operations and Disposal Groups [Abstract]  
Summary of Assets and Liabilities Held For Sale and Results of Operations Under Discontinued Operation Activities

The following summarizes the assets and liabilities of Patterson Medical as of April 25, 2015:

 

     April 25,  
     2015  

Assets held for sale

  

Receivables, net of allowance for doubtful accounts

   $ 57,876   

Inventory

     48,265   

Prepaid expenses and other current assets

     12,206   

Property and equipment, net

     22,672   

Goodwill

     537,175   

Identifiable intangibles, net

     74,804   

Other long-term assets

     1,143   
  

 

 

 

Total assets held for sale

   $ 754,141   
  

 

 

 

Liabilities held for sale

  

Accounts payable

   $ 26,341   

Accrued liabilities and other current liabilities

     12,975   

Long-term liabilities

     49,414   
  

 

 

 

Total liabilities held for sale

   $ 88,730   
  

 

 

 

The following summarizes the results of operations of our discontinued Patterson Medical operations for the periods presented:

 

     Three Months Ended      Six Months Ended  
     October 31,
2015 (a)
     October 25,
2014
     October 31,
2015
     October 25,
2014
 

Net sales

   $ 37,693       $ 125,105       $ 168,504       $ 245,678   

Cost of sales

     24,486         78,570         107,359         153,535   

Operating expenses

     22,915         27,454         54,954         54,304   

Gain on sale

     (25,520      —           (25,520      —     

Other expense (income)

     60         17         150         (115
  

 

 

    

 

 

    

 

 

    

 

 

 

Income before taxes

     15,752         19,064         31,561         37,954   

Income taxes

     22,894         7,151         29,311         14,077   
  

 

 

    

 

 

    

 

 

    

 

 

 

Net income from discontinued operations

   $ (7,142    $ 11,913       $ 2,250       $ 23,877   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(a)  Includes activity up until the sale date of August 28, 2015.
XML 58 R26.htm IDEA: XBRL DOCUMENT v3.3.1.900
Accumulated Other Comprehensive Loss (Tables)
6 Months Ended
Oct. 31, 2015
Equity [Abstract]  
Summary of Accumulated Other Comprehensive Loss

The following table summarizes accumulated other comprehensive loss (AOCL) at October 31, 2015 and April 25, 2015 and the activity for fiscal 2016:

 

     Cash Flow
Hedges
     Currency
Translation
Adjustment
     Total  

AOCL at April 25, 2015

   $ (18,668    $ (41,678    $ (60,346

Other comprehensive loss before reclassifications

     —           (15,417      (15,417

Amounts reclassified from AOCL

     1,054         11,083         12,137   
  

 

 

    

 

 

    

 

 

 

AOCL at October 31, 2015

   $ (17,614    $ (46,012    $ (63,626
  

 

 

    

 

 

    

 

 

 
ZIP 59 0001193125-15-399973-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-15-399973-xbrl.zip M4$L#!!0````(`%MSBD?1S.#HLLD``+YK"0`1`!P`<&1C;RTR,#$U,3`S,2YX M;6Q55`D``_[1:5;^T6E6=7@+``$$)0X```0Y`0``[%W;7[ZP]/#>/`]3K-D.OGYC)SCLT$\&4Y'R>3NY[-YAJ)L MF"1G@VP634;1>#J)?SY[CK.S/WSXUW_YZ=\0&EQ?#_SI9!*/Q_'SX"_#>!RG MT2P>?)S8)X8Q7!S.'^+)[+\&WZ(L'@VFD\%?W.M/`WI.!H/[V>SQ\N+BQX\? MYVDZ6GW-^7#Z<#%`:/43?UJ\W>5@(,\I/>=KEZZG\\GH`_AO\)-V.!X`DVN#Z_/E\# M]N^#+]-)!G<_/$:3YX$S'@^N[5/9X#K.XO1[/#I??NG3MW0\`)E.LI_/UN#9 MC\^GZ=T%_`2[2);2.5O<>6FOCM^X?YQ,_F;%]W*__:!P_P^6WTV,,1?YU=6M M23;EE*BW7F9QQ\MW9TG5-\.MY.(OOWSZ,KR/'R)41@"6SHNW/XZ&T\*+/4:S&5C&%*S5 M:B6)L]QP[`\1_/HK6;/:85D.V5^QKD.)K#,&\9^ES]3/+B_8Q5GILGJ8PB+<]M[Q:(>/X:7A? M_9"]4B&G290,L^HG\DL5F)+)]SB;53^SN%:!*$N&6P27#"M^8Q+?P>`?;35Z MY+QI=9/N*NX]M!/K`O[;?^?)8E#X]C._SRSZ)T:!'5#3X70R M2R;S>/3YT*9I=N[^>V+?S88QUSXP*I"^<&P*_=T/(V0="C1(8 MXY\N6L%9%-G:!2\?QK,>Y1`PHBAU'20Y"1`/98"D!)S]D%1+GD!Z$X@)95.)W=?X_3! MC[_-?H7)[%3!4F'!6IT6U5KY^D6(FU9]LBJE&$8PIY*0`LJM"+8.SQ.$IBTT MQ@1\OF5@%M&$";Q+_"F!Z/;C!**]N^3;.':R+)YE((_YPSRW;^=AFLZ2?RQB M[OY`A\QW?:PI\EU!$7<#!VDC)`I\7QJ7^(SZVH(&S(095ARB^R,K2@;R@(?I MY,ML.OS;GZ+Q/#X]93-KQY@5-5U^[=(H'8T2"S4:7T4)R,6+'I-9-%Y[Z`1A MPH1+"::R.%IW(BDB_SR[C].U87#2;EB>?="$ZZ)!;T>PU4%]OMTC+CEIB:BS M#]QPPK=YM89(-^:PE5_(A6U+`6E\'T\R\"(?;0X:?YIFV:_Q[//MU^CI],3$ MP!4BB1F7Y9EM'UQ%H5S'LRB9Q*,@2B<@T'7GZ<>WR3`Y07-A##RC9)#[ZH(@ M=F,I8L_]R/UT/(K3+/C[/)D]GR!6B-G@ISFAQ8E@\]U+F1D$<[:"E^:ENS!* MTKZG.4<*3EP7(VJ80AQ3!QG,`&#@!;[Q(.H6\!OPY1\4E^548\OK;W6%SF3T M+K0)KI\:KA26VUQ=)9(B;@AXXC3.9M=@V7Z<)M_![7V/U[_C*`K'RO.8QR"K MYIX#,H!0SJ&$(*FE:]-OH0*^2+*YS;%%4>/[@"J;P23^?.NE\:@[9_7QUW`# M+W5=3KFM6C$L$0]<@ESN,J2X2S&CTOB.NF$W$-\4-/WZLNU,[*>;B(&;AKB= M;#7U)C#;D=EIEIY`7EHKAEN1UT;L8VO-V57T'$&B=+(V0R##A3<`'UD.<2I> M_Y!:Y'&EL8=1P/Q()>/D@'IDFZ*[2J?PO[/GJW$TF<%<9>>G1SM''R6_J"]' MF'(HE8HV%6,-W!N3=*$J`>%W\+3\A3].IZ,?R7A\@N./YE,SIAN3\TXP1?C; MY16?H-LQ8!V8DU*QY2T,1;2_3F=Q=AT/8PA;0$C]8@R-#U_@&"1]QT7<5P8Y M1CI(&>YA/_`,\XU5K9U=N"K.+ILO7IHW8+5>@CG!&.E*:?JU1M/QO8[)K-I^GS*$0S,*%Q3V7A!M0RR5,>/LGNP M'?L?ZYZ_1V,KT9=,T7[C>)K-T]-,A&'(&RRD*=;XZT*JO=8#4L[Z'"`U5W:L MPZ.$"5-W92?'< M/#T'<_6&CJV`8\5+<<_;*(J(?YO$46J+Y5\^7WVYC])37.]FD+4II5BQS+_Y MYE4QZ^^CAJ;LXK=F>=A>CF\/+Y]]G(SBV^TV<\Q\M>8XL&OD2I8VM.P+JTY$ MX64AWI.<3/-QQ%G3N;02 M:'DA=96X6%][L@[%[NS3DLJB*"I?_N#RZO;$[B1MA-A-CUK)0RNMVV%7S5.G M9R)$5"]25EG]XK/WDFY!U&2(+A58MD(XH$8>/T;)"$P@]QO'JJ'5MWP;35** M&UO^6X#+9>'\SN#I,9YD\;$E5'-`0"8F(/8@I>+P3B0'AZ4G:2P:8G+!26E% MJ@&ZBAU\1TS,ZSI'NZBM#"G6+"I?OK'_6,6E)UZ@$+:^J4CSHQ*;.,OIR;+R M=Y)K1@"?8\TI+>4>K^_A=/T2]2O5B$F9`Y`Q6ZH$)>!0$81#O_R,!@XPQX3 MBQH;)88)N:;772C:7&R\(01+B,.?""%":]G,G0<\8,(/(#C6&G'0(W(E1,B, M4_#G7&HO@/AOF?YL77;L4(.MH*RE49BT\H*18$8O\]]CZE1+8H^[=JC3?.\A MD9B7INACZ+8YVGJCU>J6VCF)<'[T\4HUEX)WJMM\]8PPP[DYMFX/0%M+MR]H M,:54J*;*[>7XAY6*XEI:;X:9%HVDPAVF7>8:I(3O@U04A1A,,^0RSGPLM1MX MKR4K!$-+%A=(#CH0TKN8!..Z4S'EQH,XD:I%,76\[\`*R!A,04!84-%M88RV MN@^AY9)@SY)@59*H62+L_ES&FC#`^RK5J3!8R^0RE(-@ M_8G8U,O0#L_2V09F5C(,XXT>)GO@+$K(G6?P;)9!]/2ER>MX.+V;)/^( M1Q]'(.'D-HG6FDN`Y.%G[/KNFD5FV?QAU0S7TC)$)'6J5/(M]Q`8!30T'B":T%#[Z6NSQEG)0GW*J<^5+1_]<#6]N$VU/-4)C;%6#.QT@8AD=+3J% M=*>9-X6VT-:B">CE:_#^ZW31S,EYL#OD]I:L9F0AV45FD@>:-219%6BZ1CA" MT0`YA"C$/6ULH,F1XT.DZ7K8\XW_FIJ\!IH[("UPC^+D,@!ISI[7&E4MMJA_ MGL_R!LP0A^X+GT`$7%CIS/)OW(44K"[T0DH0-SY#8),*:B3O MOY*W`X20SQB^[#Q0#T7CS0W>=)(EHZ8[G%1NY(V24M?U70TIAO`@Y>+8]9%# M,44@)4=C$7B0Q2QBKOR4XD:;Q*80BX+ZFCQ`4@M?E!R:F#*"MZR`>TZ-W?4! M6+Q`8:!@%(0.A03=N.!0,)?&^*[0Y&6%@1!NPL/SJVUKGMP*A7A-<*4*K_&M!:N MH08IPSA,AJZ`<6Q\Y)DP"`&U]B5?1(NVB"+V\^`O]82UGJA7<3J$.3*ZB]TX M2NW.EN0IG_E>JE2MB^,1--&>'.S.CG,LB*KN^;H;7^GT=3Q)INGJ&_+=[GW9 M0X7MUQ<#+9C#&VBZ+RKRK;Y[-V#"J-#POX@&VD7<#5WDZ$`CS#V7P%2F!,?+ MM2R[D5]S73J"?FIE1(W)>AD1;I*:[5]FJ1HC4GNA<%P"PF$@*T>ZR-4A111[ MKA1@(2SP7P]_M%E6/*@IV5:)*$PADR#,8-YP:<M=]>SB0V.)'BY!QD$KS)7("UW(2X6$%!TFEF$MM9E MF"DNE_8@G7)KV<6.[Z_14YQ5_+J-'Q9;_,?CZ0]+,>1\CY*Q?86OT^MX-!_& MC=?#&HJ],C;P<>!)[2#'V)V6KK2M:7T/86T%G=$MPN_.S`^A M,3B*:=MC56#;A'5FVUM)$KH=0*7^B^]#&WD9F1)J>O0T)4%UIZ.U`=P.8T![ M*L*"!F&H(8_U*46+ M.]>ZJ+P+#>0T&H33[C2P33PM';MJ3VCUDP%[@)!H5NJC^[;'S664Y81&A0/! M-D,8%H["VW82PUGN-WR;*LQR[]YPU?P8N5+Q%&FK`FAE%*]^I])+J3F/'=5;$4PY3GD$R=$.[Y<`@0YE`)F28*NTRY>K7"5,;S;JK['3J MHK:2`+R+@0`3!>>D=/"U%_%TIY%WY(>,/4UJ2(FPKWUA'&&9K:]E-;5:.VIY M[?50(F-+M]YECR62LW`K<)QB*X%6/RSU"IR7E^N M2P2PO=)P]P#3CEE)-ZA9:M)PKPGC="':(KR`W'>K'MNF&.\!D[;[?K06FFSS M.IN33;9RPJ>K*GKV05?.'^5W[YM`_0#LM7JD+X[K,,%9;:Z`7@C4N]>Y)5`W MI`U8;-#+)5OW/MK][)S3@!P"L10.^W!TH=)G1YB@\ MX#VH4UJV#KN.I+=%64?F`3\D+#&^/;,HD*-#%W$I#-+:P\CX@>>&+M9"N2_- M#31KJ_G+(=NIZZ)MWKJD-@UX.]S$/>3L=@7$4%YNE5:#;K@+:MP>`-.\WSE6 MIFRP1Z3&[1ZVI<95=-'ZXCC4N(>YHMT-EY:[]H46Q7-2G7+C=J\XRXTKP?F6 M^.0+;UWM>EXQNV"\L6VGNBIJ>(`RC8:S[',*)G"71@]]UC!JJM,2KU+#=36' M_'[HNCK.O%T,+1WWS7L4ROV/,Q^Z*:<'1VR9K`EDO&]UM2X,XI:)DGN`:%L0 M"%6RX/V)DCOK4MM+>$ALA,%/DARW^ZH=@)><2L+K5NTJR'$[ZK'9B_)IW=Q@ M1PO-=IE=N]>[G;RP(JHV*7('S*X]),"-F%V[YBOM7KMY7\]R&[D3Y"OMH8I[ M]L$(+D@-[_YFG-(*[V;W<*V],\Y+)'(U>#>;[7;I(401U26LJ@TIK36Y[F7F M83D/:".2R`[H#;O7I+0S+2G5&>N'E)U9@'"K]3HS)5??2%9>X6\ MW/>V."IQ%:?>/)M-'_;O;'!0*9RZ,@Q=AD(J->(J),B8($"!T:&/J6^4Z[R< MOQ-X39][`.J*.Z][,[8%&:7)IA7WS9UW"-1:3&O6H->#@QZYN!;8^N/.6YUE M[)>#JT64=;GS\D$+3HM@UAX^95H0<6[D]D.>1!;T77M'$-=!MER<*7B72?N,NAWO4@1&, MM`?Y'C<0/;N^ZR)'&(X][A#JX@63$8@H[ZM8K#@V/V#0RRZS_M@&V7*60T25 M2]*GS#:X*:9NV0;9TK?8=MN$MB>FCM=Q6N'8JUM@H6VNZ[1<6>I9$*Q"$#4K M3=WO_6J%2JZN+%B[>\$Z7?CJ63!M+81U-U3ZD`+;E,*.D9*'.:O)^;?)*$Z= MNS2.FQS=?4$,D+&T_3.I(55,$M!$*%8C5BL*J[W M`Q,H%7I(.3;U@7_;D%XA<$3@DQ@E+GZE"UP[.'PZ'``;XEBTP,]I)B'=7YY/ M7T\,ZW`"Z""PN9^/',?'8"%,(Q?[D"$*[7@T4!@2Q'5.``B&V^$$L,_.:CW; MCO'LE%;]455?9KB20&!?Z+VMWO=*6;J0#E>F,65I)_.UE#(O*1@AFN%W&39. MZ+N(>-KU.CKI'@K15-$8:3JVK MEB9O;&O[0\KZ0Y?R!#_/$W_ME@1 ML^/GV_UH7-;%T@GI3]V%L@4+$A'%*'\GTO*6WBG%M9/TZ?_@6IY]OU_9Z[2F!30Y0^UTWRR_;%>K58P&U`-ER MC%2\\=:N,'[R/1G%DU$&27&^F=^/A^-HK^UWMG"VBRWO!D;G33U&7`^20/G_ M[%U;<]O&DGX_5?D/*,5))54$@_O%WIPJ7$]TUK9\;*6RNR\IB!B*V(``%P`E M\_SZ[9X!"!`$*9`B*,&S; MD@5#TWWW3X7F71.&2G?6F(VH6F%GI,!]P*P&R%01O*4J26VL$)O*. M*:#Z4.,@>YP_1:"`:;0+#?7'U#YMK2XW_2R==DK6Y;4G4-4.\FA$27L21I'V M91-T@!>&DM(\8MT3:,M6@Y?"*)[C)NH+UL:B-&6N&F#C0--X=SPO:(-7XRK- M2<60NVXA-])NG58='*6:MF^JGL)K#EHFCNWPMF4ZO`[R45!!CEB:^J?"ZI*W M_`8.`7.55/1:&^4@<#8DQ!6TWJLQ.B5A[(\9C@BBR="X#G M\-C682P)K]0\>0!*M`^GU\D`*M*W'<'C'=?0>$56--[4#847=<6155O5%=]A MC"(,5XZE^^/8)G:ZG@=6*F!\!]5=21>.;P:@N6D*ZI MRKYJZT`\]6P4&+5S#'%'CMJDMMH"^E!"]I@4P#H*0T%M")LN$(\R9YZ1A#$? M:=!LEC4;U%CSA:8V.S?5+*-JUELAV3MBVKY8RK?.FT%H2M^AH&Q>+B6,M063 MT8NO9?Y).B2K*++H!NP[6ABS6FTD_,3VS5:6!\0RJ8?/WB>H#AT>H)R.,QMOCCZXCD.2PKFR1D'!6X_NK7 MT3`F2RI43>:7E7/PKDVKE#VYMV=Y_A`U"C[THR*0L9:\EI-X%HA1F7 M1TO7:7GR?8`B%2=D![@:&5G95D=]&H"E%I.*E5Y_6GQ:RKKF_: M,*F>!4TK&`%@NAIL:!W!$DQ--&U-*,\[9)CE50^!A[&T?$.Z+"X\;&^89/0] M-#LZ'K7).,WJ??-IF<-V7=GT'%[6;8571$_G+=LV>=>7!-NV!1G6!Q`*LTCH MIKIZ-'1@W"V!L;K$WN^4_>ET4H)%J(GRZGE0Q^!WW:&>(UBT#@RAK1(>QK(K M]A9CX'%CD05I!@9ZD"TN"S*E^1\P#6`:QY3,S'7O'(EFT"+=9JMJRA&)\&!Q MRQQTMI]FTZ#O()P)VK_Y95(F9T31")I^?3Q/8*-P92N6-;.Y]N19.NUTKJI2S)RC94S]Z56M5;MQ=VQKMS[G M;??B)8XH*$*KJ,?*N%M^5ICX%)3K>"?WF=,),XP+,$VAE4>D'G1_@0[F`XEN M$Y9_;;2XSH(D#T8XUV`8T$\QG?G:(^VLI;P.4EY"_\?>8GY_`G3+?FCO,YF5 M.<2NQGL5>CJA*E"Q3*(JFYVJ8#.6'0X5KI('MM9/PE`]):;>95H=!F[_K<]3 M:)2>.Q74*+C0J MZ8[I.4?A0*N"Z9*P"GD75!N.R4IJG:6Q@&GF):Y!)^?'P^6-(3I-EHI:1\'M(<2!#E?K9>U#?DV M)7&.NA`]6Q2ACR[<%_7>>RXGS7'CBLG6\B]I?&"GA\.0CU;VE=56#H5'@&Q? M5^=`[JC3%EWG5*,_1&Q:+V8SY'N4I+MH%,6&7J_IC6:'$'YF*:@*'H MIO.;8CR/JQI+YXA>QRNF=I+SS1#6@]7;BH==6:\HGNZ3VW.D!M8N5U1S/8)] M;Y1]HOL_D2Q*P_9YWCG2AQ:7-4U-62-07U1[Z\>V^7J.^E%B+AUKU_;[8GQX MM76X@#V?U895!R314(4'EUMOF.W*Y=6!%XBR_3I?)H6[XHJ!(>[+3YM.1]3P(#VAQG*52@[/Y.4=; MA::M%M4-F1YV1=@^2ZQXL7&E4*=`VM_O!I,:J+)(TZO*HJXV\R;*^R:05"7? M@SVRP)N:`/MC"9.Y:8K&Z[XJ2+8A>YY%C$IMHY@'_2]/)#+U8G!HC0Q#'-5 MFFSUP3K.Q.Y?Y:(75@FQHNN]`>-ZZGD]!58:#"OI+<>ATT_L(RI<]`(K(UB\ M,Y%5L^TQ=O*9/0E8/)P%M'0'U7=J#XC4U!140ZJD*WN6:3$Q5;$@\;8E^+PB M.QYO68J`^;]U0Y1TP3&<6C;)AF@(.S#QX9'JLK)G)LU>2*O5*NJ*VKKR.BU0 MR8`Y/2+0BGEEL#X$N3_0`_D;',2$LBS7]67'XG4/MC**K8#-Z6L:;TBVKLFJ M).BVMN1=L^WEV^%_$)+HK9N.:*K4Z\5L)W3F2C6WUD@%6=,-S4(!@IF]L%0*9:G::IG\X:JPAY)$EP>MI@:KYJBI$B2+/NRP%!]DI0/#UQ]]A]_ M/5?768"[A2^+Z4UZ.%BJ(?B.+XF\8KHR5H_1>0-8C8?=C>A+IN_`_@4+8=(L M8X#-=:[8C*T,IR4?1A,2SO%"IS;2Z[2\^67RI0@*PI*TE8=,0?PI91Y`R]"T M:X!GQSMZQ&W%*CJZ(HN>P'N>`4M(\064%0KOJ8XANZ:OB7Z9=NS'N'@71G<_ MWA;O`!E^FG%YL8C)KQ7$ M^@O?^G#Y_K_?Q^NW MG/+#1=GQ]81PXS2.:;DG;@9+F#H!%?@UD(F[HYF*TS$75=%"6940/@M&10Y- M1`E+:P1_T/?@MQ!E`+W\SM,X"C$!(W<3Q#`-A,LGA!3Y6T3\RVP?^!1.$R`\ M4<'Y,9C.WGW_U1+>K;5/`]6K/AKM&0]3T[[Z['J?>>?J_7OKTQ=X9P04"V8Y MN>!&)(YSS(2=W/YZ(;#/LR`,J\_W45A,?KTP@.)<$$>WR:\7F$6=9!?<39J% M),.GFJ/,FA_"ZGU%8C-&417AZC-W9<,W:5&DTV6?ZI97RD=D[:#-'NK[)^OZ MEU7R9_NPR\56*+3?529]`'SKC<>\>^3><%G`6DAH&HY59F^\=X-_7XV*](9D M=?NR.*!=W/3EB;.%9LVR**Y;E]0#`SL^CW))>I\%LU\OV/_-AV>/$J"52/^> M913EQ%G!407QCOOCTKW^[2VG2D-1;8CSBJBUEN<*L-]:%)VMD.>(7/!TA%&T MH=A!%R<.\CP:1R-J\YV*+"74AP9_L>,J6J)"`^NLI,'S`]Q#2CQL1X*-<@L( M4C!2OG<\]'VQ4D4Q;5BL/7U7=7':;HR<5!Z=%3*]K MZ@$F:3*BH4(%%]!4YR>'_J:7R"P_9IA0C+YFR.J^LO9`9M"ID(H#23TRUL,L M\]=%?7Z+.JZKUYT<_XY6T;>PQ!\+^>1K_1=ZGM'\HCQ-:AP\'_:0K#XG])(B M*A8.P?498P6.K_])=JB-?L#S0NGB[_B?88H")O?<.+CU\VAV/NHEH;M3@B20.?EIF<_^C23K`BBI#Q/9I5AZI*ZAS\%ECS3\0U?Y75XA%'7$VM+5O(8XU,VW(\?95P:T=%DCK@ ML#[(@+LG'"O-5AT^9X1P!?0%O$H+>.3#O](Q]T84 MA0%NWYP@`;X(DF%W;PKM31E@*VM-59^1M%76F9FV*\"0FAB?*EE4<5 M66L,`D_D,S(%?L43^4XTW9UJW9UR:1,&%T7A, MT'1#1ID`_>O[$]9$XSX%7P\)5E:-$GHUDK-Y"N#=$&_S`!'*\B"?<.,XO8=! M!?$BCW(.X]EO`7!ZDY/LCEYI1,EL#KSQ4S2$CF)R1Y`4Q)YBKJM@/I0R]X&$%C?X/'51A*N`1 M_':.A4!CI!&\S1Y),Q`M8/S0`RI,V,JR?N%:#9+EBWG]!+S9!0V>!Z7$TE]P M]^D<1HW$GP1WN%3R>5P*@(#Q0#4C0#B2-X6/S0><\(ZS9?!+-N!M2W!.2 MT`DD^;)[G*TH:0QSN&Z1KQE?QU)2[9B!*,V8R?"9C%8.`^NH`Y?DHRR:[>HY MOU7%.:ZAJZZL\*Y@6[SBFR)O2O"/;AFRJ^NBY>GZJ560?#")L(:G^"V#'VJ9]:D;<-N&K%^[EI30L=93*I;H;U;6!*AEY7R;D1_W$\D<0C^8Q[FMN:*$*%-PAFP5H@)3SQ(%QSUKA?BI5,=#9>>=]^E)_ M=-_]_,*NZDWI<5?UFO!ZI_[:];/W)'C\E9>V]-@+ ML#.'_R7Z>D3PSY[[7CU+^D`[N&_)^4![G;47M-J?GWO%^0-67AK@UQE^]1C: M=M7NDB2=1DE0I!D]^F5;XWJS6\\I7BXT2%7MO:N=-[3%]MZ4:L_I7MXT!JKT MXJ[F`;4A2"\0M6F(+PZU.1`T[;BHORV?*Y8?$\\9JX+EC=NZ9R?A-$UX:2RO MZLI+@ZR9\DN#K(M'AMQ'JLV^]M@FGH"8;>E86MGTAJ$VL;^6)G8'^7<5:4?M M\,@[D5?ZO=+OE7Y/2+^7MK$N;YI?V-;:'(C&R]M:FP-9/_)VZRQ1:R_/Z`;4 MNFZ^&J&[Z!09=$J8SF]B-1B3&+%E@=])A->/&5L;9SH=[4QPS:LB2 M;$T498/W%0W`2++.VY8E\9(EJH:GB;YIG3YWU,:H(5$<1*-!1/1^E46!I%Q0!B]` M&\%M1FA\)`N20===.TC^PB:NT[\6*?\A*O+Y391/(NYW_Y\#[GT1#C&"!=\- M84\4Y47&LI;`YB;!X),D7#9A34D6C8(!]W%HT;>X?)&$I>#JW]QW/P^Y3_,,)Z0HO<,YIT*S?($%>\0$`S9R;E9FU>;F94A3 M3A+T19\G]!X`?L`G65C'.!B5,U,VT'@D(YBL#AN*HP3CDKZK@DJ&=9AXFJ!G;D9= MJ7,6@-*`7`/FHIS%V$`C\,[[2Y"YW"P&P`&7SS(2A&60S`B&E&&,"C?.TBDG M#D5)_0%!2D,8W@\8-Q+AY+*7REBE.,;_`W3;GD;469X;$X(=L;`8ZI4]PX"B MI3]W3Z>--,?K27D(QII%"98FU]3JN0%I@_^UGIX;?Z7LX\X5YM:/KOD MD2:CWD,#FG$ M'K%L'Q@E-BLCM7,JPZBLHM[_P&_P_JPLN\$X.9\#=S??P0<)N_H#7BY#O)#, MC7@":(72N,S,M%AA]34&'W)_ M8&#:"*,&@-/5@:C*3(0%#=LC1.T9E=J3!B>NQ!U288R1;]5:)BRU*C)YG2:" M2FP*A019O.!6YA)[`.1A2.<<8^(&E`AOE`$(MD80:?4.XI\&(>'"6GNRJ-HI M\U5&G8%2M,M?D\XU)31TO?$!H+8LJ0-#5[&W%EFWBHTS69@PM2BQ0>__+ZX> MX,6[((M2$)[C)>.-TCL"?Q?K2Z8IL\N8S(K0&/);X&LCNC"66@!%7",^%=NN MM4..LIH%;]XM5W"&^B(`/A^P.,N5)9W>P):DK``R#1;<#:'%+<(YZPE8@85> M3J$'9>0I"IPPVVPBN`2W8R`7?L4#?,YG-JVXU@'R*=`39>$?G]HU< M+O=5!;,HPVM1PJ'8`B*B8/TZBS+4QF`AC\@4*%#9FO`,B_JE$H`IKUD%$JP4VJ;ZOXI:MNV\*$=6?40FY]T2':4JA0,;E%_6:$Z7O0ILUV:EN!&GNM M1D&2UM1<;3YO8`SH"EF+#M_`,NO;U0V;M%YU*B2 MJ?8JDM,!:I48/AJ-Y#UL4D+8S&/"E'']#9C:8`Y'(!!80#*MHPXS9>6?8#=U M-:[JJSOI]`:9FM;+)B&+D``_GLE2I5U_0C)?N!XT3[S^?B`45U[7,"HOD=NYRUYFP_U_9-U M_1K.\H#O_S^R-,_K,3AE:A+Z>\;]4@Z&)N]J'!"U"6,Q>K@?W M/AJ3UC,_8>:$_.?#DNM;=_SX/5DJF,8!I?P.M%ME1(!]!U;$>@:!HU]V/]5S M9SWFY^:Y+F]E/\R4`YN08/H$[D+[9H25!K"/[/7N-^0Y4HN#XR+_UN6M54G; M5WEZ'F/^MN2I,\\!*LFX9DZTY^>)*9GBP'QY0E94AT?&_/S%Z_G:$X^>?5$< M*"^0Z87GP?3GPN(N9@=-9_16;31)8!W>+N@M1$KST#\[KC<&^@MD>FEXY&CV M;\T-^]N))7JY5O+Y;LNN:6[Q^BAL[6[GV`:I(UX%ZZM@ M_3:/'_J(4:S_443CJ$S__M22=,]S7D56GN5![UFP[',2@-]2:-#SYZ<>X4S' M]79JI<8GM^B<]YE0Y__D]IC!0YZJ2;(@"[PBZB*FP7=YP_8LWG%=2QKOGM_ZOBAZTF6SF\GC5@A==!P5DD78*!L47Y5>H).6'6;*@"(_<:" M3JIQH)\"]??/2)K=!@G=<:";9=WSLM\R$*GA\XX/4H\R%@5`HY`2=$CD?B-! M7$Q8:`WC;/3$OTQ&P^]821SJ51QA39.(AE*4K=U/TCA>\.D]1J?D\YL\"B/$ MM:04O%XZ]G._I3'Z3N6LW;+D#(VZ^W_VKJVY;2-9OZ8N= M*U(D`P8848(&<7=.5/G43J25$YY`:&#BFPP]15%I4B' MS8=;#=;Q,BG1L*R2,\2*>>;4^%APOR9O,8D]UKSQ"28/%E=@,FR>=!CAFBB) MN!`!895$HVR88PLA[(\8$J@4\*U4(BEEY=BCC-"/.G M*#)!CE,A%Z861V&27="<1^6M]%BF<%"&V46!+I5$X_0*J""PKRP.OW'$=9H( M4MX(V^-AUCQ>>8G95:H_PH3(8MXT:Q3H1!($@^3/"_P!2E,4"\K_)%F/LE3Y M1)@?>2'@P3RK<0XH0PBJ1*I6&9]_5_;CIEPSK';SE8`3CA"-D@6!2GG<(RQ( M%(,,6[6(,`.JZDED[1*(%99X8B$6X4GAVDIK5IW%L[R&A#-8OPF:IBD(;DCF(P$R M"YY7Y6U4_N'G%3ZL4I6\%@6F51[OPR@70#`/`C_DF(6/Q4\R45CRBX^*FJ-J M'7(SAUZ@^C!/,HPK61`4M*O$4ZV>J>LHB_1U&@*4" MWN1X;K0P(*ZYHR&Q*-6#D+(HPS!/I`X@6"N`T63Q63EP;MS*)^8U4RAKZBQ+ M*W@TL00W;`LRTZ7QR/W0O&""U0("2KM3Y?AY[Y);?.KZ%#8R]_NQ8$&V^_#< M;_/EPL6U((%/=7)4PL[LY2T%BRHB:2U8$%/;VQ;*)E%@ENP MH%TGN`4+>M#+Z$\\E<3_FW+24DCLJ6HH3RV?7XG7K`TUFF8WK M(KXFL1[3]<:ER*Q)JV$RUVL<&M>Z4NP"L5N0HK[=`P3KFW@$AZ$QW.N"Q-HP*L)6$FS:S-^V^=BL:F\MN:)QEXKUW+0N\+8-I^=?RK^7?R_.O M^=MB^XX3O5JC]_#%#NG7/1AAINLQ8V].O3S'98:Q+]0:S#8-IKG[0J_./-W! M$X`V6'R([6]+!EL.MAQL.;@]'&S:,>/JU(T2\""O]U!>!U&2O)$X2%AN*\*, M`,KD=1!0/GOX^&+7M7-NY[P#>\0=R_IXK=O,U=QUP^@WC=@M()$=8^WW)PTA MTC29:Z^=P-,0(HT.TSN;6[LH;XS<_\2U4R7Z=;>9:D9+C/7C[CW\W1^=UX% MM_QK^=?RK[G\:]I6^`&)&]'B$?T6G2CBPNYQ_3.1AKWY=PP(I_8FS<&R M66=_J,50>=,;A%T+&G?I97#+P9:#+0>;SL$[^J+O=E-&I_.XIHR.]?"FC"MN M>:K/7^S1;]=]J#N+1:#<:&3V/+QI_CN8>X&/ MO1#.V$M=M]5S;MK!S8YE4UD=C^G:OO1:L4V/N9L^>&J^$=W)/!U/TUBGLW;> M8%-?:^I,,PQFV!M^=[];9KSAN1I,<^%O9^]>X7=@2V%9&^X(MVO'L;OS#K#E MWS:\0]W>FIMHH97%LB^G6AK?[;82TK1Z^Y5\; M(6WM^?B:9WJ-#7S6;ISC60YSM#;K:&_S%5H./JTA7S_CX]F`1B7Z;!UN='!= M(`93!.\'"#X^7'S\LD,S0%9:)QE>SS9%K/VCVRSHS-CTRC$VTBV!D+> MB'J@;3%O9^F4QXVS9I[)/'WOQ!N"T\X>=JL%LKW]LV6Z8S%[TS4_NY85M#NI MB2W_6OZU_&LN_YJ_+6ZQ2+BL[#K^B:=GXZ_^]\\\/O03,3R?^C&G M!N4PYA<^_NT5CX+^YV//-$P5_NBVKJG_TC3=[)]_/>KKKM?'+!]=,_6^]DK) M0B'O$DED&;K3__/\J`\/ZR;`WR$0_>BBUF6TH!GXV,_#F$9$AB1!NM>1%F8/@'O M;O)*-6\PR_8.3SS[V%([/5=3K=YA3SWL>CW5,0XUS=:L3K=C]PT8][WK>2#) M%;>>A,QYS@'+9Q%L"C[$439+8#ED=X;E*[%$;M=GV@)7S*/CWJ'=-57',2S5 M,DY.5.^X=Z1JEM6U3S3SY-@\[..-[U''(-\P??W2_71^[>P09,?PFBG1V=_G<.5"]5(E#OZ\?CK5[!8YJV!0QG?W M+D/:-BYV[LU$Z^?[\O`L5/Z1!=>5Z=>9@A++E"NN4,X@L%*$::3XH.%C`5H/ MBJCXDYAS>O6<1C!*PH,`Z\*P*BR=.H0_7Z M,1CA#SX20VR$%05X5\(4T,L#!B/%RM4T"H)K);H*82Y)-DC`(/CQM0+#SF!Y M!59ZC:,81L&K8S[U!R(0TB+`];,9W#S($A'R)%&^P>8B5/RD>GKQ;+C_=K>4CX+,$##*5ZZB^!OP``88^C-!==*C_V1)2M?-XNA2)$A9.O7AMHN9 M/TP3XCJ,"M?B:0=<)8;\`%87!NEF$[BY6F'#K2TQK,DLX'A2@B/0O?65J?$F M)]=E&NS8E2N13H&WPVE>+T@/S(F@HD(8S1]$EUP%FH:Q&/`1C)%3MH2N`Z4+ MI(]&`A<-OAGBPHYR#:9GPX@H::4TW9@CT1,-4E^@G/A*F%U@\]]*\-!E)3_^ M4`CI#$8B#P@L#*^+3P?9-=S$_YO!)&`Q=>WGXIO%46HR#@N!3@)^/%#^#`/Q MC4LUP#>8<_J#\Q4'KAUA?B>L^B[F:^M]AD`F(`J[>3X;-;$-32&E62+DR M@O`B%]X$!@R1+*`S3J4)O#ML'XN M":*3DN*3+$NXG8,'N*?OFW-/L(=8R\<;..R3^_C;MS"-\MW:!GSW:8@R%?(A MV4BRR*7954JSJY"R^'01F4B(T:/"M<,HN7.GJX1TF3R^!&N>U+P3#8[>%:O" M01DJ+\Q@B%D6)YE/P0`X:P$&YZ9J+3IV,$+2H0^NT?W?9B3`:H%S\:]1+;,$ M'T`.<`3FS`=S-Y$V%JW@5(X^Y#%Z@+D"]I0/IV$41!,P?G7K"3[<'V*H`#L* MI`,=:#B$H<%\4$Y=&G,?0G^TF?#;-(-UQJ@#&('L*?F$[BF;R5#(L)0+69/I MC]%L%'ZAV>(KR_"?6'Z[9/N6E>W5XI/`3Q(Q%B`H2\+%N@O!Q@-)%DB#6K/$ M(&BW&.D\J,&X%3X3T2@INB!0S)M[U3O,MXPG"@->$H%Q7M[M#T4G$#(F%;?$ M+A@*@#X"">,`]!G]V$+/M-43@OL'?H#""Q$2IZ?2@ZC'?RWTLR5K91Q:\'8H MM>3*3V@8'!M^16TG*R'#CCS*N&4/0#L`N'NE2QV+.$EO\:,?96MC!9 ML(7[;*^!'E"_?]-2+)Q)/C)K5R M.LX@`AH.\<5:8]+J;(>YVY"%U$P;L%IL3L-+L+%1?/W\BO_(2@;+9<9VMG-O MFNGX#'M07XP4_GV&IQ-R)Y6__\AB>M'R4F!XCZUV,9BQ#2UP=]%R?([Q$"2] M)FGA13DS^9[&R8EAL(ZSX5JP_;`E'Z)HA"]&&R<"MHFYSHWS)\VP%: M"SHN$F'JAQ-11JJ-$Q7'VM;^%TVS%E0FK@11.%%AGW_1V#"#Z=86M`=H0I7$ MW%'0,U7E/<4S]_<,Z?Y8("]\DK3FZ4(+=K2>*CU?A<23//3Y%?AEU'7UD>_' MVOO1]MRWJ2;Y#M2^_'@74Z^HU*#7'S3*_V M;?,B;H-Y[69],]+SL=R.-5E"+(]9^A9LTAL6U;6;LBVT]O?9@@5;$]FMZ?Y= MESGFAGMK[*#"[O0V[&&0>VTF[/(L>OPMPSJ+N5SZF_G/M5ORHKTBMQ[N+;/K MVQ39-D5VC139Q\(J=O2'I\A:+PY'M?OQ],.GMTJQ$WOM MOR$2X=9RJ7=*Z!_(YAM5"S6&EWP MVPI6M^;IC>FPCK?A')BM(58'T=>UO4&XZKC,WG2^V]90:U@VZSCN9JG=E8/I MU4:L%R54AO1"J)N/S0FWF.7N'2R*`[KN-*[#]:-?)VL.,^V]P_/2;9/99OL: M?2/6+^]A&4[*NJKFF4"#>7KCPIQ'4^TPRVY7M)M=F65@S?/)_1WB.$:(]SD1O5"$P]T-C751MF)5D"V2D"V M+Z9<2'W0RX<_E>&]D<-P1U%='G0JKV5[PS>-L\F=_=N%.GM'L;UWB_Q:7W]' MM=*-[&!NXTXE([=<;+G8:4,^#B*.797;^!!IFXSQ]X_K'>/ M:9V].](S=69W-EQ&NH54.YL_OMV^7?>S6L!FFC[#8*ZW=T;`8;J]=S;`\)BI M[QW5NL4T9\,G)^W>>KLC\9:++1=;+NX2%_=C;XUIWO+]C$09N@7LZMF#SC5S M9U]#V&6MODCZ!1UYFG[TNBN\&,YKVA69=6D[EM'/E@#[!C_2=:/K9\ M;/FX>WSY;4=Q>UWAA%T!'P<5KZ\>75[;K^D/+V M^QD!FLWB%$[#89"-L$'D,!67B-\*\\E@#Q*4&*PP$@+5$FQF-LF2M'J>X>:@ MM$^H<2T\>K/:7&T"'OUF\4S9DBJEEB;8SC01WPN\;HZM/?"^VP"I<9N-)+"M]@-ES"5.[$\> M!MU.:,71^,K/$7/[QASMH M74DI(;S%(T1^@X%HACGF&W*4L."6'S0$AI]&2WF$E]#0! M\E8/BQ$9*"[AMO'9>2;\L$"=KB0"J!!1+"=#Z.,XM[S_&DY,7EW2CDP#-@VS M``TI3@2##:/4ZRS`&X+A$8?CT%R8)43&L-/I23Y M,Q!RF!\\*K@&34QKN-2$2CT)Q=]<=H@E1;VK-R9?'3($JRF'\%_3\$ MD?KV'D96?AUQ\;8G&Q.?$)#W_W,_/@Y'1\@O'`@N_\+'O[WB4=#_?.R9AJG" M']W6-?5?FJ:;_?.O1WW=]?JX?KIFZGWPW&+TVRLQZCN:8YH=HV^[VDGOQ-!5 MRSLR5:NC.:K;[1ZIWG%//S&\DYYN:WV];VGPQWSU7E4U2S6U7W]9-3DY_8(9 MA[@P9^-NJ0"?HT`,K^5_2Y*?C"##UCU+=[NJ[M@=U7*ZAVI7LT]4TSJV3HZ/ M=;?3@3'@QO>X=OG2W&@G\F=A"PBUUGX2!Q$F4QQGW M]G^/F]L-EU2]Y2$UJD@6^B#G:`\1B!Y= M%/H.^)F.PR5P?*%;0`U\0#:0EAY5&.RIXH_^`]&4_!S\";@E/T;D>#`6N9%4 MQKZ(06OQ\=5PH&\BS2=9F8L>34[PA!$UPP/E=6[90()Z[\H+JP^/WKW)X=!O MM81,-@ZG]I'+NTOB]T,_F2KC(+JZT3GR'IX9!UC67(;:R1PHY]EP6N<4^J*8 M+*6?1QEHTT`[<55"/P7;91EDPPB%B[A>QR'^R MD(*1PMG/2TOM[CP(HOM@325]W3#,X+(O9/VE/SH!OH)RJ?^$80+IU_^1A;Q& MOE6/^Y]#=64SU5MTEV1DB4;>0Q]SEN1..`>RP26O-U1&/3OJ*2=92&Y8:AK$ MA!\_]A:4[*B'[)/7+2@:C+ED$.7T=/DXQ86HS*=S0S'E:@I;YVLEN@J!K"0; M)&(D0/#R-O\)G_DQ^LV`3X!8C+60"A@(1H2(Y@\!T6L2I;X2^%<'^9>^".C(8RSB)*6K,;J\P&XF2`ZH=3*^SJ0A#)'Q"FO9601!`5+YL-L,-U26'46"5X^O\ M(V)US*=2[_S%UQ"FXOHOG?HP#7.)'CRLB"5`=%2G+[:BK`GEWQW&^A&I&PS?.FX%HE\G^A ML%V5L8-%)>%+?``J>U%H-DX`3`2<]N=XN[2JY4[1?PD M+;:)H-AC]"3P8PJK1Q.X)%$I,$CRX6:UL/`^>X[[A=GSH?GY$.Q1%O"S\8-V M+'(#>EXXC$,_P&WU^93SM!N.NJ.1D&)2[6R2IX_S#R'*MUS354^ M>GAD'ZN&];>MHUEOU^@ M_X'(/042@'1%B<^F+:!GFX,T2>/T%/=30$DK>T\H4N7#COOK[\PL*5(/RY8L M.22U:9'8$KF[,SOOG9T!@>=OV(*FK(PNSQ4..%>PG*=51G?L_2NCF[)0]Q-* M+.RNF)J]-\:?-R4%33`^,(FCV6A^AB*VQR_<>ZZ78KI5:/EZ^N>:DH>ZN^7; M1S9A_,9;MF2GZ!H:3&CKB@.C,!TGL]3/SW9JDY-JVJICG[B,9W-EP&ZR>1/< M@(P-H[OG9_PG7AHR'+5MU:[P915IX$/$%AZ?%N?TFXU&A8M5.QK1VVJ[)27' MB:@&0UN)"/GA,?E"'+.![JD=G;3;JF6?N+C`>LM]OW8D8'9L59?] MB$]D9>"Y`9]Q"A?Q(/&"*[ZT5&M'*K:A.K+B[#'H0M0Y])?=JNMJ9JBZ<>+[ M9`V\=B0ON]9"LC^F<[57A4C2@=$%VS2`?4]<$.[Z[39:V=R;*?Z/[0[Z+JQ!!O MR=)*Q@<:,37$P"7_>D+X)3WNE[R][8HV?1DI/V2+H?SNE85N+Z_D[E-=J7%$ MOR>:-VXME!"^?`LOPY\]IC*"?!!31[Z#4$-,932URKI')J#FQF`?KBJ-P9O: MY.AW;-5RSZ6FL@ZDK[=.?/Q0'6@M1S5/G>]6&6C;AJE:MG-::)L2F-XMQ/I8 M;B.U#;PNEV[>O%//DYNV6K'=,\.;+.CFAUYC'X2 MZ;=9_[1^(K"MNH>WNJXK5[1MU3AU'\;J06T:I^\^64FH._(JQS'$W:]8$1,K M6GV39-(GDL%+<.C,]L%FSS.V/7J`#`\881,;Q8$F!G1.M=1:R0E)()4BD.K9 ME&NI#_K#%1WW%+P;.0P/7*K+C$[EI:BO_JIV,MDZ/R_TQ*W+*@AQ_5K3/5F3 MZ(=[5#O52`-S&QN5C"RQ*+$HL=@D+)Z'8_]FLS]/[6Q)W51M\\3U?2H(M:NV MK+,+Z75TU;1.?(VT@E#;IP_?5L_K?E8)6$_1UVZKCGMV0L!6=?/L9$#;53OZ MV4&M&VI+-GT_;TM<8E%B46*Q25@\#]\:T[RS_K>S*)S?UTSWV8W.`W-G7X+9 M91SL9C_C(>D38-1UU=7/)=&]K;;K=T)S**P=U9%VY-X:H&'U)R0>)1XE'IN' MQPK6E;%D!9-:53#16ZWO'UFSI.Q=E&ICY$:'SV;)4H]OO]VNZ_M<;W^<$*#5 MK"]!]$[%`I&3A-]@"UM8#W9D]:D`$*;SPDC8+IK:9J97:9P4\[6=^3_F15@O@_:(+TW.YVAF;>WH9?W7 MLI\R!MHW_B-&72V[;`@P+QJ)UK\\[*@&,_5V6;YHYH-1D/<=Q&1]3V*3LF96Z M9(_I$EUF1L&F4\9_'(23%+F\_.T(/HN/QJ^MCF4[5M?5!IV>HQF#GJ4YAFUI M>M?MZ5VKVVWU1L"OQHM?_FC_],/.-=W7PCKOE'/\5M-FISL8NOVNUC-&MF98 MMJYUK<%`,QUCI'<-W1UU[.<6-KNX.L>$,A92.\ZZR/O4A'RIE\9%G_1E\W(O M8J(YO"B)%^]9G*X,$!7K6[.SCFL=;2#H7HOHV:JJF55L/"RG?N:I#ZIBM4;- MCPA:G<[-W5[^YG];].<(M6\R+-]N;0Z]6L<,GC`^-V=4-5=_)W MRF.RMM=QE0GR8H&>,#!+SPS`W(@3GJ!]?E9HHTL[Q1J6N#HG'-S+98^M&G=4 M9!UV`KDN%4^;X7:?R?6XZBS1(D17ZJ"`WJ$1R&UG)X\[L*G^K42)*8DIB:EZ MW0E^G!7[_-)Y`/K1JU\77;WCJH91JT)*9W%AOGJ4\M+N'%QD[YDSA9[.%(YJ MGSHQN^GF:C?@<\]7?F.>GUS73RY:+=4X=<.RZH%MZH[:.;]R@IU:*<'\2D?B3^)/XJPO^FN4[4T/$9S<1#TP[+QT> MN:[JMFMW5?=`N&MJ&AYZ,\9R#[8)ZW$OQM%MU70K4$NZ3A;@\R59/WW&:NI@ MB4&)08G!4UF"&_Q#Z`(3NY.W[VH]$; M=H?#7ELS',?2C);3U;I&U]0&G9$QZKN]CFL.GCO[L;4ETSK'AP((40@CA.#J M)%NO=AK.\AQ90LV!DVO*O@]:OJ9'\^F"Y7A>1/JR63/^74,OFSB3UTCP=^!1OH5HGZ]LMUS-XC M]#W<>O0;4]810=OH/]LA+4ZY4NYCFJVSRY="J!V6F=7 MIAR@=IVS*UOK8G'V$[<7;M:Q_G`V8Q-J*$T10GY#M1G2B">\AA+..K_^5J9= MN^2&)^^R6[M2D4\%V3YU=^@M4T([1).6P2@Q*#$H-UQ^!3*G8_I2IN M>T=*Y(I/E6NPM>%[%L#"$J[E"'],W=@'DHU7,Y/_RFS[KC#MWZ5S M@/?]C%Z,WQ=9JSTZASLX3SD-N'A+X/Z%,F43K&D0__Q"ZVRD,?=-$_X96%I+ MQPJTAM/7'$OO:H[3ZW4[+<>R1X//G<_M]HM?7,=U=&#&`OR](%HK?^WQZ#^> MG[)ME;*/EJ3=-URG[?9MK6N-=,TPVR.M:PY[VJ#MZ);3Z0[:H_:WKH=-Y]7O M@.,5ZT)!M"B$%^5WYB%6L/[L>HW";YVR3:N\H57RF%AQ`?(&*^HIM]=\<@V, MI'AQS!+82.2P,7'OM1=<`7MR^`[&`&$686G=)`)!A,5W@8G'++E%/OP"=K+/ MIE<,A;%*A:!10"V\",4?5:=&$56LXIH#`8)DNT,Y,"\A#M"6W6L`[Q';X+LC?;W^_A:Y48&SI9&!F66>8M[4XRKEWAD^:'V\&SK4_R1 MAJA$B*!C(E8J3J[,O>A+=BL!1N)35)I8JISH7)22]KDWYKY0T<`*2$GH_CEET0U@FP1$K(=9@!>H`(?DW$1N,M"2WS,8!NJ/U M*&!2Q2E*U#A[.'\43:J8S[GO(3W>0X4;Y/MZ`>I7I@82&%H!8""!\I,!$T%89ED%._&`U*&U\EDB)>C1&SF@_T/ M;\-N@.&*XKF(Q[NO8R3^="X\*E3_MTC"V-._Q]S;U\3,^E$UY$O-=X?)]&)7L--_0>29/ISBGJ MTI*M%P8H:V`/T8)$9&/>(AEZ7BS[,QQV1<_6][^BU_EVE]7DU">96EZ;>*$; MN\OGWQ?R6G/0GWCZ)#?B@63_HO32T7!><8@S;^`,86Z?(?*VPOU,.2U@>>=2@L**ANO5J1'!. ML#:Y$8G$U#&3Z*IM_NP6G0,6@=2D,#\/XB1*Y]]$@#XUG]+IU"I=6#9TD50B MJ>31`K9.6GL'UVW%L7_]Y4[5,W'*H,K+7S[Y\` M:P/LR'/RS^MD/C;I>HS$H,2@Q&#=,5C_".CN`^"W1=J@/`66:SZG-3?->&J. M[R[Q)_$G\5=?_#4K]E:10V(9K=GKQ0I&:R1-2)IHNA':)-]?8E!B4&*P[AA\ ME(1-UB3L-=7G^?F%;MTO74O/E*[!W?>"O)GVT!7![B+BOI(5KY+W`H^-?7DO M2_PC&`NUB`O",H+@G+-255<_8)LG7\9J@JZM.^USN"=;/RW\"L(VP)<_)3Z^3"=FD%`6)08E!B<&Z8[#^ MD5!Y55"N6:[Y#(RGYOCO$G\2?Q)_]<5?L^)O%3DLEO&:^L=K)%5(JFB^(=HD M_U]B4&)08K#N&#Q2:]R]>]NW=S3^Q(DY_KPUDYN^*>FESFOE+X:(39DR67LA MZZ[-L7=QWD<^Z\Z*?81%AWAX*XKNL$&H&"2<;8P#KWN+111^Y7-\K=QE%)N1 MPH=IE+7SCK!/?!R+MLW4-QY>GH=!MTZQN(W#"( M>9P@[CC>26*QP#!^D43>)(F+SKK+]PA9A$71&1>W8+.3;][5>F5H53RPC@)MK4GM!8PBT%4:(PB37>,$ M\/=5N!Q"A2'&J>BG':?C_[()L$*X0KG3_Z9Q(G8B#6!KE8E8..XGCR;I/$Z\ M8,+BHK/X[34+1$-E;*/+;K`?^(0XAL\7,#(.1AM-'9=O&:WZOCEA-=FX!.(T MC?*.R#'_JA'+P"`+(+EP"I,%V.[\WKZ:V#]YX\OLK._/`6AO?\.VS6#*0,7P!YLZ\X`YMFXAN)F[ZZ MX\P'ZGC)+]@%"%ZZ[YE)CE<5V?85%>/-$5C:"N!YQDG4`8<%C(2GAUVI,Z;S M)H08%*\+[PZ?4X74R\7+9!*E2#WP68A,N51QI>;8JYIKA3R`ZO:E!A@-O]U$ M[`]3?H.__O1#&FM7GK?X<003_0?G&<`&^R%N>_R)?4UZ?CCY\@N\IOR4/PI( M[0I8`4,?HC"`'R?4:SW^`%0_N1-_+]\FI0*_?&2SGU^PT/_\8>AVVAT-_NBF MWM+^:('"^GSY:?!9=]S/N&"]U=$_MUXH?/KS"S[];+?L3L=J?S;=D>7J+4MS M[>Y(,XQ>2^N.AHYF#4V[.S2&_8%M?\87?T$8,Q!/34K.:G4&TL0?&5[U]>^4 M-W&,6UZ@2UG%5Z&\GXWVK1VD_R90?O?N2`:K)-1&/`#JYIY?!N$2U,S4BX"- M>R'\`^^]+"R/_NM1][)7_#YX_0KDYSH6BB'^7*"47!^C>_GGZA#OPHL293^&"3Q2K9;VZ*,^A MP)Q;IP&M!TH-A!=Q)V(ERJ8"B1!>!<"W(/`B-#\CL:NH$K8M[6/Q/`*<+\1\ MI:XL!'DY&P[U:"(L55"_V7S_%"M`L8(@PJ:!`9N`Y(8A45?#*@$!03P#,0-R M"B3*G*/\O0I1.8/R1;.-3VA<,K9S]'`R3838$V-&;.:S?%`R','V\`AH6-/M M-0>;`+Z"46BM=YGLIQ6/F?C0AZDY:H4)F-E7L$FP@N0Z!(,I7Q!:A=F2+I`. M_YWZ1(AF1HA`5``=@(,*&#]ALYG080H2$`!)FP,Z:%'F,&5\!^J(*7?,BW!! M`^#,^8H(U872M'%-,`29K7Q.F^`%00JD'[%%&!'9YL;-F%WQ("#],(/',]S# M,M`0''H1+-V;A@O"$:Z(17.>@#A7R<1#6V+,8#I&@(01A]%@GB5$,`@.IF;( M161E2\D7@,KY7E"L"_2P/++I&.H.+\DMM0!D0ISQGEC,-,3UJ,+S@K6"74)Z M*^$3OD#$(GVA+HI0"J#9*`Q3M%1F2^D`8R89[8=HZ\!S/OW.IA71ZO>05"Z: MMO"^J>FZNA)2[;]^$P#?)6%TEW-OI]-ZI2J7""^?W>5H_EW8342`1)C+]S9% M3C93P?%\.++8.`(&3()T6&,T/2!`<"!\_D_Y/B1 M>:*BG[=1R.6<^8X:M$OP";!P(P`P&&7'&'.+7R/!-\4Y68< M"E#Q+R#-BUW,OUS4*D\BDQ+CDSU)+](7ZY)L![N2@5\P[-[LBNBL(L-VTRO0 M2_NQK+G)LED<8B4Z\F8.+H=08H#VY3,O@2P38FRG8VK(VS#:!_@*,".>1A(H MT>XJIX-,!L\)C3[R^/I`]6@S=.,X!+RC/4_&R%L>,"V<:7V*ARC=*$*JI?U8 ME0^?<(L14-HP87[`SF\'O=51]P67Q&58"6!7?!/ MCI[8;\PNFLCOBY9(N$+*S]))"U+H%ZJ,=P`_OA M?`R80/99^B$.FO_KG(8RHW"6T/XKR1GM`QF!2K>(S6V7&J2E,Z."-A$I>4(? M1"5?8BW&!TKGAL>P1`_5;![_$.]C''&*W#/CN&E%!+"LPH6-FBE46L.J^8S? M++V&TNS+N7":*4,6`;1-L]@J?,N"Z=*]2G+)F$%8XG>"@9@3,#K*8@2392,%)=Q/6`%PA^"0H`(V4=K%UX2HC*:"@\G"^EH M&:C@=03$B>"&(!>B:("I!#J%X"+>&3,6K(P#$-SP,(VW.!]\EKFA)=0!S/A) M:>^6V+SVIL7PM.-3$5O,1T&*B(432R[,*6PG6Q6:CZ%YA&25&T@/64>Y;40* M@,_IR&&V'&!?0^D1?HT`I%9^S3M0*_N+*7O34")F^.1]94OI9!MH!_2R"/8E M1K"5/O@;,4B`R8H54;Q[CPD#VF2.PH]E@80L]EF*F\`XPM4M<7+.P87OG_%L MXGTMQTV10"AH3F<3X,2'RQF0=`+8O?S7C"\PT*%,,EA(:9?$P*Q$`XM0<,=% M`$8%SGHYR:YC/F9K1[ MWQ#V:@!\F`=J!-D#U7^$U6#,D0^8/=,V1OW/'0R+MRX,RRZP M\'@X5N'/#9J2/5.<&AP_[#\<]`;&L#?2=`/^,MR!I75-IZ6UVT:W;8[TOJWW M#PK[__7;FT]#[?)#MP]2.0@C0'`F9S]][+Z['+W_^#M^'C!X]/W'`3WYYMVO M^/;7UTK__=OW'W]4HJOQRY8*_[T2,EW(=Y"LP*FOU^2Z^!!&>S-X_]3O\]&GXL9AL96&Y`J`5:+=L_(4G&F)9BY,H_,*T6SY-KNG[\JG$&']^ M!Y:,T@:3O]#XX@!BO/\!1-509ST:<\;WCT7<0-BWPH%!"9J)S9(@Q6@K>4W` M/R"`$A&;1C%8LJK@N6Z`W*O\QCP?A"WYW()O/%]%Y7D!$E#QF9>Y<"`VI^DD MBS?0F]?B33!.DXB#&,6O<$YT_S(I_^?%I5!1:]//A\`H5+3:04=%[!!.?T)+:!ZSTVMZ MJX%DXMMLZ4(#:/D0A2Z&2."M,VME]HKC*]C4CX(#'\&,R;P+0,'_OA"^L]`* M/'W$J9W/W*71`+YU!Q%-M[(?-#M+]?`6>&&1,]=*MLR%461_C$&R4$&BM?-> M)K($(B!)[/C@QH^D%/^17\VXT13."]'?R)">._89D$;Y`%AKZ>46[H[%]PHE M)`@HER-FYMAS$ZGACD7NN)L[^CZZ,3\FIV$<&'L1,LKC%U&/ M'8`8$SFW;7C?DG12'*GRF__,-,*PLI*WI[CG3^WMS(W"+E"RH+%+)D,D4D/B];MG$4E46 M3^.QV0"?S]"(WSKQD?*8)1]OTE$-SGK*YGT::?!6MD&C@Y1Z+NQ2>6".'^`4 M"O=^'LW$3GL`V\`#Y5&1V##N@^AH>_+I#SQ' MW;&M)/8'`3L]XUGT&<+#:WQ[7>+080YB.N/-298Z998&O]PGZ=)-B[-C>=`EMR6N*GL?='KF"UM.P!]\ M1?'2$=F6!\PQCR:7PD:O+M>K_1##XI@3@,DNZ"Y0`;#X:6`*@P&#XJ5@.+,(#*!R,-PB7_%KI+(^>T:?EK3I,-,U"U8[6<$8B_@2 M1UEW9<-UE_9RRGP^QR%E@M=DMZZ<3III`03YXMS<0@,>\)D[CND:U"R19&<4 M@(UDB+4^/.#X?[Z3^.>QV^MEG]FS_WQG6/^8+P6"EW7`\OC43.+<;!9*^KZE M_^/5V7'9.RM>V!F[I8HL5D5ME%VT5$R:&7)(HJD M-KFAK\GQ*A3Q`1/+=M+I>KEENQ#E*@KNMR*,OS82:LA$4\SCR^`FHF/7[['0]2!.+VYGDW2.!%N\+9.H*I&D/0-D MG*OJN%GJ7*D=BV@:D4VK;BQ218:X*GLL"P=;_;2&IFI$E:2Z\40]U,8UVU>& M83`0V:U137<632+6OL'B3_#0>#!PO%WTV1P9"U_/G%>Y=O)J2S:1-:,1V$9@ MSV_/3:,]XPR:H7;2*RL*D94*;+?U5^=."L0Q'ZC]+"A'_9C%)JK='/KWPCV= M'(2@%.M?0^>A:1+3JH`^::R!4[(&JBBQW'Q?$@!2.Z%54;'+S45M([1GN/%> MS86#UOY`G@:]'E^:ZZ_B/Z>1J_7C`=DBJED!1WNCT1N-?FBI_5H!)=X$S35! M M8V+5F"<^I$#X#"V;X M/D6>7;XK7PA.,`1-VX--:'J?!>LVU,"WS[9@;,B'$S18#TY2`D!H-9 M*P0!7E^5ZSQ+HH)%\7(G2HJD[3)U"F&8@;.=F3I.>H0)\FG_("8>)1R[,IX& M-!KXM,"B$\9A@@=2&!PC1T('#*B&I\?Q9'6>9,:%D:6JLVS?F$.JY*F.:?IX M4IX52W'#E9M%#BC0H&(ZX`!N7\.`SK^>TC]-C/(1=H_A">#)F6>UYA@ZA?;@ M6#4,XQ_3[-Z^F1%Y&B]#JBIE4&5]-S*]*-,I`'3,Y=G2B:U+_,J)(ZRP+%BV M)/B`K!`5U>8"',.\R#,\ML`;3E(Y0W[)RQ#,%"%X.X=NE/:6YVJW.7\!)YK$MY['KT>.#3%4N3)?VD8;D8-2;-*G)8J.']YK-U"\E^J M?Q@:MLNP`!H.?2EM_(!\T8CGLN+6$(]\#Y130/D-O8#G(R*,/ M4_8TSTY?DO5>$69HV[7 MOS+"/>`?GZ,PCHMAM--Z->SW2/@U M'0\KZ,*&^+"A%ZB&I/F+HI>.NQ)+M'#@S.,.2OO1%[]/YY[Y@$@2\2^[I=BY M>G>_!_F./@M![H,]V$<4%42F?J*]13B%O=_:'.NY2H_Y5*X*5Q=!OXO<'A6` M-VN4_ZOL/QFG>E>CA9HX_AW+*>IG)]/.C?ZMQIC/0_]FE=BX1P-"G]C=H]>[5;726[.E#EX'IV0Q_T01"A3I65:Z8>3RQ$O_Y< MM49:P7D&K$T"=]+S,3YP'(4"*^=1*A;(`XOC+#;Q+2M+]<`*=&0_A7WAA@64 MQ6GM@145NTJ5!O(HQ[PZZPOQDVEX\,+OBLY^U]+4](50S]!CN"18[P)>=\:1 M/RR];/*7>63TZV@Q/S1>JS<>!9647PZQ9='!1 M"XV'`3XS6@PRCECD'[2#@YD=17^23"):7J`P+T?8!.WM)&AOK8BJ)F;/U-:/ MV5OQRJZ^/UK73?&":L3(P[18VBS]Y2'P7=PDVCH<-;;_37HWU0O_2]Q@I ME^V\NR5T=:8&1D/#0\<,-46+KE+,=9@Y:P?GNI/TP=_DYCFBV<1NC2J2*,0$ MY2/+>W8]5VB^ABX1HPK06_5WB\[R?98WB#G-7EYZOG38.[A,;'LE8TK$UO=< MEJ6"L]:(J6N'E(_&*[;@!%A3M!:S=:$-[LEZT9&5)A['/%]9DDIIQ8G[\^V; M/(EWMLHFIK"[2>3GJ9@P!`K<(5`W"F!T\0L5L)4=5<#^M><_XVL8>G]_@O>%W[-WKMB$OX1Q?`E$;N>B=,`I^_Y<>AILCF_??;SCUT:6\RI-?]#G#5$W/N707`OA.V+)]=/\"VKX)\J:[[^0K>\-K2 M6'D[)__F])NCB-II=Z26;8BVH7=%S>R8HB.UNF*WY71-^[*KJ0JT`2]^0FY) MF>4U>F;U'CJG(Q95PG+_-O?@C6&=635C!O#1[V/]9"9U6,$^3@2&/X$$BEP. M!)*6`5^."5`@`L0EVOJ/X1?Y+8O_L MP+5[]QA1ND?G[D9O['O2%?1GK\7AR\XA*T[$K]]IGB4U.PS<_?&;H"L7LE[: M]S*2%E:2D$S'\ZG[>SL$;\HI\\/_@HA66/HZ[R[L%W\/P-K[]0/8T_,9]J4, M_+RI`K^JU%BIX5Y.J:W8;M\2M-J7^MQE18D@-7$Q[Y$FZ2W'+$UV[((^DGYM MN*,6W+&96W9^+]KOI<1S!\O7E<`N'R#C'^YXO]O-DG?A4'F(;C8.?JV=.W?# MF7Y0B;5Y2?%?#F'T;XS8+>W;/5V=532(;&Y\-[=R%5]PP2^Z57?N`ISU,'ZE M2=N-'V]2O+_6]'M,>U?!=89+Z2#4,*OZL\QYN5MW;-D'*ZH++D=9570+_A25 MKM42M=9E2W2LKB5*6KLEMQW+U#7I7KZ7E7>?1%FU#1.VS(*.VTUTEFCMLF./ MNWC1N[Y[+VN[*UTZ;7`OJ[7DX,4O M%Z0++`XX&4WXC04OU#Q#+`%Y=<6Q;%^#-O#QN4NA5:[B$H*G6YI16N)P9D9X M((-6/CC7[2^_"&ZR.GAY(9I7+_V6!00S3IRRVZ42RG-UG,:OH?[V7F-+VS+> M5&KB32O2=>W=K?L^E^'65`SA$G31K))='!W_K*C)\BN;H_Y:H&^PR>,>_\PN?O!S_Z8''-DBAF$=YYQZ ML$EJ,C',4Y^D(1%5.\19=5-AKHKH7C]CNPL/%&.HL"C'T(UCO^][1PBI$DX_DL#NIV9[\SC\*)QCJ5:@)VN.AH6@3 M''SCWY85:NG.W7K2,&MKSSD(%9RU0N1]7\"<"HI'<;@Z$,+1UAWN^0S:T*^A MWQ&*,U?U$)&=_Y_U\1_<$-C8`V`20][8`JC)X5@SB"1O#*M:DTD:*C&4XWD` MZK2M'PZ9:_L>J[DQ-11L*/BONL#EDLI?Z*^^E]10M(+T0+N"M]`4)O M$K$RTZ4"S1%-D\^@!8SCCME]/[H?L:IM('AN_"CTA^$/X9'=ZA&6@(I@8JQT M,!9R576)I/!G2_N?RQ/M^4\T3GP&`E9&9X/7_Z0(%,:K8_,C,4<^8SFOH['K M)5DC+U?#+>>^_<`RU$%1VCJMZ\Q"(XN2M/#V>RQWH+\FJ?2E2)O9N)PL!=4I M(-5NHO`2(Z"N`A8(A5_M/DQ'5CNF8]N6**LM5=2ZG:[8,J26V#45V;1:>D?6 MC6,D0ZYDXE?CW"U%N7O[9BV=QL5[IE'@.`*H+;)E,__)[M/36-_I$@PE%;*GN3P:Q/\SJ MP\:M*733FWA)[`2]6QH]^1Z-=^_[Z'1MQ6X9BF@I74O46IVNZ)AM4U1E16D9 M;4W1Y';E?!_/(D.QG0[T04YAX6&*_A&D(\O'<8>(C%9VJ!4A=?9'=,F-PRCU M`M`!\Y"=6]Z.K6P)]F2M[X90C^>&:+ING"_[.=14'#.I\3U5F/L:W]-1?$_5 MF5JS:FP^I/N%GAQB>\RF?V]6B>X*,]UXRY&7/M/-_J2BE&M/_) M"!U$M;G1P1`UDVB6_:K7*^3/WG"^AF40V=#/9+8RL2V%F/:YW-?)1+5D8DD' MO:>HHS6R6H]U_S/QQ^A?9Y&T<=A/?K@1/;QILN65E2*9P`NUTVS;3ULCVOE- M6S5DHM@;)R35=]H2,'D3H+"&>F-H);739K9*[,WS[>K*WF"<&IM#\-1UUC), MVSX_72:;&M&-/>]3KI[`W]&OHU]*LO_>I_+-9?=._E%0IK%[N-OA&; M*+)4-ZMBP_G:ID44Y5QFJQ!=58ADGGC_<3ET!SO+YI!4P[0,QQ8[*A8Z[[0,T=), M0Y0=NR4[AN-(K.",_.Y3WQW&]/=?%X:R08'WEAO[7AW*NVNLO+NV9GGW8GJS MM/DW6`>CN,QB'68-[HB+GI@7B9X^YU M#L-S*]C24*JA5$.IU\^V;A%MJ[5S!_;'M-Q@G4+:9-4FFE:K2-6FEMA1..6# MJ=:EV.#V0F$14Y;KH/ZJ:ZXZ`3JDA3^H.TP>ZZ<7#8EH9NV2E+:=MBY;1#5K M%\&P[;356FV`NYBQ85K$LBJ0I%6GT(W3B1-LZ-?0KZ%??>EW6F?GN_`81^<- MPQY+ET>V36RE=F5F-YQW34W#C\!_SYAQ-SE,7P'#22J-MZ29=_8@%3FG?#_R$"D/_B?86M_B]7YT%8`?TSP5]GGD1G_7!C=`L8DMG8OG33:)L>_)GKKV=3+=VVC7 M:HSYM+1KQX^3R'^8L`IB[B"B%'/[B."E6;ZPL\<)5[9A+8'^#$TAAER[FYUM MIZTH,E'U"H"_55OWKA:.+S2.?Q,^) M:A;Z^4&656*K&XO^RNF>VFW8Z<13-/0[KWB4U2AS6`JF<%\LW%W43H?K$N)T MG5V,JPS3UI0FPN%,=5)#ORKH].HZ25C4H>#WX.CJ]WUV[[ODFCJ@R<'U_:81 M>JI)I/JI^4W]A(I.I$:[GV_D2T/!W6KX5P#_K8?I-HL']X4.W.&?;I+0"+'_ M.)K<@`:>7P(`W"'2G]JR-$T5K>ZE(6IJJR/:;442-1V:,PW3ZNAJ=6#@9/5" M8/01;J+0HQ3C@JH&^G85"+=TG-#1`XT8>@L1?E#X-Z)"3*,GBD%(R:/@"O%D M-`H#[O[UPM%XZ,*V"ELKM.$&#!TN#/"'$:P].UX)R2,5ON.5<$^X3=P$QL<] MS%XBM,-)E`C],,*'H(6N&R.B9/%`V&>3^=\P^IL(N)4G0VP&7O/H=4#3O'P" MP_@(F!D" M)Y#?[\.GX9`.8/K)HYL0^&\43@:/@I_$0.>'&`A$X`,T@+>7-/6PQQA:)O38 MX(#V,#0_O>BD>0VQ)&0/H%=^IO^\PW01\N4B>/X-!FGT7O*(_$C8L&`D!%=R MB#^S%<<7>[1/@YX;P)C*-"RH1U"RX[$?P>(D(31`A_[(#V"QB_DC,5PV!@K+ M"$O.;FO#-%*08D`52,K_(5(U2.D6"@_AU`-UGY.?P#"#21^D M`#1E!!^A<6@AQIZRT8'I&7H^!]C,.H:OL7DBP&21DF"V(BGQ!Y@QM,!_S6EY M(=R4R`H"FL1L9CRP$J,N/?A]%/\&KW[P2U[+21!1%X2#V<,1!3HR\07:\7MT MH-"3'P[9Z/!;/G(^BSZ%4>$$4`RC29P(0*3X(W10[B%!QTHX0:8#.>S#/!!# M"L:((\P8O!5*E:U"%2Q/\)"#D).VGS`K`&86\:B.$CH&^%LR_2.*?T[9DS% M=E1H`2;@TS[AO!W$+K0X36,1*-*YYX[<`:JA?T.7R7":"O834G,X17D;(P(L M]I<_RJ@'ZT-2\,U\T;PPNWRC/[$W>!@:\(,LW!;47Q@%=#H[W3ZEQ4NH5*/()S`ULBKL#YP8,*+C70TJ"PF7'I05^5:Y$+XBYVI*)=C3FAH`=0/:*TG M['``SP&?X&JD.\.3/PA![\7#*7N]%V*WG.S^&'D-)0)7Y=&/09A0EPL,C/31 M!?*X^!6-?.3"'M`OI@+M]REN%`'V*_1!Z8#-P10YKAT#OKM8-*46;)]7V2\% M@#%'1OY&!ZB*8/1?W=$6^+]SUHUN29?M2T46-;NCBIHAF:+E.&#B=-ORI6)? MMF5=`NM&0_M1?O?IQKF[ZWZ[O?XJM*__O'&^7G5O87?[VK[@`,?+ACIKN[52 M2>S0V(O\,9(,2(#(O_%U_P:X$!47?KM[0\ZR'+.EVQU1[AJFJ+4U670DHR-* MIB5IE[;>ONP>WI!3GC7D+H3/-$"Q/8[U5AZ5CW^S-4(]75XE-B*_2I8ET\9C M/T@W%7@=U`H/*N"JP>/&%NJO2>""(L/]&>47%5R/RW)1&287!K3.N&\2Y\7NV[B?`EHZLCB12`U)V5;_^E=5AZLVR[(EDQ(Q M2Q))/*RJ4_LY545&,UMN%O!.F431-7XD80->XX=3U%UGN;.]AN-!9&6"N1^4'P`R\8@@$"XB!E-KZ! M=YQ>_E8UZ%O]`OS^!.&^\"$LL!8:AW0'/=@O#U3ZP"53B3Y+`1KTQAB9MP'Q2`8.NG'"@KDA M01^Q]>P3C8/Y9(A+@*VEL`48ZM]SGZQ6XH`M<4OA:6Y^>;B#9HCP:_G^''[V MC62.1.\AC0A(R MY6F^E;9\XKFWW@3DC%<0?>UVA/[<)]\EB[D^?>HL"5FW@^3COUL2-%ASS2+" MY>7Z==(?HC!?EI:"D'<,#O1""!Y\0"N:0U`V](#Q6!J+S5SLT"E,*)BG<)2' M&;`B^"F?/1_,:!"[Z!A?E(!:!O+RDH0M#3%*Y"0/#+71/`2%Q++W".`.@@OH M16.*LB@TS"YED0\(WT\F%.E01(0J$=QF+AS!/,:PHK!9^'LOGG/QY:$121R) M_H"\N$3(O##SUKD*2+9S:?L2)/.-0C0?4KER[UUO0B[LR`LC/OD:I)1-@XA" M6/";O6BT2,#@\0N^@7Q.B(8P9N2OQS(R^)\?"#]\V*K\VP2@`@"@!1I5H>QA[HLP>6V"T4HS$/X(JT2:F6L_Q?R&P/ MF>_`-V,(<1-&MS$ML$*>7[/<5)D&B&W6ZQ>4!-C*,#.:V2"%U*I1U'/+F$_! M.@D?/M-:YJGW/8_P&'"3W>:+Q" M3NI?&4^D>4Y#E0P->(7](/]T3O$@4OX>F0IEE/)!%',B9K`(2@]Z/:1XN-<[ M<4&Y7:/S-'31>^$=ZKD2C1C:4^$_1V\E4P@FL0IY$HDMI145#M0V M]^K=3SLX6")R5)*+X6H`(/(>A2D8C?&+W@'.&OF.I"PQX'@Q^@ MR,%%*B6E,$V,631@@FOOSO=&H,8QS41+%CWJP3IH>7R`#@0\F^B]P0+3F'Z4 MY"^+82#/\J;I(EQG1GD_0F64!UH".%>4@$/TT?"ZCQ?HMF]\"QJPPGN2A%;* MQ"ZF/$$U(S@8DB3`PZJH(4!?^&BR$!%,?*?8%,*JC+2%M#`/=?)2.W(AX4D? M[2<9;.[J4:[[XIK+=N'-M\R')^-?/DR"*/J83O;A\?$R(<@5^?F#:AK$DG/0EW"6I8H@2W9L@)W):H:'H&]^MINB5] M]@SQ?BR+-_Y[2;?D5P\VGPH?2GW(:S1;+^%7X2N(/@T%JYA>NRF=@:0.64S9 MB21^YRHN.^#`CQX87CLA)G`Q*7\'#]'@-9*DV.46?1ZEO#89T-5_X19GHQ%W M#+W)G"^0BC1Z8'R5<@#:^WI=BCFKTP/CR:+W*@S(,N6F!4;SZJ:%PWMS:T># M&S++G[F!ZZ&!6SJP>/7[V95"_QJL^^&0KSWW-6UG=D'MU1O/5`>U9M?.2-KK MUSVG^@CKYX9PL\,'UR*UKK;I,C^@"Y]!2#D6'AKGP6Z^I]0G*O\TC;W3R!L/ MIBCV)JK5J0S3L47CT`4KE<3:EM4SQ-JQ#SQ!JH)8.Z)LFH?%NFZEYMO58B^Y MG#KB&4(\=HCP3A7=YZB=AC/-VG4I>RG*AG5V;8),1SLWE"WEP"B?6J'IZ93! M-_1KZ-?0K[[T.[?`.CEI/K/0VA$5^_Q":T?4K`.'6Y7$VCP_IQNPM@[=V^74 MG-!3ZM714+"A8$/!NE.PBM.ZO@8Q%BQ@IX%U24A^KSBBX@;J]X#5W0'5@$?) MA5SJQ(+U-_0=%<+1WV;S<#!V(VKQX6,;AZ3:!)>R'2=Q-M_]M'19F!98NG[[ MQ.5;1=4SYW6OU=++NN]^XBUMDIXCPZS?2':K,[D6FKK9J]]](7/[B*Y9HV[U,^*%PLH7.,-73<<1D([@#_@N=*-VW[KNIW_&RM&O14J MY$O\.<,BS.4U6M=_EI2LLU( M^'`3S+R!8,KFQXOB.P1XY]K78'D:=KX8DFSQ$FC^*JR^N/-Y[5V(I15A5HN[ M%K1O^>\1X100XZ-8`H17#])R45Z,&@?I^_[.(<#Z>T317:2=;6#)I#<-U4R, M0(Q`O&9`%*I7P^&`$59I8I,I;T#KP@*#C#S492CM0$)KAFPT8>FB:54$%UR` MB9?X\;*^I/J/UX1G%>)I$RE8&=3`V/7O6*)3L-@V!0CU30+2!?+A'_/)(BG3 M)$8$IJ*.)V'(E@M+D(%X,1;$ALFU::7_+[CS?IQ+<44P=G9#V6%_X#GMJ8:,#=\B5 M.E;YP&-3+P;U)@JW\YCJ56X9UI[P1@T0E8"837*,8!%<3$R(.Z+>301*"@`6 M6VQ$Q:0"2JXZ&=CLN9NUZ/%!)T2)['%@>/V,*+@QIUX,ND,L]H=!_LJ:P'C3 M&4@5+V\.U]>A!]A^"'XWH7^S844*@#>P5*J:ULB^(2E4VE>4Y$NJ1L1V0XGT M:IK\412N$5]OM$C)_)FYV+J/&)`8,WMN5>4D;\HEWLO>,>7+#`4LC,5R;ZP[ MFC(0G&'62@R$%6L>)>RP1G7>4@"[^N'39?_JHY!8[I#%KC?)%\Y7X2**A;[P M=FZRLI>ZO(_0)'C@.@0;(>&*/N,5N.`,_DVE#D;$VH5\.=HXT*(3J(7$162TYQ*A(J'7<2X>AFF`I`2E1`EB4REX-U/2WHB M:57&2^63$E&$)J\/M7D+$72^J/T2ZLTHX*CB_P%K7FP3_@RHLDRBD&:GUOQ! M^F)9DVT1UW<_E03VV>**Y*RBP+;F=]CU[%DB:ZR*+&_L59Z;=UDJ2LI^\P'8 M,B;!MC5#0ME&C[Y0U$TL4.#=LJ2#3KZ-R>G#@;W@A43D@;22#G1I4[M/GL^D M8"1UJ(^"T`I#Y%K:C[)^H%8!B"AM&'<_8.?7HRYKXG,1)S)O1'U%K94(D6"+ M2Y3P+2$P#%C$&XX-AR'VGALB@;ST`=Y;C1O>24(4WEP"!"4GBIA6DX:YU;SN M=9`JHU$2"/!F:L'MOQEG>!#2Q!WA7D/:+Z,0,\74G2:M:AQR9)9@PQZ*/F^_ MP4.?HJI,AAJDY$G=D]550#6"I@1/Y)XEL10HA;0:KHPXRG*..A8[WH&MGB#M MX/*53-8;04A"'5XT594?Q&TEX(K9+=?V!*!F[F- MY2!<7-LKCNL=W`]_L^;AZCPA?M;N]IC%Y$^HG^7^K#MJ('-9`Z7MWK`*_-;S MDT+CQ(&PT?U?EC34&7FPA/Y?0<](7WFOB59>!;U>:Y"53IP*7M;L\W8A(0L+ ML42QFIH:=B7UTU3^SP.!0EETVN`=-VT>IJQ?-.%)*XRLPW9 MN_`U0^RI,@6R#=%9H!8X\)MA%E[%J69,,"S(>Z'I6-I`B`JV$V$8N8.LEU52 MZYPQI4`'?L2*+/4(0!2(?M1IBY>PIX\G45)6A.^E%>NQE*":I3,@#$$I1-4` MKTI:ORYE,(KKS+#!"#;)7`T^O%$2AA9(1XU)6''O,FJ.W6&^_!WO,.-&:;S$ M2@UD*(0YA.]DB=SR,72/D*U2!^DI[RCUC<@`8(O;.P[Y?H[2#G'-QI9CU8UK MOH!9>;Z:LE8=)1*&&_>19=K)TM$/:+L3,F;78P9FL`/Q1D3-(XI>1/[L!A*/:I$\6!/%!]@9D'1]V+_UG M(A>8Z,"N5X0+R[H&IY[<:I/"BQR7LEHMV/TU4*4P09R5OXWZ?>0P9;JR\(LG MH5D5TU0NB,`(YTY!S3D+9OU:0GQC@Y+\52V%W.$-:V#G/9!E2KOEEJA@Z7)& M7^ZO17*0"`8]O[VIUFIKX>>WURVWY^7*#'39FB$,K]:(M]O69:>OR5*[T],E MO==J2[:A]B3+D>V.U3/DOJI4:**">E'2\43XV\HPW4TI'URP$&0ZUO7.V:$+ M#>98-?/"^@>U,'$33T@S+N1_E)=$?;73:9B8]F!\?DL/]CI/)]8$))]Y@'Y;0!V(4LX8[P),CWE;6&'.0ULCZ#BT[K+MT/*R,G_:$*38I_'9G MZ,13-_@`HG:TCLMDQ#PA_NK1FU)L(_RLRK*()^VX7M+2*HT\N-="X0]?K;P6 M4'@^2$Y4`MX@/TG6PE))$T^NDI]+=L08^]'@9^AJ)IW,\@YBV$(*G("\"6?: M6!)YO1A\W)8HP)TG$($X#<.H]VJ!DSAO#ZBC_)SG1(H-OD`MY`SXLZ**&E`N M.YNII"SC<")-4NV.(^D=,*^MMNU(IFWU-*UM*8K6XS96RU'<#'@9P;0W MUU<64F>N-E7@OAPW+PIT5;&^_WG=_0Z,\)W?PBBBJJX@VC$,^*-K2K+2MB5= MMSN2;2HMR;;;[98FVZ;5[W[7@![O?Y=OH.77KW5[QJ8&YAKUZ]&VRK#'4R"8:H+0,CJ`8XIS'M.B]=%1S]P]62# MZ[[/KH-C-]R7'ERE19X.P$.$5X6PH=3QJX^K[?YL5YU=%H+63`[\HCB<3]]$ M@;ZT$-W6:M5GX0DX3D-T&BYIN.1U%&R=VCN<3H^BAGX-_1KZU9=^IQ7C4]H^ M.>ZM2WQOB)9=NYY0YQ+?OP#7$_`CSRD^KY/[>$I]A1H*-A1L*%AW"M8_`[K] M`+AP^[(Y!6Y@/B>83\UY.IW8O:%?0[^&?O6EWVGEWBIR2-QD:Y[U8`6S-0U/ M-#QQZD[H*<7^#04;"C84K#L%=]*P\9*&'=,8IO]^KYB;M6OA-X4RN$T/-)5I M3Y4(MF:A-Q&2YB)-7>!K4[^I"RQCW-0%GA'..0Q-@6!3(-C`W,#\XJ.A^B0P MZUH@Z,BB89[+K;KZ(7O*:;F&4J^9P*RV`U2+TY]G;N<*GRBB:M0^Z?^R%2HH M/`V?-'QRCJ=$IW/5H:%?0[^&?O6EWVE%^G4L$W04T5;/I4ZP?E'^"Y`]"5_R MG.+T.KF0IW1%H:%@0\&&@G6G8/TSH4VI8`-S`_,9.$^G$[\W]&OHU]"OOO0[ MK?Q;10Z+FWQ-_?,U#5^S30.#_8V[8AT]>,/AV:?BIK)F6;;86TE9;9:LGM_G?EN_;^=YQ%_%^_;(&I/.N5C_?]%$11/PRF...7#U$& MU+,!RE]8?#6Z<1^_LK#K3>8Q&]+DV(I/OG5P\JVL+D\RW@O5,LW^HE)2-FSA M].P[EHX/+CX07G'WX3.U:>K;[\*X=WM!UF$_WSD,2V/;\%EG071;TMQ M+?\05KOL7OUU#;]<-X?^4^_F!E1O]K(28/F`XM\$Z8'=_O!B"8DL0>`;_&`2 M#5\E`+/K*3CTG.8,TPAT/OAW/IVZ(>QO1-/(8[K!,IN'@[$;X>1S;X"3VV'_ M(F^8R!3-.\8?ST(V\::>[X:+XIQC=QK,<49XF+$.#DN&5?"9=&1RPCPKLY-= MSC_P\(3FQ,?!ZNQZ$0ALG`3]#&H62/)J%-AU#K5IOVP.M6T\?P[UED=>Y_/]DGM;]OG`IZ-; M.>P9)Z4W:Y186875)R6HR+:HREJ3UM@E/,D5\1%CHE=YZ?/"HM<0Y2H*+CB; MS+M'DU2?I+VIB+IJO;U\GJ(BO_3OP18'X>+HW/#,A/(J6SB&"!%^W=BBBDSP M-60SUQL*[''&_`A#!`@9`O#]0P$3.<`@;W7C_J5,HFFB+!_X;.=<5#T_=OT[[TTSA*:+FBS7 MC2?JH3:NR*Y,`O].BEDXK:MET671/G2=TPD&C4>[U_4:[VQ"QCS7LY15KIV\ M.K(C*KK9"&PCL.=G7YII+

L)=I\,?SQ MCW8QG/^7/MI2;O4JE2'ELI.>&_J>?Q=]92$5J"3%*M6N2U)EK$LRC9Q&&]`H MX]H)IK.0C9D?>?>,5S)]!0,V6/#_?_W:&:=GF(HAMR3#-EN2;K45P,36)5/5 MVYVN;7?M7G>OVIG]^CEPMK;+H_\\_'N),@(G#3&CEZG+G>L[7@";B3]?JK1) M82V#Z!&(@H?5@=,9<:P;41B4?N,/)G->.<;"V/5\6()GM+V83;'RQ@5K&S(J MF0F'\/P0Y&<03Q98_Q+%P`;C8#)D891(+&RS@W#@Q:9X<2%<@^X%`1RX?IPL MR5\)*WD^0;4"+;P.%A@%(8-GD\SZ`-X7NGXT2>I\AO^>1S'UT,AJ?MAH!(#A M.K,@Q%\A*B-A@#-N1I/@00#U<,R]"<`#6%'C,[\(G+!$T1"0,IADV05;^EY,VO?_/:XIND0Y#-O)`0;#) M`A:`)_U[%N'F!?,8?TKX_GEQ?4&%4X4WWS(?GHQ_^3`)HNAC6JH$:\#"RX00 M'H`5?OZ@FL9'HN'/JJBI"N%"]5;CD#%A"B(^1BR8CUMV-8B#6Q;FVEE3^%!& M6F'EVV1DHRX2%M&,[\]DL2/<):AAB1+27]B+Y\O75;[NGZ+K95:5. M7S4DW3$Z4JL#)J73,W7%ZLF=;MLXNOI5M^BX==6"0/>(Q-3+:2:XMR`PPEV0K&-M6T[5YEADZ^^`/-7PWH_= M^MVL,V5%U-0#[WWUT#8<532U`U=Y5@]M150L$RQ6[>9NO@+BFB$:AS9?I^6- MM7R\D"/\B[F3>%P[S699NJ@;![YY6#VT-11PJW93A%\NX)JFB)91.__TQ6QN MJJ)UZ/T^E0NVISGWKE_1;$=4 MSR;KY5BVJ*KG@JTJ&IHJRO:YX*N(CF)A!J!Q%I^C^T]IIE-#P8:"#07K3L&Z MI1F?:/3*2X3\N[1`)BF*H3JB9(X8?IN7$AW=?7RSWS4P-S"?0(QX8K<^/BB& M:,M[]X+_6(MH`9$TU;W/3VJ"I*:)]OY#O6N"I&J*BGF8G:R;*W*2ES@L792= MLSORL[3#CWNJ'M:*KHC:H?N35Q!MS1"=*F2NZNQHU?M"AVJ(BG6&\BYJYW=1 M3;-%13^[6VJJ+6K[>]SGF9T_G:/@AGX-_1KZU9=^=0N%GW%Q(UA.T53[8HJM\Z`#AU)S&4SH,;BC84+"A8-TI MN'>#[%-HRFB9+VO*:.G/;\JXY9'7^OS-7MVTC'JBOT[2M4M8Z4-V&PJ_%$"A MS\^N^U!K%GH38:61V7%H4_\SF-VG).]EIZI]5ZF.,-Y#T=1Y9%T]S[WF!=CS454595434.?'9_6FJ\YG[7+0N_>C6E<:Q2'D=PY014$_J>[_H##VQ4@8"T8?D1^%O/Q,X&P.(@;%>8N6%,XZN3 MD==",!J!>:7[W#@0V*.A\0-`R;.6(A/#>=>+`"=W3N`X'9!4W?;KO\#WD1^R8]%('WV MXFA^ZT5C3_BS_X^\`7@G"X/AH-E^)SE>.QQ M\`K`X91G=\K'3L/.`2&FD7#'?!:ZD\F"#\V.8O@EK/+@Q6,^`_QQYH6TC^DZ MZ:CIS5L$S],D;YKI/0!R`]K,'R/Q."%A6T#LLP'3G+`T,CTE+2P!SBU1J8`X MLA@^L(FXJQ.EWVR:\I,L/$!R3"8X/]['QI4/90*6&!50]((A"A"?$C\%1DV8 M-=FSP2+?LB'>C@MAC:G[Z$WG4QK-CG.\2^R0CWF?XFYX(,#)[X#6+)PL@-XH M'JM[#L9N1.BN(0Z5>[C"+4H#(>*BC(.Y05=] MB@+]CF;/_VS(LHAF$X%W<]"QB@2_[[/;<.Z&"X!#52\*>HJXR<4)]*O**`77%^DJ"\STY.Z>8-(K]\6VA0E MV13@R!%8=?@2M=`%&#"A-;^;PY+$%K!(3/J]P(2DE5$5>5R1(T@AFTW<`1OR M5Y;A?6(#EVS)&B8*&4H/OBG.`4]%`<6PS%.@1O^83XB?M(IP`U`5;[C2//:$ M(XK2->2\OH5*19,5H14=A-XM/HM\)>(N?G818T6%[2DS3T%X4Q,>/13IGK() M23(\P$!M!--$=7$+'1?48[I(Z$4_,"8/0*G'Z;JE5_*Z/N,$`!$OXSA]!FM%CK9*%,%]TLD;X+41-- M%B+N3\CPWWS_7"_$.&G.DATM3^2"> M\Q),^`K?COK%F[FIA(8L=Q:0X,:%8OU#B)COP;L`,J#1<(Y;_MD%;57R6TGB M4B0F`7`!PE<&G:P$\0W#MR^8&Z;"C(N3>PN6P_7(N]WTCJ)]28T::OWL7=J% M;J]"O;*>CNNI$+FU4AK.W`5M!='<@;4T`FGJ#AE7J;``AP$HC!9MPA(16-W; M5$GQ77S`^.262]*=[_V-JCHJJM!4`D!]*7)VLD7J/VQ=9?5ONBJ\^O?3&V/)+\1#-?==G7^OS-7EW[DIHW?=L3 ME2?%E-NZL'4IO597U,A[+1F]UT7L\#RZ[BQGR]'@[@IT8Q'3;\)?E]V;?_TJ M&.J%8JQ)T192L_%BQK9D8H]]E^1(A-'-"V4-73H3\-2]$81VZ``>BRR'+DT[ MNUJ\IL#NN05VE^O=T:.J@^-B?`6^=<%@^H$/,71($7^MKE'89S-)71'5_9M. MG^9ET4:H=Q7J-/'FO<$_JRAB+^\^NW(LKY_\Y`]TD?KLT4\HU+*&;'1 MB`WB[?FB8&N:*(KA#YZ*IE4HQ8P)PP!%!?-\P11>.89',1I(A\E<=2X_GEE. M29'EER65#.7YV9\M":,C+-6\NM*O;M)G1XXJS:U1Y\FU?3ED&_U.09,>RUP6C_.]WKN?_PF?1E1%;UP@I M/_PK+%98>)A1ZD5L][;)J$VY^0)!SBY!MT*3)*U?IHE^$OJUX8Y:<,=Y97CQ M0L9AS\_M$V]P;V9>-[SLL9HHH&[4;Z;;O+IHO MF4K_C/F$1TV-;;Q9]5=ZZY(-A9\M62LEQ=9+[[B=\*AA!M.PQ+6#K6$I:XT"J>*99/KY_B^.ZG)2R?Q-''U_(L)WCY M/HLPH[FRBW0!/(4BN0C[)++O?J+G-@*[>F-PM7KP)85_Y1+"O`ZQ-1C,IW.B M$AU7=(H)V$O*OWZ"\.D&A>[UJPAM3;.[1KLEF7*G)^FVKDIVM]^76GU%[7=M MQ>CKQK&K"+=5Y:U+D4?SZ=0-(6R,\/)O2DR>T5[*9V,@"JM\:%UU/GW$\HB- M[$+,LGK9*/\NN=K-MYQ?',\+0\SJ),N/TWW\I3+3C M1H5K\GW01>70*<%36II4N3XGA.B@.-/-KX#5;\Z/F.?0,[Q7Y)P^.7Q>='0U)71-,Z=21- M^25CQY\1H]?]JMK5!M]=N&7@:%/`6+J:?=Q+7$W3PS>Y!/9!,41=>:-$Y4EA M>_*6GXI*HX*:P')@[+^!/L'1#?_+;S_6,(W]8J0!:[MVLV5?C+4J*H<^>#JU MEH"GTY>TH5]#O[>DWVD%$6G\OS''?W1'8.\,@"6:RMX>0$V"8]T4944]<21- M3335M\L`U,FLGU*?VH:"#07?FH(OZ)6\UQV%\H4'^%5(A6?N!)Z>!O[UV`U9 MU(KCT+N=$S`W`7W6QB9_7WFGJ5888D_QIR)ZYWMAR`8X&"[Z M[_>2MG(EHM/KV:;6Z4B*W6U+>LM4I);>:DE62VDY1EONV;;^7?NNO/_==#38 MLIQ@+\>Q3+/>XX`A51_;S&^*_+[WQ73 M-DM4>Q&698*MX)')4?',."/KBG)2MN6=-WN2+:IM"3;;K=;FFR; M5K\++*0ZP$.*K>LE>FQ!HHQMPC_13=`:_&?NA>QK&`"%XL77B0MLY0][65_G M*O*"^?YW778LNX3\[CBMI\75J,MNX\LHFF,WM$X0O8K>>'7D50L$03%)Y:\B MOP:))W:^/8\\O"W'(F(5O*&0?#.L(OH*H2\;JNILW_TM>)4I0F;I2^`'J8K@ M@M-+KBY64/A-5(5J6?2W8[$&XPV&N$VG9-^6#\G>1!?J+^&+(,Z?/\[O%]7K%6:[(?GTI5+%MY[>(^-AJ:U MXK[KA?^+_1>[7C0+(H#_J'0!/-2T55'*PO*T[@L3:SP(L3-\^?@P7'F"OQ_NIZ/5$2#FSX'JF?=3SFA.>&/ MS4!*N]O5G%Y'TJRV+NE*SY):;>"G;E^5V^VVK(&(@3P9[W_7%,-42G1Z9;R7 M)+`LI;AD%16-CAQDF'K9UJP!?L5A3SY'.G4X:>#W&6TJB2QZF*9J6_JR8_X$ M+L_%?8DQ6-1[C$.7FD*[X>(R9M,(]#CUY0@F$R)SFVU9<1Y\#O-5::1BII--M8XV2_!=&/DZ>$\(']8S8@3W`#=T`QS4\29`E_& M[AN;93_Y%/AW-RR<8G!:210QG6+I"@E%CN,F%-;D)]V(=1G_\S+/-G7<'_#(/Y[-)/!JJO51^).JUB!,"3BX:L+X<` MS\2M3!N0^FK[]PK$S::A+*422F"7,0)*1.A#C+Q*&G-$1W$4O4U)I:V9]?YW2=>TWPM[LF,\AE&%I1H\3[];1+;6@J11;X63T<@)CNHL)P!*<"^=35*1_M6H]\B' M3GUS8W;E4X+>'^(?>%!S#P'8ZYSU)[:[1D5JF MHLD=NV/9P"T"MN*O+G M5SZ4=MA>_!FQX:7?3\>5Y4?F;Y[*W55",;9Q%%5;<6Q?@.@.IAW,5ZH&5M(I MVVQ?%2V\B7I=4W8X%-D7Z[T#23K6OAK],PB&T35.MJP@^9`#X0G#V3>B7$9R M^;I*!.1^"P]HU]"22Z"CE1V#$MSKLJK(3-R6)'=ZJHB<\_YWPY!7KW"M@W_% M(@X8&Y)X8([Y:O0O-AG>!)^3L;K7;(!_5O42E@U>@&TMW3K:':PE"5 M)9%_3<0W"],G#*P@%`_9\,@Z8]>4`LB.S6_J;I"=$@HKF-Y[Z(Y"J-@-YK?Q M:#Y)3N0J*2H0%!JFM:(F-N*P9-S6.&F7_CW$DRN=TE;/J*I(#A7/9Q6#\I)% M8_@2/)<2L^`FX"#<](I;EQK?<>$Y*D6UV#0V^\1RS+6WV2]=AL M"-S`TPO`_9UXR9'HS(U#+W6-^7E2SPU](.^1^:3;<733T#%5WX*H3M.EEFKT M0"VWNRW=,C735'C27J'3\+51W3.06PIS,CT-/RO&"U7D"@N"_KU.7H094Q"2([EF[NRT^;#Q]FPT'P*QTLCMKN$"UQ M]%?HQ3$#&S3Z[#YZT_GT%8@RFX>L2(W++_T50'QI1^[_IUW.V%4L'*H;N:RT>[W ME;8B679;DW09O`6[[^#V=E6U)\LJH'3L;N9;IQBTW0DZ9C2,D_6^7D.6JEO&GD5F5:2^^/VFKGX]=%K/9<<^BNW6>#.,6$"GOAPU<0?O)GE6_VNTC#7K4F>MI7].L%L0?W) MP-&,0W?(!.!'G*2#(V[PWU,W_''<]MKXY9[]U51'=&1YIV M&ME3U[ZM5/_]A>EB]RYDU.9+%`;S"$@`X?[$PWM2J&PI M_#\^$[ZP7[6IJR]I35K7-MVJJHB:X32Z]R7"\8E%T:]"X1:9X!:.I6HG"A\4 MS1!US=B7*6HWGT+11$<[3%?B4^ME>SHMPAOZG5>+=6.K"L=^,'GZ8N7LHG8Z MW)`M4;$.;->KA[8":.OJWI:K&3M2;YW4T*\*.KVZ21*:/2I@>Z#8&WET[KOF MF-IG\='U_9Z9,T.S1+E^:G[?/*%JB'*CW<^W\W]#P=?5\%MF)SSKWE/AJM27 M^?26A5>C3I(8+!0A^G'H#EZE\B5=_*EK8:K:-OO]MB;U5=.6=*NO2([3ZTD] MQ^YW9;7K6.VD7Z6:8/PT^`5<5[N3O66'%+FM]'7%,B5+;?(^Q_P!$^)`".9AEKL'E^>!"<%H!#A$[)Z%X",-/?PG^$GP_"C% M"RPR,(;/[].*X#JEU_E<(1Y[X5"8N6&\$&9AZ4SH,<-_AR>QTYOH+*9H% M?A1@)__D%Q="/PCA4;;N<0(*!`[<,EIEY&*Y0^S&\,@MBQ\8\^G1[`2"#GJ7 MULI`AP70Z8./'KQX#-Z!$/C278#`>_Y],+FG\PSX.RV18QSGG<8NWN$=AR&\ M"8FW@HPHL&Q*1=J,:RC<+G(RTZMAD2@.`UAZP(N#I^X"\$E>"4_,9[@_+GS. M+]`&(^%GD%9A%""*"X";P1KIHA?"7TRX8SYNVF0!VS>9E/;$[+XV!D*VT?.PP@9!E;!=]TF?:0(E@$OE`98 MQNX];,8#X%*S'G0^%FC-1ON_X/7/$F^+$(I,_P[?S6B\:>\&?_ M#U'X%`\OX/7A/0EY1$S@`K?%M-7`'!/O;US%!7%@_$WSH@!EQ@$R=?#@@UP`8,"BGALN M1,1N-)^,/*)+R*@\EPA!/(FB[PV\&97.I;R[B1J$2<@&#">SQT2365)A@W3A MCZ94G8/0"Y$[81="*Q8F8"UC0='^D?XP?1`I$C)AS":D`)(U\&U(Q(@WH%@` M)5V4,@';C\1S!(R%(Q0QW$K"A!:%;1\!38(+W#)AX.*=8GB:\PK?D919-LR( MA)70X`H/\';4)2(8_^>(V`'OC5]C'=N0Z_I)%(#6PX`<]JPD!,2P?6]$;(O: M_?^S]Z2];2-9_A4CR`*[@)G4Q3H:/0%(2L(&DXZ#.#V-^=20+=KFM"QY1;D= M__M]KXJ2*.JB#M*4K7SHMFR*Y+N/>H=EVZ<[L%!7SQF>KO!7$\6;;E*`.5T# M#(#"E*(O#*R/IW<#5\(.##O'HV>?/Y\[4[K`I*@*%]C4:3D4WW39DY&-)V^> MO46.$;=E0_%?.9Z9?'47-D0)F&/$'=@0[K%R6:EC0]HH-OR109CI5PMPQDJ` MS`30<)-Y*HY"&/VD>74:X+^5B\&_\FZ!_/WF7U_PA]P^4,W`=]EF%$/ MV`X)-!GV#!9_X_?)_4%]FI+$>+KP^DO^I"XKG.4&:@^3\ M#?3#-\5VJ7M[Y@__Q\=D)BBCW<0IS9R]_\,F-)":#`]6>/K/R=0;'([0R[Q, M`(DXH`87GKF5!V=6)4Z_F.:N6`(7W`.NA]#1#6PX>QH^PEN#5@,$IH]]2U7T M,('&B?4;I^Y^CFA.*5K@'$-9GAC%[I[@(SSD_?!TBM/$/3[WBLT1\C3OV\_Y MI;8/Z7K"1M;91C&VG`I(=YP.-YGINX?)!!FKH8/+Z$Q+* MV3N\IX*=&V[.D>#@FF'$U@>+A'_K+7DDWF/C0YEO'RJLMJ)W"TP%-.2,V061J/<@<+3*7S+H!Z01M]E:`Z^0*HT#LWG4WN!K: MF&IJ?"`N1>)-`@Q+5ZM>N[E[W<092T]_A3H#1X(^S9Q!IV,'&!>A)NKVP,]$ M)_TZWSF-SW(WB9T"'-BK/V`UD%U);XAHNPDC]N3>F@`+O/TASDWO MG88"0*1!ZC8*3CTYM'^NB?$,G,`X4PGOF3A7ACNA8N9<2XZ*`3AY)4J<-)PM MMBQE$CLO$XY1$2#,+7P=?SS[7/[,D:HNYQ$'=' M`_L4;-2V*0YYKC1U"NJ]UN="D9MQUP<9:L:ZPGK=4Y[Y/,L2\EX!X1--F-*Y$HN60&1H_@/]BLXP3EP'GO]M@X]B>NF.64_:24GD@7;-U0PLSAOBNC"J?>WRN2HF M/1X$Z%(C#^UI:-,G/M:)#KX4'3O/?JQ&[+4$+5B=)#"4!/GN$]=4F)>6^CI@ MQ8H`CG9EBZ63%'%8,F#-Q')"JA)7H2 M!'S:2@?P4S>`OQ@X5#=_?]T<0+<^NOCLO5?^YA'J8U\>@!;8.1`A,`/E-B1VUH0L[;A'EA0#J>X%'; M"P)!@`-]I2E3N)5LE@`PFBDCR]N&PT.J0$.;ZB"=NL):F<+^M7H!91IH6B&@ M$W//)65E`+7IL&\NT]J]C2]NOH%3C.55_<`F9N<6S60Y;URY$Z01#D,\W0FEUS+4>$(+YNG(IQ[1OO:- M"@!];:<8"$X*I2)+!NX)?25;-`^2!`R"5JO#H\!3;:X\$0H%MD=*3[-02>XS MHD(YTP&3LO&U>S5=]G2:"IRL7?H-CY;!9?IWW!T=`F0?/+3%?:AMTU:J$WDJ MZ``X\%\O`+IZ1(),$\YH2-14\0-',8],"O_7O_&2!H<)\#A%-NH^I-^F-;\' M@VY*T-G+;>+P\AA`55=H>E@)4@GP]]E\5S/D?#/DBRON<$;PYT$Z'CVB2EO&(KX.(M14Q M"B<]`V3BW:=OE/P[GZ8OOO4ZJ":P, MVN)MJ8T;$?-9A/63-<,_R[I@3=HF?I?%]OJ5[%G)B@DXK M]'BD(G#/J/",-H$7^JT.%4Q1+<*\>\:K<,\.J^BE-MG!#<8N!7BYUGYH&$3^ MA@M/L-#W`F9:7F0ZX*6:4+>D3=';E%0YQ7Y0[XL3"PV$QW.*G5,A#%VDGO$# M7S$(.2!6`U[7Q@O!H_2"E@@9"$'4,BVD'LL4.?>(VM;Y.AAD:%)`WOP%R'R^ M"%F+*!],4N"UJ`]TDCKTM/2YU];MP`\"(XR#S/(E8LPC8EO(LE4NG>'HTE9H MX8=YO^3RJ?NP+80^XQ6FY0O ME1VNI`(`=`2Q<82"'((,2PVQ(0\51)EMMZ">Y]:(K'SQXH+H^_OAX'(\O/ZK ME>#&D4$/5^79?3XMS+:-MHF;C*,J)05(<[S\)WA'?Z9X^W1S4J#$EF506@)M M#IO;'KT9J&6[R7(+R9?L2%@8DP!4T("*4,I._V%U$V?R)R$"CG$?='C#-3XE[@JKXG4FJO M3R]F-:86\34AJ*R8@7-@M";SB&*F% M[!?WCD#5:$2,6*EJ2L"W`WJ.10^+G9"S2OL6%QIE5<+S0IMG/]"7BDWS,!`=&(,N+IE#,PJD-9+2O:M1K,'(YMD)8-B M05K"I@`;&#TE;:X%2\NX3V-SBCMT]05R(?8J5`MM7293@D`.)A\%J4&(*VZE7 MP["D".?K<#":M$EE[K2I*DW6R>:2C4%,5O_:8A<6&Q_2+`/>$15F\B`FZD8 M%62[XZC-OF@#0:4H*E3+8MW#)E"V!;W`%1C^CT==VT#>'3U_'L?W*2@DVU(Z M[/6& MKF.)]4`=:*EY@W'$M%W\+LO7]I:"=,%FE^WSS5BQ@6;9IE#AV7[1+F\)VL+N M]T8;78H=2URI^0*!N;,X%??1L.;I(E*$(^`?%IX@(SE1"^TXXP>)C*;>@UUCI:JC;%PLI0ZZ&"I"J8KS6'C189: M"/OKG*ZT@(S:Y@U9;H'7D8QOETH^3(ZO9E@Q[4?I%DF_2JA:_3P9ZWI2`=]Y M8:+6`2K84:ZD*)P@UT[6&B:$V.,PQ4&5O2Q9:P$5JP(,D[R.?O<%.&MK[+V.:#77"S8QT;M'ZSZP M[6G:S$O.L74?[(B@LG)FNP]\-F\0&]E]L(B(`W4?9-VU7.9$JK'=!_7J&M=] MP%>IFJ9U']2+'+$3]GV@WU@+M5^8-U+H:DJC!X\KO:#?=!4ZBB-VO8#7_FL?-E2 M`]H/:A`9\#,U1"Y;GAD=OOV@!E!M^P'SY;:U](UM/Z@!9]A^H-C6*&M&^T$- M^,'R::X-V^8HLLK^@SK$",<\*RK8&IYH=/]!'8X7R(W@1]Y]4(-5)O;$URP4 M$[]<\T$=`H3GW+XHE$!5TWQ0!Z\#-/"I$&0TO/F@#KPHL)U&E"]T.^[6@QJT MA5IF>!K8>E`#TD-:LNJ6B!MB,U8!D(8G=J):* M&C@<6RJ8H3MW)3>GI6(?9)5JJ7!SD@M5A\?84%$#6PEPR9N_J;LV=.RUJ'MA M6+P[8/L=WC:]N!K#U8Z42!)GX[ M`B%R?:WD`R5+AMPO>>\0W8.6[.Z+C+]V3E$-%;7TZ-.M)TH4>T:K['%X&5GL6(/@6Y?^5D+7Z3AT7 MOOFT..FO=JK6`2K#D89"^/QER5I#IXX])%>"%*+RVLE:"ZA8*P3OP;;833F_ M?^*;74R:7&]RRKR\[G@ZE\L"9 M$1`VD*#3SGF4=!$)FX";1\7DCQ">726#+/\[2)/>),&.)XLW\6@4]^A+HH4+ M,(`\E%[4"0-$2\LS(053+J*V(NV6W\:M&>")U;.%PANQB['V(]=.QM6F-K+04J_C8;N MVLGNP,/AKYCKBE3`560\V0G!+G0"XQG&?<]T.&%*AUR%>KKY\QO]=Y;S\B?H?X82`5GW(=^4#`^*UQT8FRP7 M!HRQ-0YW@S%6-88FP>B!,/0%!/WB)@*]GXP[W>NDGXR?P4%*G%EH[8F<>63L M`JY`<+5=XTD\(CV::^0I\>X.V`P`^P)[`&!O!K<#],*3LD_P&7OBQ\E-$H_. MTNN[^#[^Q[N[\?CAEX\?GYZ>/J3Q]8?;X=\?H\__!*K!/VTHP;72LZ_-;I6Z MI8:??OUY->KWDE_BGP_]Y#H9_Q9CG]99+[G'$ZOAX!_OUB$A^)FD[SY95>[^ M$-R.8MNRX^[SZ\>EM__TZ\?)\S-(/\Z!^NN#U?JYMQUW1V.[9#+;1>HQ(,_L MM],+XT$O=YGV",5;]W(7@>69W?S7CQG%]B7?6N%\_>0L_=2\@G!/F[[/<-`; M#FSH=-4=_'5Q`TYBW,/KOGP.+[Z_<7Y::QY/_#5]ZG=L&9QGK,RA/'%P(SAX MN4M\XN"U')P,3AQI?#F_%3=Q2_2?IE M!Y#'1C];EYG]_6W2S9V0'QO=\&3F\1Y]P?2-D6UME4*$YJ4\&L<`\U5236282['@`.;H<^BA$MWBS1'PY8=RO0F29?5 M+1XMZ?+1W=LDH"LG/D8"SKKE1@_#$5SZQ@BXM@V@D02M)`8M_?35C637W5G2 M9]/5;XC)&I?V:09V5LVV?SLBMP^3"X\HCZE-9!1(1JS!J8&,I[3/JZ#?*>US MI'0[I7V.BVRGJ/W(27>*VH^=@*>H_5@)>(K:7UG4WC0F:U;4W@#L<"E<+8MH M)'I$"?2XDI>*T..8!S[.U;(PJ:C@^%F"L^`JN!1OJH;*]U+D'(4.*(!OPV0P MOAC$E]@O.QN6. MQWS"E_%84WFJD<0$35BDQ&7HR>6)R*ORF!A7[$/./9'P7=@=_54A4 MYA&_!%'M9541E63UG@M$%>9XB?HU?LK3-:I-1LN=5,!E%9&3:E.H4)7:9(%C M4W.DG630'5PGW7[1E.<*ZV^Q/`?-?1.JKZL[:%HD7['Q0TII2Z^,[S?,@/;B MY)I?\?O.?+\E],HY[+][[\>J8 MYM1[\4H(N3HD(PW-P*\,R7)QEXW(7GGPU6!V`J.BN&XJ^VR;LVD:X0#@N+1`^#P^6OW/IY+N=V,[W[<):/>U\Q8 MEPB>3[[=MDQSJEEZ'00\%2T=*^%.54M'1C+Q<-]7JGI1.H'\?/>(X] M'"R63@37UX_WCWVX=ODNO;=*6,*U_UH(^S4>SVWOCM/D=H!_N!C--MW@YHI. M?_CD]MV\-;*?RA"/G7:G.L2CI^"I$/%H*7BJ1'QEE8B-X[)FU=HU`CWLU$%X M@'JV,C6359:4+M#QE(Y['00\I>..E7"G=-R1T>T4OA\[[4[A^]%3\!2^'RT% M3^'[*PO?&\=ES0K?FX`>1`YO(G+X!.KUR.%5(\W"<3=09K&XS1\_JW[G^$HZG?3?(3P8]3MQ5C@F.:_?U-Q$M^M3=O(;.ZR M%V`V85O)&!."-JSWJ"',UMF#T5HG-IMC,VKD2:<=BLU:\=]Q?_B`CLSUW6#8 M']X^!X.>C76*=SCQGMT4!U\_\=Z^O#=UL!_3,<30H^^Q*UE,[Y*'-\QH;XFQ MCIR,_]_>U?:F#0/AGU23%P)3-6DMK3:IZJ:5[2O*P"J6:!+EA95_O\M[@+`9 M#2?G<-^B.#[E_#R.[;.?"\MSY%C&F+(CG(^F@#=PX>DJB@,@E?<4@=3["K)+ MGRG-P]F85*=\NL#DZG(U:(*+S::PCK42V-A!VF\?71'^=#<)O]M5EY_!IALNU[NG-#:^ MWX6JA[YX01)'V1/&D+!BMF&K#Y7TAM5H$%A1W@(=T:)D!`/`DHZPH3["UA,M M2+F"$A"2H^"$A30F>&#!M"VJWF!)'+L81&E%Z MH2ABLF`1'N\=WBPDL^H.K+;^>1-GAT!Y^JCZ8":J-WI'8?HMI]GT.Y8JL' M#I&(74L1.RKVD#9]"-IT7)0BR;ENDG,$_+DFOFB!3A'KS-85!DYT3@87OT%C MA/NE#^^!"(7W^M6;\65FT@`K4B_IB!:IE_3'DF0J*`$A MF0I.6$BF@@<67*<1SO8Y\43NL(A\RQ@YBQ\OL\JE-^Y&2<@_%F4?H.SVIKR9 M&TOK'UB*UBXLNXZ,Y+K.@=N+&0_\2,3' M-K(]Q,839[@%C;@`/!8'S;026X"^AC6M]PPK6^@D?MTC94#)(6^OGYF%<--Z]U?7B&]#>C$6A1`N6&R3M=LI2"4-U_*#=5%U^PEC^ MO8*+/U!+`P04````"`!;`L``00E#@``!#D!``#M75N/X[J1 M?@^0_^!T@,4&V+Y.)LEIG$G@OLTQT#/VVI[LP;X$;(ER:T<6'5+J;N?7;U$7 M2[)%B;(N)'OR3R_6MC#%`5XM$1OQ"?K M[>@6>5;HH0!:&SVZ_O;Z_/SU]?6, M4CMM\LPBZ_/1Z6G:W=]CPJY'?SJ[NCK[8^[+G(2^?3WZF/OIEN*X8QM(NAY= M75Q^/+V\.KV\6%[^^?KJP_7E7_XW7YILMM1=/0>C_[3^`(4O/IY"C0^C^=G\ M+(?Q/T8+XC,HO=X@?SL:>]YHSFNQT1PS3%^P?98TZB5P1\!1GWTZR2%\>Z+> M&:&K<^CFPWE:\.2WOQG%A:_?F%NH\/HA+7YY_NN7QX7UC-?HU/59@'RK4)$W M5E;U\J>??CJ/OL:EF7O-HE8>B15Q28+`D;`$_^LT+7;*?^*<_G!Y]L;LD[_R M#G^FQ,-S[(PB&JZ#[09_.F'N>N/AD^2W9XJ=3R<;VR*<\Q\O+^+ZO[\C5KC& M/D"U[_W`#;83WR%T'5%],N+M?IM/"N1O4!"`I!`07#Y,+F:1(`6)5)[S.N>5 MS9ZW)7H.-?^Q"$#R>!]3Y\'U8:A%)6YW3>(O8\X-'7MG$MUV*K:`;<@^;;4WYG>A*R_H:SOI2=(BW"]1G0[=98D`'434NL9M/Z,NA:^A<^NS6T` M*`C\GE'LN6O03'3[@%SZ=^2%>.J,&<,!BYJDV(9BCRYZ3BFZO[-\D)NHGTFQ'YU/:\_]LF3T#U1JS3IKW>8F=3%DZ\PZ7[! MG@W<7R"OC2'2&0G#,2,6,C9ULF_??-!?I=7&5N"^1,0.P:1C2>O2\DCT#XS4 M-'C&=%]1I=]OD,?W3GQ$YQAVJ*#38WJV-]N;D+D^9FR!5]SHZ\8LZ8&N`=F6 MD@5#6_:YGQ6H'6`_QD8Y]AFUM?Q'.YC\9.QG/QC&'T!N!6I^0.QN1[ MQX%MIX#D:3FINPTL2S?V1L+Q#IJ9D M1WZ0[N@9DDU]NE^/ZKI3*_$IF#`6VDFZ.H MKR3`;$EVIF]FNZ;;^#O,+.IN$K=S9(=-G1G8POQ4DO^ZQ&_!C4>L[RUP=TJ& M?IR9P=;`:N?=ZH4<_3BUY,NQ+GQ*B!F*2Z"#``+(A M14#?W(">-X0A[S,EX29Q[X!)5^[5'DI26A.E.]=ZE*Z.2.N;@SE']KZ3>B@I M:TB"7ASI48*.(J3W&;?SG.9]^[[]"[97W*VP.SD;3$>U(4AG;O6IF]J3U3?G M=K[3C`36KR!5]Z@4;X^B(--OW]@G_@MF0?)/OJL'4?R"Z'<<^>GN_QFZP3;G MA!8%):$A2N=R$'N*@< M>P%+?XE$ZO3B,DGM^GWR\S_&ED5"&,L9VG(%=!M2&L5-QCUYZ`E[GTYJ"I^K MH9N&.!\K4TNZH+PBZL5'D+$VX0>17S$(#*@5,:9&K2A!NCNGFR&7A^.AC1M$ M.3YKXB^"2#65@ZNOJ`1/M#\1T1Q_5$=7S1PHE%%'Y=0I.'^K?;\RD(YJ4`5^ MGH+(5TKX']\)OR`O\BP%MXC2+1`<>1H$4.7J*D&5S_D#P]*V?RH!"W%)MD4I MW5)5U6!Z@:$F=`L4"6G/%5%!8TXT!23F2RBF$%1ZI!*?B6?#/B)VD-:375Y- M,99J!:*)QLB1T:$ATK95DSA1NR1VT+`:?OBM1-]PE19703/C)`5US M7UL-R24E55-<+TGEA570'?G!>'H.03Z;8PN#"0[K,RQRM2BDJJK`%+D-).W< M\K+*J,[I&#G2RRNHH']&\0:Y]OW;AJ?)I7EP,CMXF9IJ$!'0X<%VYB&?'_AR M!;/ MA`9HS;1:*E"7G@=G>`URATKB+3VSSP`;Y!*5!=PR?"7CC4&> M4[DE[3`0-5O-#=)O"%S")S!-T@ERL$O M.\_,X!:TW*DD7ATRQ9+GE=0$]!_DJE:G(E754).2P`+^J,$+]BOR$?)EE(3B M[[UF%#UV)*"VO*P.5"=/,TG2G996DBQ`84684>((HV+R)=2$UZ<+UP,HPCBC M-@3V95=A"0B7J*@GGAOLD,+-GO=O`46@OJ-GG":@#"-G';]>GGA>=&-Q?.O\ MT8PXOD<].0@S*U(&T?0ZFBO%5K1%FJB/UE@+[:A'6W[M7`F.18]0;[6+SVBDHK2MV+5'Y"BI#B8BDE:0DXR,1"0&>Q MC)*0_5@^_57"*A&EA^644EO+V;*2RE(B!"Z0[#9#]M\A\EQG&]VSQB\SQ'5+ M3/MV=>/&`]A^[BIQAUK;)44^0U;DU?#MZ*_$QV'_7Q@',;5@48O.E/$-;%]2 ME.IJ)5A324E`/G_H(]G8BS-0]DLI]71)N%P*0=)%K6_D@59#R'U-:B,/QSKD MG>3R8.216J6#K1CBV'"7;60L]Y'L:+1Q,S*PN\:EV5A2BGLY(T-,CF9)PXVN MD1$H)8[D0FC5OOUA9,!_#FUH<=!:.NS$MA9(K"T(RKV>8:F=0P,`\/'*2"E&O-IVRI][29JC"O\O(7D[+PA9&2*GR30$B^](-O/I#@JGHW[X)%7-O%MEV(K M4'+/]L[S]$#H>,V??_A7A%_@G!275W)O;XZ`W17F_HIO`81W(5=5T>?N7=B/ MNL2&:4$Q8O@.Q_\718PU:4(51E!4+R[,GYOM-X:!K#@;^^#9JD-E7@'Z^#9U MX<).M77(!?DVE=QTC#>@[-PJ)5,HHB24T'%`'T^=^S?K&?DK/`>E/?7+IYDH MOK!)$THPOEF8,3"2DMTMMZ92[RNVN5,>EMI831[*DPATJS;5!\.\B\#&@KK/ M:8,D$4.,IZZBHC"2,A6W6[,\QE#>B-K_TXRS:J$1_D M57"#!O3&UWZ<91M5!(ZQYN0@I'`,.P):]^?D:BH$L_4X1F^$\9" M4*6X:B-654,Q`I>+D6]+4+XKJ9+B)1E;8$R"E14RGG;,DOB(R-B,OXBR8!HU MH07&^OM7*ZMH@4%X;Z8L(G$#BFY9MC"V(T,XG<=3)Y_Q+\)57U$UGL=\'K\$ MC&)YU=3G%HOH<*G$PI7`)-.*:J0\M&'J_((]>TF^H(`_XYQ[SED"9$T#BO"] MN`Q,%&#\'0F?`B?TTNMBQ(C$5=3<`[[9K982&D%87,V=WV6>"U'4;GEAM=&8 M1[B6]Z)YI3E MEFW?!'<*Z1_\T1-SJKP-@JM$?SQ>2>QFC+R*M-6(:D]O9'WRS4_XSK.%J^+EC3(U&S'LI9A.49F*'9ST%BV M"LJX=P7I>68JM"YY5GET(5<4862.?JNJ>*16I"D8FOW3/ MH>H#0R,?R.J>2:)3/2,S5'N8994I-4:FH';/I):Q\\;FI'9O$=0&JPNN'=`^ MT8\;@QYA(<6?048H\K)W$2:^0VC,[A/-B.2B&P;)Y(^NSQG[=G(QRO[-*_>S MA8J,Q4AHN!6P>U,BNEI_'`34?0+:GSR\)-ED3#:`8TKY46I5W&`'#:N(4OF? M:$9@>_P"`[C"7\/U$Z;\%#2[S89-PX`%R.>/L`C`-VU%(Z0'Q%5=5]^L#:7Z M]LB!S2O8AAPSZW*4[K@$D*W4V=)8/1F M26C#C+K\'-IG8*@D+WW[]HQBSUU'EXH\()=&+S%-G?B5V=37#,7R;Q8R$$"@ M6X&N2_WA((]/0#*',,<66?GNO\#HLD'F7,=%N^?K*^DO/I6^IQ![Z$C%VM`E MC.1)LKADU0/,`[!4GI9WQ?7<.^9#,SG?]3OA:?Y#\;G1X9A;080<#,GN)W@2/8_?.VEH23.?Q!,Q=?^7N"D>2LWQ&_F="[%?7$UT4 M,"P-YG/Y!BZ%],YE=ZV:>6-OP%X M5]ZOZ=QLFM(\3-\&<35=\8:9U;6]*7D&L]KP.+0)5+@;^W/,Y#V2PVRLC?3W MFC<`.1O0R%`>\SC>P(-G9.B0>2,B$Q-O4ER2>2,@L=\W,@3*O)$0[#R,C*WJ M>=??\P)1Y1@7!&G]>SB&]*`;^>B,H8-0[W0W,O6CY_UX7Z-1?)_+I,R1`1E> M8KH<=?V0KD$M*6_V;;?[-\L+>333C@'F.+H$QJF-'=<'H7IT7P[Q#G)X4DV! M0:[$?Q_W:<#E860VZ\U$E=].4/O;*-?HHA_>B:?!$.6F63L/GJY+_S@%VD3CEF<]ZQU!7$YS9G;%$EB0/'[3`HP#OW9!R3M= M\41S@/(-8"Y.E+?3=?28"C82/(SYUTB4]/ MN^W#$"XE'J[;RE"Z]NWJSPT:RD0:M6M3W9Q)V&OEHH.&E?H:6FQ6"K<@=;L#,#+:;7A6'B[[1OJ[AF=<]0II M9)R9"B9*+*9&1HP-S\NRS9V1(5XJE*!X1VADG-;P+*R-.&,/4KT$074U_)(/D M&V_&EXUMD0CMY46"E?]23@OL4*`#3M'4CPXRBS@:5-1F[("L]+FTXOW2-=QN M,H1']Z&YXS*ZTW7J\&T"6Q!/]$9TFQ8UY\#NNM$D.:P#W_Y^BUW-YD9F=])Y M+*V"6=ZB0:TSO>&NE-U8N7A_I7X&G5_&)H MO;AZJ-,%KMBQPPIHLD(WW3GNSN]OA,M)%.S!_C]\Y MM7R^0`/73R[7+)J?^^[^]/L-\OB+MOQ$>8Z!-FPGCI[MS3:-9U_@572/@2G8 M4DQ3I_2S%JEE#^+TB[%EA>LP'HO"&T"EQOX1#:G8W%20"4L,$\6"Y/#Z)JDK753F!S*^7]=/1R)"83ADAU,-F M[K::S(#BTQ%-M821CI-CV5,G8NB_0U0O>Y>=-?!;0,'H61/,L MN$K:U$&U;LQO<+1OSO M6&!+,A^3[_8XR$2"I^Z&E"9/!RDY](Y)W9&4`:O,>RPKK\+BBAXX]VW^/Q[B M^(*\PIRK12-?7Y$]N9M`V91+A"L3([%)*55;@X"ZB@';?T!:^UP,\E/ZG)W!-:4-`>3 MWJOB'7X*)HR%W*VA-Z6[DW`]K;@H27=)=AZ8S(62GJG>8691-U(CL&V*7`Q3 M9P:;!B@4'UX#)3>P4GY_1U!FQ'.M70;!NX"TC!\:T1U0[DJZ;!*9(V+5Y&L^ M!@5#A%5;(LRDT6D+3/-QRX69[)_LF#1*S6!H/B:9-RU_!N7;OV![Q7:%]6=]'>&:\YTK(Y,D M?>=C,(GH1[Q"WI>X#:[<(T-\A7V^[9:@_N=S3M438AC^^']02P,$%`````@` M6W.*1W>TE.8Z'P``K/P!`!4`'`!P9&-O+3(P,34Q,#,Q7V1E9BYX;6Q55`D` M`_[1:5;^T6E6=7@+``$$)0X```0Y`0``[5U;<]LXEGZ?JOD/6D_5UFS5.HZ= MSLQTJC-3DB^)J^S(*SO=L_O2!9.0Q`Y%J`%2MOK7+\"+2$H`"%(@`2IZZ8Y% M7+YS`!R<&X"?_O6Z\`G@Q@X"#7"V8?3[X^G@X?+V]O3_[U MSS__Z:?_.#T=3":#*Q0$T/?A>O!O!_H0@Q`.GL`K"M!B/;B"4R_P0MK8X,X+ MOCT#`O][P/[K#NA/_QY-[@87;\X'@WD8+C^<$UX?!W]Y<7+SYH?!E@J+`_3!X7_CI$D,0=^Q21!\&%V_/WY^>7YR>OWTZ M__N'BW#O[J_!3`H6OS]A_@_#LC';S[BPK M>/+G/PV2PA]>B5>J\/(N*WY^]N_[NT=G#A?@U`M("`*G5)$UQJMZ_N.//Y[% M7XNE*0XWW!0OPGI_EGQ,2A/O`XG[O$-.S%,%<@;"$NROTZS8*?N)CO MQ#WY)^OP)XQ\.('308SX0[A>PH\GQ%LL?7B2_C;'J3`6OWZ^2V!'\)PI#.*T1G.1M4#Y)XVH7I M%#YC=B&W@>MAZ(1ZX.XVNS?R*X\X/B(1AI]@0*6M M/W3=>`B!KVFJJW6@GQ`F5*,P;GT\'0'B.^0EBY"T-Y35O;1$TF.T6`"\'D^?4$C%382=.97Z#]AS MX"7][+E,8:`%*;\?,/2]!95,>'T#//PS\",XG@X)@2&)F\30I<7N//#L^;1U M2.@W*I7WD8D&0;?-\*SW6[9KS;QG'R:HKE\=/V+ZW">$W!?/]]MCGSJ$MIGQ M-0"T0[J:'S"Z87-^LP-2O2WR]Q'W^_:LD73V+T35DR""[GB93M(6I4J=_EHG M,Y]UR>(K+;K/T'K4<1\0)(R".<,:5/ MCUK2`JX.V9;!HD/+^]S.#J0=E,Y%"K&WHO-X!3?2_Y9:[SBV*=L4T`WZ[8SL M@KY$!P-B2,()G<)4PPHQ<$)J,[$18=H#_FJ1M$(W MPV<4I1\`58G2DGI$3X-N6R2:V5^D`&&TIH:Y&^WE\6W2FU:/AQ,MHEC]W]W> M[A`I.F0J2FKR@^C#TR6;VG2_-NI:JY;X'-X2$C$=M$U[HZH7C20EBML3>&US M6ZWL1$\HZ@L*(7E"&]4WUUTS,_X*$@=[R]3M'.MAX^D#U8595)+]^@1?PY&/ MG&][T*T5AGV<>:"F@;.?=ZL5./9QZHEMQ[;P*073%9>H<'ZF7QF$7`YTL[HJ MNK:#`QW,#24`;7.#]KQ$!/B?,(J6J7N'JG1\KW97,V5O4+9SK<79I0E:VQPL M.+*WG=1=S;*:$.SB2(LSJ!&0UE?,^FS?C;JRPBW/^:I.35/=XM`K=MV^QO4<=J=Z\OMJ?[],W<3= M[7F2#MNF]@[.@'^?$,"VT]AZGL&`.3/;)5NMYY1^@!U5%@@.*V7'H-@II?4%X9GK+<[2,F<@SR1K`P_MBJUO%)RZ<`KB3.8ZZ':K=X,5 M+:C^U1AJ4KM-I'$/IPNX>(:X)LQ2U18QSFD3V(F>X>F&,_60\AI(\;J;8YOL MU&8),UUD,'#9H8OD5]:4YO-T"8:S,HB.@"D>DK,$8GH"5^GNSF5Q M=;V#HN;7"VOH>?5$TUY4VA+D5(#!6[K)U("?5[&$AM(ATJ'OIQTR_IWN4A=S@- MDQ0X'R:"EGF[X^(W"#]@E)2E&W:,;7O46^W*Y&PIT#*!#IH%WA_0O76I:D5U M3K#9A:2GBJ_@%&("5-('X`ZW@9/*%T6\_D%R2? ML!A^9343M,3GP:B)`H,(BK6=[5)&D#IS*O9].IDYEB89K0M_Q7%D$2EUF]%B MB3Y!O+A#(!"[U+9*F.#PUX"PI"3HWB&6BH,7+'@M8"._K!9>;9JF$P[Y*[K> MBS),S$&E>AN$N3MZB,M8`7:RYM/(5-T@6UI[BM&BCI\Q0X$4O:P#A%V(V:6H MYW][^_9DL,0>PE2,?SRY.!E$A,)&RZ1":V3O!GM522]8&XS@&ES:4/WVK7&J M2P/7'M'4##!/-LBUW4I*=SRD17+K2_*,]K=O4^J3V/,'%N^![L>3$$;(J::YTH<(B_R@!_D->ZP4?-3-2?1"J^4 MPI26Q>`W)M6VASZ?H?:JHDJ$J;G3E*FN`E+ M:&SL39.>&VJAH[[SZS)Q,B8EJ?1?`L]EOBBJ'F77\'?&4G4L!\5UV@KT5NG] M$MTRN=CU@?"T^"'QF)$'L):D/G6+X?"X'*]+([Q->NX[1X\G5MKG\;;3,9XY M3W,05"2L=XNA_UQ>T?((BY*NV^FK[UPK_-(!WXJ]]9USAWT.32<-L:S)Y7EG M&CV_W[YS\P&C)<3A^L$'`;O$DEU=N5QTLU6+^^X15POW,W>PJBM[.YZ4L^Q, MB0WAW4,ZA=!1/KX%@:)C-KX-V0_UG-:'F)G?C;/P$!/]6S)(CR<"M,4!#NG< M0,?FP?$@P=Y^NN-Q@D:F_B&>(6@C;GS(IQ$ZBK(=XFF%3D)HAWB*H=M(V2$> MAF@MUG"(ARJTAQ<.\4`&[]S4=Z_*5_NDC9_.Z&;!Y2R;6"&,S@5P*GD7_G347.^+V:/%ZH?DSN M/B9W6Q,^%;A.4I'*7]R=I.3($?2?P\^9S M;TFX&Z)*#2W[]!5<01\MJ9D-G7F`?#1;9Q&`[=DGWKGK-V*"^Q)E:+2^![\A M'+\E)=D1Z[1@&84YNB]@(===ZK;RW5!JZ"+RBIU6<>[6;46+=*GH])J$5.6G M1DAF?:QVMH'&S5@X4C5F9I.6OCN*#:U'XPES>UW"C($+&0O)U8;=4RBYDEE6 M7C.BXA10P\2M897S4E]BH=47J!P3"X^)A;;X]ILY3(YYB34L]6,JHL;,IL,) M->X7R3BD3,/FUH_YI$&U6^$:>%.*4Z6V`6]<)U!3A+IE2U]NGVOHKBG=TR7S MG?8A370/'BA8;GW(^-R7`PU\U>83/-6D:4,?7_D2T@:N&//"0TFJFF%/7Z3K M'DXXCG3A>V&,I_GV,QVJWVRHI,!?P()V]WLP,[^A=CM^1%TTYO7*15#U_42'M\&4P:>_6$UXCR! M,?$YE'P-GZ'OTC%@U^?W@XADBI#Q-/_VE7:/N=6&3NBMDMQU.X@KI`QS5<[L M^PCX[/T*-EBQK0+=E)3U:)W)F\?43ZL[TU(MN=)@#L8EPDM$!Y@?W1&5TI3I M0@=,DGY:^GZ\)(2/+?/P7478"V;)`UL5>+E53-*PX[`3`,_+F40;WY[@;V[L MWN,Y\SHMF8VK;Q`KA<_+I8T@3\2Y-+^A7*87*$WE5X14\C,46[NE++M)7J?K M*+%0TO!#PUO3_8`CP$J,X<7([(T(U2*)OWV:#_EH)K/6GF7<=]_`;\#=H$J+ M6R[#C+N1%$:[E*$CJ-M* MGOSH,+>TEKEZ0QGQ@*C],0[@(WM(_0%BAYFR,_IG0,T!.K!0T2+*5A3GY930=O\Z8?7\!R.,,PMC+%DZ"J2KNX M?O'"^0@$WQK@VZIJ>M09-N5A+Q0V@?L.!3.F,C(E4HJ94]`4WC"%D MO6!VX[W&B5@QPCITH"#_",$Q"C.7^F/SB85.L:28, MSC2:;&'$FHTP&+Y;4@M?"TI5K&Z)EX6@I`F^9<]XL,2V1XA7GD-%R'C*\W4R M&YCP/TFM::U=''E4V4710V$DQB/V11C9Y3KJ]Q_=4W*/E(Q)<4[@/=VRKDJJJ[YI_'J[=X2W:O#FM]KZI M46M\E7T6.>7V/H6AA_(=BB_,[[]R/:,Z)E+>BF5<,K\9*VH=^HBV0@<1YMM* MPD5\`@\_T[:")96!HC[D\E70J!3&ZT..GPJ="HXM\XE_[9*:^,GZD#.N**_J M>H#[D$>N2#K726<\4UP??;STGCYF_DK65HBLYB::/RZ#+U2J%[, MS?R=I7HV&M7P1Q_>H5,<[)U$"^//QBF?SA%D#O$-`)Y%9-R^T4OJKLNY/S>T M*!`H3+^J>]&*P0L49?EC15KUAI6,SW/EFQ1-\,<*3X>"0&\CU"@R/G8=G&JV ME>5'7[8R:UW28TJ/<\@N MD#80;2X"N&/=>/+WW$3%C3PBQ0$C?U%/7*'G^(V?$SB$$QN'<-8A%T@[.KJ0 M"%X=(]GP&0Q2P,:;\Z,U?Q:-UI^A.Z-[V!4DWBRY?UUV!*#%#DUG$&^=^0/$$3)FB,SUE_H5I5A#'3L\7O_:G4 ML(""`F_KD+%;S:R-6*7AE>ZLE6@DY@T:M5>$M)#;%PNN6H4LTBM=HGV(UNY% M+F<]]RMRVR!E;DL+,!^^[3SKQ()UK)!S(E';2P[+%C7D[R*119'/RIIHOS(% M]J)>I*T:SQA0C@BT;U]6*1=]"Q)URS&ET)IRY,ERQ_'U=`J=4.`U'O.]Q9M[ MO@BK1_N&V?57EQ01AG,VEHQ[[-/X\M;,U5"'Y!+\1"'<(4('I)#F",7W1E75 M.SHX]=%`,B9OA$SQ7:_1.ED&FS7#$U5EZM1N"VD=@'7\5?H5CY0.DR%-X3@:MVAXHKV6`':3J<9LQI]#TZ41KD?76E M*AQV>J`)+JIM?\9S$14<>RKJ5-7\:8OOWX7'K_D`"&T_F[SHLLA?'26RSNJS M9D]0VPC;94-?(H7UM%05/C0-'!IWS&V\FO<0L+^3N]4YKR.FW]V"OWL<3""+ M)U(A/`+$,Y*SF4#=0,H)$VCDXO)&GN\#A!V=9?^[_CVBWV@. M6]%+_@FC:!F?=$K]P)N]^A+$:Z/2Q;)WLV9YL>;!5LK,DU4U3-/FGY\]B*DD MGJ_OV./RL@M\U2H;I>LV6$8AB<&<2^U\60U;*+BH3<&%#104]Z7=B2+U)]5K MX[N@TI#S[)C-JCV;M2/K7=<>SLWZ%!VR1M\'4&JJD>9O=#(L.*I.I#09) MC"GCF4U6S9GJ_"_;W]ZL8X\(9+=4YS?O!E(\-5[+AN%R0DUWLXDALE/BW?"C M+Y["1@HZERL\6[(/QPQ:X]TQ?V283Z$"Z^]-M<>3Y/G1O\NO4\E15_(#1#`.AZ[)A8UH>26`W MZXZG3^C;&MU[(8F>/3+WODY_N_,67@A=\9L):A6U8*0J&7#H^O]*YQ;>W([+ M`R4H:8\3?TCU2XS7="K+;'^UND:H8A,5XB7`X9I=RRYQY7*+ZID/VV)!%!NH M*MT.&I[77E92TT.*4X@Q=+.;2!^PY\!]C]`I*]5OYBG+2\)D3I%,@GYSUX]1;1(KD+\0'B;&GQ`:I7-^,L9K=$QS>4 MTJXD$I53T#S>2Q#"&57/_X@'OR)[O++B@=&S5V!%54;9FVO&4 MJ@NTBV5VF?WFYKM"IY^A[P[))?)]NC8P\'G0]VW2Q"R9@&`F$]3Y=V/HI.NL M6,)ZA+KT&N:K'T]'P&5W+9)?L!>&,!A/IZDNP)N;556,\`XN4WU]8]]N6UK2 MQ`#U^@=-G:&4A\T=HG%0K1`ENO+($A'@BU_)K*RH995\#4A\"[>[D;ABS5]8 MUFSP1N:C*+J@:\PU\T$)I3"-=LJM",CL9*$H.H$V-\R+/#0'F$M2ES6U3&N; M`U-U"5?1L\T?8]1'[]Z:N\WI0;4%@B"@8'.&3PT:ZR@;-F?P-"!9,>IB/"-' M+]4\KX7-[QS57:\5002;WSIJ,)I-8\LVOX;4=,2%X2R;7S^J2VRE9\+XTT>5 M"80*D="2`9([T(R;%[IIXQMAQD_BZR*3&W$P_AJ0[D'DQ>12(G^P,3-1%"O> MR!C%/!_SS\:K^7C$,5/Q*/(C>\;ECYIK1Q?!5GAT%!),U8.RFRDN=EWFL]J4 MD2.?U9(H;B9RRXO;_`A*)VU->NR8DVJ"9R?TMZ/6]$RPJ!)DQR!5"PY.;+%( MT58:@O&'-U4HJAL3*WAW9:E>BV9 M23C'=*%0]4^:+K)=2E/J M#W<1W3Y\CW6#VE`*:<,7TP1[BKJNPN MWMK@;,ZRJ*2*LW':G$6A1@]/J3:>#B&\FZ>.A"PMMB9K]@!3J/;FX[:.8W-6 MR;[$*8(R3;$G9L2YN48.8V5W<*10B-=O%Y7N- MWM09GJ,3RW8G5OON(2/!9YFL*F[BI*OL36E?PM65PC`_M+"K7_3! M5:1.H$R)Z8,329U2GH)DW*'4M7.7O\2-K]FC7\U2:WMOOYIQ>W3H.-$B8B?J M.$]2,]?98[18`+P>3RM+&KKS,`-%^9^]_75#!S=[NIRBQ?\3`=^;LK-6[!#6 MC8]>V(ML`IM8:]-&$C)D`Y7[1*MTS]K-6$PK'<#Q]`F\[D?JIA6+*9493+6: M,$SC$P8!29Y+'+J_14G:M>IZE54V01?3(L,U8S<*JM(9^&6-I/)(YL@(T@V2 M'7[S`2'>U$M>HZM:9_NT:.;FES(:)OP5%M%EA#&,[RGPD%O!$JU=&$T4V9JX M2HDBW#I=*]%-]\NM\[$UI/,!:](=,C-?67WP.>A@S%X2N0_N"AU,TBNT^^," M::(@NZXY9.30P!@5]*M MNI)M'I'\R3V2ZPU#DF@,S5PBE4T>?2)'G\C1)_)=^$3V$SW?BX.D+=O_,#TF MJMOST0=RX#X018/?U%$AM41$4Q9_KQT<35(2C;LXV)64MX1$["UH#=X,T=D) M#&G3F^MM).;Q2$Y5;U`3F>/(%A*JC\;$E M0#SR2/<8X(Z#GP'VV,["[DX]%]"A7-T\;8DZY#D/8!W_F=W0KD29L+()NIB# MG["-'Y)Q3XZ)5D<:O4M(6B.[8E8ZG,K:QV0+08.K?%A541\)#7L86*]*+P$<(8 MO<0AU.1]BQI$"9NPA499N$9G/V3+OYQ<`6=N*NG M%_0T1Q$!@P4,XU5JJMR M"O8,;U&;-O+HI-#P+%USQW4_F??_5COY98ZSTML#W"5M\SM%S2B4BE7S[X=H M(G=_[MRS!QR+D/=[8V6MZ[7GGC5[H>RHM"&87U`(R1-* M'PL'_B8+G(S2"_2O('&P%_-T&+BQ4V`\?<"0L`=PV*]/%,G(1\ZW@R'D`?F> M0[LY&()B;<1VD/R.S+UE6C]DG MA-P7S_?INJ<;)M7X/`HV>:JE/R-4CPBKQR,_,9O[GM@=V>S(+#L[Z]!/%!GL MT>CL0Y+58W4#//PS\".8`R>V#X84L]7\?5-Y?UBM@-SJ ME<$Y2\X*V\[V*MA6\YP)H/[,\(WGH#^0[^`,^/=)&TR8QZKV#`;,G*[&_M,9 M`_4,"*1__#]02P,$%`````@`6W.*1S3.1-BM9```JWT%`!4`'`!P9&-O+3(P M,34Q,#,Q7VQA8BYX;6Q55`D``_[1:5;^T6E6=7@+``$$)0X```0Y`0``Y%UI M<]LXFOX^5?,?L)ZJK:3*AT3=J%O8X!41BEWGXTGWO',"D&.Z%G9> M/IY\?3R;/E[>W)S\X^]__P)7K.,BVT1K\;B(;$>@A\`3?7,== MK,$M?$8V!;?8^?,94G0*^+\6'6V"<=P&8>][RP\7%CQ\_S@FQ0FGG MIKNX`&=GH:;??)L^@.&Y89SW$[\\N"O'^@`&B:\N"8(>*PTL9LT'8'2Z@[.N M<=;M/'5''XS>A^[X?Y*EW>6:X)>Y!]Z9[UGASN",/=$##^A=A MP9.__@7XA3^\49QZX$I`+RWJT.YE,+L2O M?FF*/U`AY=8U190D#`2Y)?C_SL)B9_PK'NE>]_R-6B=_YPI_(JZ-'M`,"!L^ M>.LE^GA"\6)IHY/@NSE!LVPK;$(N^/,7#GIA=6EQ#1-1ET.NX6_!UR+/3@`O M^?7A)M>A24J6_]"%;Z3-_\/S-&4F>O.08R$K-)0_7A`N(5U$6@CE8ETS)=#F M,7=)IN-"U@S29R%P1<]>(%Q>\.2]0+9'PV_.1#IWND&0_Q9\_7UJF@P)'D/J MO6MC$R,Z?:8>@:87:A,^?CR1>.`BLI\_DO*`(.JNB(DJA<2OGHI6?+>?^4,+ MFSW"Z0]/ MOB'U^N8Q8D*W"APT=G-P2M(9"(D9&LK^+/$P*'%ANHQLEMY9JB)GQ%U(95.H MWY4.RH4^_-![N(;/-KI<$8*<$NQL%E:/FPT+9%/*Z`RZHQ1F*`@DG8)`EE:X M[.67D?)KZ4MJ`3AR$%E+1]OM`&ONZ5]%IYWB*\FO),5ZQIC^(QM[+%VN;0= MS"FO%K791DAWL$:37C=J#;DLD!"FOT&LPSL!PCMOC@B`@8]V+%(SV(IS;@-/ M!='0!)G58F7S$>47Y/T,L7/K4GK-7+Q"%+\X_(<[\I\K:./9FO':):3S:]O] M\0NR7A#]%2V>$Z=O](?; M;.&WARDEP-<2\LD=C=[@F_[ MY5(DI7W(#TV3;N@F_4YW!^"?BIZ$.^-K68W@?HD(=JW/CE4#]G<+2E\$Y>[R M%D`/W)F>R]HVT.N>BO6R!GU^]"#QM'D]2'H]71)L`V/0H,]U\?MNWF[1NRL2 MWTPEOLW$'P"1;W+;#CR>"F*+:?R)#TSVRQ=?1/L(7-@E/TSI#GL[==N$FG;W MV':(Q"Z]M?Q(M`S?J:3?`=QQ/#4C^XE`A]IB;\74^F-%O05R/-F)GJ*']:"Y MP"+I[!WT^N-M'%^[!+%!=S"_:JY!++_U4S2U1<6?A`DCD!";C$;+YF0D,CP' MP&5ATP/=?ZXP0=8U=K"';AFI6#>.QZH.L]R;4HH\^E^(;_5"UO05$?B"OE(T M6]FW>);?2.\A4BG,=[=3>J)AT!E&X/?5`5_?F@E`I"+0"7RW@ M>G5!7U6DPN52I@;X`<)Q@.!F@&`0()OI`>_6"!+Z7B]+[`^F-'?L&7PB7VH,TZ+@O7>?1<\\^\+"M_4"4[E%HCW=2-1[U^P`&14,"E MLN0&@=Q3X$L&0K0FF-?LLK'A\I))/6,NF[Y"=2RG M"Y=X^%^BIY%;UWGEE6(LQPCI/3:]P2@<(R<>UP6?6KPQ9+Q1AY.2M$K#HR@` M>E%!G]P'Q!W&-OJ"O,3(V>7KG/?$?<46LCZM60O*D'VWY&]S8.=E:GKX5>RU M*-M1WH0J+5BLSW[YOM]H$.[(C]4/_VSBJ[E:=^=,BLSS%_?UPD*8TV6?_\%9LI]@2?;5 M]RFSVA*4;<.7C:S=_ET!'VTIE>YS=@>32=@7")X'7(!:J.]IOR%G?],(RDT- MGO;9+FIIWQ.=C+N9O\V:[UQRJ9>[`ZCH$97M;8$=\EO,A^.,[B]?NH\$`B%1 M4W-7FX_AXD_PEJT%X(:_%GIF31>EJV"C/=/`7[5%D-AKUL!YF"`!J*"HUE9) M(FE3K4M9%/4C;W-62BH?MA[2AKY-2RJ\XM$SLO&W-:_;!@3NY^?6P!2@MR5R M*&+X\M>T6,>0]6Y8EW&&Q=+5UMQM>V"7E['YP,L,7C7H+2W3%8#J=@(X\6^^ M3QV\@/8O"-K>G&E!Q('^+%/FNJG4(S5#R7+-%:?/K!DE&7LD$ZW7&0XZP^\] MD6A"(O!%@I3,9A="LVBC?A^[6GW,Y8WZ'37V<;1I;J@"/\X,TN&IG1?DJ*`% MZ*^V#6`\[/:Z68#7#_%=',E`=4MPO(LW&=!M%5@E\*E[=P7K"UG87GGX%3TB M6H_(XQP2Q#H@J_S73VN1K;+/ M78?!TK.=HYX1M;*Q7A`K!J'FX#VY6#?OOX?:`5,/A/Y3X%N@J2.O/G@"_HEX MH52\3&B;*SL>?W/;V&\HC-N2Q8URU5K[_'7B+S4TJ*TZM-!2X2!=_6"\VF"T MUQN%+[\V.+)V/6@7`G('HX?;96/L>J M,QR-DUFK?RUR#S_\GN'CX^>G1_TI7+@RM^VDOI0N.4XD549Y0E<];*K;BUXJ M#K9E-GI2B!P=[^1$@I5-__G6L'/182!;#FM/;"G*WBRK*]$K;Y_HC\:=S(1O M"9/OY5?B18PP^_7NW"C*JUP8[,'S>5-P0KS?K^?;-,1_?T$V/\/J$6Z]IRCW MC/+IN1*#Y"=T1_U),%GG]V%0*#/(&3!G4L',94,_)O=<\>1=K6XFNVJ1S&`M M#W"I_`TNP.7JF-FKU55CSC[DWNZU<)1?D&?;C6E>`/3! MY&[&3%FZC'I^)NYJ>>,$<.8&^CM4D747[D\MK-QJDI1#JY)Y\EDY,8)=*J%T M(,2?@D@!2&H`D8I3O9M7FHZ)D6CC2QLX5?S3H+];S*2_6:\!Z-L,5CV$!\)M M4B/LW22VF^NJ7QM@#(;[<5Y+AO4*PE2)!EM,".7S!+L'\T`(0F:*>2>![::' MJO.^QJ@SWH\==!^,K2A&&?."!TT1I1/J.X=4!T%\@C9_W>%QCI`7WF@U?<-Y M*_NYQ16".\\&^;>DAN'1UX$H(&2!4!AKMIDX34UV/=X9.WFG"G5E29?$5&$\ MVH*8*W73UC.L=?9W_;4 M<#(8]/P5KZ,1?)[LQ,-.1/,$S06?>I?C;D&WX)/+A\(!=H:]OJ]-U+>WS.[ MPQ9!;]->)6W3S;QTC+3@<46Q@R@5QQ%2<0):<#(A*NX[ESZG$H5EQLBGX&00 MO.D5R@0)H:<@%*N[1UVOP\:>#BM#H6RRI@`H%:NV8*]@AB>GM&:<59D!Z0_# MJ=FL9-,[NU.':[DX:L/43G&RE2%&Z\3.MCVW)7>!%3ZB%S&WU2^TZ@[[1;"Y MU7V55WU>%B"HQ$N-.-I*QA(PW6J_=2O#J'OB7KMD`6^<&?^0V)%048A>U!58 M)C^!W^^,BCJ'3`<02D!"B_:M!DT&HZ#CN$LP-&)8(OU+4%T6U/;BO'3:I:*4 MUB&]\E1$MVOT"\>!.=DMKNIIP;Q,DU'QCPY8+1:0K/D4S5<'KBPQ51P')3C( M#MK@`=&5K?5(OATQ4!WMK9S,N6?)-8<4W1-LHJEM!PM-/[NN]0/;]N>W)3+Y M]37P[0I9*],39Z`5'4U2KP[-5+&SX?([;;K=21&1A+I.0:B-W\P)8GU:3R;1 M&#-!,Z%4<8SUBX/_A:Q38,6QX3N5@C.M/1:UY8HL7:IUWU(C$"SCHOVJI"5, M16-*#0_6]L]:"8\IC[9FT4^(53RZG+,T0O3&B>?6IX[U^8UUN5QBL1:(K,4H MJ^3N8"VFZ.6]QOV3OTMF8'1D^UG)^P&"8YVB$^QC@\&SL!@$)O-K>&*C`70L MD#+;GU%H_%;D79BV9;4D")G7A^CPR%TGT#(F5D8Q)82MIF;;QNL/Z!4YJ[R7 M8&6>;`EK!N9(]VVCH)UO)0".7\^7G9PM>5@O:#,L MJK#UV]A<=4E(3APL`;ZU9N*U3M>-Z(+AH-UI&1X+4K4$B7FAJ6?K^[:^7^$; M7JP6K+UFH72=>T2P:TUGK%;Y@:XVXF7N9OQX#%&<->[B3B]>%MK^A,GF?H-& M52G?7M^,'Q7N%!@%1U!%2#<32%_XM@`2&,./(6;6`,C-X24#>_@X_C6T2$P1 M+F.;^.5"W"C%YU>U(K3Y)!K8`D)C@&\-$.:`RU1H?TN%-F%3,%.M^$"1]H17 M$/5#9G+&Z9A(TYS,U/>Z0;.,&;^@T&!EM:3[]A`M5]PD[DP*#JP-+GZ?.M8M M^QK;_M60E#)RM@I/[VY`D=YNX9[62X]V^OUNKVC$%]L!DH:$AX6$IHC9XX0Q M(+"FV9.4RDX6TAW7[8.'8*"B91W5FD!9TJFM(_:'SF+AD:VBY#U!2XBMS_Y] M6+=\>8V_7KI,CQT)#QN);`:!&:+!X7A6H^H M.X!*"F;8_>@%-S92$3Y7A*\]9YYKI9>F*+M:K1X5JS,I"+_R)Y63>%+U,7!V MPA_YRPT&$T,I12>,/#(VWCG\P7B_,"X'3Z\9.%?"IINU$LJZ_@86'30M8#!UWPT;"O59`@SR;+'&D9%M#=6PS;MB171\A MZQ92@P+JS:^P0^??&\=",^Q@#]WB5_Y?CR4?CIY5@(LR"PZ4?4OD62N!19L/!DG")8Q6&N4:S6\:V6#>8T04>,S<8 MJ+C6*A%DG(HXCA0!V*:H;K,F M#IWLOB`5VPRXE@,E-V9ZA2628;,O;GW)WE=T6'VTRA'=GN?DITWZP\^C.X\@ M`S.>OPX4VWSIC]BR.;E2N$>%/\F%\UA\Z8]X0?W^ZM[UEZ>?R0<59VN5"S MU31?]X$R9ZY#\KV;\:C907!H(ON+&WGJ7Y$0VGGX)%I3%81GF0M9(D:H*$:' M2*2ER&^*3(NKZ(`(-5RT5C.,+M76?M(LU+'_*'D?E_H1=D/3A?4& M64P7?CF*P;4L7&O@/:DZ."*FD[PZN"FMA\]\5>_C[0R&DSJVO\@R8&NN-6Y% MW(VVQ/W`&5?FRN4F*[PE#$RKTR=M"??1R@#JCP<%(US:1J+9T,F-8MC_!"FF=[-[EB(HN`)#]F:="H(T8$_>.NEM`>QS M\X">A!;1/`D]_#:(I*867<#35%3\6XF1@PC,?-E$-5*K)WD6?BM&JY;[>2[A M$IK86W]U+$2F+P2AC$GFHI*J;\?)-D,R?8Q!MS\>^Y?;A(+`BDL",!2E^$J: M.OSIIOP1DD`D2L,],'7X9!35D;;+68KA$MVM4A``'6WQ):1SQBC\@T_JOD*; M64.GWB4D9(V=%WZC2][)IW+/*FQQI0RJ,)EF]$+\T+EH5,4?"=%L).B!4+JX M=ZF9DT']JXH^LP&26N_[*>]-_@>*17/G$3^/;A;))YB[P>EWC^C M%^PXXD;M1F-0VJMJP'NCT'N=7:M*G)7L3E;CLR\(+4'G?X]>#>.21"D MZ`KYGY4R(4>$=HQFVU6A#>E,2F$:7&(9*@'O0C7O]:S?-A>):%'6G+/2_,`" MOTD]C+:U.,W+@5P005U8%M=36LCZM/Y*^1Y>Y/WDZD8[3L;*O]&YJ3?3\`_5`B>U^`=U\D`\!Y$:D&L]Q0D M-8-8M;[66U&TC(@B>,26B8CA*$XPTG@&K&2672.UA\4M#T4KSR[M5&*4DT[A1Q!),^2W\TWZ"0"[#A!R>;,>2!;3"D`(YR>S^^+U M(;=>Q_UCTT-9P`J$\,4'8/KQH%RZ;H#*9NXF+J6BI1F.A6NBF\7TP*S2>D]W M/.IVLB`EI)R"&TI7+4#0#CX9"9\HE]$26.2O4&6YJRG=^2W9,-AQ](`\3,1. MA2K]2FD):D$B:Y9TKG6'DV&$GTBZZ$O%\EO6HVPF"$9M05"(RJJ)O@'82I'4 MA66"YLQ,_(IN'-9-0%^0=S=[@F\%^9'WA&*LYIA1X3K%3B_&9B0-^.+`NUN7 MTO?^BQONC-_?&PK/&3"4Y;<.EZJ.R5 MDM+'-",R:4N%J;[AH!2.@,MNP0LB]7H=7J2\6JQLZ/$%'W'44CH.W/^VP2\K M5\NPMQ6FE@#OWK6QN?;_W0&`V8_K!6*F3=*I.1B-"SJEI\"7"[X%GVW$9`T! MR&@*;]K8%!:F;PDF\\-4SSM:KD-7"]YGHK^BQ7-\1WI0@3F%E+^9M6F!;*(, MC%&_'[R4%)7ILIX6 MDBQ=PGHCF9#-*Z6TO4NIEF?U\3B:!PTD@$?T(B;^]"1[+1X9:8]TYGI)"J4; MHVV7]60[94/"!_2*G()5LV09I9F>4"R_7;/?B<935$QA!!)T)??.3AA))RC, MN2M+759GI$HZIS<]U9/1*X=5RA(2;_T%+M#T#>?NVLPJJC2_M_57&$!W(CJ/ MQ0`N!WSCDK21^;Y.&56=4H>`_-1*`R$G!/6,*@BRL!>]G%XPLL@LJ'QTD66% M;$+T)IW^*!AA"#GQ\0BZAAG[N]-5[T[)>&-_GXS*/JD9>!1A)1Y\Y/JOI0$3 MUEQ#DY^UMBYJOK8+JFR\MK1++[6,.H->"@6A%+T-UYX.&=4<4M9HY:93JLG* M=EY__E^Y"X@W&Y;"HMHPX.N7WY(SBO8E;2:-+ZD5.-C%J6PD%#BE!POIU,I' M0R($N^.!(O/\Q7V]L!#F4.CS/S@"^@D$L*^^7_HW8EQC:D+[OQ$DGQWK"GJ; M8_/"H@H04*1?GC8'T1E8P=4SOBS`A0$F#7!Q:E%0GV/&+HXUC029%.-(*`U# M/4.9%?7.(^G^%;QL;'6$JU>B[O/F6_4XUE7VEMTSL5$/&[0$R9R62"U)NGEE/(ZRRJ4^]/^SP/Z.M&3Z.@68L`WX:SY6(UL00L;U!T44@+Z MC`JUQ'('K90X5FN%`^$"9M3PS4QP)N@J"H2:GL:'<,LJ&&LY6RQG$8R?7YV` M."PH$I\>H[:^`0E?J6CR$9^7\+;$]GW>/2@ZJALU/OWYZJQ?Q:.\^L1VWTE` M]WM.+"#KQ.NV0D9*^-EU7I49Z.YD.Y"MU!$"JT)J4/44H<*@$"&K?H*8`&65 M)Q;I.]U';1I>G:.\2@KRALXU'[48X%62^21M7IOX4X$<=CW&4"I:'574MA[4 M[(2%9:$&NV#@Z(:^P$]]*A[6B!ZY!/!+!&;)9S6?3L0(BZ)7J@^B6H82W/N"9LSG`J"U`K],> M"QIW+L.GF$K5;#1+'M0,B")W>!(R'T]R6,BHH&XT]U7(:J>03B3(W:D,`HGR M^/XOKNUY8M-[>_/@_L/VQ5UXW^V0CD&?L>9U-*RH98+G)8NDF+;D>*Y)&%`OFO?M#NO^OGM[&V\)WQ!7H3Z0:2^C[2=U]65U8AL,!H^3K_8:WIY MX!66("?(/8Z&PTP&L..MYK.Y`G><&HG(F8"RKLH)5-U[[NXS8W@@>\]VS4%0 MU3`;P M`M1JOE!-AZ(S2JB5N\.H)UM>`*B'@YNJVZE14S((/F:BBW><]:/]+O[I.^[: M.=JPSZM\&0U/*HG`^$/RV4*U@L#IF(":]OI$"(GNI3,XF\O[ MDQH4J?J#E.K=T"WU?;IY9!_MU0XHP]B:?J=KZKRIRFV;7M%=M-<@#_A$ZF)N MQ6V)$HHD(4D$39(1U5MJ-ZB&8T0-ZTON!E73*JAY3-0\!"+ MX(R#D5S/]B\:7)T"QZ5!<.T=7AQ7P)2OT43ML_=[[R??;+]\LYT]E_G9^TXW MIS7]P_,V/YV].N0/QT'KR#N8V/!U\?%T4D*U8']!$@%(3H+H!HBHCWLJQ`5) MQ>!]>B-!2"()UJ"/9,IBY`@Y>^+3M>?S^]1\&K4<95;:U9A'7P(Q.!"+F<>P MWV#0E.5/E]J^2S=I>?(72J4G`.M?P$I7I-*`:\LGD]FJE*PD!',U])PD3JHR M@'9C-.U@:.D?T3^=:PDMZL"%D0!?6EHU46*>61)31P_]MFT.73>Z'5\9/*9L6S8 M?:QY1:N?J^5H408_7R1^GY`C"3WT/P:EY!05N53G` M7F=-YLO*`&;,Z9RA%"P/8(:=UFEV03F8%&8Q!4?\UOB_T\W.<7>7:_8G)ZR] M>A[P]:$4D5$(%+-%4]/QO`:D@;@\-F9(,HYF'9A\L9#2PK9!(L_?L^E8W^\>E>E6;*6B0@"8`>DLV@% M/U>RFJSJPE=QL0"E,:+IUJM)E,#60XUN9P5V8RP\WQ*UI!MWS9E(AU MW[+/,)M93)>S%M'F'JNO\CG5AX>+!O6-B!D5EP;C_;Y'5^:AL0H')C(*6_O< M:)HKJTY]SB1D=52I#"/ST`*$1A\<*.N2$N+)J=JOGAN^LED'O_)`7J]2^X;^ MVJ4Z<:`%-=/1/.E:GM_B2@]0"YIB?LZIZJYP&D[#ROZ>3@V;ZJ"&4[-Z^AVQ M+@H"L%RE5*,5^M_"X[AO-`CYZ#>)?^:189(;]Z+?YJ3YYG$`VGMI[Z&FIS6, M?PTBP/.N\;2R1G=!$F(HC8<&54T@(U7'%A2B5BH)=90E-:"_<9A`S(&;(@9I M>Q=XLBA[!R5ME`@"7^.86Y,R>()"3R*3LLG>FEI]--6?9-:XI3S=5!D(%UVP MM6#$!=MVZX+CB57=%#)D\;2#)I6YEDD+F8#5QH%OD+FA;W3O'>GFF:Y?76_O M[=Y9*O<0OE+_CDUJW)W#V%T&`0WEMS]T)*)_$M920JA3K>;C13HOBWF0C(F8 MKP@V).-#(D9HYU'.:HJQ>:9HFM:=U1X6P!X&G(WI&`5RT\(N5D09J)V`U\PZ M[HEN'H[4%S$C6B,*SH M\%KG\3+9OLV1)2G=XHX"]UZ22,(GB*J77H0X))*'']@_3XSQ0GM?F[1@6G7. MK1I;(+:'.&Z/FO6%K.D,-C9D M/(T+->T1U1AC6AI]F*4EJ2`^SZ1XR'MPGVQ%WT/0B]J7D"!2`5UV,IY.E\MX MV4B*<,(H?V8Y.MGQW(*[LZV]&>+P"M>$-*XP3X>B9.K!)4_G4KAA.6AXK>.^ MP>?^GJM(/9?N>.,TG0J.IUS#/QHTT[.2U2;H9*M78)L8DW;Q-A&RU'`%:PV+M:9!W:DZ"HXO`_49#:IGX[QQ"7KT-%AG=J@ M4*/'G%9N2=K,M>B^F&L,/KT,/=04+0M]4EY,L/UIP^:+__3\O]A_KNVC$]K[ MR\V_3D'(YTN*%+,W683I75^9VR3-BW3R%P6&'6>K6`SEZZ419_(S8DW6$6]B MI\RUSPWU6FMDFB,:A\)6* MZ5EGC](UAQLJ*N5G>(-8'RDCS&1/Q90J<;E>\QKCX)L74I[;WGNV&V3W&-3T MC!N4A]Z,<#C!P2G,9#)>R6+212[ZJ'+%1`Q1M4^C69<0)7C:W:L*@K;8K]]ONP;GTC,^X+$W#],/.IC-!A,<(TH?+,#(D=,S MJ$B,:GX@\=F_[QW[Q=F+OD2#N%B9IK$!I"0H>*%X,1Y9/8('9TMR?#]"V.AE MJB1D",7W&161V7FBPGL=H2;_UX\34Q0@ZAY/9-8V/9:(TO5OS+2#I2-EBH;& MD9*8\"MSY]-QYR@BF/()4L+6_"#2RTXBA-RGUZ7:T:F85[K?B!D/UI;Z@$#I M&BUD9C4\5EQ[;N!L&G?@NI$S,TH49(1O!(WFG5=1"AR-CPX]["-"0^%]?DEB M/*5GD8(7-9(-W3JN(PZTIN6.'R1@2-'2,5I4S6Q\J`C"X&'+[VX,GKS]9@A/ M*U$T-6`4Q6RQ>3R?=X\9C*G8H.=L">?[`2)''T/%P2,0JZ@\B_@HTPX5,#H' M!HD5#8\-R86N0TXZ)#3-C`]50>$)M369=8T0"=L/-?7H:RL1).KNH#8P/JC! MT3%"*(QH>(PHGZT?,E;4T#8S9J@%!N.!`:+SHD6EJ\6'"B)#&2^JZ]NP]YRM M(Z8H3DHYVM#](!&F&5H=(TV#I8V/.&],4L]_'VQ?MD+1U.A2%!,."VO1>94C M9?IQ-F'[V2DN"XY)?)A0(<=$YP`AL:#A82'^P=W=_CI2-U#VO^M!T*&QYKDU0=0C`&VEA=9FC^:SR5):_)_59&_DQP"B4H+8^O-_)F*9G3USJ M;!X8S0L'&'2E9`W-HV2RPLO'Q\O.:[X1=#[@DLT`)LO%CGVI^N2C)%=UT.F: M82D-:W@<>?3IT78V2>?52/#!%FIJJ9L95>I$AB-E-I]T#2ZQ`+EFOTF@^2CK M.<.9,.F#(PR2S.$D1;(?*OY`(-6#GS*937OOH,5\S(^=G2RB95T M-/Y(I74E)^^(^+R]T%$=U,L:\-_NO>#DTV?Z*[QB8OT%\9@N9+$0WT%6<'_= MQ70TDN$_:`X`[)&,,_G!>1/!'*^YGD:;U77;,R9:]`"/,G9TM>PPVUCQ1@_/ M0QCG\/W.W7K^(3I/)&^2"7]/^Z840"BH4\ZGUF0:[SW%9*-L7Q`F.;:(62,UV@Z#FZG\/\88Z/".9\A]XH)GF M$A'VJU24+RR>^F_ED-*4.M`.`Q;3D>+TIXBH@EUQ$(^(7@,#1D3Z)@(64/[Z4\M69R)'!:9N"@HU92 M%-1KI1\#%=>2(Z!H`GW^'R'OUMWY4]OBJ\OK\_9F1K?DNXL^:O9OSA%\@-%[.2T[- MW\?SY/;26R#I=7IMWBG*SIKJA[%T>&O[KN/N`H:8IU?;IPT79R@?U[C4IY(! M?O?Y>!DOX26D>)`C@ACZC1?#:&=UTD[7DEN3T^67TFKM80)BKNS`60,_9O0L M(E:$`&!7FBP72Q50+HB@A7-CYP!JI1=POO!W"4T4Y!UD`D[3)(`4?*P.'9DA MC(%&RQ&E^`XV5-I&W]%JLI@W0,:X(::'IF*7/:2`NEOQB&IS7A3 M-8X)R+IQ]J>0JEHDJ9Y&1%,L`CA&SQ9S98[&MU$%-3,>ZJI@$W=@J>"SD?$T[M.? M$H\//(O[*#E]?J40\QYG[R3%_I3IA%7*?RX;6$4;..FMDL1'VKWI[LP%B+:S M%QY:'[:WO]:O[$M1+N"#>VT'KY?NAO^'GP1XL_?,Y^KQ"B2A';$PN>#'2E9) M*6UV76S"($*LYQ).7!3FB1]R;#!A>PY#6$5#T,00'+8D^CG@!EDS)O@P;N?E M52"WL"`*E`_'O?=.Z7>Z9^+E+^BH/T'<_)Y.T#8)`[_:96HEHVM,\[,?$RS?F+)*(BU6O&T+?W=^Z&_OI/ M^B[9^Y<_IZEL0LJ\10G--"X,C>N,8T)$4"*,E/Y2B@$TLMIJI*.\HM:=DCH+ MM?+:_-T['#SW*61323&]#!Y.81"RI(;EK>JO5?>27B342`)WHNED7H2%H$H$ MV8MHU2`@.P7;*IX4J?]:*EX@GW%=F MUJB`C!\1`GH2X__>+LJ7_-DJ^=YZLSGN)36KVV MP!K\\>>3Y'[,^.,+,B2A@^7"/92Q6BFCSY^E#E1TZZK6NKS[.]TY?#?*#;_9 ME?:GRL>T^G>1-[Q8;#(I1N>,#N&$L#R\CSI6.W7T^;C;%6>B4F%AS3@A])L7-3L4IMF]6>=AU+/ZOCAM!QK;H95>IBYP1XHZ\!,I/"]J7:H^)#. M%=X"9_C._6P\ST#!,W;L(J`>>EA@/;2MT$J=IK`<6]47S[O95/[HN0QVTJET M_;/:?;TD`/PX[WPV*[A\2@AINCV@6E9KM?0B0>%@54#(K(""BU]K&@3/]J\K MZM*M$WYA2B7%X'3#I:1N4+Q_XI+7)H@-%=5W[D53)\[Z"`K?8K.6<1_AB)^H MTHDY$NY$T1KIYQ?.E.2YYF]\R1@/"]Y59":7[L1NF2'6FN;,Q0MZ7B*6062O M@*_%QO9:Y_BBXG\((!7B1&]S8\23+[;C_\/>GYB4[$.OZ=,KI:'H#<;D^^*X M['>.O7]B4SQQ6?FU?12%3/>.2^_8KU0AI3=9C5&EKZSPXZ^357QFD;,D@B<_ M>"6X$L&6)'PO2,J9I*Q)PIO\X-R)8(^4'.BUFJ7%:KIBSU"@RX>?0;X';@1Z MEXG^S"\G;?3!FE=1(HE:'GC)K#4?5Z/%R[O"]07QG337C^AF M)Y:CML%NR,A,?_R[PW(7?_WZ?D_?F'E_.S'OI2E! M\H-3PX?C8*I6``E1%0%_`%=5(+#)5*@8S%KQ!@UKOK6O8.!-(@=\'74QFY11 MEFM5':"O#P^GI=592^THJW%&*;94MC$%44T'0^O?0<94A^.1LU$#J-!/@@ZH M:!E77ZG-R1U4)W4PT51[%+39)JAXNG./IS`00^986IT`>0,#2U4QX`6&UFQ4 M30(C@A=$D"1CI(W\P?6L9(!M]-2.*K4[2C&E,(XIB+):(\HR`U%6.T\;C^:+ M11.B+`,1U4G/!D35ZXF)**L=HBQ3$)4?^ZO3O=HJ@W8T,%`'$0S>K38MQ,FE M3KDI/VIEPAE5+F>+,)6U8[&-(TO1";8<*EZ#&^H[;S9OKA#D%TCO.6_' MLP=XPP4^L^1-BZ_>_TXW.WZO$0V!>TD#,\0(Q(,KD6;^[0J>YP!R8E3 MWKI+1!(+_-ES)!%+],@V9',#V:R63K-JCVAG@[HT_)WG4PY2[?_%V8:OSZ^. MO_DFR-O[*]O]2UWO7_N\[HK_.F&@I>,C:\4&8E'S+\@108\D!`FGB%3V/YQZ M8T3UZFO_A]/1*NO8J)J6NG\(P-+*_T9KH.1'23W'G1N$?G3-6LU6K.)IG9F) M7`3P;'F^7"6K`FF!3T8*=Z]U"-6L#JII&Z'KG:TPO-;88J"Q43!P=]_IFK+A MF0V\7^U?SN%TN#QX)W&[SO4I"+V#:JB$OZY_Y`3+!HW"L\EBM4H&TI@ZRQ"V9T0[:>3VAZ M.N_(5'JU`S:QX+^WW7?BN92L:XRB:;ANC?GS;1V%RZ&]X% M:)O]YHY%#'?G,+DO@X"&P>6:?2[V%2^#1]L/'[97I\!Q:1!<>X<7)S<=:=S1 M/B]3O:G%&36!-VB83T=IM&'L/PO^XL1K)E/\RTPJ$HE%$KF('1`N&6^SF,A& M4#CP+6*.-MVS_S^;P7=[0;=$8)(2]]7!(8V5C0,[%?O7^U_>?[UW@Z" M^@41,`4SX%T6"WX*.[]P4I>!O+P3P8(('M@K*N>Q@S6D'0S`M\K=@<"6&M,P M1/_A>T$'&$>OF8%=(0NXX;HU&8,`>T$$7>,0VD';^&JD(/2=EY.8Y=@[GXK2 MA(MT^8'LV0.!F$]YX2O.#+P@/O9U9?'=62BAG0E(G68D]^ M,H4A-3^@<$;8U5/G-`A@C&UI$`-070<$(,B5EC4,\]^H\EQ9_4MF()I)`A]\ MIG/@4,NHXESH.:2FZ;V>\IDJMJ"J*'XRSDE$&Z)=7#0%:SM_2/U'4]U M#6[A$:W(R?C"3U&-1NE&&G^=1.^;=WU@=^VLG';_36V?W+K2*WSU8:'J0D7/ M+VDZT.[Z&WWT6%!X<.D3?:-N?`V=O6/_=!W/_^:%-*BK1&OQOO[]=;AP0.>9 MC.:SQ2398'^C1-`GC`$1'$C&@D0\B&""5KQV+@N,S;)`TU;[N3YV=F]R6^IT>[=!W;/5%]#4OZ!R/E5+`&_"E M=W3$Q$AZYVV.'-*`/)!Z`ECIVWR%R-OR(A6A;G*9-NIXW>A^A=&[WBP8^/F# M34>#>X_ESL&#>_N+=R<\.<$K'U$?MC?T134I;'Y/(YH:A6G1U7(2-]\2-,FG MB.IO_);+(F'NB9PT#L`&UCA:B66O$2<(3N(XR=H+0F/V.L%>FD<;S$8HH(MK M4%0?-_FS3@C%/,%+"\QQXE70NHJ:WC(?Q52'S+#E$=485 MGD+;#X=78L:5N*([QW7/K4=S4.JD@=7D0]J"3`F5A5B25PTS9"2U63/,@`I[8,**K>RCIRU6FKHNM>.!@;L((+!"V]G5@F' M<:ESN9XFXX'>JN^,EK"&M(1V[+9Q>RF8P08U%MU-YR5:$C$-WZTKZUE29BU: M`QQ]!^BS&;C<0E^ M^'<^]%3':J6.;L14'$D&BGOTZQ(221[CPYJ7ZS4_R,AOD]G\ZQ2$HJ%3P_>K M?Q77]M$);39^U1M!-_I`[BQ#9+,-,5'Z[-MNL!?KYFP\[8/9-I00$-Q" MO!;%X8MI&<\Y/B(%,QK?9S.*0'N4?2:K0B:`N(.WRR#=UFPH`.8\[QSTQ=,6W$WJN:D0"O*C1WYNE@1_WM69Q[\J(:+3K_UMT MAV5&F62DR648'5H231E8EO5H^RPLX8PZ0UO"2NK%G<@:P@SKS`Q>2AB*\E*OZ+EG^Q<-;G^%ONWY&\>U_7[ M='I[)M_NSF5@H8%J9#XG1Z,B7VB" M%&4CB7"F1AM-UI[GK*T.48F90RZ(V?&J-[S;!;I^G\G,"/E(_2L[<-;BONG. M#ERD8E0D*X@&W[89)2=TH='I0O0!%*RB6]Y-3>5Z&$3D==M M9BR>;YS]*:2;WH@NT#$-TWGAX#?G6,M5%U3'S(S'=7>C?&!DR]R]-;8KEL-' M-]\RCX2EFTQ6-LM\V++D`^0F#230,%TO%SRI74QG2CCG>10`S>?IWI9/'_BE M64E3QT=^3(&72I:69;3.)-H%@2&M6%ZQ^;3/++G)6_+,2S=OU'_QL(PPEJY; MM5`?)R["`H4Z)`),:'HT;#^+:4//T#C9*9%G/XQ&;8-F7#<>'+W`WHMC:Y#@ M:N!\Z&P&31J1?>1(T7*6U-:6'R"&M)XYM:-H;ASI-'&86;.YODABW!SLC$;] M_R2:M)N9M;EI[)*B(`+^_>[PJ3K)24NBG<@91S>J@ MFEZ\*9VMBB6Y+?!PPH`+/@97]X9VO$C%``?Q\2@YXI;M59ITG&TP':VN.NI% M4*T;5E&D-HPA2&HZ`2TR*?8FJ_(0.ECVYYC!A2 MHZ)T+RD\),JC(N,[Y8HZ^Z@_6KY7VL.VU&^LZ;NV(86!J1;R@9UR8BWC"=+M M=DO7XJ[T'/2^LXR<%/E>D')#NG+_O8OX;DEDF)[-7`+#W#K.XC^KK?G[L!ZC@MZ?DJH_L8U30@G>0)":]V!M:T<:BU_ M3+2&NF`4IEUT8:9!2B%*DL4+M^[N.CHLK!YAFE[4FQXT2`.>Q:VFRWJHI91) M3!KK\L/!E1;-$*]?V:,"<-&M$&*_APUS+VRL"QU>K^]&^SIVW,4+>5@'NF]I M$(<8#@V/8O#<7WN'@^>*O9(@7]/T[(G?73'!-X_VNU@K]GW^T>J.D@]`6#>> M>TD+=OWY;)''>\241%RCK8!6 M.UK9)(H;99/8*:#KDR_"!WJT&`1([M?U` MNCFC:6VB<[#(K59TL[&!&F-*AZUWYER+K&L. M9D7!('I8!3UJR@;T[-;V^2)3J"H:8:TJ>:C3&!.LO([OVCY*KS"O?Q8!N`4! MX,ORB\FR!%]1O<@H(=VZ/:!>5GN]=*-!ZF(R3%3-@(X,WB/%7H=P>!1?P,)( M00KPI&\Y62VD0(G)F826'AK*(!.3P[V9'NZ!2O14S8(-H1OJ.V\V+WB(4M;+ M\(OM^/^P]Z>F#+'I;21PU8@$7U6=SJ1#4D8[G9[:(>'TB6"`#[S!M(]OUD[U M==P@],5.*%=:>6U8;VU!K9C.\;6+84/#/YWP]4K\@G#RHEHZ8D`R#@9T3CR/$:SA MC*`3B^WTG>U7%0B"F]'D<(I$T>"K$_\B5@F$@L5;S#^9EK/21,L+<+6 MDR''\\^+5D7P&M[XN*'NF;&J/:U?>1`EO"3<6S28&%52#<*I(!^P[Z>0U4XA M_5@LNY,<107E\?W_FDV'=Y[O_)]8F&U8IVE\$0T?,FG`X7T^M^;5@13['->P MZI63;D-.8T%=48TEI6FZ8RN@Z]]WWMM_;*C#837E/W`T37-H8K_ZGWNZL_>W M;LA&0,DP(GM"`SXD;.%Q=CZ/=R`%!1*10!DU>JMAM5#CW/Y>XRSV/W9ZZ$ M:SQ;VEG\W!'2AG(^;9Y?=9&"?Y'83R&T[86VWGT3C*V.XNK^[N[Y[O;I_(Y;<;\O3\Q`%M_`O*_D3PI8Y/4W`P#P\:C\`BH@VE^X.IO/U<`P:<3I MI6'4!;"*DK^9!1/@*"(S!3)L'K;)%>)_^-[I>.?&G7VD5T@W?^QVY'`@UTI& M^"QELHP!F=[)+LA?D)2!XH;VB_QA1O0A[8S640T&L\HS[`\?.(!I0W?;?J1` M`I[!=J+Z`<)(R\FD-;)&TP&BR)EGT^>*(9VLI9I.?/Q0`INO=[;P1PHDWYB5 MSQ)+N_O,1#N8T)5%N]>H3?#Q M@VLUH@P17TNFQ@FQ+GW87OMTXZB#9>X1K6$OX]MFJSA.B3)/Y(3X'8@1*:QX MU%69*&,1+Y*MS>\Y#]\OR(OG^]Y/?N>1\FY[?9BJNE`1'275L?W\2VS%FJ,9 MRL>1_#\O`WROB66\23VANZ%^?$L&XA&-852RX"IA8$#F7BH\5(Q@"C9N?QV= M:)"ZL4,Z;O$]RV\B(Z8D#MC3K-4H*<8M#!_D2QJ#,]*$TS8'4KUTEH\W---U MH]`5$VL*=VV"G#3 M_>EBW##RQ3Q(RH0D7,Q!YC!VD*>AAUC_EU3_=8W^F'AM&:=""/"<:#Q=SAO&1T'0H*&Q@X+UPZ):04R$%9RO"4Z93;"P$R0B M-94Y2![5C)@R?_AIQOEH(@,+>H5!7YT$/M)8'!#/)3Y]\_9O8@A2[BOHA(?* MO\K(D!H"!12>N_%MAN*9.+MT^]O[MZ^%[;*@;VKD[80`2"=U09 MI9,R09>DA$E,.6J3^TD0_PVY!_`9=(]/EK&WC>@"W,I5"X`#FP8)@;MGZA]X MU[6&44GRI%YTE=G#X_=H-BGO"',ZV5&9KW98TW-/"W[Z:5"R5A+,XC M95_:#>T=O:*VSSSFB_.+;I++(2Y%M5;-)VU%1C.RVL@&KQT=3V9RS&5L2,R' M"$8DX71!+I7%;WH`>#Z+"&A>[G8^W?&)WI$173M'>V]"O5]';R\#N+7QL`?` M>D'YI`X0JP%$D`;,9LE:%!(M%IU!G7OD.UY9U1D-(["=TY)-TP+J.IY/7"]$ M[O_1R=U50S/01+XYKLZ38W5VN0^<- M.G!0'U@M&(KW%T`+I5EC0;R=UF M`G6$C$1VZX1W-I_-.B/`2*&2D34R<(O:T`"01>:@6C)P@UC@Y`M\J29B.YVP2ACI"1 MR&Z=!T_&XVEGA)LZ01C,,&*"\"!!M8D3!(#7=X.WJ1,$B:C])PA0HD;"OT^^ M.QXM5I/.H>`C3!#.8K"N><''F2"TA%FW&&/:!.'.77L'>N\%->$C]XS>:)`Q MAE<9KZ8Y<$<$R"=.XC=R&8:^\W(*^9EY$GKDT<8[N]U#.RO1SA$$T$)/5_GG MS?)KC`15`)2`75(3!Z<_+]=K7C#.X@8+,B[[<4T/S'F#1V_OK-^C_V^Z9[XU M&:UH;R<;O`W=8IE.[7^2C`^5UL'%:#?G+\*X@RW;(?VX67L"O^-1C%[^&\XY7QA^;1\O=SX5K*7EK,"7 M!D;FQEN?.'7997@PB8#>-QE/IZOQ_TP2/"9$H[X/C"Q)Z9ZW(%86B\ZAZ1A= M4V6@.8>Z<5@Y[NT(7IW5/G=T:0=.'DM:F`LE1V!!+9EN1"G+[:\C=0/:M"+8 M^)[.+*!)&/B^]VJ9%`3D:*83@ICL;_@K>\-J'"WDA:_4C[-K<5L[C4CB+N9! M_;,P;H.L@P.W4%R>?N_9;L#S*.>-3RO9?*&QGP#H5:V@:Y8'7E:ZG"7K[)SL M!1%4A1=FE;<9DPO"V.!?JS2\"4H]"/R4)C.)2U$/.K=QW2(8@49"PV-!J+I/ M77Q0-]8*W.%N-4GJ6I1`0@1/#YT*;9YR0.$'B*/B)L:0)?_-;VB>7C2(!' MC>BLQ(YZFYTU=#RQ/*S-YQ3/FQ(PN#!@MUK-Y@M`K'A2)*;ZPT1[[9HCQ-FT MZQ8P9A9@F#7"/[4*RDP\%NH[/7J^J+5XHCNQU:::/ZI?T#DS5TH! M+Z6&,B)TU&6O6!#;Z=5:G!-J0J[.) M"`7QL2YYSJ]US)-`I#+4E4V`,<*E99WQ9I1J8*L^IW$\JS"'WU.V2JZ&R@J@ M$R(X8U=/74JG&VB-+KK&*:4+Y8\+!<3( MSM]5I9+[8U8-]]9E+M.%<&S!CQGT5O.-^B_>F3_:6/K5R*>]J&1OI[#VH%9? M4ZVR#4I@XZ4RET%`PZ"Q;D/^K,[@)A,`?LQ_-(V;($7U01$A_-J+`;3*JIY0 MW;_.EPH`4&J,!H%K[W#TZ2O+,IPWFN!R+4+*Y2]'.=A#7M4-D`9YP&7RL\G8 MRN.E0#=)#!+*Y`>GC51#.+S:5G^UM:(.Z+X5$$*,9B(F;[R#[937<%J^;!`N M(XG@!UC8O*X%,B/JAF*SB^IP=-:H;@H^BZ[F\' M@;-U(H&#;S1\V#[;OUK[2C-%(]#<*&:+^Q_G\T:(1[/R"_(BF)(*5U$3R=<[ M&6?3T#^PJ7(A85TP%9\O)@;RR[S,C`M@^,""! M.]MWWD8@^#O=[&B?.`*C:T@T`0D+!\IRN0#'E!QKDO$F=D`B[F;'EC,8+JK2 MYKT_MGOO)WF-K>!&5@CE5C`AF+1"$C2DP`W\H0++&6+*1PDG+0!A32W`T@`\ MDGR\$-+:6")Z_,'2]>@H&,]*^`$/-^HF5(@HBE#2W1JKR!JNN')R8X8]>#,Z MWI)9>`K3F*5H+MTZX7_$"_P^W7-A>9>:LH4^9)P=.L2:&EV_L$33V;G1::;U M^[-ONP'OA>6YE^Y&_&L?K2YM_G4*0EZ-TR.7Z\',D(C<70-X! MD@A$$E`R)1RZL\)^/%#!A1D"]U'%+AID5G$RY^A/DG!*#(S5R$6/>. M_>+L1==(6&V"_`7=`)-*T>*6^&5A:I6C9DBIP@#ZY;#D>N[GF`;99Y31453K M?!4$J6V"AIY,CJC2HGF,4KRA&S]R,>!-_*?%5*H MW@TK0*HQC`%(RL&\#9RJK^%AJB(+O`MV:63*.5V.J%GHZJFM'&)0;9%PIG32 M&K#)[82).'G;LX:OKG@)`6UR2<#>MUA.REA3]_##1=H0FE:Z]J'W"(.YH0Q1 M-?88Y#REX//H>YO3NJ:#KN0IW:?MI'V=<` MOJD;NS"QH(TG1C.+!7F!YY@PV7H^"5+2U484`2/_NUZ8GT/G<5YG1IEDI*O] M13AYA(!P#KU%D'@J?-]`H9V6^-`.H&G,:&$:C%PY%H_OI'RG23>GA^VU=SAX M[E.HO@@#\*+&G+E9&O@^W'16!%T@(DU&EGMB1)@(REB5%H/K/(T;S\>D1//0 M=:1HH%)45S(-]]-\0@TT$2;P'K8W]"7DEX?P)JW77J#L\5/W!@+4)&+`9VRS MZ:*$,>9KG!Y)"!)!$1M;_944H!*:.8EF:Y5FNL%4XWLR%*F,@0P?A]\7YVX` ML$F?Q(%+PAY>-+P:K20P2>@8`(Z.*D6@2%XF1]M![4-=XTP*'!3TQO3_9^]R M_;\GQZ=7I\!Q*2\)_<-7MQ9I?`T!&2I9X-F+-9Z48!)Z)"9*,JH71-#%6>L< M5ELQ.4HH$)M3#!Q1'R9*74T!5)-WRM!5:R##H":JR?B!CO@OY2ZNG4B8`<&* M7/"\9YXTR6B"8USQ*4[$)&RP![4SF$*,=I<91J/Z?/B^Q/CDT`" MPS;+LPXX'>7Z>#X0TG*;&@'ON^R+0'TE_PHF?'-RP'UT-:H9/7,4C4%F=RT% M$A]SZSA.O7IH0)/X8"VPRB8Q`DB//M_(#-\?V;<)+]W-+?OM\:`NP&Q!`!-D M2JG@SCB=UXR0"?T+(CA[\TW78U/4EM-D(++UMH.D5[1N(]?+`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`OI MP.5YC6#)C("M'K!#51 M>"3HX:.KAWH"5#>^_9-GLCY]\_9ON#?X-/J:"C-5(V!#)7=Z1"PYI&N"E^O0 M>1.=#@`?%T(%"58`T5I<(C59R<#V*7^*ZK=X)2Y;EL\XX<-P<'/DSCEG:^MV MK<88,&WAYRKP0DV'#>DG>\\&9;Z4_^Q]M<.3SR;#3W3-_PM#8S:6;*R?/QDC/X''J?#S$+DO'`1^^0-I"DJD%L@Z!690SXPGQ:A5R`V9!` MR[LL//A/U']SUK3F!CWIHWJ!6.$/7J)89<7R22<,OE(;DPI0[\3KKYC513&- M&%*Z6`DMA+0*$R"A)PM#0+'<^W]%UJ7[!4?TXN3`F]XTL(<*(5'2H)P&FB(Z*&) M5=%DRVCPOFY\NW]#?CKA:YJ0/=HA%\=SR5>Z<=8X!4I-3E:"1M4V2(B0EZ%_ MHS4K@^I7]")%*0?5X%-O"@SX?&>6KYOD9W_7"(R4*3B/ MGUFS.!$3[Z).WSM*;T&DU^7;%;?(.W)1032OK6WCGG]"M^>V;%<^GB;G*N*O MCSJG[JR!!=-`JP>KFZB7U1RDB)EWE7S8LC&*5QT$__0=-D-R'[;;K_8OYW`Z ME"P.>D5W"7*#/.`A>SY:3J,*8]$?]6%+^-`MB)*8*OOE]H+$A/76#@^JY;A1 MR[,J65_S.ZBFQ13L)R-&/WO;;7"1.[A[00YJ9;44\@)1F-;I0DPT5'APO(=M M?!C=YUU8[EQ^.VKP[/%_/)Q"\:_+\)^OSOI5@[+R=17JEP@;.S10A3Y]:IS4GG91KJ'(^OC=FQ7%%'(2>2++T0UXN%(S8# M$1=/<23^A8M(CGD9&2VRR4NI^12\<78?9W9GT3>1*VIM%4M&GKWHWXEPY#(D M0CSYH7LB1"0%&1DM4I`2)Y2;97L+R>K/T,J?U3FUDPD`K\0>K\;IN9"$CECA1CX7.X!:5D6MN)^>O6>>*>K,^8KD M)EF1M&M6)+5-#^M\DNARS9*E$S\=OU%="1N+'9U;:;BU M?5`6>O$YF-SPE>G%="P_[A55K^4$(.H+B-,00"(QSG:TA1"$$O$GT?#Q* MXD%"2YPK,^'HRT#JY0]V;^.#S1=).YNH9P0N/!L\KXBU.I.@`Z?YM*;R<2S8 M=#BF.%ZNDOKW$FK.>!JSS4@XB'KQ+3\AF\4E]VJ9<_2RR>N4F#'AF&5VQ=#E MSJ?"NM<\&%&?KR.\?[,/M+96%_Z^7E#!A()7AJ\6LPAE>4*$4\+>T'PS)>9>5LHT15*]1U[4M6)_'ZB@EUT M/IW$/=43CGQV!5M[)9\XX]_(#\$;ORF75IM%=SV?#@?;?X>8[%YQC9LV\`^# MJ$*P&,#>N,$EN=PI?]/5U7ON7T+B1G<#DD$)'S#9P+/#Y7PZJL:+A`G)<[D@ M+^_Y7\1Q`CTXG,,BUN`6T1\7VH%!'@A:V!87^3?4=][L4(2G(/1%R5SP!YNH M\#AUYSZ%+)9%]]['?6'L_2/UMYY_X)OR\$1C*#XHL6,@X<$#ZV@RBY.1C#/) ML;X@G+FY:0>*O43HN=UNZ5HLC-_QQ2P:A$2456=72+!HP_ZQX2>_-ORGP-L[ M&Y&MI&(%T?LBMGOF&O-1=S@EY;T<'9PW0QDN13\O#'JSE3,?ACJ2`DD>2"<%F($.:C!,CS MVE:$QYQ1:D(DBVW[TX9%1$<9*Z_LO2C*>WJER#=3G`G1+<)?I^^&'/R_[V MW@M.S*5:!$AMDN`$45WJ@8/!8KF*`VTB&XF$NR"I>"0O'\D$-#&2FFG@RJJ8 MN/)&9)/WCOW""YX<&M]G]L7SHS:-_*_?:7#:1QEHSNY_LB#L*[Y*0Q]6A#BL M.[@H8K56S\"-Y\F>(LNUGUYMGU[9@;-F@M\X^Q,;KEMN"K2CAA)76XD(OW1B M,AI7D]!TDYTQ(X+;!1'\!&!CC@:&QC/:*"Z+.1Q/T?E*L=)7,4G5<.33[>.3 M(?/E3IB1AYKVED8.%RS^A>__=#8LC15S<_X-X]U.7BI^^XNY&8MVUZ<@9&'1 M#Z[>)4T!6P24@?GAA)QAE8!WQI@LEX4:AN@(0\*.I/SXHKJB!:5YL0G3F%%R MQG?X28Y[SGR&!*CSH%01PL[P07"#7#KQCG)O)F4N\_Y*;9[$;1Z8CKPS)8O> M/&BW+9\8@@=*,!M`\!8-XFQU?5&(8@!3R45]_`14SKB?G2FJ\:46/2@-E3 M50&B5+UXQ2Z(%U&C^L-X9?2=I_9I(=(3W1T4K3(0(08;QN0F&Z2S6,;DS@V9 M^1WF+=%@69L3MWM7=X\OJ&!0SUM-K>DD:M25@NQ!;*3&Q)-45A/:9#'EC(J/ MC5&\OLW5>;2/6Q?&<89OT(BZH*H-;G\E^V@)7M':3;5%==HSJI4)<<=ZEK1[ M.]?Y/[JYV[!@(-I\Q&E^U/%J4TSWV=]8U&B[*3(,%Y2<8A#1X9VH%\GUY?D\ M)).!9$(D@$G$J$QC8TG0HXH1-BWO*3][(:]XBL_QDD??68LJGL#9)%O#W)Z/ M/MT[!\?E;Q7K?X#6-R-3&A3E\NQJN&^*&Q#C#/<[/7I^U*LO7=&]>H__"%M" M@%-""6Q@\>`SB]%X7@U>,2F2,LKO&XC##,D3AJQ-G,DPE76+00RC/Y:T!H@\ M7K2S\@>(">!DJ!TU*=$BL).\3T M#=F%Z(21'J$!/V6(!*GM;%1\1B>4\XSAX]1RE:R"QKZ%W)BHAQH66`UM6)$Y M3`$!%6T1_3I%W^5+((XVU'^BZN/ZO;TB`_PP_GQA%1P_-QK]2*CA8J"G+E0I0&5V6T:'G: M2>BJ<=`ZH*DL8P+F/2NY`>5!U(KXBKLX4T5 M5VFG*T&%B-L@UR0-O`$IBX8)>&*BT>YWL3[^@J2DL<;`856.FGY$+2F8RNNTQ4?@ M[3?D)$Z57SY=D^5\A#M"0AVV.&""C(6"P/@4*-WP0[+4#63C7,/#.I$FE0!\ MI]MS/X@I*>CCNO7=*^C!$7M.SK142<(?-UY M-5V4MVTY`:REO>&4LH!*:4,(Q-D*4&FT!2IF;O_WY(3O?$SS7"AFI.]@8$8F M"+S1U'09KY1'9$A&QPSP]-?.:JN==A35N9\414JCH*+H8P4#0Q(YX.?HQVEVEN\GR@D201&_=&(P-:WN:FI'58T[2D&E,@XRIBK-0.'8 M4K^*@S&E/"WNTYO)L%;MW6L2Y@92NXJ]UFHC8+#1?158K#<:#B:]]5^OWG[# M/GTT`"L_?>5!K7@K:(_#N)DZ?+,/2=EU-4=1UZY-$^WT8O/Y96 M#Z]^6LZYEM'AMZ"@*Q7$<,&C\K,B5*0&,`,8C4.4\@54H+3.B4;+R;(U8`P8 MFH91W*HJ'J'G;V;!IW[$J;7%('43?(GPWK-KZB5*3^BNDRBR!SH!TW.\&D7U M$9P`X120RB+Z*##6J$!]%40?+2RX%EJ*'N0^GQ8[2%3%&+G2"MZ&`:OZG,9Q MJL('E>RI9O7EZ*-/3W6L5NKH&G24CI0?:^2:H_B]&W[ M_KOC[D3=@^JKU;RA$PMJ,>!;C]-IO.3-J9&$W`4OXTDH1J4\2``92D.,C;O^)B9##A&=WS5G;7TUJ8*8Q'0PLK>^V@BXBC?YW/$M:;`3YK\47CZG M!DB6U"DL,`Q"?7M#O]D'&MS0K>,Z(;UWMK1F2E7WO';,U@@#=1)K.AW';0,% M.2+HD80@X12QIE^#J3=&5*\!WH/I&+7@Z]]WWMM_;*C#I[A3_@,/%-/NRSVF?":QNIE$V^K2&6!46(X:VO"#),E_NNQ9NO-\GDDH-C-J'M2=$DNE`"]NSL:+ M590)%^B<>V=#F?T.H,U8NS;UB>X`*EEM5=*2U]8")4UGU>IC9`9_NM3V7;JY M?7IX%"?P5&<3)`]J'*6KW,$.8\VL98*!B`CA5*+[7@<^WK:*-''ICE_O4C?& M]E9H6M4H4&JD:X!4>U-^F%/HCN/^`;]1C7VKN*W)#7U1;=3+G]4*`HD`\-)$ M*VDQD-(AG%!T/)*3PF^Q,X"&5E%#H=S>LU$/0==Z61$9*OT'RN1B\M_IF[=_ M8\GEO>/2A^TU^Y43JA<]0>_IS_.:A8*ZSFP\7TZ2M"]QG90NX83%>11!&FD= M='A]QR;HVY0K#JVT-8#2FK)).%ASR2707L/&D^8J5-6C:%&C4T'D>#Z:K6;E M0(%=H3J(3F,4G8#H[Z.8U44QO0AO*&BM,\-@.`[#/>^\$O=?J@>R]%D,),L$ M@>Z431>346[,%Z1(2@L1ROV5&J,HU8SE_II91I_%:L0G(K@-4 M`=I*JV!,B/]A^PX_4O3=#FE-IXK*8QJGP67>\"V&\2K&1D*"T6\G/OH\;&^<_8G]-EJ=?3B%06B[O(Y!\37; M4M&(G):BP>,O<\,(5@D'$K,@$0]Q[YH@3W+T>0=7P1D'=F>UAL#D6=5K.KE_ M5O7$L?X;ZGK\KEH&1[)E_]M$I,GMXQ/Y3'XFKF#'KH"_)=,1X/EPU<6J!L6R MBH`-!S);D\&/9DK9X-=[+"VK3SA#/_IY7LM8!?1#0,A+80#'Y/XW0Z[H1KP<9L*'>PA,#Q^51C`K]X:,J-+5F&\L() M?;C\I![37:)79M`(U+'2]XP>^S?[%_N!-X9G__A_4$L#!!0````(`%MSBD=G MQ==F3S4``$'E`P`5`!P`<&1C;RTR,#$U,3`S,5]P&UL550)``/^T6E6 M_M%I5G5X"P`!!"4.```$.0$``.U]6Y/C.'+NNR/\'W3:$2?L"/>M>L;V3.S8 MH;KU5+BZ):NJ=];G90)%0A)W*%(+D.K2_OH#\"*2$JZ\@8+X,M/=`L#,#T`B MD9G(_--_O6[\R0XB[(7!+V\^OOOP9@(#)W2]8/7+FV]/;Z=/-P\/;_[K/__Q M'_[T?]Z^G2P6D]LP"*#OP_WD+P[T(0(1G#R#US`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`.UGR^^C/P8SA;3C&&$4Z&1-`ES1X]\.+Y9'2( MR6]$*C>1B0:)[AKP_.L/]-1:>2\^3*FZ>W7\F.IHG\/0_>[Y?G?PJ9/0-1C? M`D`^2';S'(7W=,T?3D"BB<5^$W'?],LMLD[_%!+U)(BA.]MFB[1#J:+SO<[9 M+%9=NODJF^Y7Z+L$_2?@-U%$6B.A/S#2189GR^*W;P&17\QN4R?R=@FQ?8!4 ME[0V-8],_I"9FD5KB(X%5?[[-?#IW8G.Z`+Z1+US,WKVU_OK&'L!Q/@)KJC2 MUXY:T@%=/<*6DT6FEO5S-R=0ZT2UN4DA\G9D'>_@0?H_D/LX2NZ470KH&M_M MC>V2OD0F`R*(HP59PD3#BA!P(G)GHC-"M0?R3RX,,'2I]A7Z'K71N-E\/JTA MF;T>T&J5W-Y`OELNR;630_*,3>KA`HOS"W>^I^@]"<$UZ4$^E_XTNWGH`?Q> MV&AQ4@Z+Y0L$]._I?F-H!=GO[C0JUE>P@$Z,$)%%]"K:SMINE:#.@>I,(&I\ MKD4FGRA\Z>6O,\YDWVB1G9L81V3+H&RC!JONN%+\5*MSE:A+"[@-4=0I;VI? MZI"UTF>F+V&<_0"(2I2U;$?TU/ALATS3^QPQQV2`C:=F2':0]>OJ$J4OS:ZU/MZHEOD0/&,=4!^WROB'[2HLL MI8K;,WCM\EB5?J0=5]37,(+X.3RHOH7NFE_C;R%VD+?-S,Z)'C9;EEWFS_`U MNO9#YX\&?+=*QO"0F9.K@=/,NM4).<-#ZID>QT/!*2.F+Y2(<'XAOU(2"CG0 MS^Z2?'H8"/2P-I0(Z!H-\N5MB('_&87Q-C/O$)6.;=7N:Z4T)FKHJ'6XNEHB MK6L$2X;L8R-U7ZM,DX1A(=+A"JI%2.<[[F`Y+=OV`_=7Z*ZH6>'@.>M-1C4A M:,AH=2F;FI/5-7('VVE!`NYV(8F_:)3?#I>"RG>[YOTAV$$<97^DMWJR%+\` M]`=,['1W?XN]:%^R.`?N#401\()G!.B1VN]IU1FQ7:-\8MWN%B?!Y[KF]-@N MVM?24/GN`'CO4)JH?[WSU7[J=:6-.U[SLH^:YKK#J5?\=/<:UTO4G^K)_E;W MYV5F)N[OS!-\L&MN'^$*^%]2!NAQFMR>5S"@QLQNV5;[A]Y[, MRP_T#W2"?GC[X6/V4.J?R#_]/B6?=NGG[WVPRH?SP0OT?WES^OO[SNFYB1&B M7R-+$OC_"P&Z"]Q;,G4,TKA-]:@\7;KT7W[/IV7*F);I"T["AHZ(4N_7/8XY M&2DZLJG_Q15:0/(R0`GEAOG;7G'[2&)0HW.F='3D7( MV-V3$+D0)0_I/W[X\&9"&%A"998/7CB!7C7"KP M^;<1'[Y64<#T[R-,`I6[P.D_1IS$QH4"JI]&J+AWC0-*1+D<45*\2Q:@=:V2 M_^G]L;FR-R.F:N:A[,M>1#_RD:I,'R9O)X?>E3^'R\EAK$D^V+].2L/5OCD#)_VB$TP[X2<1@=`,0VA."DP@R#JMJ M?8UP54@\(0/'S4S0JK%0TK7UE:AAPB789$03"-QMMGZXAS#+/:.LG\C[F>"F MR$;#)/HH+TR_M!U'FQ,UAY%%ATFW4E!KW*RV=V&R(M$.5'N;I@WL7`>4[$)J?0TPU%(9'BTG_L@=;40M6I+S?U\#5[8 MQ00/Q;ZD-R'Q/+#;FJ&:/E@KDM&7K.&W<.DY'I\%:4<3_#RM0Q11B5]ZN\?A M@-G4",T"-YE$-U;J:H8GQ?OB0&Z(VG?"@=T"OP60;$2R'9]F\]3=S*&;T="$ M<[UJ'&=YTB5>A(,#_]_ML8\:\/#,5+8&NBLC4_5=6QK9+,V+$H6Q_Y" MF@>.5I,(L@)$FZ]MRB`R<*ES31N^0J`;H5"&2N11+Q0I.R5[(]PXGL0#9I_L M%/M-,!/YS@K<[#P`6MJCM6,E"GQKG`T[B%[""T&X#-5X7)QG7L@F>UZE0T.,ZCN$*5LWZ-*:"D$.I>`&:GN5E[6?'>+!9`V6E^ MU@.*&=I70&2GH5`3(F;$9H&1G=9"78P:QCL7<%I_!=6#\Q2AJSH7SN'K#3H! M3J/BII!VS-G5<3,=V4%+:F MU*L'GTHTLJVI]>HAQHK[K)=0[Z<4H0"NDGNH11@)336UDNKIJ%S#R+^4RIX# M.EFJI2M9JJ6TV^2?#ZK^A&C^&$^^`+3R@G\QD6NI=/K<>CO/)3CA.43)XK^% MCD_^=X"-G]V!W]50=HJ3@AKBK$6B'@/C0!)(K]+3#$>84+&`.Q@(TH64VQC) ME)&=E/DRIN5N'0ZU[+:#H5JR3L1]AL#%K>?'$5?X\%H/B'+-&3CN922W"CV. MYBA<R0(C& MY04`[1^(=I&$#9">1$LA]*T>`J++0,Q/UM+=%X>)(-EAB7A+MEEM5*JC#);3 M3(PTYK4RCGENV=6?)6J=UA!#YU%_%>N,=P;<:Z]LO1'-(7"X(THT!EYK%^VLXHM=)UPFII+%L,QXY?%%?'_Q,#WUOND[+/ MM+8ZE!WUS<<=&AKW1`?W5IGCW]D_(Q!@LBNH63APD[_YJ9'8_6NPV8/2X<<6*KF2JD^\-:VOML>$-410RP9H>[28 M-I8<_VVSL+#SV[4TX_K>NS@L?$]GQ^RO%L)^XX M04"*[1FE:X%V$HE9+['T.3VUK1M<4D?$'3L_:N5Z'?[2ZQ!2?G23[5G7V@!5 M[6EQ?^G8AO%TG-8>N/?#[_B!`(A@";KL%?F/U(`A>D5.1Y@D0YAX,%[$Z-R' M:+H)4>3]/8&.$Q[&;V\BX*V@!C^'"TANL8Z7%#$J+FG/(05XCD*Z9-WK_3<, MW8?@8`F=.A%9S$ER('$`8">?,H)9:=(.J92"%?6U\*+-A5V,/#]7*_S!9$:M MKY5<_7XU(+[(V>&%9'\X"`),3Y#D_UKL<88PQ>/QSD^KK%1V/MO4)F"Z_IA# M08$A_QJCH#ZF"11N(=%!'$]TC%::&$ERL%P2966VO'MUUB!8P0712&8!>YMQ M>-`:P@B/KPXDIS)XS3PFU-:=VR:A2ZTCY)Z:'FJGZXG'=*,QS3_+M2W%@K4/ MR2M'6DGB96D&^9S).AIZ^LH2XP=-4ED+KS'0L/G5V(\-!QT0#@PE1H]GU@## MYJ_>NA8--&Q^FZ]KU4$'A(.Z&J$QP+#YJ[>NAV8342>S^;I6'71,4<&C<@[V MB1WN/D0+N(T1N7Y@.%M6,B\S25?H:)*?V9)6HWC`."8'.A09Y$0]#'.0NP;D ME!]:FJ3X.9PZY)I*[F\QIO4NWG/@BB:>!2(\.6-E'EB#^`$?Y0Z$#H)A?1?!_/EN7J-#R^Y!U-\_-8 M+B"CP$:UO6GJ2X=%$@["N&? MZ0MEWE%@>P*"W@2%,*#']K0$?:'O'YYX1V?8]J MY0!DV>WJ/;V]7/!$9NAZ3W0O$$L%,UBS][O#/\E:W]*GSH1Z+WDO>SD>63&; M/?F]E%7(-UW5>PA\V4M0R11M^ZOA=F!M&IG5['GQ\%_\UX]H8AU"*EZ[>B_& M+!`(33$5>JSK99&[0%0U_&"VYY_K:)U6H@[JY:J[O'79--*R6=:[2SFG&K[: M:I8Z[U($@DX0>+/T>F>[;#5-H-P2%A>E^>O;C>OD/*M3%F0'T4MXB:C*SJ*+ M$I.U_?UM^D]LKPK2FD!M%/]O>QV1=E!N^#K<]LQ'?2_EIFF/AK]L58+YZF%W M.?GS6L)0>&RIT!O/$?X MZ)TDK,GPU//$I?'>!LC'98+I!JA#[(8X1_`P# MHHKX4]?U4N(>@F6(-FE`K8E<>A[CD(6/7X'([GP""DNS0KJ[6#A MZ2%'AA^364LM&IMM'&6QM<>9NZ<;R@R/U5;&-O(*/$L/NH#;$$7@Q2?TKT2O M1@4=AE:&75A,M8-Z])4,0B:B^G<]6D@U6V/U'O"%DPL1:`K>YL5QL5`8F2-/0[B1K M]C2*D/<2)T+R.2Q>@F3A#U.$Z*U3=&JV,+`)/+23JS.9UQUE0)SR,O/K\,D9 M8TCU7;NH65!'=3@+9ZH.>&T(%-M?`+>P&!6J/71>/WP0:D(2AH<3@P$>CN6@ M\FCU@6`1K#RR\J<80\4\]">=],Z(K>N$"74?/V2TT7\AJJBW`?ZO$/C1.JEH M$X`4L"^0KJLCRI2ZF#B[\N#@TN1GX9CP-MP`CY>*0]YO*-R\>KQEPFL]$,K) MAH=)[5-U\HLN`^%AGCUWG"//@5,_^3CYY\]AZ'[W?)^6@'*(\"67W5OHQDZ4 M[%*1M:S=;[0B"7*2R"']XJ5;^@MX]3;Q9@'3M!&I/V2ZC%)3@`]3P40MU$GS M^Q`=4DP`/Z7M>-8[_93)U5+BA48SK0+O[]!]<,FQYRT]<)#:^9,%N2UK1<<(P0E*ZCKK]N$;*E'TW!RR;AW#'^"ON`D7YE M($C)O#_"+D;JE22/>N^!0R'="U0*1D/S]`H5.693,]50#ML<8L8*.!QA](C_ M3A^K3W?`\]-K\(*>[#`_\CFLMOD%$PA)V!L$;;DR5MCU2_'*$L+%?JL@-T7PK;CZ0YG@F=XA\C0&N5C(E,SK$*'P>YI` MA_P2[3F\:@UAQ/-;+5HKR&+.:CF(_,;%J][/B$^^M)N1W)G`AYA<6&`00[[N M<]S*"*7.FHA]^MJ7<>_$U_O2WY[I,<%C17>85NZE-)?&8P@"OD'JJ(4)A+\% MF/IQH:N0N);=MA6L#D.3!1?Z.[+?RS*,CZ!2/Y,&.(2-M=>[HPZ>FMMB?MU46O M=7N6[5E[50'NUD5@>]9>D\M8Z%2HEZ=W!+X=GT.]O+WVHE]8!FW/\5%W7;;D MDVZ4[L-">%LUVMN>_Z/NKI;8U&U/W:$+VXEYL5'6C;,(*]6%B&G_MCUOABY( MLM##9EDQ[,.KGK.L7EK7\T-1%/Y0D5[:+@?;+8S\X(O*I#R5M2:3_%G@N-7D3=9BT3]*5]`:I.BU6H4Y&@=Z.]NP=Y/*G M+<&T_$-6DWD.]H)HS'YIL`_E9%\:P3;]\KDC.CZIZQ[C8VM]LG*>UR"0O*'I MEX;S1WE'VH>(]PZDFV^=.VJE?^D!M_+7SAVYBWLH6YN'1-84\KPWC9[]W7-' M4U"5LG-$^=\^(U3S$Z^?72W]FD7(Z;^D;_6KXS/H@3T8'$:\>G>8-X[CR^ M\.O6&V=[?6Z30!\]Q1SOHU5;]OB:L)6E)_#Y[O&-'T_AF<7Q7=6;H ME>3-^#R(/@_*]_ZQ+2)=3=Y16=ISDHWQO5`T'`A11` M?'L`>PD%U4%$[5NFJ+P`U&AB]AB"W;63,&@[[7QC&/0`/2CU+M9C%'4?H79C MX'1/0"O$--9Q8)^/]U`5_F96^C$NNJ0.U+H]7$J(\Y@^MRZ"-6PC94"U#0\7 MC*?HQEO)^2DR%MH>-=\`/X5KK.T!\$W1JV$4MKVD3$V#8S7U?0U+F.V"LH%Y MD+'9V18BVQ\#C'%DIM'34I_&Q-T*B&K+VQS5JQ'5,=ZQ2;SCMP#$+EEW],WP M?8@V@&QN$#@>\!<0QWYD(LR1,6\Y=0_!DOXO68AJX1"*@PPD5`T7-.95J.[) MOK@):8VSV`M669DJN@<@X0+>K(FDH*I`J1):X-Z]$J[(`D^2V"?K_2N,9LMG M\*J.5O>D#`WSK$!:#8CRGD,P"^GM&HF\/,7F`KT:+<+8W;;NSPDRB,.,_BE% M#[H%>%/7]5):2W-EX@ACDI<6M)XMBVE_"&BA)4A34MF:C&)M) M`1$YZJF(K)="E%:GC=9%Q-S0LZ^)3D.$[%\#[GAVR?- M6L%P0>?C\*P+W0"\)D>#'W['SR']RRR.DK]-H]_6GK-F8'8-5UXP!RCR'(\< M4HE\)2L@0MY+G.QPUCST\5F36E)-B5FIDUU[J]JN@C8`M[TSP?:@FA9`5E&# M;,\VV!1&Z1EG>SQ,4P![.>!L#ZEIYSAK=N.S/D M\9R5.,Y?H>_>AR@YC4RD+$BC1I<:VA[G?E!G)!/7G1IT2@P+348/2I;7OS5)<3+BP!'0*6O6>-B!8Y%5'*B6&FAM M90A''SPRG(H`;8H1E8^8P*F"U'D>UUIUKPF3::)MMKD[2`;_,+MNUE3MHR032\ M8QZ[E&Q_)VT>]A/?E>W)^[J`O`VCE>W%TH:$>Y\5T\XA)BE]1DPP+'[[1CZ/ M.$(C\G:IL!A*W`H-YLW?Z^7+(%D0ITW3IWOI$S_^4]NVOS*8")^>MB,'VKW'-_.=7H2;J>6[ENW.TZY7N88-IC\?ZB#,E:6B[LP4S_GO MU\`'@9-$)28YR:&;&2?WU_L\P]<37"7)$MHN@ZQ6^=A@<<&;$&U#LI#89:EX MK5HJX4@F3%`;NO*["6PD55^-%F15I.WW*Z/4Y054;F-$-*/T#;V$8F87HSP$ M)UE\"QDDL:WJC6&2RT=)9>W3=B:I?48@P&EY"0+M/$;.&F!8RK!X2'\CXT=G M)+-%&0\4*]5>K+8V0GEZI`I+8U;;&*&2*"M)#H\C34!4?E7YJV%'-%C MFUD2TCUW%PS<)"DY[BNB6GQR75#]$RE4C*769\T(0_BP]*]*H;;CJ[_MCC\N M(@QSA.U..C$6+!.6[6XUI9M`10!7(>Q/0SX+ZVMN=9TMF3_?O6;NLH-.;>#R M)RA_192R>!.GUN)-B"+O[Z+8L1H#F;CL"LC\C$+,N^]*NPV,%WX&-DFGTR\L\GTH#-J/8P9G@]65GJ_"ET'<*EK;:!27\AV*Z5-H94+M5M5V:[A)"K M"-33A\\I/JI+6(\2`M5Y+SO\:)P6I*7*4=+,QGIV<1^W$'D[\JD=/%2X?`@( MAG%Z6QM,X3#X$A5T"=Q)C(9&HNPK9-P#!Q)Y%_.S"?*:FZ?]"XABNHQOB8A5 MHK[2P3S]IR7#A=27FING_1FBC1+524,S].;B@]9RH)+WF7Q2@K>@BUD>"D`7 M'OY#*&4$78;"`XW1^Q6Z*^H+.SP@5KX&-QG1+`(G/C`N9X\UXV^X,7CYP+D, M_$)6^)J`]K\0<*+RA#WJXXBA\VX5[MY[P0[BB*+X*?LSI?M3";_T7TN4?`W3 M$Y]Y8,E:FYUY433/<2M#9K9C%4L@9'BM6UFK]P2(>>@%T2R`3_2Q6E%QZ@D& M1'--^\UL:8DX`IO:-K#F)X;,9$+_FU.?MVBC.#?6+""-$3C"(_ MF8WJ]ZC\8M&FV--,]#75:/*-D6@VW!CLTY:MX%I2JA)UB[\M."U-X):$:"XA MHO?&)XAVGD-$R&S)LC12&P!F_R2T)K3Z":-/'[D6SLKK1JYMR_:8 M/PH<4107J;_%]A`]"3Y*GC3;8_!4,%*P2]G^RJ0)3,?I`^TL,B%!J*[AV/:' MR(JP,>V"MC\U5L2&%6]/V*C,J MRH"J=\KVRC"*B^PDAJ99#9=SPH6;_D!L3+`^48020J>>K!R7"[CU#=F$^]#ET;$\[@Z=@]\-"?@1_# M(]-+9E'':8IWJJ:2?W*I>N&2/^#0]USZF#/+>/&TAK1JL('8E3(!C_0S=.WR M@[6YS4W$W;"($4;1"#J,KXK&5T7CJZ(=+`3:R96)RR.KCY%W)SD9N$0;:\]? M[]G[Z'J?3=`MQ-XJR*H8\!_;=/A!T['Z.97JSS2J'4S37^"=I62(#I.EP(RH M]W`X*Q6IK9P@3/"8IOXJZQ2GPPN4GZC$`#DK8ZK!QVLWD!4.F'Y8O"R)] MS/:+F%P7+2,E7.NV1T8T@HJQJ2XG2J)&Z.[1,7XYH1)C#%SO,7!=ZM^7,Q6" M&QAOEPN5W4:Q/SN(7L(+P8ZG3C>*`CH+`+N_.,O4Q`MQ*_8+M)H/UUJ1:@IL MIA#JT\=W!FZ3HC`HPVB1KG?XTNWDPD\#/ M)I-^J9YH$1T4JJ5"#>\]K;7^U00'*0& M2]I7YUFVWBX[VAH-OK?M7B&XR*GI5+D:(\T'`KZ:GF&]J6AX.X"E?-L? M)ZYW#6%CR#5:V.[[U+DSZ,B`2]%0].XG*@CV']$Q"-/OP?[]!0+Z]U352SV3 M@5N)X$A^=TONMEFP@#34@XC;:X`](S'Q*:D'D@K&.'+76A+U1O#M-E^C.1O)9+?9`!&P[.ZK&IK M:#>VW_>Z@+>?J,(+!5=PK^BO'*<]<-:-XK0S7YG.98`9M"U1N*TWQ#<'L.[2 MMM^NJW>K8Z*KIN_:;J-4N49R=K=@45\,:CJ7)B:,K)NO[>_U.D'OJO\HD0'; MQH=9?UQV$>6UMLJ^=@9"GCMK%^9W>J*>HU3S'\J&>DC2X*=)ML@L30.76BVB M?8E4\2+5&*#54GO/WH9LPNG@=QS-W$ M.`HW$&6VA6`UF--NZC@T"3=>0`=Z.WJWO/9\'[KW1?6`XI$?FJ-PA0#7)5]S ML%9D."VR1>19^,<^_$)66OSBX;7W;?G71V_C1=#E5R55Z]@*C3=@"QRR6+^1 MM84.Q:Y81'%:#BWD5NMKA"NR;V&`4QD:N`L8>>G-3OD]GLX(9CB,J;6= MR/9H3VMN"H(PF$W;6?''@N_$/5!9]?S6W5##BK<1M6R%BMOLK,O+(GE255NA0?\UCZ+Q;A;OW+O3HY=*.IP`)V[=$409YL1B^ M@%=O$V_2XAISB/*ES"90O;N9T(M<[:3OK@02C-'0/+TW(((KHIW^/9E\R3M6 M:9_*0[[[TT5^A[T[Q3>C[9&<@9= MUL4(+5_+"DM&X9 MMGH1=$%34)C=G6&M,U5E%=QZRM5:CKKC2NE\76JM.Z0$E-+K:6G%9P M"5;NC86MSMJ'-9J0L*_4D2'Z4JQMI*RYI)A>?1R;#Y=*#92B6WO:S.> M&_\`BV)85W%&V77_ESO"^9N+[7ZVU::I[X(_K#&^NZ!85G;9`03>_OP$J^Y* MVU?-B2/V1/.[E/W#:?H>SF;(?FPEXB0= MZ^[5\6,W=RTE;LK[$#T!=E"WM(\YQ&;+W!F6I)UX"#(:Z>HC.K(7Q-"=;2%* MY;8(7KV1S+R30&2CD'N",-+MN%5+$?=$6/C\753YW4B=E'1FJ'!)TRIC;@D; M1DLC!R+9.'@!=Y`L+'[0[7$K(Y0Z:^C&/IPM!9+\>I_]*,H,6V&8=4P6M425 M[59F'46E`N:Q>F]K8&M3H)@WMT9AK3N(7D+;X%(TWM@:W=ITE=6R%MD:"]L. MF$V#8(>?6%SI0L?0TOOW10_2SI\<@17588Y"-R;*1RLI4L(`QQNJA`C>3)XV M:L4<2M\7;"FOT\!]"I?1=[*4^$0(6K="35(A+H.63P6CE0DC24;!#*6O6T1O MRIE-#=),"\QEI&"A:9#??C0TCX;FT82K:<(UAW&?TNHQWY#&PM!NW(@S`J M3!TGWL0T?89[6@F=&HN?XLT&H/UL*6UI*&MU3A29O<_D;*.4W).E<0NQMPH2 M:M'_Q,#WEC1)`<.^'WW^%[HICV&AU:".1>Z*)*KP`LDN$]C`#YI5,X&SY M#%Z;L7H8Y6(X_?UJR+R*+!1:0QCF\1F!`/OI:>G^-4X?K:G*)E%G$WREY2`H MW&$@B_%CMS42WRI8(]>0J!(T8X0/,/:6GI.`+=MI348TDZFR2@T]Z!0VT4V, MJ&HVAT3;<260M/H)HQ&(1PM7*0*1V:>E+)=._KH5NAP3IZ"A2;6]KJYRE"!' M[V1L9!W;)LN0S"J*AGTC:@/:1F+1=O-:&P"W*W7KF>Q^2A$/X(I^TG[,]77@ M9D:!5&+_RZT<-"=>[Q^(\#/ĦQVI='2^1HB52VSI`I1A!@>`O3 M_S\$#S1M$,31W2NM[<%,"2'O-#0KZ2VYY>S(Y.\@+M2L*4X5K'IF4NF0HYUT MM)..=M(VC'GRW6M[2.&0K7DZ]M-+L>:IGJVVAS&.9KO1;#?B*[%KBSX,\`>520 MT.HY'P6<*'4WSUMZ"?&<.=@G?\UK,"IQQNUL@B_J!,14SD,\"^Y>Z:.`V,-K M2MAL2>GFL"3O9X(;JC_.ENE&YA!>:6*:1@4YRFT^%-K)'=)+Y^1D9CD!X2=-C=`DAI)Y/H"7:I//#Y>U;2/YEIM;'5;JMBJZI4WV/N+5L+--=#1R@;;2]_J015<_7(UG*/ M:G;8LKP2W.=L%UHRYB6 M-GSJKAO;WZLV6GGV!U*ULC%/7`:V1ZYHHR8P.=C^_$X;*P47INTO\!K*>[X[ MV_;B`[7$V:GOHUD-@O.$B1OKR;H+6!\@JX70J:$QQ^>B+CY6!(N1J/J?RE@<^:8+DZ:=MUL9&M5X@@(- M.Z]E/( M=1#BZ"S=I,7FJ+\GKS;'I?U,,H!POHD)U"%*YD.1R`)7^>+8]0E[&F,Y1)::DP>Y5':1J; MT78_A29THGUNNU]"$ZIZ&[(_[X7!L_IK&$'\'-Y[`2#``/_PK!1?9Q4V;R%V MD)<0/`WLF\E3=P'93Z.RXLV;[Y1(S;N,8V3G$]HFJ?_E>Z==4Z&WDQ?/H. M7HY&DKUE)_T-7^+VTP!&1 M87'@I*)*9T5I#V.F.C$Y,5*LC_,[%8E*2H*9PZOV,&=TH"O*2]OO?'JH5?>Y M[9<\/6S43RK;H]+T<).>@K:'H^G!I7^,V1ZBIH>?_M'87[B:)?>X)!!@O,75 M24)[*)-[+!4IW@[!_=;S8YIYCD(L4U7KCG8^F[DV7J-M)MG31&=Y(;\FL=\' M0[91H>51W%JLW:JTDN\"+X2.ZB]*WP`UFXR^)?'L@:#U8> M64E3C&&43@;9:5,\!RB:+1G<*&D<'7_4K$I&?;>K@"9R?7#)?B77!DI[A9/` M??3`"PUPI8H+QO%&6U5KYROG=#RTCK#M-CM=@+L6!;;;`>OJ.\H'Y84'>A`M M9QMBX']&8;S%#X'CQRZYRU'E)XW#@FX1AC60>PJ;N.3"669&EBY8EI@":NTA=CNPH5#NMV4J]9X>IO@8^S?S_ MM(8P(OP5@?S%K&)U!;L_2LY<0AF9O`L7:I_#T/WN^7ZBIU<5\X$H/DH42D27 MWAA&$O'KS4,#-HB')6@UYI0:OZ(YJI#-5@QEJ#8!@BMH754,U2U@3:"U?XFH!GT%)U\?*D M9`1A44ZS'=)DAP_!8:IGR\/TSR%*W#V!H^$`;NL[`T2+0WV8^LCN@8?^#/RX M*5;:7[%(1K<^`;8KTOWB7T=<7+@*?EB43'NQB<`J!D&20T_8Q4APF!!4=2:& M(4-59J02#R/F_L(U52$ZYE11&[9=<3H<2,N"KBIA;5\@H+2ZLV!!R^?0&C#) MNFND MFN"KJQFX<#%T$^,HW$"4_12L:@H2CIM-,#S#L29H;6+;'[XND5ZG[4QN-"[5 M194MP:1<^'9X@BOZ_P7DR59D-SF1I1R!4C5V!C:D2:;E8KR MK(+"N/ED&)F['Y>>P@<1@?8WSX6EUR8+N(-!#._)`KDC,"$"=2YF\?5^CD(W M=I*;TA-$.\_1":AM^WMF;^;'DUSBZ7J?_:B.C=YH0Q!_C47WT`5=W9FVW1-2 M#\36AJ,/>EHTQN_!=2XVH M`[%N5$F1!K@Q&YN)A65#J$+X,+:9&/GC$KJCS8+EQCLI5&+8%6=-<24=AYF@ MRSF6L1EWVNE.>X0KX'])QZ`.ON1E]`H&-(>EZ>O;QHORP,8*7'-D550)``/^T6E6_M%I M5G5X"P`!!"4.```$.0$``.U=W6_CN!%_+]#_@^T&FRN^W*@)=IF5R9=DDKB_O4=4A^63)F6;"?K`'I)+'%F.,/YD2*'7U_^ M^3P/T",1DG)V<=(Z?7^""/.X3]GTXN1AV&@/K[K=DW_^\N<_??E+HX$&`W3- M&2-!0);H=X\$1&!%T`@_<\;G2S3T9F2._X;&6!(?<89^OQS"8`74 MR`:1#$M`V7<'AT[6 M99[-Q&*)U6I]_ORY:5(SU*%L3#%>I/03+,>&.DYHFL)]WVJBJ7-M`E$#J(B@ M7I9U.Y_%HVE\E;)E2_U3,TK,4'N`4266>7))O-,I?VS&B=JH,ZM$O%`(J'B; M6.-4S?O1XO4)+6:#A&(.\NS-BEET2K'/*'LD4A5S16G%EC%,/5G,9I(T5\OB MDM0KYH&$#1QJ(3:P0,HZC\)B2M0]GA.YP!ZI#$9H^>:$J1LNYM=D@L,`2N:_ M(0[HA!+_!($$0<>A(CF"D*U(?M%2OF#&N#)MF'G6;Q8+RB8\?H07NJ*>"QZ0 M$2`4Z1\/@VX9?57<*#Z'6&#._PQ15RR[D(N8F[Q-$_8L3)T6J3Z*1 M3R:44:-YZWT+-5#"GOT)HE`D"V6$?6FN2U@7'L+7H\=^,;\]''AA8!AOX3EF MCBE=:_UKV+OM7K='\'#9OFW?7W70\&NG M,QK6_JSFSZXF),6NB]/<7OI8SDO#$?R[Z]R/AJAW@[KW5[V[#FK?7Z/>Z&MG M`+1W_4'G*S!V?^LDR>\>&`Y]JHC_4^W6:FZ]PG)V$_`GV64^%<13Q1ZVR=S. M_K2+LZ_:PZ_HYK;W;5A[M*)'[[DBWD92LJ(E-=$>H(NM)IMYE]B M265OTL\8/2+/ZC+@WO<,`@XJUHV8G_4GF$HOX#(4!!Y^)0S&:4'M_H.X'T:& M8TC5:JY*>3>7;Q'E=O/?U]W<]OX;TNB#+VM?[^5K*-<%ESCX5?!P`2VU%X0Z M)**+FT-_EH6@YT+'/G19[XJ"O3-QX^,?Z_C("D8KR354]H+*KYS[3S0(H,WN MZL'3E(X#TI:2J)V!45&D&P:?K:]!+-V,SGIJ1@1:Y8*B;&I,[-=\$$$?P:I' MTF52"3,8EN#-K\2?0@UO>Y`$RI/=FXY],G#BI?7>:C;2O%"J"'.QNCYZM>S21A%)1M6?W\NR03/7_`5EPH>*QP"Y5OHP< MMZ\_VK77B$2IS-K5^U5BX!)D1I@TO3@=]M7$%:OR-B%N)W^R0PA>.-=N(LG0 M()<#NN6R;KSW'1N,U>[=_F)>MY>M>*`6@[I2AGJ10>W./7MVNM*-\//NO3.' M`+=CK0A@)$LOQZG[6'OZ]99,<7`7R=!=8A,XFQ*@JCH\*R?)[6DKEF>$HK[@ M'B&ZDUZ[^[7G=OH\H-J%+S3'DXIW`\..[D5S/>A=(J">]7MM9(STL/JE8>(VIP!UP4$J@V_=61"\[+5@#X#CF!RM`XT!9N4%CQ>HV MS!76^/D1DX85T+*38#X+$M`Y?-;% M,NW&]R;10-V(%,0'LEN*QS2(%H%)"<,PWX665\G?#3YWJ!.ZEI&*NNDQ2J)$ M2V341#D]3;N4T30[/`$!<5@C4==09Q1&L<8UL@^([*2PUR-9G>-C::ZK<%H-G<-!)]WTV!=<[\''Z:AF0&08J%*(V2K$ M#10K<+H9*&E.>DH?F;PR8;$HMQH?N^&C>*:D5.^H"JL;"W;\<\,$2]UE>@WO MKSX*42$2=<[L$GZ)0[T@E[=_@R(":O&9;^\7"8+3.)HNQ48>H$LW/BS MHL&E9I4S9(DJACY6)@';$HV7*-$GG6&HX?L MRP$OQ9MN^S90U8.Z@WUYT^4!Z3`HNS*A5.=]!Q%NZ%B1[JV+&.K>_&O"(A-< MA+I)P&8U@,^"7G$OL*?BQ7,Z`@2O?,+`"AT"Y`'5!XCZ<0T?S@C4Y6IH.FC. M3A!^K+P_/[_2`EJO1$.D542ICBA1$E&&4C515L^D$421IC6*7P+%G&H# MD'K%`%I-U2='R"5?TX*I^]Y5MQJZ7T4C-^JM4'\)U$=JNQ#/-P)]I7[$;_95 MK3H(^84*N=RQ3J0M:'8I6%$\)4[WVVK5Z+*!/EI`0,?+;)U81_=! M9;MQ:DT.;%KDUM@4N$ET0%CEVFV&4D7,1'K=^AX4:65ZE!4XW2BQ9@8<**G[ MCP?T?>:8DS(.WT;N]G+!$0J)N-JQ!W:L=:9)*?^6Y'*[V0K;VZ>BU.X^>#W. MKT8N69O+,+F=76+YJQ(BWV@OAGY@ROVK\']F]Z*%?) M0,%6>K=WK:AA]B"OVKGP6O_1%]P-R`29N^O.]85M%R>2SA=ZF5[T#@M/\[MO MO6LN!%\0H<,PS41L(L#BSE^S9U"R5GZQ5HF$F2"3BQ-]P5TCN3#L#^`X?9X' M"8FB2N=RM9*#M"#Y-X2#X*1YO);GW5C"<&`H,/PZ%?-&[`[PF`0E30;:`I-O MM80W8NUZ-2]A-+`4&)T]OZK(]B_-[&5W\)2_#.\+F`XC*<0*+^G;<&,FBB[E MO.6>$>1@T4^-A*^A7^F[0\]:I\_2CU6LHL&JI*MID/!5U.-!OJL)@VW6G3G6*^)*'QDK(#HH47)Y:3I,L8_K46(FIKLO: MC:REU$AX](^],E^_V[54[BF3^;47(NQ;8DMID&&+?^\%!^O2V5)*K+BBGXV5 M@.HJK-UA6TJ!A$?_V"_SM=MPR^6>,)E?&_*/[\0U"ERMAP@G"8VE6\UR<*!'J MCHZ^7/L<.D"4^R/#Z(K?E_R.*A!`Y8P^3/YS2^=ZLZ7EOY+TQ^32@I-#[_`SG8?S`7FD M$A[[)NOV1$41R(!HFMY$KS8QY.#0ON`1+0[:<_W)E=E">:DP3X:6\SQ7"X[8H)7ML%7YS/@%%XX M-J58UIK\R?X;+%H1Y6"FDO<_KA&[)A,"PQ0_=QS+@'B$/J[Y:2OE&VC6$AL> M&,&"$3_UT`TALL#6#70O9JEGVJ8#F],]2N3_".KV",)^(+X(^+-&`_X=+EIYV*!NRKS'I5/BW:< M]X6>]_H5].JQM3%$2?J]Z]_*R!>L@-ECV`L-2X]F_\;%=_@'_46J]+&*_PFC MVQ?S);._M+=7;N[3ZTT]Z#PO]':<:`)T4XE5E_-R977`SQGWS-XE:!(Z8)-: MYM8I1AIF2Z04^1'U'?5-HXM8XR&?J"Y5OAU.K#97;S#)[S8'%O92GE< M0-Z@[#>J9H5M"]JA,"[5.O8D5<$DW;&=M*T&V,%/LDU$ULI8Z>"1Q<1Z8\#9%;7/G2`/+I(I@)[$[OQUC/-;7G% M`[VQ0>!@@]4[23JF4@&Y(IK"NL&>/@)B"5UIJCN(/0;=;%,Y1T]\-..AQ$R? MDCZDSXH09E7J_44=4Q.@ZZR^F\+7^QSD-T&5(JPWF<2#RXS=6RF/R-T#+2H] MB5Q<83GKLDG`G^2(ZX=>J,Q36WV;46]64*)*IAX@]4< M;"(XIDH^(F)^R[&M_'K"42F]ZO-),V.5^R07IKZ%"<:1P#ZYUTL'K]/PQL0. MS[K)CLI/J:;9B(W3I&+"8S+J@7GPN9MR0?]'_((Y@0WI1S0)\,"D/@6'^`/R MR(/'>*$+]%\-E"WGE",_+A?%&F]LW392')L9>BCEIQWI0CN*27Z@(5^:T7IF M^/E_4$L!`AX#%`````@`6W.*1]',X.BRR0``OFL)`!$`&````````0```*2! M`````'!D8V\M,C`Q-3$P,S$N>&UL550%``/^T6E6=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`6W.*1U\D#U@C%@``V5@!`!4`&````````0```*2!_`Q0````(`%MSBD=WM)3F.A\``*S\`0`5`!@```````$```"D@6_@ M``!P9&-O+3(P,34Q,#,Q7V1E9BYX;6Q55`4``_[1:59U>`L``00E#@``!#D! M``!02P$"'@,4````"`!;&UL550%``/^T6E6=7@+``$$)0X```0Y M`0``4$L!`AX#%`````@`6W.*1V?%UV9/-0``0>4#`!4`&````````0```*2! M]&0!`'!D8V\M,C`Q-3$P,S%?<')E+GAM;%54!0`#_M%I5G5X"P`!!"4.```$ M.0$``%!+`0(>`Q0````(`%MSBD=2?PGEIA```-VH```1`!@```````$```"D M@9*:`0!P9&-O+3(P,34Q,#,Q+GAS9%54!0`#_M%I5G5X"P`!!"4.```$.0$` 7`%!+!08`````!@`&`!H"``"#JP$````` ` end XML 60 R49.htm IDEA: XBRL DOCUMENT v3.3.1.900
Accumulated Other Comprehensive Loss - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Oct. 31, 2015
Oct. 25, 2014
Oct. 31, 2015
Oct. 25, 2014
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Gains and losses on cash flow hedges, tax $ 265 $ (2,321) $ 350 $ (7,134)
Amounts reclassified from AOCL     12,137  
Increase in interest expense     1,405  
Currency Translation Adjustment [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Amounts reclassified from AOCL     $ 11,083  

XML 61 R41.htm IDEA: XBRL DOCUMENT v3.3.1.900
Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($)
$ in Thousands
Oct. 31, 2015
Apr. 25, 2015
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash equivalents $ 4,949 $ 90,569
Derivative instruments, assets 835 1,255
Total assets 5,784 91,824
Derivative instruments, liabilities 835 1,255
Fair Value, Inputs, Level 1 [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash equivalents 4,949 90,569
Total assets 4,949 90,569
Fair Value, Inputs, Level 2 [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Derivative instruments, assets 835 1,255
Total assets 835 1,255
Derivative instruments, liabilities $ 835 $ 1,255
XML 62 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
General
6 Months Ended
Oct. 31, 2015
Accounting Policies [Abstract]  
General

Note 1. General

Basis of Presentation

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of Patterson Companies, Inc. (“Patterson”) as of October 31, 2015, and our results of operations and cash flows for the periods ended October 31, 2015 and October 25, 2014. Such adjustments are of a normal recurring nature. The results of operations for the periods ended October 31, 2015 and October 25, 2014 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the financial statements included in our 2015 Annual Report on Form 10-K filed on June 24, 2015.

Such unaudited condensed consolidated financial statements include the assets and liabilities of PDC Funding Company, LLC (“PDC Funding”) and PDC Funding Company II, LLC (“PDC Funding II”), wholly owned subsidiaries and separate legal entities under Minnesota law. PDC Funding and PDC Funding II are fully consolidated special purpose entities established to sell customer installment sale contracts to outside financial institutions in the normal course of their business. The assets of PDC Funding and PDC Funding II would be available first and foremost to satisfy the claims of its creditors. There are no known creditors of PDC Funding or PDC Funding II.

Through fiscal 2015, Patterson was comprised of three reportable segments: dental supply, veterinary supply and rehabilitation supply. This fiscal year, we reorganized our reportable segments as a result of our acquisition of Animal Health International, Inc. and our divestiture of our wholly-owned subsidiary Patterson Medical Holdings, Inc., the entity through which we operated the rehabilitation supply business. We now present three different reportable segments: Dental, Animal Health and Corporate. Prior period segment results have been restated to conform to this revised current period presentation.

Fiscal Year End

We operate with a 52-53 week accounting convention with our fiscal year ending on the last Saturday in April. The second quarters of fiscal 2016 and 2015 include the 13 weeks ended October 31, 2015 and October 25, 2014, respectively. The six months ended October 31, 2015 and October 25, 2014 include 27 and 26 weeks, respectively. Fiscal 2016 will include 53 weeks and fiscal 2015 included 52 weeks of operations.

Comprehensive Income

Comprehensive income is computed as net income including certain other items that are recorded directly to stockholders’ equity. Significant items included in comprehensive income are foreign currency translation adjustments and the effective portion of cash flow hedges, net of tax. Foreign currency translation adjustments do not include a provision for income tax on earnings from foreign operations that are considered to be indefinitely reinvested outside the U.S. The income tax benefit/(loss) related to cash flow hedges was $(265) and $2,321 for the three months ended October 31, 2015 and October 25, 2014, respectively. The income tax benefit/(loss) related to cash flow hedges was $(350) and $7,134 for the six months ended October 31, 2015 and October 25, 2014, respectively.

 

Earnings Per Share

The following table sets forth the computation of the weighted average shares outstanding used to calculate basic and diluted earnings per share (“EPS”):

 

     Three Months Ended      Six Months Ended  
     October 31,      October 25,      October 31,      October 25,  
     2015      2014      2015      2014  

Denominator for basic EPS – weighted average shares

     98,525         98,802         98,981         99,066   

Effect of dilutive securities

     660         574         693         713   
  

 

 

    

 

 

    

 

 

    

 

 

 

Denominator for diluted EPS – weighted average shares

     99,185         99,376         99,674         99,779   
  

 

 

    

 

 

    

 

 

    

 

 

 

Potentially dilutive securities consisting of stock options, restricted stock and stock purchase plans representing 899 shares for the three and six months ended October 31, 2015 and 124 shares for the three and six months ended October 25, 2014 were excluded from the calculation of diluted earnings per share because their effect would have been anti-dilutive.

Recently Issued Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU No. 2014-09 supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605),” and requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In July 2015, the FASB deferred the effective date of this pronouncement by one year to December 15, 2017 for interim and annual reporting periods beginning after that date. Early adoption is permitted, but not before the original effective date, which for annual periods was December 15, 2016. We are evaluating the new standard, but do not, at this time, anticipate a material impact to our financial statements once implemented.

In July 2015, the FASB issued ASU No. 2015-11, “Inventory (Topic 330), Simplifying the Measurement of Inventory.” ASU 2015-11 requires inventory measured using any method other than last-in, first-out (LIFO) or the retail inventory method to be subsequently measured at the lower of cost or net realizable value, rather than at the lower of cost or market. Subsequent measurement of inventory using the LIFO and retail inventory method is unchanged. We are required to adopt the new pronouncement in the first quarter of fiscal 2018, and plan to do so at that time. Early adoption is permitted. We are evaluating the effect of adopting this pronouncement, but do not, at this time, anticipate a material impact to our financial statements once implemented.

In August 2015, the FASB issued ASU No. 2015-15, “Interest – Imputation of Interest (Subtopic 835-30), Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements.” This ASU states that ASU No. 2015-03, “Interest – Imputation of Interest (Subtopic 835-30), Simplifying the Presentation of Debt Issuance Costs” does not address debt issuance costs for line-of-credit arrangements, and therefore the SEC staff would not object to an entity deferring and presenting these related debt issuance costs as an asset and subsequently amortizing the deferred issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. At this time, we do not believe that ASU No. 2015-15 will have a material impact on our financial statements and related disclosures.

In September 2015, the FASB issued ASU No. 2015-16, “Business Combinations (Topic 805), Simplifying the Accounting for Measurement-Period Adjustments.” This ASU requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. The amendments in this ASU require an entity to present separately on the face of the income statement or disclose in the notes the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. We are required to adopt the new pronouncement in the first quarter of fiscal 2017, with early adoption permitted. We are evaluating the effect and timing of adopting this pronouncement, but do not, at this time, anticipate a material impact to the financial statements once implemented.

In November 2015, the FASB issued ASU No. 2015-17, “Income Taxes (Topic 740), Balance Sheet Classification of Income Taxes.” This ASU eliminates the current requirement for an entity to separate deferred income tax liabilities and assets into current and noncurrent amounts in a classified statement of financial position. This ASU requires that deferred tax liabilities and assets be classified as noncurrent in the classified statement of financial position. We are required to adopt the ASU in the first quarter of fiscal 2018, with early adoption permitted. We are evaluating the effect and timing of adopting this pronouncement, but do not, at this time, anticipate a material impact to the financial statements once implemented.

 

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year presentation.

XML 63 R10.htm IDEA: XBRL DOCUMENT v3.3.1.900
Fair Value Measurements
6 Months Ended
Oct. 31, 2015
Fair Value Disclosures [Abstract]  
Fair Value Measurements

Note 6. Fair Value Measurements

Fair value is the price at which an asset could be exchanged in a current transaction between knowledgeable, willing parties. The fair value hierarchy of measurements is categorized into one of three levels based on the lowest level of significant input used:

 

  Level 1 - Quoted prices in active markets for identical assets and liabilities at the measurement date.

 

  Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

 

  Level 3 - Unobservable inputs for which there is little or no market data available. These inputs reflect management’s assumptions of what market participants would use in pricing the asset or liability.

 

Our hierarchy for assets and liabilities measured at fair value on a recurring basis is as follows:

 

     October 31, 2015  
     Total      Level 1      Level 2      Level 3  

Assets:

           

Cash equivalents

   $ 4,949       $ 4,949       $ —         $ —     

Derivative instruments

     835         —           835         —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

   $ 5,784       $ 4,949       $ 835       $ —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities:

           
  

 

 

    

 

 

    

 

 

    

 

 

 

Derivative instruments

   $ 835       $ —         $ 835       $ —     
  

 

 

    

 

 

    

 

 

    

 

 

 
     April 25, 2015  
     Total      Level 1      Level 2      Level 3  

Assets:

           

Cash equivalents

   $ 90,569       $ 90,569       $ —         $ —     

Derivative instruments

     1,255         —           1,255         —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

   $ 91,824       $ 90,569       $ 1,255       $ —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities:

           
  

 

 

    

 

 

    

 

 

    

 

 

 

Derivative instruments

   $ 1,255       $ —         $ 1,255       $ —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Cash equivalents – We value cash equivalents at their current market rates. The carrying value of cash equivalents approximates fair value and maturities are less than three months.

Derivative instruments – Our derivative instruments consist of interest rate contracts. These instruments are valued using observable inputs such as interest rates and credit spreads.

Certain assets are measured at fair value on a non-recurring basis. These assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments under certain circumstances, such as when there is evidence of impairment. There were no fair value adjustments to such assets during the six-month periods ended October 31, 2015 or October 25, 2014.

Our debt is not measured at fair value in the condensed consolidated balance sheets. The estimated fair value of our debt as of October 31, 2015 and April 25, 2015 was $1,058,425 and $746,685, respectively. The fair value of debt was measured using a discounted cash flow analysis based on expected market based yields (i.e. level 2 inputs).

The carrying amounts of receivables, net of allowances, accounts payable, and certain accrued and other current liabilities approximated fair value at October 31, 2015 and April 25, 2015.

XML 64 R27.htm IDEA: XBRL DOCUMENT v3.3.1.900
General - Additional Information (Detail)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Oct. 31, 2015
USD ($)
shares
Oct. 25, 2014
USD ($)
shares
Oct. 31, 2015
USD ($)
Segment
shares
Oct. 25, 2014
USD ($)
shares
Apr. 25, 2015
Segment
Accounting Policies [Abstract]          
Number of reportable segments | Segment     3   3
Income tax benefit/(loss) related to cash flow hedges | $ $ (265) $ 2,321 $ (350) $ 7,134  
Securities excluded from calculation of diluted earnings per share | shares 899 124 899 124  
XML 65 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.1.900 html 113 233 1 false 38 0 false 9 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.pattersoncompanies.com/taxonomy/role/DocumentandEntityInformation Document and Entity Information Cover 1 false false R2.htm 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.pattersoncompanies.com/taxonomy/role/StatementOfFinancialPositionClassified CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME (Unaudited) Sheet http://www.pattersoncompanies.com/taxonomy/role/StatementOfIncome CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME (Unaudited) Statements 3 false false R4.htm 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://www.pattersoncompanies.com/taxonomy/role/StatementOfCashFlowsIndirect CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 4 false false R5.htm 106 - Disclosure - General Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock General Notes 5 false false R6.htm 107 - Disclosure - Acquisitions Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsBusinessCombinationDisclosureTextBlock Acquisitions Notes 6 false false R7.htm 108 - Disclosure - Discontinued Operations Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsDisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock Discontinued Operations Notes 7 false false R8.htm 109 - Disclosure - Goodwill and Other Intangible Assets Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlock Goodwill and Other Intangible Assets Notes 8 false false R9.htm 110 - Disclosure - Derivative Financial Instruments Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock Derivative Financial Instruments Notes 9 false false R10.htm 111 - Disclosure - Fair Value Measurements Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock Fair Value Measurements Notes 10 false false R11.htm 112 - Disclosure - Securities Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock Securities Notes 11 false false R12.htm 113 - Disclosure - Customer Financing Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsCustomerFinancingTextBlock Customer Financing Notes 12 false false R13.htm 114 - Disclosure - Segment Reporting Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock Segment Reporting Notes 13 false false R14.htm 115 - Disclosure - Accumulated Other Comprehensive Loss Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsComprehensiveIncomeNoteTextBlock Accumulated Other Comprehensive Loss Notes 14 false false R15.htm 116 - Disclosure - Debt Issuance Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock Debt Issuance Notes 15 false false R16.htm 117 - Disclosure - Income Taxes Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock Income Taxes Notes 16 false false R17.htm 118 - Disclosure - Legal Proceedings Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsLegalMattersAndContingenciesTextBlock Legal Proceedings Notes 17 false false R18.htm 119 - Disclosure - General (Policies) Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlockPolicies General (Policies) Policies 18 false false R19.htm 120 - Disclosure - General (Tables) Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlockTables General (Tables) Tables http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock 19 false false R20.htm 121 - Disclosure - Acquisitions (Tables) Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsBusinessCombinationDisclosureTextBlockTables Acquisitions (Tables) Tables http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsBusinessCombinationDisclosureTextBlock 20 false false R21.htm 122 - Disclosure - Discontinued Operations (Tables) Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsDisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlockTables Discontinued Operations (Tables) Tables http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsDisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock 21 false false R22.htm 123 - Disclosure - Goodwill and Other Intangible Assets (Tables) Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlockTables Goodwill and Other Intangible Assets (Tables) Tables http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlock 22 false false R23.htm 124 - Disclosure - Derivative Financial Instruments (Tables) Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlockTables Derivative Financial Instruments (Tables) Tables http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock 23 false false R24.htm 125 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables Fair Value Measurements (Tables) Tables http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock 24 false false R25.htm 126 - Disclosure - Segment Reporting (Tables) Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlockTables Segment Reporting (Tables) Tables http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock 25 false false R26.htm 127 - Disclosure - Accumulated Other Comprehensive Loss (Tables) Sheet http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsComprehensiveIncomeNoteTextBlockTables Accumulated Other Comprehensive Loss (Tables) Tables http://www.pattersoncompanies.com/taxonomy/role/NotesToFinancialStatementsComprehensiveIncomeNoteTextBlock 26 false false R27.htm 128 - Disclosure - General - Additional Information (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureGeneralAdditionalInformation General - Additional Information (Detail) Details 27 false false R28.htm 129 - Disclosure - General - Computation of Basic and Diluted Earnings Per Share (EPS) (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureGeneralComputationOfBasicAndDilutedEarningsPerShareEPS General - Computation of Basic and Diluted Earnings Per Share (EPS) (Detail) Details 28 false false R29.htm 130 - Disclosure - Acquisitions - Additional Information (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureAcquisitionsAdditionalInformation Acquisitions - Additional Information (Detail) Details 29 false false R30.htm 131 - Disclosure - Acquisitions - Summary of Total Purchase Price Consideration and Preliminary Fair Value of Assets Acquired and Liabilities Assumed (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureAcquisitionsSummaryOfTotalPurchasePriceConsiderationAndPreliminaryFairValueOfAssetsAcquiredAndLiabilitiesAssumed Acquisitions - Summary of Total Purchase Price Consideration and Preliminary Fair Value of Assets Acquired and Liabilities Assumed (Detail) Details 30 false false R31.htm 132 - Disclosure - Acquisitions - Summary of Acquired Intangible Assets Excluding Goodwill (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureAcquisitionsSummaryOfAcquiredIntangibleAssetsExcludingGoodwill Acquisitions - Summary of Acquired Intangible Assets Excluding Goodwill (Detail) Details 31 false false R32.htm 133 - Disclosure - Acquisitions - Summary of Unaudited Pro Forma Financial Result (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureAcquisitionsSummaryOfUnauditedProFormaFinancialResult Acquisitions - Summary of Unaudited Pro Forma Financial Result (Detail) Details 32 false false R33.htm 134 - Disclosure - Discontinued Operations - Additional Information (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformation Discontinued Operations - Additional Information (Detail) Details 33 false false R34.htm 135 - Disclosure - Discontinued Operations - Summary of Assets and Liabilities Held For Sale (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesHeldForSale Discontinued Operations - Summary of Assets and Liabilities Held For Sale (Detail) Details 34 false false R35.htm 136 - Disclosure - Discontinued Operations - Summary of Results of Operations Under Discontinued Operation Activities (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfResultsOfOperationsUnderDiscontinuedOperationActivities Discontinued Operations - Summary of Results of Operations Under Discontinued Operation Activities (Detail) Details 35 false false R36.htm 137 - Disclosure - Goodwill and Other Intangible Assets - Goodwill Balances and Related Activity by Business Segment (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetsGoodwillBalancesAndRelatedActivityByBusinessSegment Goodwill and Other Intangible Assets - Goodwill Balances and Related Activity by Business Segment (Detail) Details 36 false false R37.htm 138 - Disclosure - Goodwill and Other Intangible Assets - Balances of Other Intangible Assets Excluding Goodwill (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetsBalancesOfOtherIntangibleAssetsExcludingGoodwill Goodwill and Other Intangible Assets - Balances of Other Intangible Assets Excluding Goodwill (Detail) Details 37 false false R38.htm 139 - Disclosure - Derivative Financial Instruments - Additional Information (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureDerivativeFinancialInstrumentsAdditionalInformation Derivative Financial Instruments - Additional Information (Detail) Details 38 false false R39.htm 140 - Disclosure - Derivative Financial Instruments - Fair Value of Interest Rate Contracts Included in Condensed Consolidated Balance Sheets (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureDerivativeFinancialInstrumentsFairValueOfInterestRateContractsIncludedInCondensedConsolidatedBalanceSheets Derivative Financial Instruments - Fair Value of Interest Rate Contracts Included in Condensed Consolidated Balance Sheets (Detail) Details 39 false false R40.htm 141 - Disclosure - Derivative Financial Instruments - Effect of Interest Rate Contracts on Condensed Consolidated Statements of Income and Other Comprehensive Income (OCI) (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureDerivativeFinancialInstrumentsEffectOfInterestRateContractsOnCondensedConsolidatedStatementsOfIncomeAndOtherComprehensiveIncomeOCI Derivative Financial Instruments - Effect of Interest Rate Contracts on Condensed Consolidated Statements of Income and Other Comprehensive Income (OCI) (Detail) Details 40 false false R41.htm 142 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureFairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Details 41 false false R42.htm 143 - Disclosure - Fair Value Measurements - Additional Information (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformation Fair Value Measurements - Additional Information (Detail) Details 42 false false R43.htm 144 - Disclosure - Securities - Additional Information (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureSecuritiesAdditionalInformation Securities - Additional Information (Detail) Details 43 false false R44.htm 145 - Disclosure - Customer Financing - Additional Information (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureCustomerFinancingAdditionalInformation Customer Financing - Additional Information (Detail) Details 44 false false R45.htm 146 - Disclosure - Segment Reporting - Additional Information (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureSegmentReportingAdditionalInformation Segment Reporting - Additional Information (Detail) Details 45 false false R46.htm 147 - Disclosure - Segment Reporting - Information about Reportable Segments (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureSegmentReportingInformationAboutReportableSegments Segment Reporting - Information about Reportable Segments (Detail) Details 46 false false R47.htm 148 - Disclosure - Segment Reporting - Sales Information by Product (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureSegmentReportingSalesInformationByProduct Segment Reporting - Sales Information by Product (Detail) Details 47 false false R48.htm 149 - Disclosure - Accumulated Other Comprehensive Loss - Summary of Accumulated Other Comprehensive Loss (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveLoss Accumulated Other Comprehensive Loss - Summary of Accumulated Other Comprehensive Loss (Detail) Details 48 false false R49.htm 150 - Disclosure - Accumulated Other Comprehensive Loss - Additional Information (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureAccumulatedOtherComprehensiveLossAdditionalInformation Accumulated Other Comprehensive Loss - Additional Information (Detail) Details 49 false false R50.htm 151 - Disclosure - Debt Issuance - Additional Information (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureDebtIssuanceAdditionalInformation Debt Issuance - Additional Information (Detail) Details 50 false false R51.htm 152 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.pattersoncompanies.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation Income Taxes - Additional Information (Detail) Details 51 false false All Reports Book All Reports pdco-20151031.xml pdco-20151031.xsd pdco-20151031_cal.xml pdco-20151031_def.xml pdco-20151031_lab.xml pdco-20151031_pre.xml true true XML 66 R38.htm IDEA: XBRL DOCUMENT v3.3.1.900
Derivative Financial Instruments - Additional Information (Detail)
1 Months Ended 3 Months Ended 6 Months Ended
Aug. 31, 2015
USD ($)
Mar. 31, 2015
USD ($)
Jan. 31, 2014
USD ($)
May. 31, 2012
Oct. 31, 2015
USD ($)
Oct. 25, 2014
USD ($)
Oct. 31, 2015
USD ($)
Derivative
Oct. 25, 2014
USD ($)
Apr. 26, 2014
USD ($)
Derivative [Line Items]                  
Interest expense         $ 17,154,000 $ 8,544,000 $ 29,297,000 $ 17,312,000  
Long-term Debt [Member]                  
Derivative [Line Items]                  
Period of long-term loan             10 years    
Long-term loan         250,000,000   $ 250,000,000    
Interest Rate Cap [Member]                  
Derivative [Line Items]                  
Notional amount of derivatives         500,000,000   $ 500,000,000    
Maturity date             2022-02    
Number of interest rate caps purchased by PDC Funding | Derivative             1    
Number of interest rate caps sold | Derivative             1    
Replacement Interest Rate Cap Agreement [Member]                  
Derivative [Line Items]                  
Notional amount of derivatives $ 100,000,000               $ 100,000,000
Maturity date 2023-07                
Interest Rate Swap [Member]                  
Derivative [Line Items]                  
Interest expense         $ 703,000 $ 49,000 $ 1,405,000 $ 97,000  
Interest Rate Swap Agreement with Bank [Member]                  
Derivative [Line Items]                  
Maturity date       2015-04          
Interest Rate Swap Agreement [Member]                  
Derivative [Line Items]                  
Notional amount of derivatives     $ 250,000,000            
Percentage of senior notes     5.17%            
Senior notes amount due     $ 250,000,000            
Settlement of swap   $ 29,003,000              
Interest Rate Swap Agreement [Member] | Senior Notes 3.48% [Member]                  
Derivative [Line Items]                  
Percentage of senior notes         3.48%   3.48%    
Period of long-term loan             10 years    
Maturity date of long-term loan             Mar. 24, 2025    
Aggregate principal amount         $ 250,000,000   $ 250,000,000    
Interest Rate Swap Agreement [Member] | 5.17% Senior Notes [Member]                  
Derivative [Line Items]                  
Maturity date of long-term loan     Mar. 25, 2015            
XML 67 R20.htm IDEA: XBRL DOCUMENT v3.3.1.900
Acquisitions (Tables)
6 Months Ended
Oct. 31, 2015
Business Combinations [Abstract]  
Summary of Total Purchase Price Consideration and Preliminary Fair Value of Assets Acquired and Liabilities Assumed

The following table summarizes the total purchase price consideration and the preliminary fair value amounts recognized for the assets acquired and liabilities assumed related to the acquisition, as of the acquisition date:

 

Total purchase price consideration

   $ 1,108,203   
  

 

 

 

Receivables

   $ 161,427   

Inventory

     195,367   

Prepaid expenses and other current assets

     33,005   

Property and equipment

     44,178   

Identifiable intangibles

     434,300   

Other long-term assets

     40,869   
  

 

 

 

Total assets acquired

     909,146   
  

 

 

 

Accounts payable

     122,129   

Accrued liabilities and other current liabilities

     19,395   

Deferred tax liability

     177,789   
  

 

 

 

Total liabilities assumed

     319,313   
  

 

 

 

Identifiable net assets acquired

     589,833   

Goodwill

     518,370   
  

 

 

 

Net assets acquired

   $ 1,108,203   
  

 

 

 

 

Summary of Acquired Intangible Assets Excluding Goodwill

The following summarizes the intangible assets, excluding goodwill, acquired as of June 16, 2015. Intangible assets are amortized using methods that approximate the pattern of economic benefit provided by the utilization of the assets.

 

     Gross Carrying
Value
     Weighted
Average Life
(years)
 

Unamortized – indefinite lived:

     

Trade names

   $ 12,300         indefinite   

Amortized:

     

Customer relationships

     291,900         15.0   

Trade names

     111,400         10.0   

Developed technology and other

     18,700         12.2   
  

 

 

    

Total amortized intangible assets

     422,000         13.6   
  

 

 

    

Total identifiable intangible assets

   $ 434,300      
  

 

 

    
Summary of Unaudited Pro Forma Financial Result

The unaudited pro forma financial results may not be indicative of the results that would have occurred had the acquisition been completed as of April 27, 2014, nor are they indicative of future results of operations.

 

     Six Months Ended  
     October 31,      October 25,  
     2015      2014  

Pro forma net sales

   $ 2,725,116       $ 2,650,613   

Pro forma net income from continuing operations

     70,957         74,754